INDEX
Page
references
in
bold
face
refer
to
a
major
discussion
of
the
entry.
Positional
and
configurational
designations
in
chemical
names
(e.g.,
3-,

,
N-,
p-,
trans,
D
-,
sn-)
are
ignored
in
alphabetizing.
Numbers
and
Greek
letters
are
otherwise
alphabetical
as
if
they
were
spelled
out.
Note:
Chapters
33–35,
which
are
only
available
on
our
book
companion
website,
www.wiley.com/college/voet,
are
separately
indexed
at
this
website.
A
A77,
1116
AAA

domain,
1184–1185
AAA

family
of
ATPases,
1197,
1206
AAA

proteins,
1197–1198
AADP

(3-aminopyridine
adenine
dinucleotide
phosphate),
1125
A
antigen,
415
aaRSs,
see
Aminoacyl-tRNA
synthetase
Abasic
sites,
1218
Abbé
refractometer,
156
AB
blood
type,
22
ABCA1
(ATP-cassette
binding
protein
A1),
458
ABC
transporters,
766–768,
767F
Abe
(abequose),
379F
Abelson,
J.,
1312,
1351
Abequose
(Abe),
379F
A
(amyloid-
protein),
311–312
A
precursor
protein
(PP),
311–312
Ab
initio
methods,
305
Abl,
708
A
blood
type,
22
ABO
blood
group
system,
22,
414–415
Abortive
initiation,
1267–1268
Abrin,
1395T
Absolute
configuration,
74–75
Absolute
rate
theory,
484–487
Absorbance:
in
Beer–Lambert
law,
90
of
DNA
and
nucleic
acids,
90,
92,
92F
Absorbance
spectrum,
92
AC,
see
Adenylate
cyclase
ac
4
C
(N
4
-acetylcytidine),
1347F
ACAT,
see
Acyl-CoA:cholesterol
acyltransferase
ACC
(acetyl-CoA
carboxylase),
962–964
Accepted
names,
enzymes,
479
Acceptor,
tRNA,
1346
Acceptor
control,
862
Accessory
pigments,
908–909
Accessory
proteins:
G
proteins,
692
GroEL/ES
system,
294–302
peptidyl
prolyl
cis-trans
isomerases,
292
protein
disulfide
isomerases,
290–292,
290F,
291F
Accommodation,
1388
ACE
(angiotensin
converting
enzyme),
547F
ACE
inhibitors,
547F
Acetal,
520F
Acetaldehyde,
re
and
si
faces,
77F
Acetaminophen,
544–545,
544F,
1000
Acetate,
as
cholesterol
precursor,
975F,
976–977
Acetate
ion,
45,
45T,
48F
Acetic
acid:
creation
in
Miller-Urey
experiments,
32T
distribution
curve,
48,
48F
titration
curve,
47,
47F
Acetimidoquinine,
544–545,
544F
Acetoacetate,
959,
960F
decarboxylation,
510–511
and
degradation
of
leucine/lysine,
1040–1041
and
degradation
of
phenylalanine/tyrosine,
1043–1047
degradation
of
tryptophan,
1041–1042
Acetoacetyl-CoA,
960
-Aceto--hyroxybutyrate,
1075
Acetolactate,
1075
Acetone,
959
and
cell
wall
lysis,
130
dielectric
constant
and
dipole
moment,
43T
protein
solubility
in,
134
Acetonel,
679F
Acetonyl-CoA,
806–807
Acetylcholine
(ACh),
527,
778–780
Acetylcholine
receptor
(AChR),
780–781,
780F
Acetylcholinesterase,
781–782,
782F
diffusion-limited,
490,
491
inactivation
by
DIPF,
527
Michaelis–Menten
kinetic
constants,
489T
Acetyl-CoA,
561,
561F
in
citric
acid
cycle,
789,
792–796,
792F,
795F,
816–819
and
degradation
of
leucine/lysine,
1040–1041
and
integration
of
pathways,
1090
in
ketogenesis,
960–961,
960F
pyruvate
carboxylase
regulation,
873–874
Acetyl-CoA
acetyltransferase,
960–961
Acetyl-CoA
carboxylase
(ACC),
962–964
Acetyl-coenzyme
A,
see
Acetyl-CoA
N
4
-Acetylcytidine
(ac
4
C),
1347F
N-Acetyl-
D
-galactosamine,
392F
Acetyl-dihydrolipamide-E2,
795
N-Acetylglucosamine,
see
NAG
N-Acetylglutamate,
1025,
1029,
1070F,
1071
N-Acetylglutamate-5-semialdehyde,
1070F,
1071
N-Acetylglutamate
synthase,
1029,
1070F,
1071
N-Acetylimidazolium,
513
ε-N-Acetyllysine,
79F
N-Acetylmuramic
acid,
see
NAM
N-Acetylneuraminic
acid,
see
NANA
N-Acetylneuraminidate,
392F
Acetyl
phosphate,
580,
607
Acetylsalicylic
acid,
998
N-Acetylserine,
79F
O-Acetylserine,
1071
Acetyl
transferase
(AT),
967,
968
N-Acetylxylosamine
(XylNAc)
residue,
523
ACh,
see
Acetylcholine
AChR,
see
Acetylcholine
receptor
Acids,
45
dissociation
constants,
45–47,
46T
polyprotic,
48–50,
49F
Acid-base
buffers,
48
Acid-base
catalysis,
506–510
Acid-base
indicators,
51
Acid-base
reactions,
45–47
and
amino
acids,
72–73
for
protein
assays,
131
and
standard
state
conventions,
60
Acid
chain
hypothesis,
446
Acidic
solutions,
47
Acidosis,
955
Ackee
fruit,
948
Ackers,
G.,
353
Aconitase,
789,
790F,
808–809,
808F
cis-Aconitate,
789
ACP
(acyl-carrier
protein),
961
ACP
synthase,
961
Acquired
immune
deficiency
syndrome,
see
AIDS
Acridine
orange,
157
Acromegaly,
685
Acrosomal
protease,
525T
Acrylamide,
147,
147F
ACTH,
see
Adrenocorticotropic
hormone
Actin,
10,
10F,
301,
857
in
erythrocyte
membranes,
413F,
414
helical
symmetry,
269
Actinomycin
D,
79,
1272,
1272F
Action
potentials,
775–777,
775F,
776F
Activated
complex,
485
Activation
barrier,
486
Activators,
96,
351
Active,
rolling
mechanism
(DNA
unwinding),
1185–1186,
1186F
Active
transport,
420,
747
ATP-driven,
758–768
ion-driven,
768–771
Activity,
59–61
Activity
coefficient,
61
Acute
intermittent
porphyria,
1056
Acute
lymphoblastic
leukemia,
1034
Acute
pancreatitis,
537
Acyl-carnitine,
946
Acyl-carrier
protein
(ACP),
961
Acyl-CoA:cholesterol
acyltransferase
(ACAT),
455,
984
Acyl-CoA
dehydrogenase,
948F
I-1
I-2
Index
Acyl-CoA
dehydrogenase
(AD),
947,
948
Acyl-CoA
oxidase,
958
Acyl-CoA
synthases,
945–946
Acyl-dihydroxyacetone
phosphate,
971
1-Acyldihydroxyacetone
phosphate,
1007
Acyl-enzyme
intermediate,
533
2-Acylglycerol,
941
1-Acylglycerol-3-phosphate
acyltransferase,
971
Acyl
group
transfer,
565
Acyl
phosphates,
580
N-Acylsphingosine
phosphocholine,
1008
Acyltransferase
(AT),
968
AD,
see
Acyl-CoA
dehydrogenase;
Alzheimer’s
disease
ADA,
see
Adenosine
deaminase
ada
gene,
1216
Adair,
G.,
348
Adair
constants,
349
Adair
equation,
348–349
Ada
protein,
1216
Adapter
proteins,
see
APs
Adaptive
enzymes,
1261
Adaptor,
705–711,
709
Adaptor
hypothesis,
1345
ADAR1,
1150–1151,
1150F
and
RNA
editing,
1322–1323,
1323F
ADAR2:
and
RNA
editing,
1322,
1323F
Addison’s
disease,
681
Adducin,
412F–413F
Ade,
see
Adenine
Adenine,
18,
83,
83T.
See
also
Watson-Crick
base
pairs
and
genetic
code,
100T,
1343T
IR
spectra
of
derivatives,
1155F
modified
nucleosides
of,
1347F
and
point
mutations,
1339–1340
Adenine
phosphoribosyltransferase
(APRT),
1114
Adenohypophysis,
682
Adenosine,
83T,
578,
1130F
Adenosine-3¿,5¿-cyclic
monophosphate,
see
cAMP
Adenosine-5¿-(-amino)
diphosphate
(AMPPN),
763,
763F
Adenosine-5¿-(,-imido)
triphosphate,
see
AMPPNP
Adenosine-5¿-(,-methylene)
triphosphate
(AMPPCP),
763,
763F,
764
Adenosine-5¿-phosphosulfate,
183
Adenosine-5¿-phosphosulfate
(APS)
kinase,
1072
Adenosine
deaminase
(ADA),
1130F,
1131
Adenosine
diphosphate,
see
ADP
Adenosine
monophosphate,
see
AMP
Adenosine
triphosphate,
see
ATP
S-Adenosylhomocysteine,
1034
S-Adenosylmethionine,
see
SAM
Adenyl-3¿,5¿-uridyl-3,¿5¿-cytidyl-3,¿5¿-
guanylyl-3¿-phosphate,
84F
Adenylate
cyclase
(AC),
653,
697–698,
1286
Adenylate
kinase
(AK),
582
and
glycolysis
control
in
muscle,
627–628,
628F
X-ray
structure
of
porcine,
254,
255F
Adenylic
acid,
see
AMP
Adenylosuccinate,
1112
Adenylosuccinate
lyase
(PurB),
1109F,
1111,
1112
Adenylosuccinate
synthetase,
1112F
Adenyltransferase,
1069,
1071
ADH,
see
Alcohol
dehydrogenase;
Antidiuretic
hormone
Adhesins,
382
Adipocytes,
388–389,
388F,
1096,
1097F
Adiponectin,
1096,
1097F
Adiponectin
receptors,
1096
Adipose
tissue,
389
brown,
860
glucose
uptake
regulation
in,
751F
and
other
organs,
1091F,
1093
A-DNA,
1146F,
1147F,
1148–1149,
1148T,
1151
AdoCbl,
see
5¿-Deoxyadenosylcobalamin
AdoMet,
see
SAM
ADP
(adenosine
diphosphate),
17,
82
in
Calvin
cycle,
931
in
catabolism,
561,
561F
in
citric
acid
cycle,
816–817
in
glycolysis,
594F,
595
in
GroEL/ES
system,
295–302
RuvB
binding
of,
1231
and
thermodynamics
of
life,
578–583
ADP/ATP
carrier,
771
ADP-glucose,
645
ADP-glucose
pyrophosphorylase,
931
ADPNP,
see
AMPPNP
ADP-ribosylated
diphthalamide
residue,
eEF2,
1398
ADP-ribosylation,
1398
ADP-ribosylation
factor,
see
ARF1
Adrenal
glands,
672F
Adrenaline,
see
Epinephrine
-Adrenergic
receptors,
664,
680
Adrenocortical
steroids,
680
Adrenocorticotropic
hormone
(ACTH),
673T,
682–683
Adrenoleukodystrophy
(ALD),
767,
958
-Adrenoreceptors,
660,
680
Adriamycin,
1169
Adsorption
chromatography,
132T,
135,
143–144
Adult-onset
diabetes,
1102–1103
Aequorea
victoria,
120
Aerobes,
6.
See
also
specific
organisms
Aerobic
fermentation,
594F
Aerobic
metabolism,
864–865
Aerobic
oxidation,
594F
Affinity
chromatography,
132T
ion
exchange,
136
metal
chelation,
145
mRNA,
158
for
proteins,
118,
141–143,
141F
Affinity
labeling,
527
Aflatoxin
B
1
,
1225
AFM
(atomic
force
microscopy),
376
Africa,
sickle-cell
anemia
in,
188,
343
African
clawed
toad,
1202
African
sleeping
sickness,
799
Agard,
D.,
456
Agarose
gel
electrophoretogram,
106F
Agarose
gels:
in
affinity
chromatography,
142,
142F
in
gel
electrophoresis,
147–149
in
gel
filtration
chromatography,
139,
140T,
141
in
ion
exchange
chromatography,
137
AGC
family
of
protein
kinases,
730
A

gene,
1261–1262,
1264
a
gene
(fruit
fly),
25F
Agglutinin,
366
Aggrecan,
373–375,
373T,
374F
Aging,
telomere
length
and,
1210–1211
Aglycone,
366
AGO,
see
Argonaute
Agonist,
539,
680
Agouti
related
peptide
(AgRP),
1099
Agrin,
373T
Agrobacterium
radiobacter,
106F
AgRP
(agouti
related
peptide),
1099
AICAR,
see
5-Aminoimidazole-4-
carboxamide
ribotide
AICAR
transformylase
(PurH),
1109F,
1111
AIDS
(acquired
immune
deficiency
syndrome),
123,
545–546.
See
also
HIV
AIR,
see
5-Aminoimidazole
ribotide
AIR
carboxylase,
1109F,
1111
AIR
synthetase
(PurM),
1109F,
1110
AK,
see
Adenylate
kinase
AKAPs
(A-kinase
anchoring
proteins),
714
Akey,
C.,
424
A-kinase
anchoring
proteins
(AKAPs),
714
Akt,
see
Protein
kinase
B
Akt1/PKB,
734
Akt2/PKB,
734
Akt3/PKB,
734
Ala,
see
Alanine
ALA
(-aminoleuvulinic
acid),
1048
ALAD
(-aminoleuvulinic
acid
dehydratase),
1048
Alanine:
biosynthesis,
1067–1073
degradation
of,
1030–1034
and
degradation
of
tryptophan,
1041–1042
genetic
codes
for,
100T,
1343T
half-life,
1413T

helix/
sheet
propensity,
302T,
304
hydropathy
scale
for,
264T
in
Miller-Urey
experiments,
32T
in
native
unfolded
proteins,
283
nonessential
amino
acid,
1065T
nonpolar
side
chain,
70
Ramachandran
diagram,
224F,
225
structure
and
general
properties,
68T,
71F
(S)-Alanine,
76,
77F
-Alanine:
creation
in
Miller-Urey
experiments,
32T
in
pyrimidine
catabolism,
1136
L
-Alanine,
76,
77F
Alanine
tRNA,
176,
1345
AlaRS,
1351
ALAS-1,
1056
ALAS-2,
1056
ALA
synthase,
1056
Ala-tRNA
Cys
,
1359
Albumin,
154F,
542,
677.
See
also
Serum
albumin
Alcaptonuria,
569
Alcohols:
effect
on
protein
denaturation,
265
reactions
to
form
hemiacetals
and
hemiketals,
361F
Alcohol
dehydrogenase
(ADH),
479
in
fermentation,
618–619
and
methanol
oxidation,
505
molecular
mass
of,
140F
stereospecificity
of,
470–473
Alcoholic
fermentation,
470,
593–594,
616–619,
616F
Alcohol:NAD

oxidoreductase,
479
ALD,
see
Adrenoleukodystrophy
Aldehydes,
hemiacetal
formation
of,
361F
Aldehyde
dehydrogenase,
447F
Alditols,
364
Aldohexoses,
360F
Aldolase,
568
binding
to
erythrocyte
membrane,
412
in
glycolysis,
596F,
600–603,
600F,
602F
half-life,
1408T
molecular
mass
determination
by
gel
filtration
chromatography,
140F
sedimentation
coefficient,
154F
Aldol
condensation,
568
Aldol
histidine,
239F
Index
Aldonic
acids,
364
Aldopentoses,
360F
Aldoses,
360F,
361
Aldose-ketose
interconversion,
567,
567F
Aldosterone,
681
Aldotetroses,
360F
Aldotrioses,
360F
ALD
protein,
958
Aledronate,
679F
al
gene
(fruit
fly),
25F
Alignment
score
(AS),
196
Alkaptonuria,
25–26,
1045–1047
1-Alkyl-2-acyl-
sn-glycerophosphoethanolamine,
1007,
1007F
Alkylacylglycerophospholipids,
574,
1005,
1007–1008
O
6
-Alkylguanine-DNA
alkyltransferase,
1216
O
6
-Alkylguanine
residues,
1215,
1216
1-Alkyl-sn-glycerol-3-phosphate,
1007
Allantoic
acid,
1134
Allantoin,
1134
Allantoinase,
1135F
Alleles,
21
Allison,
A.,
187
Allo
forms
(enantiomers),
75–76
Allolactose,
97,
117
1,6-Allolactose,
1261
Allopurinol,
1135
D
-Allose,
360F
Allosteric
control:
ATCase
activity,
476–479
gluconeogenesis,
878–879,
879F,
879T
glycogen
phosphorylase
and
glycogen
synthase,
647–650
hemoglobin,
347–354
and
metabolic
flux,
620,
624
D
-allo-Threonine,
76,
76F
L
-allo-Threonine,
76,
76F
Allotransplantation,
121
Alloxanthine,
1135
Allysine,
238
Allysine
aldol,
239F

1
Adrenergic
receptors,
680

2
Adrenergic
receptors,
680
/
Barrels,
982

Motifs,
249–250,
249F
/
Barrels,
250,
252,
254,
300
/
Domains,
250,
300

Configuration,
of
nucleotides,
83

Domains,
249F

Helix,
226,
226F,
227F
globular
proteins,
246
helix
forms
vs.,
228F
physical
basis
of,
304
Ramachandran
diagram,
224F
and
space
filling,
281
-Ketoglutarate:ferredoxin
reductase,
815
-MSH
(-melanocyte
stimulating
hormone),
1099

Oxidation,
of
fatty
acids,
958–959,
959F

Particles,
572

Solenoid,
433
-Synuclein,
720
-Tocopherol,
866
Alternative
splicing,
1317–1318
Altman,
S.,
1330
D
-Altrose,
360F
Altschul,
S.,
201
AluI,
105T,
106,
109
Alumina,
144
Alzheimer¿s
disease
(AD),
309,
311–312,
458–459,
720
Amanita
phalloides
(death
cap),
1280
-Amanitin,
1280
amber
codon,
1343
amber
mutants,
half-lives
of,
1408
amber
suppressor,
1362
Ambros,
V.,
1326
Ames,
B.,
1224
Ames
test,
1224–1225,
1225F
Amethopterin,
492,
1129
Amido
black,
149F
Amidophosphoribosyl
transferase,
1108,
1109F,
1114
Amines,
biosynthesis
of,
1058–1062
-Amino
acids,
67,
67F,
70F
D
-Amino
acids,
73–75,
79
L
--Amino
acids,
75,
75F,
226
L
-Amino
acids,
73–75,
75F,
78
Amino
acids,
15,
67–80.
See
also
Protein
sequencing
acid-base
properties,
72
as
biosynthetic
precursors,
1047–1064
chemical
synthesis
of
polypeptides,
206–209
classification
and
characteristics,
70–71
conformation
angle
distribution,
224F
creation
in
Miller-Urey
experiments,
32T,
33
defined,
67
energy
recovery
by
citric
acid
cycle,
789
essential
and
nonessential,
1019,
1065T
genetic
code,
99,
100T,
1338–1345,
1343T
hydropathy
scale
for
side
chains,
264T
as
metabolic
fuels,
1095=4–1095
as
neurotransmitters,
782–783,
783F
nomenclature,
72–73
nonstandard,
78–80,
79F,
80F
optical
activity,
73–78
peptide
bonds,
70
and
phylogenetic
tree,
6
of
proteins,
67–73,
68T–69T
in
protein
synthesis,
98–100
racemization,
116
side
chains
as
covalent
catalysts,
511
transport
in
blood,
973
Amino
acid
biosynthesis:
alanine,
1067–1073
arginine,
1071
asparagine,
1067–1073
aspartate,
1067–1073
citric
acid
cycle
intermediates,
818
cysteine,
1071–1072
essential
amino
acids,
1072–1078
GCN2
regulates,
1400–1401
glutamate,
1065–1071
glutamine,
1067–1073
glycine,
1071–1072
histidine,
1078
integration
and
interrelationships
of,
1090
isoleucine,
1075
leucine,
1075
lysine,
1072–1073,
1075
methionine,
1072–1073,
1075
nonessential
amino
acids,
1064–1072
ornithine,
1071
phenylalanine,
1075–1078
proline,
1071
serine,
1071–1072
threonine,
1072–1073,
1075
tryptophan,
1075–1078
tyrosine,
1075–1078
valine,
1075
Amino
acid
deamination,
1019–1020
oxidative,
1023–1025
transamination,
1020–1023
Amino
acid
metabolism,
561F.
See
also
Urea
cycle
I-3
alanine,
cysteine,
glycine,
serine,
and
threonine
degradation,
1030–1034
amino
acids
as
metabolic
fuels,
1094–1095
arginine,
glutamate,
glutamine,
histidine,
and
proline
degradation,
1034
asparagine
and
aspartate
degradation,
1034
biosynthesis
of
psychologically
active
amines,
1058–1062
deamination
of
famino
acids,
1019–1025
glucogenic
and
ketogenic
amino
acids,
1029–1030
heme
biosynthesis,
1047–1058
heme
degradation,
1056
integration
and
interrelationships
with
other
pathways,
1090
isoleucine,
methionine,
and
valine
degradation,
1034–1039
leucine
and
lysine
degradation,
1040–1041
overview
of
common
metabolic
intermediates,
1029F
phenylalanine
and
tyrosine
degradation,
1043–1047
tryptophan
degradation,
1041–1042
and
urea
cycle,
1025–1029
D
-Amino
acid
oxidase,
1025
L
-Amino
acid
oxidase,
1025
Amino
acid
residues,
70,
188,
302T
Amino
acid
sequencing,
see
Protein
sequencing
Amino
acid
stem,
tRNA,
1346
Aminoacrylate,
1031
Aminoacrylate-PLP
Schiff
base,
1078
Aminoacylation,
tRNA,
1345–1362
Aminoacyl
peptide,
170
Aminoacyl
site,
see
A
site
Aminoacyl-tRNA,
98,
1349,
1349F
Aminoacyl-tRNA
synthetase
(aaRS),
99,
1349–1359
characteristics
of,
1350F
classes
of,
1350–1351
Class
I,
1350–1354,
1350T,
1355F,
1358,
1358F
Class
II,
1350–1351,
1350T,
1354–1355,
1355F,
1358,
1358F
and
CysRS
in
archaebacteria,
1359
and
Gln-tRNA
Gln
formation,
1358–1359
proofreading
by,
1355–1358
recognition
by,
1351–1352,
1351F,
1352F
-Aminobutyric
acid
(GABA),
79–80,
80F,
783,
1049
biosynthesis,
1058–1060
-Amino--chlorobutyrate,
1408
Aminoglycosides,
1395
Amino
groups,
43F
5-Aminoimidazole-4-carboxamide
ribotide
(AICAR),
1078,
1104,
1109F,
1111
5-Aminoimidazole-4-(N-
succinylocarboxamide)
ribotide
(SAICAR),
1109F,
1111
5-Aminoimidazole
ribotide
(AIR),
1109F,
1110
-Aminoisobutyrate,
1136
-Aminoisobutyric
acid,
32T
-Aminoleuvulinate
synthase,
1048,
1049
-Aminoleuvulinic
acid
(ALA),
1048
-Aminoleuvulinic
acid
dehydratase
(ALAD),
1048
Aminomethyltranferase
(AMT),
1032
-Amino-n-butyric
acid,
32T
Aminopeptidases,
166,
168,
168T
Aminopeptidase
M,
specificity
of,
168T
Aminoprocollagen
peptidase,
1403–1404
-Aminopropionitrile,
239,
276
Aminopterin,
1129
2-Aminopurine,
see
2AP
I-4
Index
3-Aminopyridine
adenine
dinucleotide
phosphate
(AADP

),
1125
Amino
sugars,
365
Amino
terminus,
see
N-terminus
Aminotransferases,
1020,
1136F
Ammonia,
32,
33,
43T,
1025
Ammonification,
1083
Ammonium
ion
(NH

4
),
45,
45T,
47,
47F
Ammonium
persulfate,
146F
Ammonium
sulfate,
133F,
134
Ammonotelic
organisms,
1025
Amoeba,
13F,
398T
AMP
(adenosine
monophosphate),
83T
in
animal
catabolism,
1130F
and
DNA
ligase,
1187
in
glycogen
metabolism,
648–650
from
IMP,
1112F
synthesis
of,
1111–1113
and
thermodynamics
of
life,
578
AMP
deaminase,
1131
AMP-dependent
protein
kinase
(AMPK),
963
and
cholesterol
biosynthesis,
989
in
fatty
acid
metabolism,
973,
975
and
glycogen
synthase
cascade,
660
and
hypoxia,
864
and
metabolic
homeostasis,
1095–1097,
1097F
and
noninsulin-dependent
diabetes,
1103–1104
Amphibolic
pathways,
789
Amphipathic
materials,
44
Amphiphilic
materials,
43–44
Ampholytes,
67,
151,
151F
Amphoteric
substances,
67
Ampicillin,
26,
107F,
111,
377F,
378,
621
AMPK,
see
AMP-dependent
protein
kinase
AMPPCP,
see
Adenosine-5¿-
(,-methylene)
triphosphate
AMPPN,
see
Adenosine-5¿-(-amino)
diphosphate
AMPPNP
(adenosine-5¿-(,
-imido)
triphosphate),
609,
633,
768,
1231
Amprenavir,
550F
amp
R
gene,
107F,
111,
621
AMT
(aminomethyltranferase),
1032
-Amylase,
370,
469
Amylin,
310
Amylo-(1,4
n
1,6)-transglycosylase,
646,
667
Amylo-1,6-glucosidase,
667
-Amyloid,
312
Amyloids,
309–310
Amyloid
diseases,
310–311
Amyloid
fibrils,
309,
309F
Amyloidoses,
309–310
Amyloid
plaques,
311–312,
458–459
Amyloid-
protein
(A),
311–312
Amylopectin,
369–370,
370F
Amyloplast,
11F
-Amylose,
369,
369F
Amytal,
831
Anabaena,
4F
Anabolism,
17,
561–562
Anaerobes,
6.
See
also
specific
organisms
Anaerobic
autotrophs,
814
Anaerobic
fermentation,
594F,
614–619
Anaerobic
metabolism,
864–865
Analbuminemia,
944
Analytical
ultracentrifuge,
154
Anaphase,
20F,
21F
Anaphase-promoting
complex
(APC),
1414
Anaphylaxis,
1000
Anaplerotic
reactions,
818–819
Anchoring
proteins,
714
Andersen’s
disease,
667
Anderson,
W.
F.,
122
Androgens,
673T,
680,
991
Anencephaly,
1035
Anesthetics,
neuronal
membranes
and,
398–399
Anfinsen,
C.,
278
Anfinsen
cage,
298,
300
Angelman
syndrome
(AS),
1251
Angina
pectoris,
686
Angiosperms,
13F
Angiotensin
converting
enzyme
(ACE),
547F
Angiotensin
I,
547F
Angiotensin
II,
547F
Angiotensinogen,
547F
Anhydrides,
formation
of,
515T
8-Anilino-1-naphthalenesulfonate
(ANS),
287
Animals,
7F,
12,
13F.
See
also
specific
organisms
in
carcinogenesis
tests,
1224
divergence,
192
DNA
polymerases,
1202–1205,
1202T,
1203T
FAS-I,
965–967,
966F
metabolic
homeostasis,
1096–1101
organ
specialization,
1090–1095
Animal
cells,
7F
Animalia,
12
Anion
channel,
412,
413F
Anion
exchangers,
135,
989–990
Ankyrin,
413F,
414
Ankyrin
repeats,
414,
414F
Annealing
conditions,
93
Anomeric
carbon,
361
Anomeric
forms,
cyclic
sugars,
361–363
ANS
(8-anilino-1-naphthalenesulfonate),
287
Antagonist,
539,
680
Antenna
chlorophylls,
905–906,
906F
Anterograde
transport,
428
Anthrax,
714–715
Anthrax
toxin,
714–715
Antibiotics,
protein
synthesis
inhibition
and,
1395–1398
Antibiotic-resistant
transposons,
1242
Antibodies,
131,
150.
See
also
Monoclonal
antibodies
Anticodons,
98,
1330,
1346,
1389F
Anticodon
arm,
1346
Anticodon
stem-loop
(ASL),
1394,
1394F
Anti
conformation,
1152F
Antidiuretic
hormone
(ADH),
683
Antifolates,
1129–1130
Antigens,
376
Antigenic
groups,
in
bacterial
cell
walls,
378–379
Antimycin,
831,
849
Antioxidants,
865–866
Antipain,
1409
Antiparallel

pleated
sheets,
224F,
229–230,
232
Antiport,
758F
Antirrhinum,
22
Antisense
oligodeoxynucleotide,
1402–1403
Antisense
oligonucleotides,
1402–1403
Antisense
RNA,
1323,
1402
Antisense
strand,
1266
Antisnorkeling,
406
2AP
(2-aminopurine),
1339,
1339F
AP1,
435–436
AP2,
435–436,
436F
AP3,
436
AP4,
436
Ap
5
A,
628
ApA,
melting
curve
of,
1157F
APC
(anaphase-promoting
complex),
1414
AP
endonuclease,
1218
Aphidicolin,
1203
Apical
domain,
410
ApoA-I,
see
Apolipoprotein
A-I
ApoA-II,
see
Apolipoprotein
A-II
Apocytochrome
c,
448
ApoE,
see
Apolipoprotein
E
apoE4
gene,
312
Apoenzyme,
473–474,
1023
Apoferritin,
140F
Apolipoproteins,
449–451,
986
Apolipoprotein
A-I
(apoA-I),
450–451,
450F,
450T,
451F,
458
Apolipoprotein
A-II
(apoA-II),
450T,
458
Apolipoprotein
B-48,
450T,
452,
1322
Apolipoprotein
B-100,
449F,
450T,
452,
455,
1322
Apolipoprotein
C-I,
450T
Apolipoprotein
C-II,
450T,
451
Apolipoprotein
C-III,
450T
Apolipoprotein
D,
450T
Apolipoprotein
E
(apoE),
312,
450T,
453,
455–456,
456F
Apolipoprotein
E2,
458–459
Apolipoprotein
E3,
458,
459
Apolipoprotein
E4,
458,
459
Apomyoglobin,
173F,
284,
289
Apoproteins,
449–451
Apoptosis,
717
Apparent
dissociation
constants,
348
Appetite
control,
1098,
1099,
1100F
Applied
Biosystems,
184
A
precursor
protein,
311–312
APRT
(adenine
phosphoribosyltransferase),
1114
AP
(adapter
protein),
435–436,
436F
APS/Cbl
complex,
738
AP
sites,
1218
APS
(adenosine-5¿-phosphosulfate)
reductase,
1072
Aptamers,
214,
1300
Apurinic
sites,
1218
Apyrase,
183
Apyrimidinic
sites,
1218
AQP0,
756
AQP1,
756–757,
757F,
787
AQP12,
756
Aquaglyceroporins,
756
Aquaporins,
399F,
756–757,
757F,
787
Aqueous
solutions,
40–50
acids,
bases,
and
buffers,
45–50
hydrocarbon
transfer
in,
262–264,
263T
nucleotide
base
stacking
in,
1156–1157
polyprotic
acids,
48–50
and
properties
of
water,
40–45
araBAD
operon,
1287,
1291–1294,
1292F,
1293F
Arabidopsis
thaliana,
177T,
182,
1410F
Arabinose,
glucose
and,
1286
D
-Arabinose,
360F
L
-Arabinose,
1291–1294
AraC,
1292–1294
Arachidic
acid,
387T
Arachidonate,
994
Arachidonic
acid,
387T,
994–997,
995F
araI
1
,
1292
araO
2
,
1292
Arber,
W.,
104
Archaea,
6,
7F,
13F,
192
Archaeal
introns,
1307T
Archaebacteria,
6,
1359
Archaeoglobus
fulgidus,
177T
Arcuate
nucleus,
1099
AREs
(AU-rich
elements),
1327
ARF1
(ADP-ribosylation
factor),
434–435,
435F,
695–696
Index
ARF
GAP,
437
ARF
nucleotide-binding
site
opener
(ARNO),
434
Arg,
see
Arginine
Arginine:
biosynthesis,
571F,
1071
degradation,
1034
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T

helix/
sheet
propensity,
302T
isoelectric
point,
72
location
in
globular
proteins,
246
side
chains,
71,
264T
specific
rotation,
74
structure
and
general
properties,
69T
trypsin-catalyzed
cleavage,
170
Argininosuccinase,
1028
Argininosuccinate
synthetase,
1028
Argonaute
(AGO),
1324,
1325,
1325F
ArgRS,
1352
A-RNA,
1151
ARNO
(ARF
nucleotide-binding
site
opener),
434
Arnold,
E.,
1208
Arnold,
W.,
906
aroH
operon,
1297
Aromatic
amino
acid
decarboxylase,
1060
ar/R
constriction,
756
Arrhenius,
A.,
45
Arsenate,
636
Arsenic,
799,
822
Arsenicals,
799
Arsenite,
799
ARSs,
see
Autonomously
replicating
sequences
Arteriosclerosis,
456–458
Arthropods,
13F
AS,
see
Alignment
score;
Angelman
syndrome
Ascobolus,
13F
Ascorbic
acid
(vitamin
C),
236,
364–365,
364F
A-side
transfer,
472
A
(aminoacyl)
site,
98F,
1373,
1385,
1387
ASL,
see
Anticodon
stem-loop
Asn,
see
Asparagine
Asp,
see
Aspartic
acid
L-Asparaginase,
1034
Asparagine:
biosynthesis,
1067–1073
degradation,
1034
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246–247
half-life,
1413T

helix/
sheet
propensity,
302T
as
nonessential
amino
acid,
1065T
side
chains,
71,
264T
structure
and
general
properties,
69T
Asparagine
synthetase,
1068
Aspartame,
1087
Aspartate,
71.
See
also
Aspartic
acid
biosynthesis,
1067–1073
degradation,
1034
half-life,
1413T
as
nonessential
amino
acid,
1065T
Aspartate
aminotransferase,
876,
877F
Aspartate
transcarbamoylase,
see
ATCase
Aspartic
acid:
degradation,
1034
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246

helix/
sheet
propensity,
302T
isoelectric
point,
72
in
Miller-Urey
experiments,
32T
side
chains,
71,
264T
structure
and
general
properties,
69T
Aspartic
proteases,
546–549,
548F
Aspartokinase,
1072,
1075T
-Aspartyl-AMP,
1068
Aspartyl
phosphate,
759
Aspartyl--phosphate,
1075
Aspirin,
994,
998,
999F
Aspirin-triggered
epi-lipoxins
(ATLs),
1004
AspRS,
tRNA
Asp
and,
1354–1355,
1354F,
1355F
Asp-tRNA
Asn
,
1358
Assembly
factors,
1365
Astbury,
W.,
233
Asthma,
680
Asx,
68T,
73.
See
also
Asparagine;
Aspartic
acid
Asymmetric
centers,
74–76
Asymmetric
PCR,
116
AT,
see
Acetyl
transferase
AT-AC
introns,
1319
AT-AC
spliceosome,
1319
Ataxin-1,
1252
ATCase
(aspartate
transcarbamoylase),
475F,
478F
allosteric
control,
476–479
feedback
inhibition,
474–479
in
UMP
synthesis,
1115F,
1116
X-ray
structure,
476F
Atheromas,
456
Atherosclerosis,
456–458
Atherosclerotic
plaques,
240,
457F
ATLs
(aspirin-triggered
epi-lipoxins),
1004
Atomic
fluctuations,
307,
308
Atomic
force
microscopy
(AFM),
376
Atorvastatin,
990,
991F
ATP
(adenosine
triphosphate),
82,
559,
586.
See
also
Electron
transport;
Oxidative
phosphorylation;
Photosynthesis
and
aerobic
vs.
anaerobic
metabolism,
864–866
in
ATCase
feedback
inhibition,
475
in
Calvin
cycle,
931
in
catabolism,
561,
561F
in
citric
acid
cycle,
789,
816–817,
819
consumption
of,
582–583
coupled
reactions
with,
579F
and
DNA
ligase,
1188
effect
on
hemoglobin
oxygen
binding,
330
in
electron
transport
chain,
823–824,
824F,
828,
829
formation,
582–583
in
gluconeogenesis,
877–878
in
glycogen
metabolism,
648–649
in
glycolysis,
593,
594F,
595,
600,
608–610,
613
in
GroEL/ES
system,
294,
298–300
in
mitochondria,
9
in
nitrogen
fixation,
1082
overview
of
roles,
17
in
oxidative
phosphorylation,
845–863,
846F
photorespiration
dissipates,
935
in
photosynthesis,
902,
926
production
control
for,
863–864,
863F
in
protein
folding,
300
source
of
free
energy
for
metabolic
pathways,
561F
sources
of,
during
exercise,
1092F
structure,
578F
and
thermodynamics
of
life,
578–583
in
transcription,
95–96,
1265
turnover
rate,
583
and
vesicle
fusion,
444–445
ATP/ADP
carrier,
448
ATP-ADP
translocator,
448,
768,
771
ATPases:
A-,
F-,
P-,
and
V-types,
758
(Ca
2
)-ATPase,
762–764
(H

-K

)-ATPase,
764–765
(Na

-K

)-ATPase,
758–762
and
molecular
chaperones,
293
ATP-cassette
binding
protein
A1
(ABCA1),
458
ATP-citrate
lyase,
818,
968
ATP-driven
active
transport,
758–768
ATP
mass
action
ratio,
862
ATPS,
698
ATPS,
294,
444–445,
1204F
ATP
sulfurylase,
183,
1072
Atractyloside,
771
Attenuation,
1296–1299
Attenuator,
1297–1299
A-type
ATPases,
758
AU-AC
introns,
1307T,
1319
AU-AC
spliceosome,
1319
AUG
(codon),
1343
AU-rich
elements
(AREs),
1327
Aurora,
1402
Autocrine
hormones,
671
Autoimmune
disorders,
688
cyclosporin
A
for,
292
multiple
sclerosis,
777
and
type
1
diabetes,
1102
Autolysis,
131
Autonomously
replicating
sequences
(ARSs),
109,
1205
Autophagic
vacuoles,
1409
Autophosphorylation,
670,
700
Autoradiography,
94–95,
95F,
148,
572
of
sequencing
gels,
177–178,
178F
Autosomes,
23
Autotrophs,
5
Auxilin,
436
Auxotropic
mutants,
570
Avery,
O.,
86
Avidin,
577,
873
Avogadro’s
number,
53T
Axial
groups,
in
sugars,
363
Axon,
771
5-Azacytosine
(5-AzaC)
residue,
1249
Azaserine,
80,
80F,
1142
3¿-Azido-3¿-deoxythymidine
(AZT;
zidovudine),
546,
1207
Azidomet,
135F
Azotobacter
vinelandii,
1080F–1081,
1341
AZT,
see
3¿-Azido-3¿-deoxythymidine
Azurin,
135F
B
Babcock,
G.,
844
Baboons,
xenotransplantation
with,
121
BAC-ends
(sequence-tagged
connectors),
181
Bacilli,
4
Bacillus,
4F
Bacillus
subtilis,
376,
377F,
1284
Bacillus
thuringiensis
(Bt),
122
Bacitracin,
888–889,
889F
Backside
attack,
514F
BACs
(bacterial
artificial
chromosomes),
108–109,
113,
114,
181
Bacteria.
See
also
specific
organisms
conjugation
of,
1262–1264,
1262F
divergence
of,
192
DNA
base
composition,
84
DNA
size,
94T
and
eukaryotic
protein
production,
118
fatty
acids
of,
387
genetic
regulation
of
sugar
transport,
765T,
766,
767F
I-5
I-6
Index
Bacteria
(Contd.)
genetics
of,
26
glutamine
synthetase
regulation,
1069F
glycogen
synthase,
645
glycoproteins
of,
375–379
homologous
recombination
in,
1225
microfossil,
29F
phylogenetic
tree
for,
7F
in
prokaryotic
classification,
6
RNAP,
96,
1265–1266
self-compartmentalized
proteases
of,
1419–1420
spores
of,
see
Spores
virulence
of,
375
Bacterial
artificial
chromosomes,
see
BACs
Bacteriochlorophyll
a
(BChl
a),
135F,
903,
904F
Bacteriochlorophyll
b
(BChl
b),
903,
904F,
916
Bacteriophages,
27,
1190
DNA,
86–88
RNAP,
1265
Bacteriophage
:
cloning
vector,
108,
108F,
111F
DNA
size,
94T
electron
micrograph,
108F
helix–turn–helix
motif,
1288
template
binding,
1264
Bacteriophage
434,
helix–turn–helix
motif,
1288,
1289F
Bacteriophage
M13:
cloning
vector,
108,
108F
replication,
1190,
1190F
Bacteriophage
MS2,
sequencing,
176
Bacteriophage
P1,
Cre
recombinase,
1243–1244
Bacteriophage
P22,
1288
Bacteriophage
ΦX174:
genetic
map,
1344,
1344F
Pol
I,
1177
replication,
1190–1193,
1192F
template
binding,
1266
Bacteriophage
SP01,
1284
Bacteriophage
T2,
1264,
1265F
attachment
to
E.
coli,
87F
DNA,
94F,
94T
in
Hershey–Chase
experiment,
87,
87F
Bacteriophage
T4,
27F,
28,
1264,
1265F
cloning
vector,
109
DNA
size,
94T
FC0
mutation,
1340
template
binding,
1266
Bacteriophage
T5,
attachment
of,
86F
Bacteriophage
T6,
94T,
1263F
Bacteriophage
T7,
in
chain-terminator
method,
179
Bacteriopheophytin
b
(BPheo
b),
910–911
Bacteriorhodopsin
(BR),
850–851,
851F
membrane
structure,
402–403,
403F
Baculovirus
vectors,
108
Baker,
D.,
305,
306,
310
Baker’s
yeast,
see
Saccharomyces
cerevisiae
Balch,
W.,
437
Baldwin,
R.,
285,
287
Baltimore,
D.,
545,
1207
Bamacan,
373T
BamHI,
105T
Ban,
N.,
966–968
B
antigen,
415
Banting,
F.,
575,
1102
Barber,
J.,
916
Barford,
D.,
722,
723
Barnett,
J.,
750
Barrels:
/,
982
/,
250,
252,
254,
300
,
231F,
448–449
Swiss
roll,
252,
253F
TIM,
252,
254F,
300
up-and-down
,
251–252
Barré-Sinoussi,
F.,
545
Basal
cells,
16F
Basal
laminae,
373
Basal
level,
1261
Bases,
45–47.
See
also
Nucleotide
bases
and
buffers,
48
nucleic
acid,
see
Nucleic
acid
bases
Base-catalyzed
hydrolysis,
RNA,
85,
85F
Base
excision
repair
(BER),
1216,
1218
Base
flipping,
1215
Basement
membranes,
373
Base
pairs,
18,
84,
1154–1156.
See
also
Watson–Crick
base
pairs
association
constants
for
formation,
1155T
complementary,
89
non-Watson–Crick,
1154–1156,
1154F
and
recombination,
28
Base
stacking,
in
B-DNA,
89
Basic
helix–loop–helix/leucine
zipper
(bHLH/Zip),
987
Basic
Local
Alignment
Search
Tool,
see
BLAST
Basic
solutions,
47
Basolateral
domain,
410
Bassham,
J.,
927
Batrachotoxin,
777
Battersby,
A.,
1053
Baumeister,
W.,
1414
Bax,
A.,
656
B
blood
type,
22
BBP
(branch
point-binding
protein),
1312,
1314
BChl
a,
see
Bacteriochlorophyll
a
BChl
b,
see
Bacteriochlorophyll
b
BCKDH
kinase,
1039
BCKDH
phosphatase,
1039
BCM7,
534–535
Bcr,
718
B-DNA,
88F,
1145–1148,
1146F,
1147F
conversion
to
Z-DNA,
1149F
structure
of
ideal,
1148T
three-dimensional
structure,
89F
Watson–Crick
structure,
88–90
Beadle,
G.,
26,
570
Becker,
J.,
1002
Beckmann,
R.,
422,
424
Bed
volume,
in
gel
filtration
chromatography,
138
Beer–Lambert
law,
90
Begg,
G.,
171
Behenic
acid,
387T
Beinert,
H.,
834
Benign
tumors,
703
Benner,
S.,
472
Benson.
A.,
927
Benzamidine,
556
Benzene,
43,
43T
Benzer,
S.,
28
Benzoic
acid,
945
BER,
see
Base
excision
repair
Berg,
P.,
109,
1350
Berger,
J.,
1167–1168,
1188,
1195,
1275
Bergström,
S.,
994
Beriberi,
474T,
617–618
Berman,
H.,
236,
1287
Bernal,
J.
D.,
241,
331
Berry,
E.,
838,
840
Berzelius,
J.,
469
Best,
C.,
575
Best,
G.,
1102

1
-Adrenergic
receptors,
690

2
-Adrenergic
receptors,
690
-Adrenergic
receptor
kinase
(ARK),
697

Motif,
249,
249F
ARK
(-Adrenergic
receptor
kinase),
697
-Arrestins,
697

Barrel,
231F,
448–449

Bends,
232,
233F

c
,
717–718

Cells,
pancreatic,
see
Pancreatic

cells

Clamp,
Pol
III,
1182–1183,
1183F

Configuration,
nucleotides,
83

Domains,
249–254,
249F

Hairpin
motif,
249,
249F

Helix,
314
-Horseshoe,
GyrA
intein,
1407
-Lactamase,
378

Oxidation,
fatty
acids,
945,
947–950,
958

Particles,
572

Pleated
sheets,
229–232,
229F–232F
globular
proteins,
246
propensities
and
classifications
of
amino
acid
residues
for,
302T
Ramachandran
diagram,
224F
and
space
filling,
281

PP
(A
precursor
protein),
311–312
-Propeller,
692

Ribbons,
1290–1291

Sandwich,
251
Beta
structures,
proteins,
229–232,
229F–232F

Subunit,
Pol
III,
1182–1183
b
gene
(fruit
fly),
25F
BglI,
105T
BglII,
105T
BH
4
(5,6,7,8-tetrahydrobiopterin),
686,
1043–1044
bHLH/Zip
(basic
helix–loop–helix/leucine
zipper),
987
Bi
Bi
reactions,
498–499
Bibliome,
576
Bicyclic
cascade,
650,
651F
Bidirectional
replication,
1174,
1176
Bienert,
H.,
808
Bifurcated
hydrogen
bond,
261
Bilayers,
see
Lipid
bilayers
Bile
acids,
941,
992,
993F
Bile
pigments,
1056
Bile
salts,
941,
943–944,
989–990,
992–993
Bilins,
909
Bilirubin,
1056
Bilirubin
diglucuronide,
1056,
1057
Bilirubin
UDP-glucuronosyltransferase,
1056
Biliverdin,
1056
Bimolecular
reactions,
483
Binding
modules,
705–711
Binding
specificity,
protein
purification
and,
132
Bioavailability,
542
Biochemical
literature,
34–36
Biochemical
review
publications,
35T
Biochemistry,
14–19
biological
structures,
14–17,
16F
defined,
3
expression
and
transmission
of
genetic
information,
18–19
genetics
review,
19–28
metabolic
processes,
17
Bioethics,
123
Bio-Gel
A,
139
Bio-Gel
P,
139
Biogenic
amines,
782
Bioinformatics,
194
globular
proteins,
256–259
phylogenetic
tree
construction,
203–205,
203F
Index
sequence
alignment,
195–203
sequence
databases,
194–195
Biological
evolution,
29,
30F
Biological
membranes,
see
Membranes
Biological
structures,
14–17,
16F
Biopterin,
1043
BIOSIS
Previews,
35
Biosynthesis,
561
Biotin,
473T,
577,
857,
873
Biotin
carboxylase,
963
Biotin
carboxyl-carrier
protein,
963
Biotinyllysine,
873
Bipolar
disorder,
736
Bishop,
M.,
705
1,3-Bisphosphoglycerate,
see
1,3-BPG
2,3-Bisphosphoglycerate,
see
2,3-BPG
Bisphosphoglycerate
mutase,
596F,
611,
611F
2,3-Bisphosphoglycerate
phosphatase,
596F,
611
Bisphosphonates,
679,
679F
Bisubstrate
enzyme
reactions,
497–501,
498F
Bisulfite
ion,
1249
Bisulfite
sequencing,
1249
Black,
J.,
764
Blackburn,
E.
H.,
1210
Black
mouth,
342
Blaese,
M.,
122
BLAST
(Basic
Local
Alignment
Search
Tool),
201,
202F
Blastocyst,
1250
Blobel,
G.,
420,
424,
1371
Bloch,
K.,
961,
975,
976
Block,
S.,
1273
Blood,
973
ABO
blood
groups
system,
22,
414–415
buffering,
48
universal
donors/recipients,
466
Blood–brain
barrier,
542,
783
Blood
clotting
factors,
recombinant,
119
Blood
glucose,
638,
661–664,
1094
Blood
groups,
22,
414–415
Blood
group
determinants,
414–415
Blood
plasma,
323–324
Blood
vessels,
235
BLOSUM45
substitution
matrix,
201
BLOSUM62
substitution
matrix,
201,
203
Blow,
D.,
527
Blue-green
algae,
see
Cyanobacteria
Blundell,
T.,
549
Blunt
ends,
106
Blunt
end
ligation,
1188
Boat
conformation,
363,
363F
BOC-amino
acid,
206
BOC
(tert-Butyloxycarbonyl)
group,
206–208
Bohm,
A.,
1303
Bohr,
C.,
328
Bohr,
N.,
329
Bohr
effect,
hemoglobin,
328–329,
328F,
329,
340
Boltzmann,
Ludwig,
55
Boltzmann
constant
(k
B
),
53T,
55,
486
Bonaparte,
N.,
799
Bone,
235,
540
Bongkrekic
acid,
771
Boniva,
679F
BoNT/A,
442
BoNT/G,
442
Borhani,
D.,
451
Boron,
31
Borsook,
H.,
1408
Botulinus
toxin,
780
Botulism,
442,
1340
Bovine
20S
proteasome,
1417
Bovine
pancreatic
ribonuclease
A,
470.
See
also
RNAse
A
acid-base
catalytic
mechanism,
508–510,
509F
physical
constants,
153T
Bovine
pancreatic
trypsin
inhibitor,
see
BPTI
Bovine
papillomavirus,
E1
protein,
1184–1185,
1185F
Bovine
somatotropin
(bST),
119
Bovine
spongiform
encephalopathy
(BSE),
312,
315
Box
C/D
snoRNAs,
1329
Box
H/ACA
snoRNAs,
1329
Boyer,
H.,
107
Boyer,
P.,
612,
845,
856,
857
1,3-BPG
(1,3-bisphosphoglycerate),
580,
596F,
607,
609
2,3-BPG
(2,3-bisphosphoglycerate):
in
glycolysis,
610
and
hemoglobin
oxygen
binding,
329–331,
329F–331F,
340–341
BPheo
b
(bacteriopheophytin
b),
910–911
B
protein,
1314
BPTI
(Bovine
pancreatic
trypsin
inhibitor),
308–309,
533,
533F
BR,
see
Bacteriorhodopsin
Brachet,
J.,
1260
Bradykinin,
208
Bragg,
L.,
331
Bragg,
W.,
331
Brain,
metabolic
relationships,
1090–1091,
1091F
Branch,
phylogenetic
trees,
203–204,
203F
Branched-chain
-keto
acid
dehydrogenase,
1039
Branching
enzyme,
646,
667
Branch
migration,
1226,
1230–1234
Branch
points,
phylogenetic
trees,
203–204,
203F
Branch
point-binding
protein,
see
BBP
Brändén,
C.-I.,
256,
929
Branton,
D.,
408
Braunstein,
A.,
1021
BRCA1,
1236
BRCA2,
1236
Breaker,
R.
R.,
1300,
1318
Breast
cancer,
119–120,
1236
Breathing
motions,
306
Breathnach,
R.,
1305
Brenner,
S.,
1264,
1340,
1341
Brewer’s
yeast,
617F
Briggs,
G.
E.,
488
Brij
30,
399F
Brij
35,
399F
Brinster,
R.,
86
British
anti-lewisite,
822
Brittle
bone
disease,
240
Brodsky,
B.,
236
Bromide
ion,
45T
5-Bromo-4-chloro-3-hydroxyindole,
110
5-Bromo-4-chloro-3-indolyl--
D
-
galactoside
(X-gal),
110
Bromohydroxyacetone
phosphate,
604
5-Bromouracil,
1339,
1339F
Bronsted,
J.,
45
Bronsted
acid,
45
Bronsted
base,
45
Brouillette,
C.,
451
Brown,
A.,
323,
488
Brown,
D.,
1283
Brown,
M.,
452,
453,
987
Brown
adipose
tissue,
860
Brown
algae,
13F
Browner,
M.,
1001
I-7
Brown
fat,
860
Brownian
ratchet,
428,
1280
Bruice,
T.,
514,
515
Brünger,
A.,
441,
444
Brush
border
cells,
38,
768
BSE,
see
Bovine
spongiform
encephalopathy
B-side
transfer,
472
bST
(bovine
somatotropin),
119
Bt
(Bacillus
thuringiensis),
122
Bt
corn,
122
5-BU,
see
5-Bromouracil
Bubonic
plague,
722
Buchanan,
J.,
1107
Buchner,
E.,
470,
593
Budding
yeast,
see
Saccharomyces
cerevisiae
Buffers,
47–48
Buffer
capacity,
51
Bugg,
C.,
656
Bundle-sheath
cells,
936
-Bungarotoxin,
781
Burley,
S.,
1303,
1378
Burns,
J.,
620
Burst
phase,
in
protein
folding,
286
Butryl-ACP,
965
tert-Butyloxycarbonyl
(BOC)
group,
206–208
Butyrylcholinesterase,
782
bw
gene
(fruit
fly),
25,
25F
Bypass
DNA
polymerases,
1222
C
C1
domain,
730–731
C2
domain,
727,
730–731
C3G,
737F
C
4
cycle,
934–937,
936F
CA1P
(2-carboxyarabinitol-1-
phosphate),
930
Ca
2
,
see
Calcium
ion
Ca
2
-binding
protein,
678
(Ca
2
)-ATPase,
762–764
CABP
(2-carboxyarabinitol-1,
5-bisphosphate),
930,
930F
CACCC
box,
1282
cacophony
pre-mRNA
(Drosophila
melanogaster),
1322
Caenorhabditis
elegans:
genome
sequencing,
177T,
182
miRNA,
1326
sense
RNA
injection
for,
1323
trans-splicing
in,
1320
Cahn,
R.,
76
Cahn-Ingold-Prelog
system,
76–77
N
5
-CAIR,
1111
CAIR
(carboxyaminoimidazole
ribotide),
1109F,
1111
Cairns,
J.,
1173,
1181
Calcineurin
(CaN),
724–725
Calcitonin,
673T,
677,
678
Calcium
ion
(Ca
2
),
45T,
805,
816–817
Calcium
metabolism,
677–678
Calmodulin
(CaM),
655–658,
688,
764
Calmodulin-dependent
protein
kinase
I
(CaMKI),
658
Calmodulin-dependent
protein
kinase
II
(CaMKII),
699
Calnexin
(CNX),
427,
885–887,
886F,
887F
Caloric
restriction,
1101
Calorie
(unit),
53,
53T
Calpain,
736
Calreticulin
(CRT),
427,
885–887,
886F
Calvin,
M.,
927,
930
Calvin
cycle:
control
of,
932–934
free
energy
changes
from,
933T
net
reaction,
931
I-8
Index
Calvin
(Contd.)
in
photosynthesis,
927–934,
929F
stoichiometry
of,
931
CaM,
see
Calmodulin
CAM
(Crassulacean
acid
metabolism),
937
Cambillau,
C.,
941
Camels,
erythrocyte
membranes,
414
CaMKI
(calmodulin-dependent
protein
kinase
I),
658
CaMKII
(calmodulin-dependent
protein
kinase
II),
699
cAMP
(adenosine-3¿,5¿-cyclic
monophosphate),
653
and
AraC,
1292
and
blood
glucose
control,
661
and
catabolite
repression,
1286
controlling
fatty
acids
with,
861
and
eicosanoid
mediation,
993
and
integration
of
metabolic
cycles,
1089
cAMP-dependent
protein
kinase
(CAPK),
653
cAMP-phosphodiesterases
(cAMP-PDEs),
698
cAMP
receptor
protein
(CRP),
1286
cAMP
response
element
(CRE),
879
Camptothecin,
1170
CaN
(calcineurin),
724–725
Cancer.
See
also
related
topics,
e.g.:
Carcinogenesis
and
cell
cycle,
1202
cell
metabolism,
864–865
and
chaperone
proteins,
720
and
DNA
methylation,
1251
and
gene
therapy,
123
role
of
glycoproteins
in,
381
and
telomeres,
1211–1212
thymidylate
synthesis
inhibition,
1129–1130
and
tyrosine
kinase-based
signaling,
703–705
Canis
familiaris
(dog),
genome
sequencing,
177T
Cantor,
C.,
158
CAP,
see
Catabolite
gene
activator
protein;
Cbl-associated
protein
cap-0,
1302
cap-1,
1302
cap-2,
1302
Cap
binding
protein,
eIF4E,
1378
Capillary
electrophoresis
(CE),
152
CAPK
(cAMP-dependent
protein
kinase),
653
Capping,
of
telomeres,
1210
Capping
enzyme,
1302,
1302F
19S
Caps,
1411F
Capsids,
26
Caps
structure,
1302,
1302F
Capsule,
bacterial,
4
Carbamates,
329,
1025
N-Carbamoylaspartate,
475
Carbamoyl
aspartate,
in
UMP
synthesis,
1115F,
1116
Carbamoylation,
hemoglobin,
340
Carbamoyl
phosphate,
475,
1025–1028,
1115F
Carbamoyl
phosphate
synthetase
(CPS),
1025–1028
Carbamoyl
phosphate
synthetase
I
(CPS
I),
1116
Carbamoyl
phosphate
synthetase
II
(CPS
II),
1115F–1116
Carbanions,
563,
563F,
568–569,
569F
Carbocation,
563,
563F
Carbodiimides,
207
Carbohydrates,
359.
See
also
Glycoproteins;
Monosaccharides;
Oligosaccharides;
Photosynthesis;
Polysaccharides
analysis
of,
366–367
in
collagen,
238
energy
recovery
from,
789
Fischer
convention
for,
360–361
functional
groups
of,
43
glycoprotein,
380–381
low
carbohydrate
diets,
1106
from
photosynthesis,
5
Carbohydrate
metabolism,
561F
Carbohydrate
microarrays,
383
Carbohydrate
recognition
markers,
439
Carbon,
properties
of,
29,
31
Carbon–carbon
bonds,
breaking
and
mak-
ing,
562–563,
567–569,
568F
Carbon
dioxide:
in
Calvin
cycle,
927,
931
compensation
point
in
plants,
935–936
in
photosynthesis,
901,
903,
935–937
transport
by
hemoglobin,
328–329
Carbonic
anhydrase:
diffusion-limited,
490
metal
ion
catalysis,
511–513,
512F
Michaelis–Menten
kinetic
constants,
489T
tertiary
structure,
246F
Carbon
monoxide,
heme
group
and,
324
Carbon
monoxide
dehydrogenase,
954
Carbonylcyanide-p-
trifluoromethoxyphenylhydrazone
(FCCP),
860
Carboxyaminoimidazole
ribotide,
see
CAIR
2-Carboxyarabinitol-1,5-bisphosphate,
see
CABP
2-Carboxyarabinitol-1-phosphate
(CA1P),
930
Carboxyatractyloside
(CATR),
771
-Carboxyglutamate,
79F
-Carboxyglutamic
acid,
79
Carboxy-hemoglobin,
solubility
and
ionic
strength
of,
133F
Carboxyl
groups,
43F
Carboxyl
terminus,
see
C-terminus
Carboxyltransferase,
963
Carboxymethyl-cellulose
ion
exchangers,
see
CM-cellulose
ion
exchangers
Carboxymethyl-CoA,
806
Carboxymethylcysteine,
607
Carboxymyoglobin,
1057
Carboxypeptidases,
165–166,
168T
Carboxypeptidase
A,
168T,
231F,
254F,
473
Carboxypeptidase
B,
168T
Carboxypeptidase
C,
168T
Carboxypeptidase
Y,
168T
Carboxyphosphate,
873,
1025
Carboxyprocollagen
peptidase,
1403–1404
Carboxypropyl-CoA,
955
Carcinogens,
1202,
1224–1225
Carcinogenesis,
1224
Cardiac
glycosides,
761–762,
761F
Cardiolipin,
389T,
398T,
1005,
1006F
Cardiotonic
steroids,
761–762
Carell,
T.,
1215
Carnitine,
946
Carnitine
palmitoyltransferase
I,
946,
975
Carnitine
palmitoyltransferase
II,
946
-Carotene,
122,
908,
976
Carotenoids,
905F,
907–909
Carrager,
B.,
437
Carriers,
745,
748
Carsonella
ruddii,
177T
CART
(cocaine
and
amphetamine-
regulated
transcript),
1099
Cartilage,
235,
240T,
375
Caruthers,
M.,
211
Casein,
150
-Casein,
534
-Casein,
547
Casein
kinase
1,
660
Casein
kinase
2,
660
CASP
(Critical
Assessment
of
Structure
Prediction),
305
Caspersson,
T.,
1260
Cassette
exons,
1318
Cassette
mutagenesis,
119–120
Catabolism,
17,
561–562,
561F
purine
ribonucleotides,
1130–1134
pyrimidine
ribonucleotides,
1136
Catabolite
gene
activator
protein
(CAP),
654
and
AraC,
1292
and
catabolite
repression,
1286–1288,
1287F
Catabolite
repression,
766,
1285–1288
Catalase,
10,
866,
935
heme
group
in,
324
horse
liver,
153T
Michaelis–Menten
kinetic
constants,
489T
molecular
mass
of,
140F
sedimentation
coefficient,
154F
Catalysis,
free
energy
of
reaction
for,
487,
487F
Catalysts,
469
Catalytic
constant,
490
Catalytic
triad,
529
Cataplerosis,
1090
Cataplerotic
reactions,
818
Cataracts,
and
galactose,
633
Cate,
J.,
1366
Catechol,
680,
1059
Catecholamines,
680,
1058–1060
Catenation,
1163,
1163F
CATH
(Class,
Architecture,
Topology,
and
Homologous
superfamily),
256T,
258
Cathepsins,
1408–1409
Cathepsin
D,
439,
547
Cathepsin
E,
547
Cathepsin
K,
540
Cation
exchangers,
135–136
CATR
(carboxyatractyloside),
771
Cattle,
see
Cow
Caveolae,
411
Caveolins,
411
C

backbone,
244–245
Cbl-associated
protein
(CAP),
737F
CBP,
see
CREB-binding
protein
CCA-adding
polymerase,
1331
CCAAT
box,
1282
CCAAT/enhancer-binding
protein

(C/EBP),
572
c-Cbl,
1412–1413,
1412F
CCdA-p-Puro,
1383,
1383F
C
chain,
proinsulin,
280–281,
280F
CCHL
(cytochrome
c
heme
lyase),
448
CCK,
see
Cholecystokinin
CCT
chaperonins,
301–302,
301F
CCVs,
see
Clathrin-coated
vesicles
CD,
see
Circular
dichromism
Cdc6,
1206–1207
Cdc7,
1205
Cdc18,
1206–1207
Cdc45,
1205
CDKs
(cyclin-dependent
protein
kinases),
1202,
1206–1207,
1414
cDNA:
depositing
on
DNA
chips,
212–213
and
PCR,
116
reverse
transcriptase,
1207–1208
CDP-diacylglycerol,
1004–1005
CD
spectroscopy,
284–285,
285F
Cdt1,
1206,
1207
CE
(capillary
electrophoresis),
152
Index
C/EBP
(CCAAT/enhancer-binding
protein
),
572
Cech,
T.,
1306–1308
Celebrex,
543,
1000
Celecoxib,
999–1000
Celera
Genomics,
181–182
Cells,
3,
16F.
See
also
Prokaryotes
eukaryote,
7F
human,
12F
plant,
11F
prokaryotic,
4F
Cell
cycle,
1202,
1202F.
See
also
Apoptosis
Cell
division:
meiosis,
21F
mitosis,
20F
in
mitosis,
1202
Cell
growth,
1202,
1211
Cell
membranes,
4,
4F,
7F.
See
also
Plasma
membranes
Cellobiose,
367,
367F
Cellophane,
141
Cell
proliferation,
1202.
See
also
Cancer
Cell
sorters,
575
Cellular
immunity,
292
Cellulase,
369
Cellulose,
11,
359,
367–369,
368F
Cellulose-based
ion
exchangers,
137–138,
137F
Cell
walls,
4
plant
cells,
11,
11F
prokaryotes,
4F
Central
dogma
of
molecular
biology,
95,
95F,
1260
Centrifugation:
differential,
130
ultra-,
132T,
152–156,
159
Centrioles,
7F
Centromeres,
20,
24F,
109
Ceramides,
390,
1008–1009
Cerebrosides,
391,
1008–1010,
1009F,
1010F
Ceruloplasmin,
140F
Cesium
chloride,
156,
156F
CETP
(cholesteryl
ester
transfer
protein),
458
Cetuximab,
720
Cetyltrimethylammonium
bromide
(CTAB),
399F
CE
website,
see
Combinatorial
extension
of
optimal
pathway
C-extein,
1407
CF
1
CF
0
complex,
926
cf
gene
(fruit
fly),
25,
25F
CFI
(cleavage
factor
I),
1302
CFII
(cleavage
factor
II),
1302
c-fos
proto-oncogene,
705
CFTR
(cystic
fibrosis
transmembrane
regulator)
protein,
427–428
CFTs
(channel-forming
toxins),
416–418
CG,
see
Chorionic
gonadotropin
c
gene
(fruit
fly),
25F
cGMP,
687
cGMP-dependent
protein
kinase,
687
cGMP-phosphodiesterase
(cGMP-
PDE),
692
CGN,
see
Cis
Golgi
network
Chagas-Cruz
disease,
799

Chain,
hemoglobin,
193,
194

Chain,
hemoglobin,
193,
194

Chain,
hemoglobin,
194
ε
Chain,
hemoglobin,
194

Chain,
hemoglobin,
194
Chain,
hemoglobin,
194
Chain
elongation:
protein
synthesis,
1372–1373,
1379–1388
RNAP,
1270–1272,
1270F,
1271F
Chain
initiation:
codons
for,
1343
protein
synthesis,
1373–1379
RNAP,
1267–1269
Chain
termination:
protein
synthesis,
1391–1395
RNAP,
1271F,
1273–1275
Chain-terminator
method,
176.
See
also
Sanger
method
Chair
conformation,
363,
363F,
519F
Chalfie,
M.,
120
Chamberlin,
M.,
1273
Chambon,
P.,
1305
Chang,
G.,
767
Changeux,
J.-P.,
349
Channel
formers
(ionophores),
748
Channel-forming
membrane
proteins,
416–418
Channel-forming
toxins
(CFTs),
416–418
Channeling,
794,
1028,
1075
Ca
2
channels,
772
Chaotropic
ions,
266
Chaperone
proteins,
293–302,
720
role
in
secretory
pathway,
421F,
427–428
Chaperonins,
293
CHAPS
(detergent),
399F
Chargaff,
E.,
84,
86,
88
Chargaff’s
rules,
84,
85,
88
Charge
relay
system,
536
Charges,
of
amino
acid
side
chains,
71
Charge
shielding,
513
Charge
transfer
complex,
803–804,
804F
Chase,
M.,
87
CHCRs,
see
Clathrin
heavy
chain
repeats
Checkpoint,
in
cell
cycle,
1202
C
Helix,
242F
Chemical
carcinogens,
704–705
Chemical
coupling
hypothesis,
845
Chemical
damage,
DNA
susceptibility
to,
1214F
Chemical
equilibria,
see
Equilibrium
Chemical
evolution,
29,
30F,
31–33,
185–194
and
gene
duplication,
192–194
and
neutral
drift,
188–192
rates
for
proteins,
191F,
192
and
sickle-cell
anemia,
185–188
Chemical
kinetics:
elementary
reactions,
483
reaction
rates,
483–484
and
spontaneous
processes,
54
transition
state
theory,
484–487
Chemical
logic,
563–565
Chemical
mutagenesis,
1339–1340
Chemical
mutagens,
1181,
1339–1340
Chemical
potential,
58,
744
Chemical
protons,
843
Chemical
synapses,
778
Chemical
synthesis:
of
genes,
118
of
oligonucleotides,
209–214
of
polypeptides,
205–209
Chemiluminescence,
183
Chemiosmotic
hypothesis,
846
Chemokines,
717
Chemolithotrophs,
5
Chemotaxis,
717
Chemotrophs,
559
Cheng,
X.,
1248
Chenodeoxycholate,
992
Chickens:
cancer
viruses,
704–705
embryonic
development,
14F
lactate
dehydrogenase
H,
153T
ovalbumin,
1304,
1304F,
1305F
as
source
of
proteins
for
purification,
130
triose
phosphate
isomerase,
231F,
252,
254F
I-9
Chicken
foot
(Holliday
junction),
1234
Chimeric
vector,
104
Chimpanzees,
116,
177T
Chipman,
D.,
523
Chiral
centers,
74–76
Chirality,
74,
78,
225–226
Chiral
organic
synthesis,
78
Chi
sequences,
1230
Chi
structures,
1228
Chitin,
369,
369F
Chiu,
W.,
301
Chl,
see
Chlorophyll
Chl
a,
see
Chlorophyll
a
Chl
b,
see
Chlorophyll
b
Chloramphenicol,
107,
1395T,
1396F,
1397
Chloride
ion,
45T
Chlorocruorins,
325
Chloroform,
43T,
144
Chlorophyll
(Chl),
12,
403,
903–912.
See
also
Photosynthesis
absorption
spectrum,
905F
electronic
states,
905F
Chlorophyll
a
(Chl
a),
903,
904F,
905F,
908,
916,
917
Chlorophyll
b
(Chl
b),
903,
904F,
905F,
908
Chloroplasts,
11F,
13F
photorespiration
in,
935
photosynthesis
site,
11–12,
901–903
Chloroquine,
1058,
1409
Cholate,
992
Cholecalciferol-25-hydroxylase,
678
Cholecystokinin
(CCK),
673T,
675
Cholera
toxin
(CT),
694–697,
1398
Cholesterol,
392–393,
393F
and
dietary
EPA,
1002–1003
excretion
of,
993
fluidity
of,
398
and
LDL,
449F
in
membranes,
398T,
400F
metabolism
of,
975,
984–987
synthesis
of,
1096
takeup
by
LDL,
453–455
transport
of,
452F,
456
utilization
of,
991–993
Cholesterol
7-hydroxylase,
993
Cholesterol
biosynthesis,
975–976
citric
acid
cycle
intermediates,
818
control
of,
989–991
HMG-CoA
in,
976–977
HMG-CoA
reductase
in,
987–989
lanosterol
in,
982–984,
985F
and
LDL
receptor
activity,
989–991
pyrophosphomevalonate
decarboxylase
in,
977–978
squalene
formation,
978–982,
979F
Cholesteryl
esters,
393,
449F,
984,
986
Cholesteryl
ester
hydrolase,
466
Cholesteryl
ester
transfer
protein
(CETP),
458
Cholesteryl
stearate,
393
Cholestyramine,
990
Choline,
389T,
390,
779
Choline
acetyltransferase,
779
Cholinergic
synapses,
778–780
Chondroitin-4-sulfate,
371F,
372
Chondroitin-6-sulfate,
371F,
372
Chorionic
gonadotropin
(CG),
132,
673T,
684
Chorthippus
parallelus,
24F
Chou,
P.,
302,
303
Chou–Fasman
method,
302–303
Chromate,
1075,
1076F,
1077F
Chromatids,
20,
24,
24F
Chromatin,
7F,
8
Chromatogram,
144
I-10
Index
Chromatographic
separations,
135
affinity
chromatography,
118,
141–143
gel
filtration
chromatography,
138–141
ion
exchange
chromatography,
135–138
nucleic
acids,
157
proteins,
135–146
Chromatophores,
902
Chromogenic
substrates,
110
Chromophore,
402,
908
Chromosomal
theory
of
inheritance,
22–26
Chromosomes,
4,
19–20,
19F
bacterial
artificial,
see
BACs
[bacterial
artificial
chromosomes]
in
meiosis,
21F
in
mitosis,
20F
multiforked,
1195,
1195F
number
of,
in
eukaryotes,
19T
of
prokaryotes,
4
recombination
of,
see
Recombination
replication
of,
see
DNA
replication
sex,
22–23
and
telomere
capping,
1210
yeast
artificial,
see
YACs
(yeast
artificial
chromosomes)
Chromosome
walking,
114,
114F,
180
Chronic
myelogenous
leukemia
(CML),
718
Chyle,
451
Chylomicrons,
449,
451–452,
944
and
cholesterol
biosynthesis,
986
properties,
449T
transport
in
blood,
973
Chylomicron
remnants,
451–452,
986
Chymosin,
547
Chymotrypsin,
470,
525,
525T,
529T,
565
active
sites,
529F,
531F
catalytic
mechanism,
531–537
gene
duplication,
194
kinetics
and
catalytic
group,
525–527
Michaelis–Menten
kinetic
constants,
489T
proenzymes,
538
X-ray
structure,
527–529,
528F
-Chymotrypsin,
153T,
538,
538F
-Chymotrypsin,
538,
538F
Chymotrypsinogen,
140F,
264F,
527,
538,
538F
CIC
channels,
755–756,
755F
Ciechanover,
A.,
1410
Cilia,
10
Ciliates,
7F,
13F
Cimetidine,
764
Ciprofloxacin
(Cipro),
1167,
1170,
1395
Circular
dichromism
(CD),
284–285,
285F
cI
repressor,
1288
Cis-acting
elements,
1264
Cis
cisternae,
428,
429F
Cis
configuration,
28,
388
Cis
Golgi
network
(CGN),
428,
429F
Cis-SNARE
complex,
444–445
Cis-splicing,
1320
Cisternae,
428
Cisternal
maturation,
428
Cisternal
progression,
428
Cis-trans
test,
28,
28F
Cistrons,
28,
1264,
1340
Citrate:
in
citric
acid
cycle,
789,
790F
glycolysis
inhibition,
863–864
and
metabolic
cycles,
1088–1089
Citrate
condensing
enzyme,
806
Citrate
synthase,
568,
621
in
citric
acid
cycle,
789,
790F,
806–808,
806F,
807F,
815–816
Citric
acid
cycle,
561F,
789–820
acetyl-CoA
synthesis,
792–805
aconitase,
789,
790F,
808–809,
808F
amphibolic
functions,
789,
817–819,
818F
citrate
synthase,
789,
790F,
806–808,
806F,
807F,
815–816
coupling
to
glycolysis,
594F
electron-transport
chain,
824F
energy-producing
capacity,
813
enzymes
of,
806–815
evolution
of,
814–815
fumarase,
790F,
791,
812–813,
812F
integration
of,
813–814,
1090
isocitrate
dehydrogenase,
789,
809–810,
809F,
815–816
-ketoglutarate
dehydrogenase,
789,
810,
815–816
malate
dehydrogenase,
790F,
791,
813
net
reaction,
791
overview,
789–792,
790F
oxaloacetate
in,
873F
pathways
using
intermediates,
818,
872F
pyruvate
dehydrogenase
complex,
792–800,
804–805,
805F
rate-controlling
reactions
of,
815–816
regulation,
815–817,
816F
replenishing
intermediates
of,
818–819
succinate
dehydrogenase,
791,
811–812,
812F
succinyl-CoA
synthetase,
791,
810–811,
811F
Citrulline,
80,
80F,
571F,
1028
L
-Citrulline,
686
Citryl-CoA,
807
CJD,
see
Creutzfeldt-Jakob
disease
Claisen
ester
cleavage,
949–950
Claisen
ester
condensation,
568
Clamp
loader,
1196–1198,
1197F
Clans,
of
Pfam
families,
258
Clardy,
J.,
1116
Clark,
B.,
1380
Class,
Architecture,
Topology,
and
Homologous
superfamily,
see
CATH
Class
I
aaRSs
(aminoacyl-tRNA
synthetases),
1350–1351,
1350T,
1355F,
1358,
1358F
X-ray
structure
of,
1352–1354
Class
I
promoters,
1286
Class
I
release
factors,
1391–1392
Class
II
aaRSs
(aminoacyl-tRNA
synthetases),
1350–1351,
1350T,
1355F,
1358,
1358F
X-ray
structure
of,
1354–1355
Class
II
major
histocompatibiliy
complex
(MHC)
proteins,
1102
Class
II
promoters,
1286–1287
Class
III
promoters,
1287
Classical
thermodynamics,
587
Classification
number,
470
Clathrates,
262F,
263
Clathrin,
430–439
Clathrin
barrel,
437F
Clathrin-coated
vesicles
(CCVs),
431–439,
431F,
433F,
434F
Clathrin
heavy
chain
repeats
(CHCRs),
432F,
433
Clathrin
heavy
chains,
430,
432,
432F
Clathrin
light
chains,
430,
432,
432F,
433F
Claude,
A.,
1362
Clausius,
R.,
56
Cl
channels,
755–756,
755F
Cleavage
and
polyadenylation
specifying
factor
(CPSF),
1302–1303
Cleavage
factor
I,
1302
Cleavage
factor
II,
1302
Cleavage
sites,
type
II
restriction
enzymes,
105,
105T
Cleavage
stimulating
factor
(CstF),
1302–1303
Cleland,
W.
W.,
498,
536
Clinical
trials,
542–543
Clones,
104,
113–114
Cloning.
See
also
Molecular
cloning
directional,
117,
117F
molecular,
see
Molecular
cloning
shotgun,
113
Cloning
vectors
(vehicles),
104,
106–109
Clore,
M.,
656
Closed
complexes,
1268
Closed
conformations:
Klentaq1,
1179–1180,
1179F
Rep
helicase,
1186
Closed
systems,
52
Clostridium
botulinum,
442,
1340
Clotting,
see
Blood
clotting
Cloverleaf
structure,
1329–1330,
1329F,
1346F
ClpA,
1419
ClpP,
531,
531F,
1419,
1419F
Clp
protease,
1419
ClpX,
1419
CLUSTAL,
201–202,
202F,
205,
304
Cmc
(critical
micelle
concentration),
394
CM-cellulose
ion
exchangers,
137–138,
141
CML
(chronic
myelogenous
leukemia),
718
CMP
(cytidine
monophosphate),
83T,
1136F
CMV
(cytomegalovirus),
1403
Cn3D,
256T,
258
CNBr,
see
Cyanogen
bromide
CNX,
see
Calnexin
CO
2
compensation
point,
935–936
CoA,
see
Coenzyme
A
Coagulation,
see
Blood
clotting
Coated
pits,
454,
454F
Coated
vesicles,
428–439,
429F
Coatomer,
430
Cobalamin
coenzymes,
473T,
474T
Cobalt
ion,
1158
Cobratoxin,
781
Cocaine
and
amphetamine-regulated
transcript
(CART),
1099
Cocci,
4
Cochaperone
proteins,
293
Cockayne
syndrome
(CS),
1218
Cocoonase,
525T
Coding
strand,
1266
Codominant
traits,
22,
23F
Codons,
95F,
98–101,
1338,
1343T
anticodon
interactions
with,
1389F
frequently
used,
1360
nonsense
suppressors,
1362,
1362T
triplet,
1340–1341
Coelenterates,
13F
Coenzymes,
473–474,
473T,
474T
biosynthesis
of
flavin,
1138
biosynthesis
of
nicotinamide,
1136–1138
as
covalent
catalysts,
511
Coenzyme
A
(CoA),
82,
473T,
795T.
See
also
Acetyl-CoA
biosynthesis,
1138–1139
discovery,
791–792
Coenzyme
B
12
,
954–955,
954F
Coenzyme
Q
(CoQ;
ubiquinone):
electron-transport
chain
coenzyme,
829–830,
836F
in
oxidative
phosphorylation,
848–849
Coenzyme
Q:Cytochrome
c
oxidoreductase
(Complex
III),
840–841,
840F
Coenzyme
QH*,
836F
Coenzyme
QH
2
,
836F,
848–849
Coenzyme
Q
reductase,
834–835,
837–840
Cofactors,
473
Index
Cohen,
P.,
1025
Cohen,
S.,
107
Cohesive
ends,
105.
See
also
Sticky
ends
Coil
conformation,
230,
232
Coiled
coil
structure
(keratin),
234,
235F
Cointegrate,
1239–1240,
1239F–1241F
Cold
denatured
proteins,
284
Cold-labile
proteins,
130
Colicins,
418
Colicin
E3,
1375
Colipase,
941–942,
941F
Coliphage,
1190
Collagen,
78,
163,
235–240
assembly,
1405
diseases
associated
with,
240
isoelectric
point,
134T
Ramachandran
diagram,
224F
sedimentation
coefficient,
154F
Collagen
1(I),
236F
Collagen
fibrils,
237–240,
237F,
239F,
240T
Collective
motions,
307,
308
Collins,
F.,
181
Collman,
J.,
328
Collodion,
141
Colony
hybridization,
113–114,
114F
Colony-stimulating
factors,
119
Combinatorial
chemistry,
541
Combinatorial
extension
of
optimal
pathway,
256T,
258
Comparative
modeling,
304–305
Compare
3D,
258
Competitive-binding
studies,
674–675
Competitive
inhibition,
493–494,
494F,
747
Complementary
base
pairing,
18,
89
Complementation
group,
27
Complementation
tests,
24–25,
25F,
27
Complement
C1,
525T
Complement
C9,
1317
Complement
system-mediated
reactions,
121
Complex
I
(NADH
dehydrogenase,
NADH:
coenzyme
Q
oxidoreductase),
832T,
834–837,
836F–837F,
845
Complex
II
(Succinate
dehydrogenase,
succinate:
coenzyme
Q
oxidoreductase)
493,
947
in
citric
acid
cycle,
791,
811–812,
812F
and
electron
transport,
832T,
837–840,
839F,
845
Complex
III
(Coenzyme
Q:Cytochrome
c
oxidoreductase,
cytochrome
bc
1
),
832T,
840–841,
840F,
847–850,
849F,
912
Complex
IV
(Cytochrome
c
oxidase,
COX),
153T,
188,
584,
832T,
841–845,
842F,
851–852,
851F,
852F
Complex
V
(proton–translocating
ATP
synthase),
see
F
1
F
0
–ATPase
Complex
oligosaccharides,
888
Complex
systems,
736–738
Complimentary
DNA,
see
cDNA
Composite
transposons,
1237,
1237F
-Conarachin,
140F
Concanavalin
A,
230,
231F,
246F,
249F,
366
Concanavalin
B,
153T
Concentration,
free
energy
and,
58,
61
Concentration
cells,
586
Concerted
general
acid-base
catalyzed
reaction,
507
Condensation
reactions,
for
peptide
bonds,
70F
Condensing
enzyme,
965
Conformational
coupling
hypothesis,
845
Conformation
maps,
223–225
Congenital
erythropoietic
porphyria,
1056
Conjugate
acid,
45
Conjugate
base,
45
Conjugate
redox
pair,
584
Conjugation,
1225
Connective
tissues,
235
Connexins,
415,
416
Connexin
26
(Cx26),
416,
417F
Connexons,
415–416
Conservatively
substituted
positions,
188
Conservative
replication,
90
Constitutive
enzymes,
1261
Constitutive
heterochromatin,
182
Constitutive
mutation,
1262
Contact
inhibition,
381,
703,
1202
Contigs,
180
Contour
lengths,
94
Controlled
rotation,
1166,
1166F
Convergent
evolution,
317
Cooley’s
anemia,
219
Coomassie
brilliant
blue,
149,
411
Cooper,
J.,
1048
Cooperative
binding,
326
Cooperative
process,
92
Cooperman,
B.,
1122
Coordinate
expression,
of
enzymes,
1264
Copia,
1246
COPII
protein,
429F,
430,
437–439,
437F,
439F
COPI
protein,
429F,
430,
437
Coproporphyrinogen
I,
1056
Coproporphyrinogen
oxidase,
448,
1053
CoQ,
see
Coenzyme
Q
Cordycepin,
1270
Core
enzyme,
1265,
1267,
1269
Corepressor,
1297
Core
promoter
element,
1282
Core
proteins,
373
Corey,
R.,
221,
229
Cori,
C.,
595,
651,
880
Cori,
G.,
595,
651,
880
Cori
cycle,
880,
880F
Cori’s
disease,
667
Corn:
Bt
corn,
122
chloroplast,
902F
and
pellagra,
474
transposons,
1236,
1244
CORN
crib
mnemonic,
for
handedness
of
amino
acids,
75,
75F
Cornea,
collagen
fibrils
in,
240T
Cornish-Bowden,
A.,
623
Cornynephage
b,
1397
Corpeus
luteum,
683
Correlated
invariants,
1346
Correlated
spectroscopy
(COSY),
243
Corrin,
954
Cortex,
679
Corticosterone,
680
Corticotropin-releasing
factor
(CRF),
673T,
682
Cortisol,
680
Cosmid
vectors,
108
Cosmid
walking,
181
Cos
site,
108
COSY
(correlated
spectroscopy),
243
Coulomb
(unit),
53T
Coulomb’s
law,
42,
259
Coumadin,
543F
Coumarin,
1167
Coupled
reactions,
60–61,
131
Coupling,
translational,
1398
Covalent
catalysis,
510–511
Covalent
modification,
624
gluconeogenesis,
878–879
glycogen
metabolism,
650–651
Cow.
See
also
related
topics
e.g.:
Bovine
pancreatic
ribonuclease
A
20S
proteasome,
1417
I-11
cellulose
digestion,
369
mad
cow
disease,
312,
315
as
source
of
proteins
for
purification,
130
COX,
see
Complex
IV
Cox,
M.
M.,
1234
COX-1,
998,
999
COX-2,
998,
999
COX-2
inhibitors,
999–1000,
999F
COX-3,
1000
Coxibs,
999
Cozymase,
594
CP43
subunit
(PsbC),
of
photosystem,
916
CP47
subunit
(PsbB),
of
photosystem,
916
CP-320473,
982
CPDs
(cyclobutane
pyrimidine
dimers),
1214–1215
CPE
(cytoplasmic
polyadenylation
element),
1402
CPE-binding
protein
(CPEB),
1402,
1402F
CpG
islands,
1249
cPLA
2
(cytosolic
phospholipase
A
2
),
727
Cpn10,
294
Cpn60,
294
CPS
(carbamoyl
phosphate
synthetase),
1025–1028
CPS
I
(carbamoyl
phosphate
synthetase
I),
1116
CPS
II
(carbamoyl
phosphate
synthetase
II),
1115F–1116
CPSF
(cleavage
and
polyadenylation
specifying
factor),
1302–1303
Craik,
C.,
530
Cramer,
W.,
920
c-Ras
proto-oncogene,
705,
708–709
Crassulacean
acid
metabolism
(CAM),
937
Cravatt,
B.,
404
CRE
(cAMP
response
element),
879
Creatine,
1092
Creatine
kinase,
505,
570,
571F,
583
CREB,
see
CRE
binding
protein
CREB-binding
protein
(CBP),
283–284,
283F
CRE
binding
protein
(CREB),
283–284,
283F,
879
Cre
recombinase,
1243–1244,
1245F,
1259
Cretinism,
677
Creutzfeldt-Jakob
disease
(CJD),
312,
314,
315
CRF,
see
Corticotropin-releasing
factor
Crick,
F.,
88,
95,
236,
1146,
1173,
1260,
1340,
1341,
1345,
1360
Cristae,
9,
824,
825F
Critical
Assessment
of
Structure
Prediction
(CASP),
305
Critical
micelle
concentration
(cmc),
394
Critical
nucleus,
347F
CrkII,
737F
Crocodiles,
blood
oxygen
utilization,
357
Crofts,
A.,
840
Crop
plants,
122.
See
also
Corn;
Rice
Cro
protein,
1288,
1289F
Crossing-over,
20,
24,
24F,
1226–1228
Cross-linking
agents,
270–271,
270F
Cross-
spines,
310–311
Crotoxin,
153T
CRP
(cAMP
receptor
protein),
1286
CRT,
see
Calreticulin
Cryo-electron
microscopy
(cryo-EM),
301,
1365–1366
in
citric
acid
cycle
research,
798
in
secretory
pathway
research,
422–426,
422F,
423F,
425F
Cryptic
branch
site,
1306
Cryptic
splice
sites,
1318

Crystallin,
140F
-B
Crystallin,
252,
253F
I-12
Index
Crystallization,
protein,
134–135,
241–243
Crystallographic
symmetry,
270
Crystal
proteins,
122
CS
(Cockayne
syndrome),
1218
CsA,
see
Cyclosporin
A
c-Src
gene,
705,
706
CstF
(cleavage
stimulating
factor),
1302–1303
CT,
see
Cholera
toxin
CTAB
(cetyltrimethylammonium
bromide),
399F
CTD
(C-terminal
domain),
1277,
1286–1288
CTD
(C-terminal
domain)
kinases,
1277
CTD
(C-terminal
domain)
phosphatases,
1277
C-terminal
domain,
see
CTD
C-terminus,
73
in
protein
sequencing,
165–168
in
protein
synthesis,
1371–1373
CTP
(cytidine
triphosphate),
475F
in
ATCase
feedback
inhibition,
475
synthesis
of,
1118–1119
in
transcription,
96,
1265
CTP
synthetase,
1118
C-Type
cytochromes,
316,
316F,
317F
Cud
chewing,
369
Cul1,
1412,
1413F
Cullin
family,
1412,
1421
Curare,
781
Curie
(Ci),
591
Curry,
S.,
944
Curved
arrow
convention,
564
Cusack,
S.,
1381
Cushing’s
syndrome,
681,
743
Cut-and-paste
transposition
mechanism,
1237–1239,
1238F
Cx26,
see
Connexin
26
Cyanate,
Hb
and,
340
Cyanide,
831
-Cyanoalanine,
80,
80F
Cyanobacteria,
5–6,
7F,
12,
13F
Cyanogen
bromide
(CNBr),
142,
170–171
Cyanosis,
342
3¿,5¿-Cyclic
AMP,
see
cAMP
Cyclic
AMP
response
element-binding
pro-
tein,
see
CREB-binding
protein
(CBP)
Cyclic
cascade,
647–650
Cyclic
depsipeptide,
748
3¿,5¿-Cyclic
GMP,
see
cGMP
2¿,3¿-Cyclic
nucleotides,
508
Cyclic
processes,
53
Cyclic
symmetry,
of
proteins,
268,
268F
Cyclins,
214F,
1202
Cyclin-dependent
protein
kinases,
see
CDKs
Cyclobutane
pyrimidine
dimers
(CPDs),
1214–1215
Cyclobutylthymine
dimer,
1214–1215,
1214F
Cyclohexane,
conformations
of,
363,
363F
Cycloheximide,
1395T,
1396F
Cyclooxygenase
(COX),
406,
997
Cyclopentanoperhydrophenanthrene,
392
Cyclophilin,
724F,
725
Cyclopropane,
398
Cyclosome,
1414
Cyclosporin
A
(CsA),
292–293,
724
Cyglar,
M.,
886
Cys,
see
Cysteine
CysRS,
in
archaebacteria,
1359
Cystathione,
1034
Cysteine:
amino
groups,
208F
biosynthesis,
1071–1072
degradation,
1030–1034
disulfide
bonds,
71,
71F,
168–169
and
fluorescence
resonance
energy
transfer,
286
genetic
codes
for,
100T,
1343T

helix/
sheet
propensity,
302T
as
nonessential
amino
acid,
1065T
side
chains,
71,
208F,
264T
structure
and
general
properties,
69T
Cysteine
proteases,
1417
Cysteinyl-adenylate,
1359
Cystic
fibrosis,
122–123,
427–428
Cystic
fibrosis
transmembrane
regulator
(CFTR)
protein,
427–428
Cystine,
71.
See
also
Cysteine
disulfide
bond
cleavage
in
protein
sequencing,
168–169
stereoisomers,
76,
76F
D
-Cystine,
76,
76F
L
-Cystine,
76,
76F
meso-Cystine,
76,
76F
Cys-tRNA
Cys
,
1359
Cyt,
see
Cytosine
Cytidine,
83T,
1136F
Cytidine
deaminase,
1136F,
1322
Cytidine
monophosphate,
see
CMP
Cytidine
triphosphate,
see
CTP
Cytidylic
acid,
see
CMP
Cytochalasin
B,
769
Cytochrome
a,
838,
838F
Cytochrome
b,
838,
838F,
1408T
Cytochrome
b
5
,
401–402,
402F,
971
Cytochrome
b
6
,
920
Cytochrome
b
6
f
complex,
915,
920–921,
921F
Cytochrome
b
559
,
916
Cytochrome
b
562
,
250F,
251
Cytochrome
bc
1
,
see
Complex
III
Cytochrome
b
H
,
838
Cytochrome
b
L
,
838
Cytochrome
c,
16F,
188–189,
838,
838F,
841–843
amino
acid
sequence,
186T–187T,
189F,
196F
evolution
of,
189,
191F,
316,
317F
folding
of,
284,
289,
289F
half-life,
1408T
isoelectric
point,
134T
molecular
mass,
140F
phylogenetic
tree,
189,
190F
physical
constants
of,
153T
sedimentation
coefficient,
154F
visible
absorption
spectrum,
838F
X-ray
structure
of,
247F
Cytochrome
c
1
,
838F,
840,
848
Cytochrome
c
2
,
912
Cytochrome
c
heme
lyase
(CCHL),
448
Cytochrome
c
oxidase
(COX),
see
Complex
IV
Cytochrome
c
reductase,
188
Cytochrome
f,
914–915,
915F,
920
Cytochrome
P450:
detoxification
reactions,
1225
and
drug
metabolism,
543–545
in
fatty
acid
oxidation,
959
in
heme
biosynthesis,
1055
polymorphic,
545
X-ray
structure,
543F
Cytochrome
P450
reductase,
686
Cytoglobin,
325
Cytokines,
688
c
Cytokine
receptor,
123
Cytokine
receptors,
717
Cytokinesis,
20F,
21F
Cytomegalovirus
(CMV),
1403
Cytoplasm,
4,
1326–1327
Cytoplasmic
polyadenylation,
1401–1402
Cytoplasmic
polyadenylation
element
(CPE),
1402
Cytosine,
18,
83,
83T.
See
also
Watson–Crick
base
pairs
and
genetic
code,
100T,
1343T
IR
spectra
of
derivatives,
1155F
modified
nucleosides
occurring
in
tRNAs,
1347F
and
point
mutation
generation,
1339–1340,
1340F
Cytoskeleton,
10–11,
10F
Cytosol,
9–11.
See
also
related
topics,
e.g.:
Fatty
acid
biosynthesis
citric
acid
cycle
in,
815
gluconeogenesis
in,
876–877,
877F
glycolysis
in,
595
heme
biosynthesis
in,
1054
metabolic
functions,
562T
mRNA
transport
to,
101
Cytosolic
phospholipase
A
2
(cPLA
2
),
727
D
D,
see
Dihydrouridine
D1
protein,
1314
D1
protein
(PsbA),
of
photosystem,
916
D2
protein
(PsbD),
of
photosystem,
916
DAG,
see
Diacylglycerol
DAHP
(2-keto-3-deoxy-
D
-
arabinoheptulosonate-7-phosphate),
1075,
1076F
DAI
(double-stranded
RNA-activated
inhibitor),
1400
Dailey,
H.,
1055
Dalgarno,
L.,
1374
Dalton
(unit),
5
dam
gene,
1247
Dam
methyltransferase
(Dam
MTase),
1196,
1220,
1247
Danio
rerio,
177T
Dansylamino
acid,
165,
166F
Dansylaminoethylthiogalactoside,
770
Dansyl
chloride,
165,
166F
Dansyl
polypeptide,
166F
Dark
reactions,
photosynthesis,
902,
926–937
C
4
cycle,
934–937
Calvin
cycle,
927–934
photorespiration
and
C
4
cycle,
934–937
D
arm,
1346
Darnell,
J.,
718
Darst,
S.,
1268
Darwin,
C.,
19,
28–29,
799
Davies,
D.,
1076
Davis,
R.,
109
Dayhoff,
M.,
198
Dbf4,
1206
Dbf4-dependent
kinase
(DDK),
1206
Dbp5,
1327
DCCD
(dicyclohexylcarbodiimide),
207–208
dcm
gene,
1247
Dcm
methyltransferase
(Dcm
MTase),
1247
DCMU
(3-(3,4-dichlorophenyl)-1,
1-dimethylurea),
915
DDBJ
(DNA
Data
Bank
of
Japan),
195T
ddC
(2¿,3¿-dideoxycytidine),
1208
dd
CTP
(2¿,3¿-dideoxyCTP),
1178–1180
DDE
motif,
1238–1239
ddI
(2¿,3¿-dideoxyinosine),
1208
DDK
(Dbf4-dependent
kinase),
1206
ddNTP
(2¿,3¿-dideoxynucleoside
triphosphate),
117
DEAD-box
family,
1379
Deadenylases,
1327
DEAE-cellulose
ion
exchangers,
137,
141
Deamination:
of
amino
acids,
see
Amino
acid
deamination
of
bases,
1322–1323,
1339–1340,
1339F
Death
cap
(Amanita
phalloides),
1280
Index
Death-inducing
signal
complex,
see
DISC
5-Deazaflavin,
1215
6dEB
(6-deoxyerythronolide
B),
968
Debranching
enzyme,
370,
639,
642–643,
667
DEBS
(deoxyerythronolide
B
synthase),
968
Decamethonium
ion,
788
Decapping
enzyme,
1327
Decay,
of
DNA,
116–117
Decoding,
1379
Decorin,
373T
de
Duve,
C.,
9
Deep
View,
257
Deformylase,
1374
Degeneracy,
of
genetic
code,
99,
1338,
1341,
1343–1344,
1360–1361
Dehydroascorbic
acid,
364
L
-Dehydroascorbic
acid,
364F
7-Dehydrocholesterol,
678
Dehydrogenases,
318,
498
Deinococcus
radiodurans,
1259
Deisenhofer,
J.,
294,
403,
453,
840,
910
de
Lange,
T.,
1213
Deletion
mutations,
1340
DeLucia,
P.,
1181
Dematin,
412
Denaturation:
of
DNA,
90–93,
92F
of
proteins,
see
Protein
denaturation
Denaturation
temperature,
57
Denatured
proteins,
57
Denitrification,
1083
Denitrifying
bacteria,
6
De
novo
methods,
305
Density
gradients,
155
3¿-Deoxyadenosine,
1270
5¿-Deoxyadenosylcobalamin
(AdoCbl),
954–955,
954F
Deoxycytidine
deaminase,
1124
6-Deoxyerythronolide
B
(6dEB),
968
Deoxyerythronolide
B
synthase
(DEBS),
968
Deoxygenated
hemoglobin
(deoxyHb),
329,
331
and
BPG,
341,
341F
structure,
331–333,
334F–335F
Deoxygenated
hemoglobin
S
(deoxyHbS),
343–344,
343F–347F
DeoxyHb,
see
Deoxygenated
hemoglobin
DeoxyHbS,
see
Deoxygenated
hemoglobin
S
Deoxynucleoside
triphosphates,
see
dNTPs
Deoxynucleotides,
82–83
2-Deoxy-PIP
2
,
728
Deoxyribonucleic
acid,
see
DNA
Deoxyribonucleotides,
82–83,
82F,
1119–1130.
See
also
specific
nucleotides
Deoxy-D-ribose,
18
-
D
-2-Deoxyribose,
365
2¿-Deoxyribose,
1119–1126
2¿-Deoxy-
D
-ribose,
83
Deoxyribosomes,
1308
Deoxy
sugars,
365
Deoxythymidine,
83T,
1136F
Deoxythymidine
monophosphate
(dTMP),
83T,
1127–1128
Dephospho-CoA
kinase,
1138,
1139F
Dephospho-CoA
pyrophosphorylase,
1138,
1139F
Depsipeptides,
1272
Dermatan
sulfate,
371F,
372
Dermatosparaxis,
1404
Desamido
NAD

(nicotinate
adenine
dinucleotide),
1138
Desaturases,
969–971
de
Saussure,
T.,
901
Desensitization,
697
Destruction
box,
1414
Detergents,
262,
265,
399F
Detergent-resistant
membranes
(DRMs),
411
Deubiquitinating
enzymes,
see
DUBs
Deuterium,
see
Hydrogen
exchange
de
Vos,
A.,
684
Dextran
gels,
137,
139,
140T,
141
-Dextrinase,
370
Dextrins,
370
Dextrorotatory
molecules,
74
D
forms
(amino
acids),
74–76
d
gene
(fruit
fly),
25F
DGLA
(dihomo--
linolenic
acid),
994
DH
(-hydroxyacyl-ACP
dehydrase),
965
DHA
(4,7,10,13,16,
19-Docosahexenoic
acid),
387T,
971
DHAP,
see
Dihydroxyacetone
phosphate
Dhe-Paganon,
S.,
1250
DHF,
see
Dihydrofolate
DHFR,
see
Dihydrofolate
reductase
DHODH,
see
Dihydroorotate
dehydrogenase
Diabetes
insipidus,
743
Diabetes
mellitus,
310,
1102–1104,
1409.
See
also
Insulin
1,2-Diacylglycerol,
941
Diacylglycerol
(DAG),
661,
994
Diacylglycerol
acyltransferase,
971
Diacylglycerol
lipase,
994
Diacylglycerophospholipids,
1004–1005,
1005F
Diagonal
plot,
196
Dialysis,
117,
132T,
141,
141F
Diaminopimelic
acid,
123,
377F
Diastase,
469
Diastereomers,
75–76
Diatoms,
13F
Diatomaceous
earth,
144
6-Diazo-5-oxo-
L
-norleucine
(DON),
1142
O-diazoacetyl-
L
-serine,
1142
Diazotrophs,
1080
Dicer
(RNase),
1324
3-(3,4-Dichlorophenyl)-1,1-dimethylurea
(DCMU),
915
Dickens,
F.,
892
Dickerson,
R.,
89,
529,
1148
Dicyclohexylcarbodiimide
(DCCD),
207–208
N-,N’-Dicyclohexylurea,
207
Didanosine,
1208
2¿,3¿-Didehydro-3¿-deoxythymidine,
1208
2¿,3¿-DideoxyCTP
(ddCTP),
1178–1180
2¿,3¿-Dideoxycytidine
(ddC),
1208
2¿,3¿-Dideoxyinosine
(ddI),
1208
Dideoxy
method,
176.
See
also
Sanger
method
2¿,3¿-Dideoxynucleoside
triphosphate
(ddNTP),
177
Dielectric
constants,
42–43,
43T
2,4-Dienoyl-CoA
reductase,
952
3,5-2,4-Dienoyl-CoA
reductase,
952
Diethylaminoethyl
cellulose
ion
exchangers,
see
DEAE-cellulose
ion
exchangers
Diethyl
ether,
43T,
144,
398
Diethylpyrocarbonate,
312–313,
313F
Diet-induced
thermogenesis,
1099–1100
Differential
centrifugation,
130
Diffusion
coefficient,
745
Diffusion-controlled
limit,
490
Digalactosyl
diacylglycerol,
902
Digitalis,
539,
761–762,
761F
Digitoxin,
761–762
Dihedral
angles,
222–225
Dihedral
symmetry,
of
proteins,
268,
268F
Dihomo--linolenic
acid
(DGLA),
994
7,8-Dihydrobiopterin,
1043–1044
I-13
Dihydroceramide,
1009
Dihydroceramide
reductase,
1009
Dihydrofolate
(DHF),
445,
492,
1062,
1127
Dihydrofolate
reductase
(DHFR),
300,
445,
492,
1044,
1062,
1129–1130
Dihydrolipoamide,
in
citric
acid
cycle,
794–795,
795F
Dihydrolipoamide
dehydrogenase,
796
Dihydrolipoyl
dehydrogenase,
792,
801–804,
801–814,
802F,
804F
Dihydrolipoyl
transacetylase
(E2),
792,
793F,
795–797,
796F,
797F
Dihydrolipoyl
transsuccinylase
(E2o),
810
Dihydroorotase,
1115F,
1116,
1118
Dihydroorotate,
1115F,
1116
Dihydroorotate
dehydrogenase
(DHODH),
1115F,
1116
Dihydropteridine
reductase,
1044
Dihydrosphingosine,
391F,
1009
Dihydrouracil,
1136F
Dihydrouracil
dehydrogenase,
1136F
Dihydrouridine
(D),
1346,
1347F
Dihydroxyacetone,
361,
361F
Dihydroxyacetone
phosphate
(DHAP),
596F,
600–603,
929,
944F
Dihydroxyacetone
phosphate
acyltransferase,
971
1,25-Dihydroxycholecalciferol
(1,25(OH)2D),
678,
679
3,4-Dihydroxyphenylalanine,
see
L-DOPA
Dihydroxythymine,
1136F
Diimine,
1082
Diisopropylphosphofluoridate
(DIPF),
526–527
Diketogulonic
acid,
364
L
-Diketogulonic
acid,
364F
Diketopiperazine,
243F
Dill,
K.,
262,
281,
287
Dimers,
267
Dimethoxytrityl
(DMTr)
protecting
group,
210F,
211
N
6
-N
6
-Dimethyladenosine,
1156–1157
Dimethylallyl
pyrophosphate,
977
1-Dimethylamino-naphthalene-5-sulfonyl
chloride,
see
Dansyl
chloride
5,6-Dimethylbenzimidazole
(DMB),
954
N,N-Dimethylformamide,
see
DMF
N
2
,N
2
-Dimethylguanosine
(m
2
2
G),
1347F
Dimethyloxaloacetate,
511
Dimethylsuberimidate,
270,
270F
Dimethyl
sulfate
(DMS),
1267
Dimethyl
sulfoxide,
see
DMSO
dinB
gene,
1222
2,4-Dinitrofluorotoluene
base,
1177
2,4-Dinitrophenol
(DNP),
860
Dinoflagellates,
13F
Dintzis,
H.,
1371
Dinucleotide-binding
fold,
256
Dioldehydrase,
1018
Dipeptides,
70,
70F
DIPF
(diisopropylphosphofluoridate),
526–527
Diphosphatidylglycerol,
389T
1,3-Diphosphoglycerate,
607
2,3-Diphosphoglycerate
(DPG),
329
Diphthalamide
residue,
eEF2,
1398
Diphtheria,
1397–1398
Diphtheria
toxin
(DT),
123,
153T,
1395T,
1397–1398
Diplococcus
pneumoniae,
85
Diploid
cells,
24F
Diploid
genome,
182
Diploid
number,
19
Dipolar
ions,
70
Dipole-dipole
interactions,
260–261,
260F
I-14
Index
Dipole
moment,
39,
43T
Dipyrromethane,
1053
Directional
cloning,
118,
118F
Direct
transposition,
1237–1239
Disaccharides,
367
Disc
electrophoresis,
148,
148F,
149F
Discontinuous
pH
electrophoresis,
148,
148F
Discriminator
base,
1351F
Disorder,
entropy
and,
54–57
Dissociation
constant
(K
a
):
and
acid
strength,
45–47,
46T
and
pH,
47
of
polyprotic
acids,
49–50
Distal
histidine,
in
hemoglobin,
332,
340
Distance-based
tree-building,
205
Distance
matrix,
204–205
Distributive
enzymes,
1177
Disulfide
bonds:
cysteine,
71,
71F
insulin,
165F
interchange
reaction,
280F
keratin,
235
in
native
proteins,
292
in
protein
sequencing,
168–169,
172,
184
and
protein
stability,
264–265
Divergent
evolution,
254,
317
Dixon,
J.,
736
DL3,
714
D-loops,
1213
DM
(myotonic
dystrophy),
1252
DMB
(5,6-dimethylbenzimidazole),
954
DMF
(N,N-dimethylformamide),
134,
262
DMS
(dimethyl
sulfate),
1267
DMSO
(dimethyl
sulfoxide),
43T,
134,
262
DNA
(deoxyribonucleic
acid),
3,
18,
1145.
See
also
related
topics,
e.g.:
DNA
repair
A-DNA,
1146F,
1147F,
1148–1149,
1148T,
1151
B-DNA,
1145–1148,
see
B-DNA
as
carrier
of
genetic
information,
85–88
and
central
dogma
of
molecular
biology,
95,
1260
chemical
structure,
84–85
cloning,
see
Molecular
cloning
complementary
base
pairing,
18
decay
of,
116–117
denaturation
and
renaturation,
90–93,
92F,
93F
double
helical
structure,
1145–1148
fractionation,
156–159
frictional
ratio,
155
junk,
1317
mutationos
of,
see
Mutations
in
nucleus,
8–9
replication,
18F,
90,
101–104,
102F
sedimentation
coefficients,
154F
semiconservative
replication,
1173–1174
semidiscontinuous
replication,
1175–1176,
1175F
size,
94–95
structure,
18F
supercoiled,
1158–1170
transcription,
95–98
X-ray
diffraction,
88F
Z-DNA,
1146F,
1147F,
1148T,
1149–1151
DnaA
boxes,
1194,
1195
dnaA
gene,
1196
DnaA
protein,
1194–1195,
1206
dnaB
gene,
1182T
DnaB
helicase,
1191,
1193–1194
DNA-binding
domain,
705
DnaB
protein,
1206
in
prokaryotic
replication,
1190,
1190T,
1191,
1195,
1199
in
unwinding
of
DNA,
1183,
1184,
1184T
DNA
chips,
see
DNA
microarrays
DnaC
protein,
1190,
1190T,
1195,
1206
DNA
Data
Bank
of
Japan
(DDBJ),
195T
DNA-directed
DNA
polymerases,
see
DNA
polymerases
DNA-directed
polymerases,
1173.
See
also
DNA
polymerases
dnaG
gene,
1176
DNA
glycosylases,
1218
DnaG
protein,
1190T
DNA
gyrase,
1166–1169,
1174–1175,
1190,
1195
DnaJ,
293
DnaK,
293
DNA
ligase,
103,
103F,
1176
in
DNA
replication,
1187–1188,
1188F,
1189F
in
mismatch
repair,
1220
DNA
ligase
IV,
1224
DNA
methylation,
1246–1252
DNA
methyltransferase,
104,
105
DNA
microarrays,
211–213,
211F,
212F,
213F
dnaN
gene,
1182T
DNA
photolyases,
1214–1215,
1215F
DNA
polymerase,
101–103,
102F,
1173–1174,
1174F
bypass,
1222
error-prone,
1222
eukaryotic,
1202–1205,
1203T
intercalating
agents
inhibit,
1272
nucleotidyl
transferase
mechanism,
1180F
in
PCR,
114–115
properties
of
selected
animal,
1203T
replication
fidelity,
1200–1201,
1201F
RNA-directed,
95F,
116
and
semidiscontinuous
replication,
1175–1176
and
TERT,
1210
T7
DNA
polymerase,
179
DNA
polymerase

(pol
),
1202–1203
DNA
polymerase

(pol
),
1205
DNA
polymerase
,
see
Pol

DNA
polymerase
,
see
Pol

DNA
polymerase
ε,
see
Pol
ε
DNA
polymerase
,
see
Pol
DNA
polymerase
␩,
see
Pol
␩
DNA
polymerase
,
see
Pol
DNA
polymerase
,
see
Pol

DNA
polymerase
I
(Pol
I),
103,
103F,
1176–1181
in
bacteriophage
X174
replication,
1191
in
bacteriophage
M13
replication,
1190F
error
correction,
103–104
error
rate,
1220
as
A
family
polymerase,
1202
in
gene
manipulation,
109
role
in
recombination
repair,
1234
in
site-directed
mutation,
119
T.
thermophilus,
1179F
use
in
nucleic
acid
sequencing,
177–179
DNA
polymerase
II
(Pol
II),
1181,
1181T
as
B
family
polymerase,
1202
role
in
SOS
repair,
1222
DNA
polymerase
III
(Pol
III),
103,
1182–1183
as
C
family
polymerase,
1202
error
correction,
103–104
role
in
mismatch
repair,
1220
DNA
polymerase
IV
(Pol
IV),
1182,
1222
DNA
polymerase
V
(Pol
V),
1182,
1222
DNA
polymerase
A
family,
1202,
1205
DNA
polymerase
B
family,
1202
DNA
polymerase
C
family,
1202
DNA
polymerase
D
family,
1202
DNA
polymerase
X
family,
1202
DNA
polymerase
Y
family,
1202
dnaQ
gene,
1182T
DNA
recombination,
see
Recombination
DNA
repair,
1213–1225
and
carcinogen
identification,
1224–1225
direct
damage
reversal,
1214–1216
double-strand
break
repair,
1223–1224
excision
repair,
1216–1219
mismatch
repair,
1220
and
Pol
I,
1181
and
replication
fidelity,
1200–1201
and
SOS
response,
1221–1223
DNA
replicase,
1182
DNA
replication,
18–19,
1145,
1173–1213.
See
also
related
topics,
e.g.:
DNA
ligase
enzymes
for,
1176–1189
in
eukaryotes,
1201–1213
in
meiosis,
21F
in
mitosis,
20F
overview,
1173–1176
in
prokaryotes,
1173,
1190–1201,
1200F
semiconservative
nature
of,
90,
91F,
1173–1174
semidiscontinuous,
1175–1176,
1175F
telomeres,
1209–1213
unwinding,
1183–1187
and
viruses,
27
DNA–RNA
hybrids,
96,
1151,
1151F
DNase
I,
1181
DNA
sequencing:
automated,
179–180
genome
sequencing,
180–182
Sanger
method,
176–180
sequence
databases,
194–195
DNA
topoisomerases,
1176
DnaT
protein,
1190,
1190T
DNA
unwinding
elements
(DUEs),
1194
dnaX
gene,
1182T
DNMT1,
1250
DNMT3a,
1250
DNMT3b,
1250
DNP
(2,4-dinitrophenol),
860
dNTPs
(deoxynucleoside
triphosphates):
in
chain-terminator
method,
177–179
in
DNA
replication,
101,
1170,
1174F
and
replication
fidelity,
1200–1201
Docking
proteins,
420,
710
4,7,10,13,16,19-Docosahexenoic
acid,
see
DHA
Dodecyltriethylammonium
bromide
(DTAB),
399F
Dodson,
E.,
1216
Dogs:
fatty
acid
experiments
with,
945
number
of
chromosomes,
19T
Dolichol,
883,
883F
Dolichol-P-mannose,
884
Dolichol-PP-oligosaccharide
synthesis,
884F,
885
Domains:
of
life,
6
of
proteins,
247,
281
Domain
swapping,
718
Dominant
traits,
20–22
DON
(6-Diazo-5-oxo-L-norleucine),
1142
Donnan
equilibrium,
787
Donohue,
J.,
88
Dopamine,
80,
80F,
783,
1058–1060
Dopamine
-hydroxylase,
1060F
Dopamine
receptors,
689
Dot
matrices,
sequence
alignment
using,
196–197,
197F
Dot
plot,
196
Double
blind
tests,
542–543
Double-displacement
reactions,
499
Index
Double
helical
structure,
of
DNA,
88–90
Double-reciprocal
plot,
490,
490F,
494F–496F,
499F,
500F
doublesex
(dsx)
pre-mRNA
(Drosophila
melanogaster),
1318
Double-sieve
mechanism,
1356
Double-strand
breaks,
see
DSBs
Double-stranded
DNA,
see
dsDNA
Double-stranded
RNA,
see
dsRNA
Double-stranded
RNA-activated
inhibitor
(DAI),
1400
Double-stranded
RNA-activated
protein
kinase
(PKR),
1400
Doublié,
S.,
1303
Doubly
wound
sheets,
254,
255F
Douce,
R.,
1032
Doudna,
J.,
1324
Down
mutations,
1266
Down’s
syndrome,
312
Doxorubicin,
1169,
1170
DPG
(2,3-diphosphoglycerate),
329
dp
gene
(fruit
fly),
25F
Dpo4,
1222,
1222F
Drew,
H.,
89,
1148
Driving
force,
587
drk
protein,
709
DRMs
(detergent-resistant
membranes),
411
Drosha,
1325
Drosophila
melanogaster,
23F
alternative
splicing,
1318,
1319F
cacophony
pre-mRNA,
1322
chromosome
number,
19T
complementation
test,
25F
DNA,
94,
94T,
95F
Dscam
protein,
1318
genetic
experiments,
23–26
genetic
map,
25F
genome
sequencing,
113,
177T,
182
mitochondria,
1344T
per
gene,
120F
26S
proteasome,
1411F
replication,
1176F,
1202,
1205F
RNA
interference,
1324
spliceosomes,
1312F
transposons,
1244,
1246
ubiquitin,
1409
Drugs,
78,
396,
968
Drug
design,
539
cytochromes
P450,
543–545
discovery
techniques,
539–541
HIV
protease
and
its
inhibitors,
545–551
pharmacology,
542–545
structure-based,
541
Drug
discovery,
539–541
Drug–drug
interactions,
544
Druker,
B.,
719
DSBs
(double-strand
breaks),
1223–1224,
1235F
Dscam
protein,
1318
dsDNA
(double-stranded
DNA),
18F
detection
by
electrophoresis,
158,
158F
Klentaq1,
1180
replication,
102–103,
1174
from
semiconservative
replication,
90
dsRNA
(double-stranded
RNA),
85,
1323
DSX-F
protein,
1318
DSX-M
protein,
1318
dsx
(doublesex)
pre-mRNA
(Drosophila
melanogaster),
1318
DT,
see
Diphtheria
toxin
DTAB
(dodecyltriethylammonium
bromide),
399F
dTMP,
see
Deoxythymidine
monophosphate
DUBs
(deubiquitinating
enzymes),
1417–1418,
1420–1421
Ducruix,
A.,
709
DUEs
(DNA
unwinding
elements),
1194
Dunathan,
H.,
1033
Dunn,
M.,
1078
Duplex
DNA,
90,
1159F.
See
also
dsDNA
(double-stranded
DNA)
dUTP,
1218
dUTP
diphosphohydrolase
(dUTPase;
dUTP
pyrophosphate),
1126
Dutton,
L.,
841
Dutzler,
R.,
755
du
Vigneaud,
V.,
205
Duysens,
L.,
909
Dwarfism,
685
Dyad
axes,
89F
Dynamic
mutations,
1251–1252
Dynamin,
436
Dynamite,
743
Dynein,
440
Dystrophin,
1305
E
E1,
see
Pyruvate
dehydrogenase;
Ubiquitin-activating
enzyme
E1b,
799
EI
(Enzyme
I),
of
PTS
system,
765
E1o,
see
-Ketoglutarate
dehydrogenase
E1p,
799
E1
protein:
of
bovine
papillomavirus,
1184–1185,
1185F
and
Rho
factor,
1275–1276
E2,
see
Dihydrolipoyl
transacetylase;
Ubiquitin-conjugating
enzyme
EIIA,
of
PTS
system,
765,
767F
EIIB,
of
PTS
system,
765
EIIC,
of
PTS
system,
765
EII,
of
PTS
system,
765
E2o
(dihydrolipoyl
transsuccinylase),
810
E3,
see
Ubiquitin-protein
ligase
E3,
1413,
1414
E3b,
799
E3
binding
protein
(E3BP),
798
E3o,
799
E3p,
799
E4P,
see
Erythrose-4-phosphate
E6-associated
protein
(E6AP),
1414
E6
protein,
1414
E.
coli,
4–5,
4F.
See
also
Bacteriophages;
specific
genes

1776
strain,
123
Ada
protein,
1216
ampicillin
resistant,
26
aspartokinase
isoenzymes,
1075T
BAC
replication
in,
109
and
bacteriophages,
27F,
28,
86F,
87,
87F,
1340
biological
structures,
14,
15F
carbamoyl
phosphate
synthetase,
1027–1028
catabolite
repression,
1285–1288
CCA-adding
polymerase,
1331
chromosome
replication,
1195
cloning
of,
104
DNA
conservation
experiments,
90,
91F
DNA
ligase,
1188,
1188F,
1189F
DNA
methylation,
1247
DNA
of
humans
vs.,
8–9
DNA
repair,
1214
DNA
replication,
102F–104F,
103,
104
DNA
size,
94T
elongation
cycle,
1380F
enzyme
induction,
1260–1264
fMet,
1374
genome
sequencing,
113,
177T
GroEL/ES
system,
294–302
I-15
heat
shock
proteins,
293,
294
homologous
recombination,
1228–1230
inclusion
bodies,
117,
117F
internal
structure,
5F
isocitrate
dehydrogenase,
817
lac
operon,
97,
97F
membrane
of,
398T
mismatch
repair,
1220,
1220F
molecular
composition,
5T
multiforked
chromosomes,
1195,
1195F
nonsense
suppressors,
1362,
1362T
nucleotide
excision
repair,
1217
Pol
I,
1176–1181,
1181T
Pol
I
Klenow
fragment,
1178F
Pol
II,
1181,
1181T
Pol
III,
1181T,
1182–1184,
1182T,
1183F
Pol
IV,
1182
Pol
V,
1182
pre-mRNA
splicing,
1312
primase,
1188–1189,
1189F
promoters,
1266,
1267F
pUC18
cloning
vector,
107,
107F,
111
pyrimidine
synthesis
regulation,
1118F
pyruvate
dehydrogenase
complex,
792,
793F
RecBCD,
1231,
1231F
replication,
1174F,
1192–1200,
1193F
replication
in,
1183–1187,
1184T
replication
rate,
1174–1175
replisome,
1196F
Rho
factor,
1276F
ribosome
complements,
1363T
ribosomes,
367F,
1363–1365,
1363F–1366F,
1370–1371
RNAP,
1265–1266
RNA
primers,
1176
RNAP
subunits,
1277T
RuvABC
in,
1231
semidiscontinuous
replication,
1175
shuttle
vectors,
118

factors,
1284
simultaneous
transcription
and
translation,
1283F
as
source
of
proteins
for
purification,
130
termination
pathway
in
ribosomes,
1391F
Ter
sites
and
oriC
locus,
1199F
thymine
dimer
effect,
1214–1215
topoisomerase
III
Y328F
mutant,
1163–1165,
1164F
TPP-sensing
riboswitch,
1300,
1300F
transcription
in,
1271–1273,
1273F,
1284–1301
translation
in,
1375F,
1376F
tRNA
genes,
1330
two-dimensional
gel
electrophoresis
of,
152F
type
II
restriction
enzymes,
105T
UV
absorbance
spectra
of
nucleic
acids
and
DNA,
92F
E54K
mutation,
1239
Ealick,
S.,
1116
Early
endosome
antigen
1
(EEA
1),
734,
735F
early
genes,
1284
Eaton,
W.,
346,
353
4E-BP1,
1401
4E-BP2,
1401
4E-BP3,
1401
Ebright,
R.,
1286,
1287
EBS
(epidermolysis
bullosa
simplex),
235
Echinoderms,
13F
Eck,
M.,
716,
721
Eclipsed
conformation,
222,
223F
EcoRI,
105,
105F,
105T,
106
EcoRII,
105T
I-16
Index
EcoRV,
105–106,
105F,
105T,
109
ECS
(editing
site
complementary
sequence),
1323F
Ectodomains,
453,
684
ED
50
,
539
Edema
factor
(EF),
anthrax,
715
Edidin,
M.,
408
Editing:
of
DNA
chain,
1170,
1201
of
tRNA,
1355–1358
Editing
site
complementary
sequence
(ECS),
1323F
Editosome,
1321–1322
Edman,
P.,
165,
171
Edman
degradation,
165,
167F,
171,
172,
174
Edman’s
reagent,
165,
167F
EDTA
(ethylenediaminetetraacetic
acid),
157
EEA
1,
see
Early
endosome
antigen
1
eEF1A,
1388,
1389F
eEF1B,
1388
eEF1B
,
1388,
1389F
eEF1B
,
1388
eEF2,
1388,
1398,
1405
EF,
see
Edema
factor;
Elongation
factor
EF1A,
1379
EF1B,
1379
EF2,
1385–1386
Effectors,
348,
442,
625T,
688
EF-G,
1375T,
1385–1388,
1386F
EF
hands,
656
Efstradiadis,
A.,
1306
EF-Ts,
1375T,
1379,
1381–1382,
1382F
EF-Tu,
1375T
in
chain
initiation,
1382F,
1386,
1386F,
1388
and
Gln-tRNA
Gln
,
1358
and
initiator
tRNA,
1380–1381,
1381F
and
translational
accuracy,
1390–1391
Egelman,
E.,
1228
EGF,
see
Epidermal
growth
factor
EGF
receptor,
699
EH,
see
Enoyl-CoA
hydratase
E
Helix,
242F
EHK
(epidermolytic
hyperkeratosis),
235
Ehlers-Danlos
syndromes,
240,
1404
Eicosanoid
metabolism,
993–997
for
leukotrienes
and
lipoxins,
996F,
1000–1004
for
prostaglandins,
prostacyclins,
and
thromboxanes,
996F,
997–1000
Eicosanoid
receptors,
689
5,8,11,14,17-Eicosapentaenoic
acid,
see
EPA
8,11,14-Eicosatrienoic
acid,
994
eIF1A,
1376
eIF2,
1376,
1399–1401
eIF2,
1399–1401
eIF2B,
1379,
1399
eIF2
kinases,
1399
eIF2
phosphatase,
1399
eIF3,
1376
eIF4A,
1378
eIF4B,
1365,
1379
eIF4E,
1378,
1399,
1401
eIF4F,
1378
eIF4G,
1327,
1378
eIF4H,
1379
eIF5,
1379
eIF5B,
1379
eIFn,
1376,
1378
80S
subunit
(ribosome),
1370T,
1371,
1371F
Einstein
(unit),
903
Eisenberg,
D.,
310,
929,
1068,
1315
EJC
(exon
junction
complex),
1326–1327
Eklund,
H.,
934,
1119,
1122
Elastase,
525,
525T,
529T
gene
duplication,
194
proenzymes,
538
specificity,
169T
X-ray
structure,
528F,
530,
534–535,
535F
Elasticity
coefficient,
622
Elastin,
240,
529
Electrical
synapses,
778
Electric
fish,
779–780
Electroblotting,
111
Electrochemical
cells,
584,
584F
Electrochemical
potential,
745
Electromotive
force
(emf),
584
Electron
acceptor,
584
Electron
density,
241
Electron
density
maps,
241–242,
242F
Electron
donor,
584
Electronic
complementarity,
Watson–Crick
base
pairs,
1155–1156
Electron
pairs,
acids/bases
and,
45
Electron
paramagnetic
resonance
(EPR),
911
Electron
paramagnetic
spectroscopy,
911
Electron
spin
resonance
(ESR)
spectroscopy,
911
Electron-transfer
flavoprotein
(ETF),
948
Electron-transfer
reactions,
586
Electron
transport,
188,
386,
823,
828–845.
See
also
Oxidative
phosphorylation
and
acyl-CoA
reoxidation,
948
Coenzyme
Q:Cytochrome
c
oxidoreductase,
832T,
840–841,
841F
components
of,
833–845
cytochrome
c
oxidase,
832T,
841–845,
842F
inhibitor
studies,
831,
831F
in
mitochondria,
823–828
NADH:Coenzyme
Q
reductase,
832T,
834–835
net
reaction,
824F,
829–830,
829F
P/O
ratio,
831–833,
833F
in
purple
photosynthetic
bacteria,
909–913,
913F
reduction
potentials
of
components
in
testing
mitochondria,
832T
rigid
coupling
of
phosphorylation
and
oxidation,
831–833
sequence
of,
829–833
thermodynamics,
828–829
two-center,
in
photosynthesis,
913–925
Electron
tunneling,
841
Electrophiles,
563–564,
563F
Electrophilic
catalysis,
510
Electrophoresis,
132T
capillary,
152
gel,
147–150
isolelectric
focusing,
150–152
nucleic
acids,
158–159
paper,
146–147
proteins,
146–152
SDS–PAGE,
150
Electrophoretic
mobility,
146
Electroplaques,
779,
779F
Electrospray
ionization
(ESI),
172
Electrostatic
forces,
protein
stability
and,
259–261
Elements,
periodic
table,
31F
Elemental
composition,
humans,
29T
Elementary
reactions,
483
11S
regulator,
1418–1419
Elimination
reactions,
566–567,
567F
Elion,
G.,
1130
ELISA,
see
Enzyme-linked
immunosorbent
assay
Ellis,
J.,
293
Elongases,
969–971
Elongation
factor
(EF),
422–423,
1375T,
1379
Elution,
in
ion
exchange
chromatography,
136
Embden,
G.,
595
Embden–Meyerhoff–Parnas
pathway,
595.
See
also
Glycolysis
EMBL
Nucleotide
Sequence
Database,
195T
Embryogenesis,
1250–1251,
1401
Embryological
development,
14F
Embryonic
stem
cells,
121
Emergent
properties,
738
Emf
(electromotive
force),
584
Enantiomers,
74–76,
74F
Endergonic
processes,
57
End
groups,
amino
acid,
165–168
Endo,
T.,
446
Endo
conformation,
1153,
1153F
Endocrine
glands,
671,
672F
Endocrine
hormones,
671
Endocrine
system,
672F
Endocytosis,
8,
433,
454F,
986,
986F
Endoglycosidases,
366
Endonucleases,
1160,
1407–1408.
See
also
Restriction
endonucleases
Endopeptidases,
169–170,
169T,
194
Endopeptidase
Arg-C,
169T
Endopeptidase
Asp-N,
169T
Endopeptidase
Glu-C,
169T
Endopeptidase
Lys-C,
169T
Endoplasmic
reticulum
(ER),
7F,
9,
11F
metabolic
functions,
562T
rough,
see
Rough
endoplasmic
reticulum
secretory
pathway
in,
420–424
smooth,
see
Smooth
endoplasmic
reticulum
-Endorphin,
673T,
685
Endosomes,
455F
Endothelial
NOS
(eNOS),
686–688
Endothelium,
686
Endothermic
processes,
53
Endotoxins,
688
-Endotoxins,
122
End
point,
of
titration,
51
Enediolate
anion,
567
Energy,
53
conservation
of,
52–54
and
evolution,
34
metabolic
processes,
17
for
prokaryotes,
5–6
Energy
barrier,
to
free
rotation
of
polypeptide
backbone,
222–223
Energy
coupling,
845
Energy
metabolism
strategies,
1088–1090
Energy-rich
bonds,
580
Energy-rich
compounds,
see
High-energy
compounds
Energy
surface,
in
landscape
theory,
287
Energy
transduction,
587,
845
Engelman,
D.,
1365
Englander,
W.,
285
Englemann,
T.,
901
Enhancers,
1282–1283,
1337
Enolase,
567,
596F,
612–613,
613F
Enolate,
568,
569F
Enol
forms,
of
nucleotide
bases,
88
Enol
phosphates,
580
5-Enolpyruvylshikimate-3-phosphate
synthase
(ESPS-synthase),
1075
eNOS
(endothelial
NOS),
686–688
Enoyl-ACP
reductase
(ER),
965
Enoyl-CoA
hydratase
(EH),
947,
947F,
948,
958
Enoyl-CoA
isomerase,
950
3,2-Enoyl-CoA
isomerase,
952
Enteropeptidase,
537
Index
Enthalpy,
53–54
Entner–Doudoroff
pathway,
636–637
Entropy,
55–57
of
peptidyl
transferase
reaction,
1384–1385
and
protein
folding,
284,
287
and
temperature,
56F
unitary
entropy
change,
263T
env,
1246
Enzymatic
interconversion,
see
Covalent
modification
Enzymes,
4,
163,
469–479.
See
also
specific
enzymes
activity
control,
474–479
allosteric
control,
476–479
in
assays,
131
catalytic
activity
of,
243
chemical
catalysts
vs.,
469
coenzymes,
473–474
for
DNA
replication,
1176–1189
DNA
replication
error
repairing,
103–104
feedback
inhibition
control
for,
475
geometric
specificity,
472–473
as
globular
proteins,
241
historical
perspective,
469–470
for
liposome
delivery,
396
nomenclature,
479
one
gene-one
enzyme
maxim,
26
processive
and
distributive,
1177
selective
catalysis
by,
588–589
stereospecificity,
470–472
substrate
specificity,
470–473,
470F
Enzyme
I
(EI),
of
PTS
system,
765
Enzyme
catalysis.
See
also
Drug
design
acid–base
catalysis,
506–510
covalent
catalysis,
510–511
electrostatic
catalysis,
512
lysozyme,
517–525
metal
ion
catalysis,
511–512
and
preferential
transition
state
binding,
515–516,
516F
and
proximity/orientation
effects,
512–515
serine
proteases,
525–537
zymogens,
537–538
Enzyme
Commission,
470
Enzyme
induction,
1260–1264
Enzyme
inhibition,
493–496
Enzyme
kinetics,
482,
487–492
bisubstrate
reactions,
497–501
competitive
inhibition,
493–494
data
analysis,
490–491
and
flux
control
coefficient,
621–622
Haldane
relationship,
491–492
Michaelis–Menten
kinetics,
488–491,
496–497,
501–503
mixed
inhibition,
495–496
pH
effects,
496–497
reversible
reaction,
491–492
uncompetitive
inhibition,
495
Enzyme-linked
immunosorbent
assay
(ELISA),
131–132,
132F
Enzyme-substrate
complex,
470F,
488
Enzymology,
469
EPA
(5,8,11,14,17-eicosapentaenoic
acid),
387T,
971,
994,
1002–1003
Epidermal
growth
factor
(EGF),
453–454,
997,
1317
Epidermal
growth
factor
(EGF)
receptor,
699
Epidermis,
16F
Epidermolysis
bullosa
simplex
(EBS),
235
Epidermolytic
hyperkeratosis
(EHK),
235
Epigenetic
genome
changes,
1249–1250
Epigenetic
reprogramming,
1250–1251
Epimers,
361
Epimerization,
567
Epinephrine,
673T,
679–680
in
fatty
acid
metabolism
regulation,
973
in
glycogen
metabolism
regulation,
660
synthesis,
1058–1060
Epithelial
cells,
373,
410
Epitopes,
205
EPO,
see
Erythropoietin
Epoxy-activated
agarose,
142,
143F
2¿,3¿-Epoxy-ATP,
1180
EPR
(electron
paramagnetic
resonance),
911
E
protein,
1314
Equatorial
groups,
in
sugars,
363
Equilibrium,
55,
58–61,
587
Equilibrium
constants,
45–47,
58–59,
58T
Equilibrium
density
gradient
ultracentrifu-
gation,
90,
91F,
155,
156,
159
Equilibrium
thermodynamics,
587–588
Equivalence
point,
48
ER,
see
Endoplasmic
reticulum;
Enoyl-ACP
reductase
Erabutoxin,
781
ERAD
process,
427
Erbitux,
720
eRF1,
1392
eRF3,
1392
Ergocalciferol,
678
Ergosterol,
393,
678
ERKs
(extracellular-signal-regulated
kinases),
713
Ernst,
O.,
694
ERp57,
886
Error
catastrophe,
587
Error
correction:
in
DNA
replication,
103–104
in
RNA
replication,
1281,
1281F
Error-prone
DNA
polymerases,
1222
Erythomycin,
1395T,
1396F
Erythrocruorins,
325
Erythrocytes,
324–325
heme
synthesis
regulation,
1055–1056
and
sickle-cell
anemia,
185–188,
185F,
343–347
Erythrocyte
ghosts,
411
Erythrocyte
glucose
transporter,
746–748,
746F,
747F
Erythrocyte
membranes,
411–414,
411F
and
blood
groups,
414–415
composition,
398T
freeze-etch
micrograph,
410F
glycophorin
A,
401F
Erythromycin
A,
968,
969F
Erythropoietic
protoporphyria,
1055
Erythropoietin
(EPO),
119,
123,
717
D
-Erythrose,
360F
Erythrose-4-phosphate
(E4P),
636,
896,
929
D
-Erythrulose,
361F
Escherich,
T.,
4
Escherichia
coli,
see
E.
coli
ESEs,
see
Exonic
splicing
enhancers
ESI
(electrospray
ionization),
172
ESI-MS,
173
E
(exit)
site,
1373,
1385,
1387
ESPS-synthase
(5-enolpyruvylshikimate-
3-phosphate
synthase),
1075
ESR
(electron
spin
resonance)
spectroscopy,
911
Essen,
L.-O.,
1215
Essential
amino
acids,
1019,
1065T,
1072–1078
Essential
fatty
acids,
971
ESSs
(exonic
splicing
silencers),
1306
Esters,
rates
of
reaction
and
motional
freedom,
515T
-Estradiol,
681
Estrogens,
458,
673T,
680,
991
I-17
ESTs
(expressed
sequence
tags),
181
ETF
(electron-transfer
flavoprotein),
948
ETF:ubiquinone
oxidoreductase,
837,
948
Ethanol,
783.
See
also
Yeast
alcohol
dehydrogenase
dielectric
constant
and
dipole
moment,
43T
from
Entner–Doudoroff
pathway,
636,
637F
from
fermentation,
616
prochiral
atoms
of,
77F
protein
solubility
in,
134
Ethanolamine,
389T,
390,
1004
Ethics,
of
gene
therapy,
123–124
Ethidium
ion,
157,
1161–1162,
1162F
Ethyl-CoA,
874
Ethylenediaminetetraacetic
acid
(EDTA),
157
Ethylene
glycol,
265
O
6
-Ethylguanine
residues,
1216
N-Ethylmaleimide
(NEM),
440–441
Ethylnitrosurea,
1340
Etoposide,
1169,
1170
Eubacteria,
6,
192
Euchromatin,
182
Eukarya,
6,
7F
Eukaryotes,
3,
6–14
cellular
architecture,
8–12
chromosome
number,
19T
citric
acid
cycle
in,
789
DNA,
86,
88,
94T
DNA
methylation,
1248–1251
DNA
replication,
1201–1213
evolution
of,
13F,
34
genome
sequencing,
176
glucose
transporters,
751
introns
of,
1316
metabolic
pathway
location,
562
mismatch
repair,
1220
mRNA
posttranscriptional
modification,
1302–1327
nuclear
pores
of,
1327
nucleotide
excision
repair,
1217
phylogeny
and
differentiation,
12–14
polypeptide
synthesis,
1376–1379,
1388,
1392
RecA-like
proteins,
1230
ribosomes,
1369–1371
rRNA
processing,
1328–1329
secretary
proteins,
421F
translational
in,
1376–1379,
1377F
translation
in,
1398–1402
transposons,
1244–1246
Eukaryotic
gene
expression:
in
bacteria
vs.
eukaryotic
cells,
118–119
and
colony
hybridization,
114
and
mRNA
lifetime,
101
posttranscriptional
modification,
97–98
RNAP,
96,
1276–1283
transcriptional
initiation,
96
European
corn
borer,
122
Evans,
M.,
262
Evans,
R.,
1104
Even-chain
fatty
acids,
945F
Evolution,
29,
30F.
See
also
Chemical
evolution;
Mutations
of
citric
acid
cycle,
814–815
convergent
and
divergent,
252,
254,
317,
531
and
divergence
of
kingdoms,
192
of
protein
structures,
316–318
and
transposition,
1242
Evolutionary
distance,
189
Evolutionary
tree,
13F
Excinuclease,
1217
Excision
repair,
1216–1219
Excitatory
synapses,
778
Exciton
transfer,
905
I-18
Index
Exclusion
limit,
in
gel
filtration
chromatography,
138
Exercise,
ATP
for,
1092F
Exergonic
processes,
57
Exit
site,
see
E
site
Exo
conformation,
1153,
1153F
Exocrine
gland,
675
Exocytosis,
8,
440F,
751–752
Exoglycosidases,
366
Exons,
98,
1304–1305
cassette,
1318
and
protein
modules,
1317
splicing,
1305–1308
Exonic
splicing
enhancers
(ESEs),
1306,
1314
Exonic
splicing
silencers
(ESSs),
1306
Exon
junction
complex
(EJC),
1326–1327
Exon
skipping,
1314
3¿
n
5¿
Exonuclease,
103–104,
104F
Pol
I,
1177,
1180–1181
and
reverse
synthesis
of
DNA,
1200–1201,
1201F
5¿
n
3¿
Exonuclease,
103,
103F
in
chain-terminator
method,
177
Pol
I,
1177,
1181
Exonuclease
I,
1220
Exonuclease
VII,
1220
Exopeptidases,
165–166,
168T
Exosomes,
1327,
1327F
Exothermic
processes,
53
Expressed
sequences,
97,
1304
Expressed
sequence
tags
(ESTs),
181
Expression,
see
Gene
expression
Expression
platform,
1300–1301
Expression
profile,
213
Expression
vector,
117
Exteins,
1405,
1406F,
1407
Extensive
quantities,
61
External
nodes,
phylogenetic
trees,
203,
203F
Extracellular-signal-regulated
kinases
(ERKs),
713
Extrinsic
membrane
proteins,
400
Ex
vivo
gene
therapy,
122
Eyring,
H.,
484
F
F1,6P,
see
Fructose-1,6-bisphosphate
F
1
F
0
-ATPase
(Complex
V,
proton-
translocating
ATP
synthase),
758,
852–859,
865
F1P,
see
Fructose-1-phosphate
F2,6P,
see
Fructose-2,6-bisphosphate
f
5
C
(5-Fluorocytosine)
residue,
1248
F6P,
see
Fructose-6-phosphate
FAAH,
see
Fatty
acid
amide
hydrolase
Fab
New
hemoglobin
fragment,
251F
Fabry’s
disease,
1013T
Facilitated
diffusion,
420,
750–752
Factor
IX,
1317
Factor
X,
1317
Facultative
anaerobes,
6
FAD
(flavin
adenine
dinucleotide),
82,
790F
biosynthesis,
1138
in
catabolism,
561F
in
citric
acid
cycle,
791,
794,
795T
reactions
of,
565,
566F
FADHⴢ
(flavin
adenine
dinucleotide,
radical
form),
565F
FADH
2
(flavin
adenine
dinucleotide,
fully
reduced
form),
565F
in
catabolism,
561F
in
citric
acid
cycle,
789,
790F,
791,
819
in
electron-transport
chain,
823,
824F,
828,
829
FAD
pyrophosphorylase,
1138
FAICAR
(5-formaminoimidazole-4-
carboxamide
ribotide),
1109F,
1111
Familial
amyloid
polyneuropathy,
310
Familial
Creutzfeldt–Jakob
disease,
314
Familial
hypercholesterolemia
(FH),
456–457,
466,
989
Familial
type
III
hyperlipoproteinemia,
459
Faraday
(unit),
53T,
584
Farber’s
lipogranulomatosis,
1013T
Farnesyl
group,
406,
838
Farnesyl
pyrophosphate
(FPP),
978,
979F
Farnesyl
pyrophosphate
synthase,
978
FAS,
see
Fatty
acid
synthase
Fasman,
G.,
302,
303
Fast-twitch
muscle
fibers,
619
Fat,
see
Adipose
tissue
Fats,
940.
See
also
Triacylglycerols
Fatal
familial
insomnia
(FFI),
314
Fat
cells,
see
Adipocytes
Fat-soluble
vitamins,
474,
993
Fatty
acids,
386–388
activation,
945–946,
946F
in
citric
acid
cycle,
789
essential,
971
glycogen
vs.,
638
and
insulin
resistance,
1102,
1103F
names
of,
387T
transport
in
blood,
973
Fatty
acid
amide
hydrolase
(FAAH),
404–406,
405F
Fatty
acid
anions,
44,
44F
Fatty
acid
biosynthesis,
964F
acetyl-CoA
carboxylase,
962–964
carbon–carbon
bond
formation,
965F
citric
acid
cycle
intermediates,
818
elongases
and
desaturases,
969–971
fatty
acid
synthase,
964–968
mitochondrial
acetyl-CoA
transport,
968–969
and
other
pathways,
1089–1090
regulation,
974F
triacylglycerol
synthesis,
971–973,
972F
Fatty
acid
oxidation,
945
and
AMP-dependent
protein
kinase,
1096
glycolysis
inhibition,
864
hormonal
regulation,
973–975,
974F
minor
pathways,
958–959
odd-chain
fatty
acids,
952–957
and
other
pathways,
1089–1090

oxidation,
947–950,
958
regulation,
973–975,
974F
and
transport,
946–947,
946F
unsaturated
fatty
acids,
950–952

3
Fatty
acids,
1003

6
Fatty
acids,
1003
Fatty
acid
synthase
(FAS),
568,
962,
964–968
Fatty
acylated
proteins,
407
Fatty
acyl-CoA,
947F
Fatty
acyl-CoA
desaturases,
970–971,
971F
Fatty
streak
lesions,
458
Favism,
897
FBLD
(fragment-based
lead
discovery),
541–542
F-box,
1412,
1413F
F-box
protein
family,
1412
FBP,
see
Fructose-1,6-bisphosphate
FBPase,
see
Fructose-1,6-bisphosphatase
FBPase-2
(fructose
bisphosphatase-2),
663
FC0
mutation
(phage
T4),
1340
FC1
mutation
(phage
T4),
1340
FC2
mutation
(phage
T4),
1340
FC3
mutation
(phage
T4),
1340
FC4
mutation
(phage
T4),
1340
FC5
mutation
(phage
T4),
1340
FCCP
(carbonylcyanide-p-
trifluoromethoxyphenylhydrazone),
860
F

cell,
1262–1263
F
cell,
1262–1263
Fd,
see
Ferredoxin
FDP
(fructose-1,6-diphosphate),
600
FdUMP
(5-fluorodeoxyuridylate),
1127–1129
Feathers,
233
Feedback
inhibition,
474–479,
620,
623–624
Feher,
G.,
910
Feigon,
J.,
1212
Female
sex
hormones,
681
FeMo-cofactor,
1081–1082
Fen
(fenfluramine),
543
FEN-1
(flap
endonuclease-1),
1207
Fenfluramine
(fen),
543
Fenn,
J.,
172
Fen–phen,
543
Fe-protein,
1080–1082
Fermentation,
6,
469–470,
593–594
alcoholic,
593–594,
616–619
energetics,
619
homolactic,
593,
614–616
Ferns,
13F
Ferredoxin
(Fd),
835,
835F,
934F
Ferredoxin-NADP

reductase
(FNR),
924,
924F
Ferredoxin-thioredoxin
reductase
(FTR),
933–934,
934F
Ferritin,
140F,
381
Ferrochelatase,
1055
Fe–S
cluster,
see
Iron–sulfur
clusters
Fesik,
S.,
707
Fetal
hemoglobin,
193–194,
331
Fetulin,
140F
F
factor,
1262–1263
F¿
factor,
1263
Ffh
polypeptide,
422
FFI
(fatal
familial
insomnia),
314
FGAM,
see
Formylglycinamidine
ribotide
FGAM
synthetase
(PurL),
1109F,
1110
FGAR,
see
Formylglycinamide
ribotide
FGF,
see
Fibroblast
growth
factor
FH,
see
Familial
hypercholesterolemia
Fibrillarin,
1329
Fibrils,
238–240
Fibrin,
191,
310
Fibrinogen,
191
in
amyloid
diseases,
310
frictional
ratio,
155
isoelectric
point
(human),
134T
molecular
mass,
140F
physical
constants
(human),
153T
solubility,
133F,
134
Fibrinogen
amyloidosis,
310
[Glu
1
]Fibrinopeptide
B,
175F
Fibrinopeptides,
190,
191F
Fibroblasts,
9F,
454F,
1211–1212
Fibroblast
growth
factor
(FGF),
375,
700
Fibroblast
interferon,
1399
Fibromodulin,
373T
Fibronectin,
684
Fibrous
proteins,
226,
232–240.
See
also
Collagen;
Keratin
collagen,
235–240
keratin
in,
233–235,
234F
Fick’s
first
law
of
diffusion,
745
Fields,
S.,
705
Fiers,
W.,
176
50S
subunit
(ribosome),
1363T,
1366–1368,
1368F,
1371,
1384F
Fight
or
flight
response,
664
Filamentateous
bacteriophage
M13,
108,
108F
Fillingame,
R.,
853
Index
Filmer,
D.,
352
Fingerprinting,
147,
174
Finishing,
181
Fink,
G.,
1245
Finzel,
B.,
1151
Fire,
A.,
1323
FirstGlance,
256T,
257
First
law
of
thermodynamics,
52–54
First-order
rate
equation,
483–484
First-order
reactions,
483,
484F
Fischer,
A.,
123
Fischer,
E.,
70,
75,
352,
360,
470,
651,
722
Fischer
convention,
75–76
Fischer
projections,
75,
75F
Fish,
embryonic
development
of,
14F
Fission
yeast,
see
Schizosaccharomyces
pombe
Fitzgerald,
P.,
549
5¿
end,
of
nucleic
acids,
84
FK506,
292–293
FK506
binding
protein
(FKBP12),
292,
293,
724–725
FKBP12-rapamycin-associated
protein
(FRAP),
737F
Flagella,
4,
4F,
10
Flagellates,
7F
Flagellin,
10,
1243,
1388
FLAP,
see
5-lipoxygenase-activating
protein
Flap
endonuclease-1
(FEN-1),
1207
Flatworms,
trans-splicing
in,
1320
Flavin,
566
Flavin
adenine
dinucleotide,
see
FAD
Flavin
adenine
dinucleotide,
fully
reduced
form,
see
FADH
2
Flavin
adenine
dinucleotide,
radical
form
(FADHⴢ),
565F
Flavin
coenzymes,
473T,
1138
Flavin
mononucleotide,
see
FMN
Flavin
mononucleotide,
radical
form,
see
FMNHⴢ
Flavin
mononucleotide,
reduced
form,
see
FMNH
2
Flavobacteria,
7F
Flavodoxin,
135F
Flavokinase,
1139F
Flavoprotein,
801
Flavoprotein
dehydrogenase,
828,
828F
Flavr
Savr
tomato,
1403
Fleming,
A,
376
Fletterick,
R.,
433,
530,
640
Flipases,
420
Flip-flop,
396,
419–420
fljA
gene,
1243
fljB
gene,
1243
fljC
gene,
1243
Fluid
mosaic
model,
of
membranes,
408–411
9-Fluorenylmethoxycarbonyl
(Fmoc)
group,
207
Fluorescamine,
149
Fluorescence,
286,
904–905
Fluorescence
recovery
after
photobleaching
(FRAP),
396–397,
396F
Fluorescence
resonance
energy
transfer
(FRET),
284,
286,
286F,
299,
300
Fluoroacetyl-CoA,
809
Fluorochlorobromomethane,
enantiomers,
74F
Fluorocitrate,
809
(2R,3R)-2-Fluorocitrate,
809
5-Fluorocytosine
(f
5
C)
residue,
1248
5-Fluorodeoxyuridine,
1129
5-Fluorodeoxyuridylate
(FdUMP),
1127–1129
Fluorophore,
396
5-Fluorouracil,
1129
Flurbiprofen,
998
Flux,
589,
593,
619,
745
Flux
control
coefficient,
620–622
fMet,
see
N-Formylmethionine
fMet-tRNA
Met
f
,
1373–1374,
1376
FMN
(flavin
mononucleotide),
686,
834,
836F,
1138
FMNHⴢ
(flavin
mononucleotide,
radical
form),
836F
FMNH
2
(flavin
mononucleotide,
reduced
form),
836F
Fmoc
(9-fluorenylmethoxycarbonyl)
group,
207
FMR1
gene,
1251,
1252
FMR
protein
(FMRP),
1251
FNR,
see
Ferredoxin-NADP

reductase
Foam
cells,
457
Fodor,
S.,
212
Folate,
1062
Folds,
249F,
250–251
Folding-trap
mechanism,
448
Foldons,
289,
289F
Fold
recognition,
305
Folic
acid,
474T,
1062
Follicle-stimulating
hormone
(FSH),
673T,
683
Following
substrate,
498
Fomivirsen
(Vitravene),
1403
Fontecilla-Camps,
J.,
941
Food,
energy
content
of,
941T
Footprinting,
1267
Forespore,
1284
Fork-junction
promoter
DNA
fragment,
1268
Formaldehyde,
505
Formamide,
43T
5-Formaminoimidazole-4-carboxamide
ribotide,
see
FAICAR
Formate
dehydrogenases,
1361
Formic
acid,
32T
N-Formiminoglutamate,
1034
N
5
-Formimino-tetrahydrofolate,
1034,
1062
Formylglycinamide
ribotide
(FGAR),
1109F,
1110
Formylglycinamidine
ribotide
(FGAM),
1109F,
1110
N-Formylmethionine
(fMet),
79,
79F,
1373–1374
N-Formylmethionine-tRNA
Met
f
(Met-tRNA
Met
f
),
1373–1374
Formylmethionyl-tRNA,
1063
N
10
-Formyl-tetrahydrofolate,
1062
Forskolin,
698
Förster,
T.,
286
Förster
distance,
286
48S
Initiation
complex,
1379
40S
subunit
(ribosome),
1370T
43S
Preinitiation
complex,
1376–1377
Fos,
713,
737F
Fosamax,
679F
Fossil
fuels,
901
Fossil
record,
29,
192
Foster,
S.,
376
4-Helix
bundle,
241,
250F
454
Life
Sciences,
182
454
sequencing
system,
182–184,
183F
4-Helix
bundle,
of
SNAREs,
441–442
4.4
16
Helix,
228
Fowler’s
solution,
799
Fowlpox
virus,
94T
F
pili,
1262
FPP,
see
Farnesyl
pyrophosphate
F
protein,
1314
Fractional
saturation,
325
Fractionation,
132,
156–159
Fragile
X
syndrome,
1251–1252
I-19
Fragment-based
lead
discovery
(FBLD),
541–542
Frame,
1341
Frameshift
mutations,
1222,
1341
Frameshift
suppressors,
1362
Franceschii,
F.,
1376
Frank,
H.,
262
Frank,
J.,
422,
1365,
1371,
1388
Franklin,
B.,
393–394
Franklin,
R.,
88
FRAP
(FKBP12-rapamycin-associated
protein),
737F
Free
energy,
57–58
and
concentration,
58,
61
and
enzyme
catalysis,
537
and
equilibrium
constants,
58T
membrane
transport,
744
and
protein
folding,
284,
287
standard
state,
58–60
unitary
Gibbs
free
energy
change,
263T
Free
energy
of
activation,
486,
487
Free
energy
of
formation,
59–60,
59T
Freeman,
H.,
921
Freeze-etch
technique,
408–410,
409F
Freeze-fracture
technique,
408–410,
409F
French
press,
130
FRET,
see
Fluorescence
resonance
energy
transfer
Frey,
P.,
536
Frictional
coefficient,
146,
155
Frictional
ratio,
155
Fridovich,
I.,
865
Frogs,
chromosome
number
of,
19T
Fromme,
P.,
922
Fructofuranose,
361
-
D
-Fructofuranose,
362F
-Fructofuranosidase,
488
Fructokinase,
630
Fructose,
361,
361F,
362F,
630–631,
631F
Fructose-1,6-bisphosphatase
(FBPase),
582,
630,
877,
933F
and
glycolysis,
593,
594F,
629
and
metabolic
cycles,
1088–1089
Fructose-1,6-bisphosphate
(FBP;
F1,6P),
479,
596F,
600
Fructose-1,6-diphosphate
(FDP),
600
Fructose-1-phosphate,
630
Fructose-1-phosphate
aldolase,
630
Fructose-2,6-bisphosphate
(F2,6P),
627,
663–664
Fructose-6-phosphate
(F6P),
582,
582F
and
erythrose-4-phosphate,
636
in
glycolysis,
596F,
598–600
Fructose
bisphosphatase-2
(FBPase-2),
663
Fructose
intolerance,
630
Fruit
flies,
see
Drosophila
melanogaster
Frydman,
J.,
301
FSH,
see
Follicle-stimulating
hormone
FTR,
see
Ferredoxin-thioredoxin
reductase
FtsY,
423
F-type
ATPases,
758
F-type
H

-ATPase,
852,
854F
L
-Fucose,
365
Fumarase,
481,
567,
947
in
citric
acid
cycle,
790F,
791,
812–813,
812F
diffusion-limited,
490
Michaelis–Menten
kinetic
constants,
489T
molecular
mass,
140F
Fumarate,
493,
947
in
citric
acid
cycle,
790F,
791,
811
degradation
of
phenylalanine
and
tyrosineto,
1043–1047
hydration,
481
Fumarate
hydratase,
812–813
I-20
Index
Functional
groups:
in
Cahn–Ingold–Prelog
system,
76
hydrogen
bonding,
43F
pK
values
of,
72
Fungi,
7F,
12,
13F
divergence
of,
192
FAS-I,
967–968,
967F
Furan,
361
Furanoses,
361
Furey,
W.,
616
Furylfuramide,
1225
Fusidic
acid,
1395T,
1396F
Fusion
pore,
442,
443F
Fusion
proteins,
118,
431
Futai,
M.,
857
Futile
cycle,
629
Fyn,
708,
715
FYVE
domains,
734,
735F
G
G
0
phase,
1163,
1206
G
t,
see
Transducin
G1,6P
(glucose-1,6-bisphosphate),
642
G1P,
see
Glucose-1-phosphate
G
1
phase,
1202,
1205,
1206F
G,
see
Free
energy
G
2
phase,
1202,
1206
G6P,
see
Glucose-6-phosphate
G6Pase,
see
Glucose-6-phosphatase
G6PD,
see
Glucose-6-phosphate
dehydrogenase
G6P
translocase,
661
G
A2
ganglioside,
1011
GABA,
see
-Aminobutyric
acid
Gab-1
(Grb2-associated
binder-1),
738
gag,
1245
Gag-pol
polyprotein,
546
Gag
polyprotein,
546
Gal,
see
Galactose
Galacitol,
633
Galactans,
366
Galactocerebrosides,
391,
1009–1010
Galactocerebroside-3-sulfate,
1010
Galactokinase,
631
D
-Galactosamine,
365
D
-Galactose,
110,
360F,
361,
392F
Galactose
(Gal):
and
glucose
in
E.
coli,
1286
in
glycolysis,
630–633,
632F
Galactose-1-phosphate
uridyltransferase,
631
Galactosemia,
632–633
-Galactosidase,
107F,
110,
366,
367
in
enzyme
induction,
1261–1262
molecular
mass,
140F
sequencing,
165
Galactoside
permease,
769.
See
also
Lactose
permease
1--Galactosylceramide,
1010
Galactosyl
diacylglycerol,
902
Galactosyltransferase,
882
D
-Galacturonic
acid,
364
Gallo,
R.,
545
Gallus
gallus,
genome
sequencing
of,
177T
GalNAc
transferase,
890
Gametes,
20

Complex,
Pol
III,
1182
Gamma
radiation,
572

Resolvase,
1239–1241,
1241F

Transposon,
1239–1241,
1241F
Gangliosides,
392,
392F,
1008
biosynthesis,
1010–1011,
1011F
GAP,
see
Glyceraldehyde-3-phosphate;
GTPase-activating
protein
GAP-containing
inositol
phosphatase
(GIP),
735
GAPDH,
see
Glyceraldehyde-3-phosphate
dehydrogenase
Gap
junctions,
membranes,
415–416,
416F
Gap
penalties,
201
GAPs,
705–711
GAR
(glycinamide
ribotide),
1109F
Garavito,
M.,
997
Garrod,
A.,
25–26
GAR
synthetase
(PurD),
1109F,
1110
GAR
transformylase
(PurN),
1109F,
1110
Gas
constant,
53T
Gas–liquid
chromatography
(GLC),
366
Gassman,
P.,
536
Gastric
inhibitory
peptide
(GIP),
673T,
675
Gastric
mucosa,
764–765
Gastrin,
673T,
675
Gastroesophageal
reflux
disease
(GERD),
764
Gastrointestinal
hormones,
675–676
Gastrula,
1250
GatA
subunit
of
Glu-Adt,
1358
GatB
subunit
of
Glu-Adt,
1358
GatC
subunit
of
Glu-Adt,
1358
Gated
pore,
750–751
Gating,
of
ion
channels,
771–775
Gaucher’s
disease,
1013T
Gay-Lussac,
J.,
469
GC
(guanylate
cyclase),
687
GC
box,
1282
GCN2,
1400–1401
GCN4,
1400–1401
GCPR
kinases
(GRKs),
697
G-CSF
(granulocyte
colony-stimulating
factor),
717
G
D3
ganglioside,
1011
GDH,
see
Glutamate
dehydrogenase
GDI,
see
GDP
dissociation
inhibitor;
Guanine
nucleotide
dissociation
inhibitor
GDP
(guanosine
diphosphate):
in
citric
acid
cycle,
790F,
791
and
EF-Tu,
1380–1381,
1381F
in
secretory
pathway,
420,
423–424
in
vesicle
formation,
434–435,
437
GDP
dissociation
inhibitor
(GDI),
441
GEFs,
see
Guanine
nucleotide
exchange
factors
Geiger
counting,
572
Gelatin,
236
Gel
electrophoresis:
for
measuring
supercoiling,
1162
of
nucleic
acids,
158–159,
158F,
179
of
proteins,
132T,
147–150,
148F
pulsed-field,
158–159,
159F
for
restriction
maps,
106,
106F
two-dimensional,
152,
152F
Gel
filtration
chromatography,
138–141,
139F,
157,
169
Geminin,
1206–1207
GenBank,
195T
Genes,
21–22.
See
also
Chromosomes;
DNA
and
bacterial
conjugation,
1262–1264
chemical
synthesis,
118
duplication
of,
193–194,
317–318
fruit
fly
experiments,
22–25
liposome
delivery,
396
manipulation,
109–111
one
gene-one
enzyme
maxim,
26
reporter,
120–121,
120F
self-splicing,
1306–1308
sex
linked,
24
and
tetranucleotide
hypothesis,
85
Gene
A
protein,
1191,
1193
Gene
expression,
25–26,
95–104,
95F
DNA
replication,
101–104
eukaryotic,
see
Eukaryotic
gene
expression
overview,
18–19,
95–101
prokaryotic,
see
Prokaryotic
gene
expression
and
RNAi,
1325–1326
transcription,
95–98
translation,
95,
98–101
General
acid
catalysis,
506–507
General
base
catalysis,
507
General
import
protein
(GIP),
446
General
recombination,
1225
Gene
sequence
databanks,
195T
Gene
splicing,
97–98,
1305.
See
also
Spliceosomes
alternative
splicing,
1317–1318
cis-
and
trans-splicing,
1319–1320
exons,
1305–1308
pre-mRNAs,
1312
role
of
splicing-associated
factors,
1312,
1314
self-splicing
genes,
1306–1308
significance
of,
1316–1317
Gene
therapy,
122–124,
991
Genetic
anticipation,
1251
Genetic
code,
87,
88,
1338–1345
briefly
summarized,
1421
deciphering,
1341–1343
mitochondrial
deviations
from
ideal,
1344T
nature
of,
1343–1344
nonuniversality
of,
185,
1344–1345
standard,
1343T
in
translation,
99,
100T
Genetic
control,
metabolic
flux
and,
624
Genetic
crosses,
20,
21F
Genetic
diseases,
26,
112–113,
122–123.
See
also
specific
diseases
Genetic
engineering,
104.
See
also
Molecular
cloning;
Recombinant
DNA
technology
Genetic
information,
18–19.
See
also
Genes
Genetic
maps,
24,
25F
Genetic
mutations,
see
Mutations
Genetic
recombination,
1225
Genetics,
19–28.
See
also
specific
topics
bacterial,
26
chromosomal
theory
of
inheritance,
22–26
chromosomes,
19–20
Mendelian
inheritance,
20–22
viral,
26–28
Genome,
8–9,
94,
1173.
See
also
Human
genome
Genome
Analyzer,
184
GenomeNet,
195T
Genome
sequencing,
176,
177T,
180–185,
180F
Genomes
OnLine
Database
(GOLD),
195T
Genomic
imprinting,
1251
Genomic
libraries,
113–114
Genotypes,
21–22,
22F
Gentisic
acid,
173
Geometric
complementarity,
of
Watson–
Crick
base
pairs,
1154–1155
Geometric
specificity,
enzymes,
472–473
George
III,
King
of
England,
1056
Geranylgeraniol,
903
Geranylgeranyl
groups,
406
Geranyl
pyrophosphate,
978–979
GERD
(gastroesophageal
reflux
disease),
764
Gerhart,
J.,
475
Gerlt,
J.,
536
Germ
cells,
19,
20,
21F
Germ
plasm
theory,
19
Index
Gerstmann–Sträussler–Schneiker
(GSS)
syndrome,
314
GFP
(green
fluorescent
protein),
120–121,
120F,
121F
GGAs,
436
GH,
see
Growth
hormone
Ghrelin,
1099
Giardia
intestinalis,
1324,
1324F
Gibbs,
J.
W.,
57
Gibbs
free
energy,
57–60,
58T.
See
also
Free
energy
Gierasch,
L.,
294
Gigantism,
685
Gilbert,
W.,
1284
Gilman,
A.,
690
GIP,
see
GAP-containing
inositol
phosphatase;
Gastric
inhibitory
peptide;
General
import
protein
Girvin,
M.,
853
GK,
see
Glucokinase
GKRP
(glucokinase
regulatory
protein),
662
GLA,
see
-Linolenic
acid
GLC
(gas–liquid
chromatography),
366
GlcNAc,
see
NAG
Gleevec,
719–720
Gln,
see
Glutamine
GlnRS,
1352–1354,
1353F,
1355F
Gln-tRNA
Gln
,
1358–1359,
1359F
Globins,
193–194,
193F,
324
Globin
fold,
251
Globosides,
1008,
1010–1011,
1011F
Globular
proteins,
241

helix
in,
226

pleated
sheets
in,
230
hierarchical
organization,
281–282,
281F
nonrepetitive
structures
in,
230–233
structural
bioinformatics,
256–259
tertiary
structure,
245–256
X-ray
and
NMR
structure,
241–245
-Globulins,
134T,
140F
Glu,
see
Glutamic
acid
Glu-AdT,
see
Glu-tRNA
Gln
amidotransferase
Gluathione
peroxidase,
897
Glucagon,
140F,
660,
673T,
973
Glucans,
366
Glucocerebrosides,
391,
1010
Glucocorticoids,
673T,
680,
991,
1090
Glucocorticoid
hormone
response
element
(GRE),
879
Glucocorticoid
receptor,
879
Glucogenic
amino
acids,
1029–1030,
1090,
1095
Glucogeonesis,
359
Glucokinase
(GK),
597,
662–664
Glucokinase
regulatory
protein
(GKRP),
662
Gluconeogenesis,
562,
571,
871–880
and
AMP-dependent
protein
kinase,
1096
and
citric
acid
cycle,
818
and
Cori
cycle,
880
gluconeogenesis
pathway,
872–878
and
glycolysis,
595,
878F
and
other
pathways,
1088–1089
regulation
of,
878–879
and
starvation,
1101
stimulation
by
FBPase-1,
664
Gluconic
acid,
364
1,5-Gluconolactone,
642
D
-Glucono--lactone,
364F
Glucopyranose,
361
-
D
-Glucopyranose,
362F
-
D
-Glucopyranose,
362F,
363F
D
-Glucosamine,
365
Glucose,
565F.
See
also
Blood
glucose;
Electron-transport
chain
complete
oxidation
of,
823
and
E.
coli,
1285–1286,
1286F
in
Entner–Doudoroff
pathway,
636,
637F
membrane
permeability
coefficients,
747T
mutarotation
of,
507–508
and
noninsulin-dependent
diabetes,
1103F
transport
in
blood,
973
Glucose-1,6-bisphosphate
(G1,6P),
642
Glucose-1-phosphate
(G1P),
370,
631,
639,
932
Glucose-6-phosphatase,
877
Glucose-6-phosphatase
(G6Pase),
661,
666,
1088–1089
Glucose-6-phosphate
(G6P),
565F,
638–639
as
energy-rich
compound,
580
in
Entner–Doudoroff
pathway,
637F
in
glycolysis,
596F,
597–598
and
metabolism,
1089,
1094
Glucose-6-phosphate
dehydrogenase
(G6PD),
894,
894F,
897–898
Glucose-6-phosphate
isomerase,
598
D
-Glucose,
359–362,
362F,
392F
L
-Glucose,
360
-
D
-Glucose,
363F,
507
-
D
-Glucose,
507
Glucose-alanine
cycle,
878,
1022–1023
Glucose-dependent
insulinotropic
polypeptide,
675
Glucose-fatty
acid
cycle,
864
Glucose
metabolism,
567
Glucose
transport:
ATP-driven
active,
758–768
in
erythrocytes,
746–748,
746F,
747F
and
faciliated
diffusion,
750–752,
750F,
751F
ion-driven
active,
768–771
maltoporin
in,
749–750
in
muscle
and
fat,
751F
-Glucosidase,
370
-1,4-Glucosidase
deficiency,
666
Glucosidase
II,
886
1--Glucosylceramide,
1009–1010
D
-Glucuronic
acid,
364
D
-Glucurono--lactone,
364F
GluProRS,
1351
GLUT1,
751
GLUT2,
662,
751
GLUT3,
751
GLUT4,
661,
737F,
751
GLUT4
storage
vesicles,
751
GLUT5,
751
GLUT12,
751
Glutamate,
71.
See
also
Glutamic
acid
biosynthesis,
1065–1071
degradation,
1034
and
nitrogen
fixation,
1080
as
nonessential
amino
acid,
1065T
Glutamate-5-phosphate,
1070F,
1071
Glutamate-5-semialdehyde,
1034,
1070F,
1071
Glutamate–aspartate
aminotransferase,
1022
Glutamate–aspartate
carrier,
827–828
Glutamate
dehydrogenase,
266
Glutamate
dehydrogenase
(GDH),
153T,
818,
1020,
1023–1033,
1024F
Glutamate
receptor
pre-mRNA,
1322
Glutamate
synthase,
934,
1065–1067
Glutamic
acid,
see
also
Glutamate
degradation,
1034
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246
half-life,
1413T

helix/
sheet
propensity,
302T
I-21
isoelectric
point,
72
in
Miller–Urey
experiments,
32T
in
native
unfolded
proteins,
283
in
PEST
proteins,
1413
side
chains,
71,
264T
structure
and
general
properties,
69T
Glutaminase,
1023,
1025–1027,
1034
Glutamine:
amino
group,
208F
biosynthesis,
1067–1073
degradation,
1034
and
E.
coli
nonsense
suppressor,
1362T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246–247
half-life,
1413T

helix/
sheet
propensity,
302T
in
native
unfolded
proteins,
283
as
nonessential
amino
acid,
1065T
side
chains,
71,
208F,
264T
structure
and
general
properties,
69T,
71F
Glutamine
amidotransferase,
1025–1027,
1066–1067,
1078
Glutamine
PRPP
aminotransferase
(PurF),
1108,
1111
Glutamine
synthetase,
269F,
591,
1023,
1029,
1068–1071
-Glutamyl
cycle,
1061,
1061F
-Glutamyl
cyclotransferase,
1061
-Glutamylcysteine
synthetase,
1061
Glutamyl
group,
73T
-Glutamyl
kinase,
1070F,
1071
-Glutamylphosphate,
1068
-Glutamyltransferase,
1001
-Glutamyl
transpeptidase,
1061
Glutaraldehyde,
270,
270F
Glutaredoxin,
1124
Glutathione,
142
Glutathione
(GSH),
544–545,
544F,
803,
1060–1062
Glutathione
disulfide
(GSSG),
803
Glutathione
peroxidase,
866,
1003,
1060F
Glutathione
reductase
(GR),
801,
803,
1060F
Glutathione-S-transferase,
see
GST
Glu-tRNA
Gln
,
1358
Glu-tRNA
Gln
amidotransferase
(Glu-AdT),
1358,
1359F
Glu-tRNA
Glu
,
1358
Glx,
68T,
73.
See
also
Glutamic
acid;
Glutamine
Gly,
see
Glycine
Glycans,
365–366
Glyceraldehyde,
75,
75F
D
-Glyceraldehyde,
75,
75F,
360F,
361
L
-Glyceraldehyde,
75,
75F,
76,
77F
Glyceraldehyde-3-phosphate,
636
from
Calvin
cycle,
927–929,
931
in
Entner–Doudoroff
pathway,
637F
in
glycolysis,
595,
596F,
600–603
topological
diagram,
254F
Glyceraldehyde-3-phosphate
dehydrogenase
(GAPDH):
domains,
248,
249F
and
erythrocyte
membrane,
412
in
glycolysis,
596F,
607–608,
607F,
608F
half-life,
1408T
molecular
mass,
140F
(S)-Glyceraldehyde,
76,
77F
Glyceraldehyde
kinase,
630
Glycerate,
935
L
-Glycero-
D
-mannoheptose,
379F
Glyceroglycolipids,
1004
Glycerol,
364,
388,
389T
Glycerol-3-phosphate,
580,
828,
828F
sn-Glycerol-3-phosphate,
389,
389F
Glycerol-3-phosphate
acyltransferase,
971
I-22
Index
Glycerol-3-phosphate
dehydrogenase,
828,
828F,
944
Glycerolipids,
1004F
Glycerol
kinase,
630,
766,
944
Glyceroneogenesis,
971,
973,
1093
Glycerophosphate
shuttle,
828,
828F
Glycerophospholipids,
389–390,
389F,
394–395,
1004–1008
N
6
--Glyceryl
lysine,
601
Glycidol
phosphate,
604
Glycinamide
ribotide
(GAR),
1109F
Glycine:
biosynthesis,
1071–1072
as
chemical
messenger,
79–80
conjugates
of,
993,
993F
degradation,
1030–1034
electrostatic
influences,
72
genetic
codes
for,
100T,
1343T
half-life,
1413T

helix/
sheet
propensity,
302T,
304
in
heme
biosynthesis,
1048
isoelectric
point,
72
in
Miller–Urey
experiments,
32T
in
native
unfolded
proteins,
283
as
nonessential
amino
acid,
1065T
optical
activity,
74
steric
hinderance,
224–225,
224F,
225F
structure
and
general
properties,
68T
titration
curve,
72,
72F
Glycine
cleavage
system,
1031–1033
Glycine
decarboxylase
multienzyme
system,
1031–1033
Glycine
synthase,
1031–1033
Glycocalyx,
381,
414,
414F
Glycoconjugates,
359
Glycoforms,
380
Glycogen,
359,
370,
370F,
638
fatty
acids
vs.,
638
particle
fabrication,
646–647
Glycogen
branching,
646–647
Glycogen
breakdown,
638–644
glycogen
debranching
enzyme,
370,
639,
642–643,
667
glycogen
phosphorylase,
639–641
and
other
pathways,
1089
phosphoglucomutase,
639,
642
Glycogen
debranching
enzyme,
370,
639,
642–643,
667
Glycogenin,
380,
645–646,
646F
Glycogen
metabolism,
638–668
blood
glucose
maintenance,
661–664
control
of,
647–666
covalent
modification
in,
650–651
glycogen
breakdown,
638–644
glycogen
phosphorylase
bicyclic
cascade,
651–660
glycogen
storage
diseases,
666–668
glycogen
synthase
bicyclic
cascade,
660
glycogen
synthesis,
644–647
stress
response,
664–665F
thermodynamics,
643–644
Glycogen
phosphorylase,
370,
639–641
allosteric
control,
479,
647–650
bicyclic
cascade,
651–660
covalent
modification,
1405
deficiency,
667
Glycogen
storage
diseases,
666–668
Glycogen
synthase,
644,
645,
647–650
Glycogen
synthase
kinase-3
(GSK3),
660
Glycogen
synthesis:
glycogen
branching,
646–647
glycogen
synthase,
644
and
other
pathways,
1089
UDP–glucose
pyrophosphorylase,
644
Glycolate,
935
Glycolate
oxidase,
935
Glycolate
phosphatase,
935
Glycolic
acid,
32T
Glycolipids,
359,
381,
398T,
400F
Glycolipid
metabolism,
1004
glycerophospholipids,
1004–1008
sphingoglycolipids,
1008–1013
sphingophospholipids,
1008–1009
Glycolysis,
569,
593–634.
See
also
Electron-
transport
chain;
Fermentation
aerobic,
864
aldolase,
596F,
600–603
and
AMP-dependent
protein
kinase,
1096
anaerobic,
614–619,
864
and
citrate,
863–864
effectors
of
nonequilibrium
enzymes,
625T
electron-transport
chain,
824F
enolase,
596F,
612–613
and
fatty
acid
oxidation,
864
fermentation,
614–619
and
free
energy
changes,
625T
fructose
utilization,
630–631
galactose
utilization,
630–633,
632F
and
gluconeogenesis,
878F
glyceraldehyde-3-phosphate
dehydro-
genase,
596F,
607–608
hexokinase,
596F,
597–598
mannose
utilization,
630,
633,
633,
633F
and
metabolic
regulation
and
control,
619–630
net
reaction,
594F,
595
and
other
pathways,
1088
overview
of,
595–596,
596F
phosphofructokinase,
596F,
600,
625–627,
626F,
630
phosphoglucose
isomerase,
596F,
598–600
phosphoglycerate
kinase,
596F,
608–610
phosphoglycerate
mutase,
596F,
610–612
pyruvate
kinase,
596F,
613–614
for
rapid
ATP
production,
619
regulation
in
muscle,
624–630
triose
phosphate
isomerase,
596F,
603–606
Glycomes,
382–383
Glycomics,
382–383,
578
Glycone,
366
Glycophorin
A,
400–401,
401F,
413F
Glycoproteins,
359,
373
in
bacterial
cell
walls,
375–379
biosynthesis,
880–892
formation,
101
glycomics,
382–383
proteoglycans,
373–375
structure
and
function,
379–382
Glycoprotein
carbohydrates,
380–381
Glycosaminoglycans,
370–372
Glycosidases,
364
Glycosides,
363
Glycosidic
bonds,
83,
363–365,
880–881,
883F
Glycosphingolipids
(GSLs),
391,
1004
Glycosylation,
101
Glycosylceramides,
1009–1010
Glycosyl–enzyme
intermediate,
522
Glycosyl
group
transfer,
565
Glycosylphosphatidylinositol
(GPI),
407–408,
408F,
890–892,
891F
Glycosylphosphatidylinositol
(GPI)
membrane
anchors,
882,
891F
Glycosyltransferases,
881,
1010
Glyoxylate,
935
Glyoxylate
cycle,
880,
881F
Glyoxylate
pathway,
10
Glyoxylic
acid,
1135F
Glyoxysome,
10,
880
Glyphosate,
1075
G
M1
Gangliosidosis,
1013T
G
M2
-activator
protein,
1011,
1012F
GM-CSF,
see
Granulocyte-macrophage
colony-stimulating
factor
GM-CSF
receptor,
717–718,
718F
GMP
(guanosine
monophosphate),
83T,
1111–1113,
1112F,
1130F
GMPPNP
(guanosine-5¿-(,-imido)
triphosphate),
710–711
GMP
synthase,
1112F
GMR,
717–718
GnRF,
see
Gonadotropin-releasing
factor
Goiter,
677
GOLD
(Genomes
OnLine
Database),
195T
Gold,
L.,
213
Goldberg,
J.,
434,
438,
1223
Golden
rice,
122,
122F
Goldman
equation,
775
Goldsmith,
E.,
713
Goldstein,
J.,
452,
453,
987
Golgi,
C.,
9
Golgi
apparatus,
7F,
9,
11F.
See
also
Post-
translational
modification
metabolic
functions,
562T
vesicle
formation,
428–440
vesicle
fusion,
440–445
Golgi
network,
428,
429F
Golgi
stack,
428,
429F
Gonadotropin-releasing
factor
(GnRF),
673T,
683
Gonadotropins,
683
Gonads,
680,
681
Goodman,
M.,
1222
Google
Scholar,
35
Gorter,
E.,
395
Gouaux,
E.,
417
Gourse,
R.,
1266
Gout,
1134–1135,
1142
GPCRs,
see
G-protein-coupled
receptors
GPI,
see
Glycosylphosphatidylinositol
GPI-linked
proteins,
407–408,
408F
GPI
membrane
anchors,
see
Glycosylphos-
phatidylinositol
membrane
anchors
G-protein-coupled
receptors
(GPCRs),
689,
993
G
proteins,
407,
423,
688,
692,
695F,
1314,
1376,
1395
G-quartets,
1212–1213,
1212F
GR,
see
Glutathione
reductase
Gradient
elution,
137
Gram,
C.,
6
Gramicidin
A,
79,
748,
787
Gram-negative
bacteria,
6,
376,
376F,
403
Gram-positive
bacteria,
6,
7F,
13F,
376,
376F,
398T
Gram
stain,
6
Grana,
902
Granulocyte
colony-stimulating
factor
(G-CSF),
717
Granulocyte-macrophage
colony-stimulating
factor
(GM-CSF),
381,
717.
See
also
GM-CSF
receptor
Granulocytes,
381
GRASP
(Graphical
Representation
and
Analysis
of
Surface
Properties),
259
Gray,
H.,
841
Grb2,
708,
709
Grb2-associated
binder-1
(Gab-1),
738
GRE
(glucocorticoid
hormone
response
element),
879
GreA,
1281
GreB,
1281,
1282
Greek
key
motif,
249F,
250
Green
algae,
13F,
19T
Greenberg,
G.
R.,
1108
Index
Green
fluorescent
protein,
see
GFP
Green
photosynthetic
bacteria,
6
Green
revolution,
122
Green
sulfur
bacteria,
923
Greider,
C.,
1210
Grendel,
F.,
395
GRF,
see
Growth
hormone-releasing
factor;
Guanine
nucleotide
releasing
factor
GRIF
(growth
hormone
release-inhibiting
factor),
683
Griffith,
F.,
86
Griffith,
J.,
1213
Grindley,
N.,
1240
GRKs
(GCPR
kinases),
697
gRNAs
(guide
RNAs),
1321,
1321F,
1324
GroEL/ES
system,
293–302,
295F–297F,
307,
307F,
352
Gronenborn,
A.,
656
Ground
substance,
371
Group
I
chaperonins,
293
Group
I
introns,
1306–1309,
1307T,
1309F,
1310F
Group
II
chaperonins,
293,
301–302
Group
II
introns,
1307T,
1308
Group
III
introns,
1307T
Group
transfer
reactions,
564–565,
564F
Group
translocation,
765–766
Growth
hormone
(GH),
86,
571,
683.
See
also
Human
growth
hormone
Growth
hormone
release-inhibiting
factor
(GRIF),
683
Growth
hormone-releasing
factor
(GRF),
673T,
683
Grunberg-Manago,
M.,
1341
G-segment,
of
DNA,
1169
GSH,
see
Glutathione
GSH
synthetase,
1061
GSK3
(glycogen
synthase
kinase-3),
660
GSLs,
see
Glycosphingolipids
GSSG
(glutathione
disulfide),
803
GSS
(Gerstmann–Sträussler–Schneiker)
syndrome,
314
GST
(glutathione-S-transferase),
142,
1001,
1060F
GT
(UDP-glucose:glycoprotein
glucosyltransferase),
886
GTP
(guanosine
triphosphate):
in
citric
acid
cycle,
789,
790F,
791
and
EF-Tu,
1380–1381
gluconeogenesis,
877–878
hydrolysis
of,
1394–1395
in
secretory
pathway,
420,
423–424
in
transcription,
96,
1265
in
vesicle
formation,
436,
437
in
vesicle
fusion,
441
GTPase:
in
secretory
pathway,
423
in
vesicle
formation,
434–437
in
vesicle
fusion,
441
GTPase-activating
protein
(GAP),
423,
437,
692,
1376
GTP-binding
factor,
1395
GTPS,
436F,
692
Gua,
see
Guanine
GU-AG
introns,
1307T
Guanidinium
ion,
117,
169,
284
Guanidino
group,
580
Guanine,
18,
83,
83,
83T.
See
also
Watson–Crick
base
pairs
and
genetic
code,
100T,
1343T
IR
spectra
of,
1155F
modified
nucleosides
of,
1347F
and
point
mutations,
1339–1340
in
purine
catabolism,
1130F
tautomeric
forms,
88F
Guanine-7-methyltransferase,
1302
Guanine
deaminase,
in
purine
catabolism,
1130F
Guanine
nucleotide
dissociation
inhibitor
(GDI),
692
Guanine
nucleotide
exchange
factors
(GEFs),
423,
434,
692,
705–711,
1379
Guanine
nucleotide
releasing
factor
(GRF),
692
Guanosine,
83T,
1130F
Guanosine
binding
site,
1310F
Guanosine
diphosphate,
see
GDP
Guanosine
monophosphate,
see
GMP
Guanosine
triphosphate,
see
GTP
Guanylate
cyclase
(GC),
687
Guanylic
acid,
see
GMP
Guide
RNAs,
see
gRNAs
Guillemin,
R.,
683
D
-Gulose,
360F
GW1516,
1104
Gymnosperms,
13F
Gypsy
moth,
122
GyrA,
1166–1169
GyrA
intein,
1407,
1407F
Gyrase,
1166.
See
also
DNA
gyrase
GyrB,
1166–1168,
1168F
H
H,
see
Enthalpy
H1,
1243
H1
gene,
1243
H2,
1243
H2
gene,
1243
H
2
PO
4
,
see
Hydrogen
phosphate
ion
H
3
PO
4
(phosphoric
acid),
49F
Haber,
F.,
1083
Haber
process,
1083
HAD
(3-
L
-hydroxyacyl-CoA
dehydrogenase),
947,
947F,
948,
958
Hadju,
J.,
534
HaeII,
105T
HaeIII,
105T,
109
Haeckel,
E.,
12
Haemophilus
influenzae,
176,
177T
Hair,
233–235,
275
Haldane,
J.
B.
S.,
32,
488
Haldane
relationship,
491–492
Hales,
S.,
901
Half
cell,
584
Half-chair
conformation,
519F,
1153
Half-life,
484
Half
reactions,
585–586
Half-time,
484
Haloarcula
marismortui,
1365,
1368
Halobacteria,
6,
398T,
402
Halophiles,
7F
Hamm,
H.,
692
Hammerhead
ribozymes,
1310–1311,
1311F
Hanson,
R.,
571,
879
H
antigen,
415
Haploid
cells,
24F
Haploid
genomes,
182
Haploid
number,
19
Haplotype,
106
Harden,
A.,
594
Hard
water,
465
Harrison,
S.,
424,
431,
433,
716,
725,
1288
Hartl,
U.,
300
Hartley,
B.,
525
Hasemann,
C.,
663
Hatch,
M.,
936
Haworth,
N.,
366
Haworth
projection
formulas,
361,
362F
Hb,
see
Hemoglobin
HbA,
see
Hemoglobin
A
I-23
Hb
Bibba,
342
Hb
Boston,
342,
343F
Hb
Bristol,
342
Hb
Cowtown,
358
HbE,
342
Hb
Hammersmith,
342
Hb
Harlem,
344
Hb
Hyde
Park,
358
Hb
Kansas,
343
Hb
KorleBu,
344–345
HbM,
342
Hb
Memphis,
345,
358
Hb
Milwaukee,
342,
343F
HbM
Iwate,
342
Hb
Philly,
342
Hb
Rainer,
357
Hb
Riverdale-Bronx,
358
HbS,
see
Hemoglobin
S
Hb
Savannah,
342
Hb
Yakima,
343
HCR
(heme-controlled
repressor),
1399
HD
gene,
1252
HD
(Huntington’s
disease),
1252
HDL
(high
density
lipoprotein),
449,
449T,
451,
456,
458
HDPR
(6-hydroxy-1,6-dihydropurine
ribonucleoside),
1132
Heart,
625T,
816,
817,
1093
Heart
attack,
456,
865
Heartburn,
764
Heart
muscle,
1092
Heat,
53
Heat-labile
enterotoxin
(LT),
696
HEAT
repeats,
722–723
Heat
shock
locus
UV,
see
HslUV
Heat
shock
proteins,
293,
294.
See
also
Molecular
chaperones
Heat
shock
protein
10
(Hsp10),
294
Heat
shock
protein
40
(Hsp40),
293
Heat
shock
protein
60
(Hsp60),
294F
Heat
shock
protein
70,
see
Hsp70
Heat
shock
protein
90,
see
Hsp90
Heavy
chains,
clathrin,
430
HECT
domain,
1410
Heinrich,
R.,
620
Heinz
bodies,
342
Helical
structures,
225–229,
225F
collagen
triple
helical
structure,
236–238,
237F
Helical
symmetry,
proteins,
269,
269F
Helicases,
1163,
1176,
1183–1187
Helicase
II,
1217
Heliozoansus,
13F
Helix:
,
226–227
basic
helix–loop–helix/leucine
zipper,
987
C,
242F
DNA
as,
88–90,
88F
E,
242F
4-helix
bundle,
241,
250F
H,
248F
interwound,
1160,
1160F
left-handed,
224F,
225F,
1149–1151
,
224F,
228
and
pitch
of
protein,
225
right-handed,
224F–226F
superhelix,
433,
1158–1160,
1162
3
10
,
224F,
226,
228
3.6
13
(),
226,
227F
toroidal,
1160,
1160F
Helix–capping
position,
262
Helix–turn–helix
(HTF)
motif,
1240,
1288–1290,
1289F,
1290F
Helper
T
cells,
545–546
I-24
Index
Hemagglutinin,
380
-Hematin,
1058
Hematocrit,
324
Heme
a,
839F
Heme
b,
839F.
See
also
Iron-
protoporphyrin
IX
Heme
b
562
(heme
b
H
),
838
Heme
b
566
(heme
b
L
),
838
Heme
c,
839F
Heme
c
i
(heme
x),
920
Heme-controlled
repressor
(HCR),
1399
Heme
group,
324–325,
574,
574F
biosynthesis,
1047–1058
degradation,
1056
Heme
oxygenase,
1056
Heme-regulated
inhibitor
(HRI),
1399,
1399F
Hemerythrin,
325
Heme
x
(heme
c
i
),
920
Hemiacetals,
361,
520F
Hemifusion,
442,
443F
Hemiketals,
361
Hemin,
1055
Hemmings,
E.,
116
Hemocyanin,
153T,
325
Hemoglobin:
abnormal,
341–347
affinity
for
CO,
1056–1057
allosteric
regulation,
347–354

and

chains,
332T–333T
and
Bohr
effect,
328–329,
328F,
329,
340
BPG
and
oxygen
binding
of,
329–331,
329F–331F,
340–341
carbon
dioxide
transport,
329
conformational
fluctuations,
306,
306F
cooperativity,
352–354
and
distal
histidine
residue,
340
and
erythrocyte
membrane,
412
function,
323–331
gene
duplication,
193–194
heme
group,
324–325
Hill
plot,
327F
as
“honorary
enzyme,”
323
hydrogen
exchange
for,
309F
isoelectric
point
(human),
134T
isolation,
129
lamprey,
135F
molecular
pathology,
342–343
optimal
sequence
alignment
for,
197F
oxygen
binding,
325–328,
334–339
Perutz
mechanism,
334–340
rate
of
evolution,
191,
191F
and
sickle-cell
anemia,
81,
185–188,
343–347
solubility
of,
133F
in
Southern
blotting,
112
structure
and
mechanism,
267F,
332–341
Hemoglobin
A
(HbA),
175F,
186
Hemoglobin
E,
342
Hemoglobin
F,
see
Fetal
hemoglobin
Hemoglobinopathies,
342–343
Hemoglobin
S
(HbS),
175F,
186–188,
277,
343–347
-Hemolysin,
416–418,
418F
Hemolytic
anemia,
185,
342,
343
Hemophilia,
119
Hemozoin,
1058
Henderson,
R.,
402
Henderson–Hasselbalch
equation,
47–48,
72
Hendrickson,
W.,
702
Hen
egg
white
(HEW)
lysozyme,
275–276,
276T,
470,
517–525,
517F,
518F,
524F
Henri,
V.,
488
Henry’s
law,
61
Henseleit,
K.,
791,
1025
Heparan
sulfate,
373
Heparin,
371F,
372–373,
372F,
375,
700
Hepatitis
B
vaccine,
119
Hepoxilins,
1000
Heptahelical
receptors,
689
Heptoses,
360F
HER2
receptor,
119–120
Herbivores,
cellulose
digestion
by,
369
Herceptin,
119–120
Hereditary
elliptocytosis,
414
Hereditary
nonpolyposis
colorectal
cancer
(HNPCC),
1220
Hereditary
ovalcytosis,
414
Hereditary
spherocytosis,
414
Hermit
crabs,
chromosome
number,
19T
Herriott,
R.,
86
Hers,
H,-G.,
663
Hers’
disease,
667
Hershey,
A.,
87
Hershey–Chase
experiment,
87F
Hershko,
A.,
1410
(15R)-HETE
([15R]-
hydroxyeicosatetraenoic
acid),
1004
(15S)-HETE
([15S]-
hydroxyeicosatetraenoic
acid),
1003
Heterocysts,
1083
Heterogeneous
nuclear
ribonucleoprotein
(hnRNP),
1314
Heterogeneous
nuclear
RNA
(hnRNA),
1304
Heterogeneous
nucleation,
346,
347F
Heterokaryon,
408
Heterolytic
bond
cleavage,
563,
956
Heteropolysaccharides,
365–366
Heterotrimeric
G
proteins,
688–689
adenylate
cyclases,
697–698
G
protein-coupled
receptors
(GCPRs),
689–690
phosphodiesterases,
688–689
structure
and
function,
690–697
Heterotrophs,
6
Heterotropic
allosteric
effect,
348,
351,
351F,
354
Heterozygous
genotypes,
21–22
Heuristic
algorithms,
201
Heuser,
J.,
444
HEW,
see
Hen
egg
white
lysozyme
1-O-Hexadec-1¿-enyl-2-acetyl-sn-glycero-3-
phosphocholine,
1008
Hexane,
43,
43T,
144
Hexokinase
(HK),
565
in
gluconeogenesis,
872
in
glycolysis,
596F,
597–598
mannose
utilization,
633
Hexokinase
D,
662
Hexokinase
IV,
662
Hexosaminidase
A,
123,
1011,
1012F
Hexosaminidase
B,
1013
Hexoses,
360F
Hexose
monophosphate
(HMP)
shunt,
892.
See
also
Pentose
phosphate
pathway
Hfr
cells
(high
frequency
of
recombination),
1263
hGH,
see
Human
growth
hormone
hGHbp
(human
growth
hormone
binding
protein),
684
HGPRT
(hypoxanthine-guanine
phosphoribosyltransferase),
1114
H
Helix,
248F
HIC,
see
Hydrophobic
interaction
chromatography
Hidden
Markov
models
(HMMs),
202
High-altitude
adaptation,
330–331,
330F,
357
High
density
lipoproteins,
see
HDL
High-energy
compounds,
580–581.
See
also
specific
compounds
High
frequency
of
recombination
(Hfr)
cells,
1263
High-mannose
oligosaccharides,
888
High-performance
liquid
chromatography,
see
HPLC
High
potential
iron-sulfur
proteins,
see
HIPIPs
High-throughput
screening,
541
HI/HA,
see
Hyperinsulinism/
hyperammonemia
Hihydrosphingosine,
390
Hill,
A.,
326
Hill,
C.,
1419
Hill,
R.,
903
Hill
constant,
327
Hill
equation,
326–328,
348
Hill
plot,
327–328,
327F
Hill
reaction,
903
HindIII,
105T
Hin
DNA
invertase,
1243
hin
gene,
1243
Hinny,
1251
HIPIPs
(high
potential
iron–sulfur
proteins),
202F,
281F
Hippuric
acid,
945
His,
see
Histidine
his
operon,
1299,
1299T
His
tag,
145,
857
Histamine,
80,
80F,
783,
1058,
1059
Histamine
receptors,
689
Histidine:
biosynthesis,
1078
degradation,
1034
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246

helix/
sheet
propensity,
302T
and
hemoglobin,
332,
341
isoelectric
point,
72
side
chains,
71,
264T
structure
and
general
properties,
69T
Histidinodehydroxymerodesmosine,
239F
Histones,
78,
134T
Histone
H4,
190–191
Histrionicatoxin,
781
Hitchings,
G.,
1130
HIV
(human
immunodeficiency
virus),
208–209,
1207
HIV-1,
545–546,
545F
polyproteins
of,
546,
546F
protease
of,
208–209,
546,
548–551,
548F
reverse
transciptase
of,
1207–1209,
1209F
HIV-2,
545
HIV
protease:
of
HIV-1,
208–209,
546,
548–551,
548F
inhibitors
of,
545–551
and
polyproteins,
1404
HK,
see
Hexokinase
(H

–K

)-ATPase,
764–765
HMG-CoA,
960,
976–977,
1040–1041
HMG-CoA
lyase,
960
HMG-CoA
reductase,
977,
987–989
HMG-CoA
reductase
kinase
(RK),
989
HMG-CoA
synthase,
960,
976
HMIT,
751
HMMs
(hidden
Markov
models),
202
HMP
(hexose
monophosphate)
shunt,
892.
See
also
Pentose
phosphate
pathway
HNPCC
(hereditary
nonpolyposis
colorectal
cancer),
1220
hnRNA
(heterogeneous
nuclear
RNA),
1304
hnRNP
(heterogeneous
nuclear
ribonucleoprotein),
1314
Index
HO
2
ⴢ
865
Hoagland,
M.,
1345
Hodgkin,
A.,
776
Hodgkin,
D.
C.,
241,
331
Hofmeister,
F.,
70
Hofmeister
series,
266
Hofmeyr,
J.-H,
623
Hofrichter,
J.,
346
Hol,
W.,
696,
792,
1165
holA
gene,
1182T
holB
gene,
1182T
holC
gene,
1182T
holD
gene,
1182T
holE
gene,
1182T
Holley,
R.,
176,
1345
Holliday,
R.,
1226
Holliday
junction,
1226,
1226F,
1233F
in
recombination
repair,
1234–1236
and
RuvABC,
1230–1234
Holoenzymes,
473,
722,
1265.
See
also
Pol
III
holoenzyme;
RNAP
holoenzyme
Homeostasis,
619–620,
1096–1101
Homing
endonuclease,
1407–1408
Hominy
grits,
481
Homocitrate,
1081–1082
Homocysteine,
80,
80F,
1034
Homocysteine
methyltransferase,
1037
Homogeneous
nucleation,
346,
347F
Homogenizer,
130
Homogentisate,
1045,
1047F
Homogentisate
dioxygenase,
1045
Homogentisic
acid,
25,
569
Homolactic
fermentation,
593,
614–616
Homologous
end-joining,
1235–1236,
1235F
Homologous
pairs,
19
Homologous
proteins,
188–192,
194–196
Homologous
recombination,
1222,
1225–1236,
1227F
Homology
modeling,
304–305
Homolytic
bond
cleavage,
563,
956
Homo
neandertalensis,
116
Homopolypeptides,
205
Homopolysaccharides,
365–366
Homo
sapiens,
14,
116.
See
also
Humans
Homoserine,
759
Homotropic
allosteric
effect,
348,
350–351,
354
Homozygous
genotypes,
21–22
Honig,
B.,
259
Hood,
L.,
181
Hoogsteen
geometry,
1154
Hooke,
R.,
3
Hop
diffusion,
411,
411F
Hopene,
983
Horecker,
B.,
892
Hormones,
671–674,
673T.
See
also
Glucagon;
Insulin
assays
for,
131
in
brown
fat,
860–862,
861F
for
calcium
metabolism,
677–678
classification,
671,
672F
epinephrine
and
norepinephrine,
679–680
for
fatty
acid
metabolism,
973–975,
974F
gastrointestinal,
675–676
growth,
684–685
hypothalamus
and
pituitary,
682–683,
1099,
1100F
menstrual
cycle
control,
683–684
nitric
oxide,
685–688
opioid
peptides,
685
pancreatic
islet,
675
quantitative
measurements,
674–675
steroid,
680–682
thyroid,
676–677
Hormone-sensitive
triacylglycerol
lipase,
861,
944,
973
Horn,
233,
234
Horowitz,
N.,
3,
34
-Horseshoe,
GyrA
intein,
1407
Horwich,
A.,
294,
297,
298
Host
organism,
104
Host-specific
modifications,
104
Hough,
E.,
1044
Housekeeping
genes,
1282
HpaII,
105T,
1249
(15S)-HPETE
([15S]-hydroperoxyeicosa-
tetraenoic
acid),
1003
5-HPETE,
see
5-
Hydroperoxyeicosatetraenoic
acid
12-HPETE,
see
12-
Hydroperoxyeicosatetraenoic
acid
15-HPETE,
see
15-
Hydroperoxyeicosatetraenoic
acid
HPETEs
(hydroperoxyeicosatetraenoic
acids),
1000
HPK1,
714
HPLC
(high-performance
liquid
chromatography),
145–146,
157,
171,
366
HPr,
of
PTS
system,
765
H-protein,
1031
HPV
(human
papillomavirus),
1414
H-Ras,
709
HRI,
see
Heme-regulated
inhibitor
Hsc70,
436
HslU
caps,
1419
HslUV
(heat
shock
locus
UV),
1419,
1420F
HslUV
protease,
1419
HslV
subunit,
1419–1420,
1420F
Hsp10
proteins,
294
Hsp40
proteins,
293
Hsp60
proteins,
294F
Hsp70
proteins,
293,
421F,
445
Hsp90
proteins,
293,
720
HTH,
see
Helix–turn–helix
motif
HU,
1195
Hubbard,
S.,
700
Huber,
R.,
403,
653,
806,
910,
1414,
1415,
1419,
1420
Hugging
dimer,
1050
Human
cells,
12F
Human
cytomegalovirus
protease,
531
Human
genome,
176,
177T,
1402
Human
genome
project,
181–182
Human
Genome
Sequencing
Consortium,
181,
182
Human
growth
hormone
(hGH),
119,
250F,
251,
259F,
684–685
Human
growth
hormone
binding
protein
(hGHbp),
684
Human
growth
hormone
receptor,
684–685
Human
immunodeficiency
virus,
see
HIV
Human
papillomavirus
(HPV),
1414
Humans,
16F.
See
also
Homo
sapiens
apoB,
1322
BBP,
1314F
biological
structures,
14
c-Cbl-UbcH7-ZAP-70
complex,
1412F
chromosome
number,
19T
cloning,
1251
Cul1–Rbx1–Skp1–F-box
Skp2
complex,
1412F
cytochrome
c,
196F
DNA
repair,
1214
DNA
size,
94T
E.
coli
DNA
vs.,
8–9
elemental
composition,
29T
embryonic
development,
14F
evolutionary
divergence
of,
116
fuel
reserves
for,
1101T
genomic
libraries,
113
I-25
hormones,
673T
Pot1,
1213
RFLPs
of,
106
Skp1-Skp2
complex,
1412
telomere
length,
1211
transposons,
1244,
1246
ubiquitin,
1409
UDG,
1219F
Hünefeld,
F.,
323
Hunger,
1098,
1099
Huntingtin,
1252
Huntington’s
disease
(Huntington’s
chorea),
1252
Hurley,
T.,
646
Hurwitz,
J.,
1265
Huxley,
A.,
776
Hwang,
P.,
431
Hyaluronan,
371–372
Hyaluronate,
371F,
372,
372F
Hyaluronic
acid,
371–372,
375
Hyaluronidase,
372
Hybridization,
93
Hybrid
oligosaccharides,
888
Hybridoma,
131
Hybrid
proteins,
118
Hyde,
C.,
1076
Hydrated
ions,
43
Hydrazine,
166,
168
Hydrazinolysis,
166,
168
Hydrochloric
acid,
46
Hydrocortisone,
680
Hydrodynamic
volume,
155
Hydrogen,
in
Miller-Urey
experiments,
32
Hydrogen
bonding:
in
base
pairs,
84,
89,
1156
in
collagen
triple
helical
structure,
237F
and
enzyme
substrate
specificity,
470F
in
functional
groups,
43F
in

helix,
227F
in
HIV
protease-1,
549F
low-barrier
vs.
short,
strong,
535–536
in

pleated
sheet,
229–230,
229F
in
proteins,
261–262
and
tRNA
tertiary
structure,
1348–1349
in
water,
41–42,
41F
Hydrogen
exchange,
285–286,
309F
Hydrogen
ions,
60
Hydrogen
peroxide,
10
Hydrogen
phosphate
ion
(H
2
PO
4
),
47,
47F
Hydrogen
sulfide,
324
Hydrolases,
479T
Hydrolysis,
base-catalyzed,
85,
85F
Hydronium
ion,
45,
45F,
46
Hydropathies,
264,
264T,
304
5-Hydroperoxyeicosatetraenoic
acid
(5-HPETE),
996F,
997,
1000
12-Hydroperoxyeicosatetraenoic
acid
(12-HPETE),
996F,
997,
1000
15-Hydroperoxyeicosatetraenoic
acid
(15-HPETE),
996F,
997,
1000
Hydroperoxyeicosatetraenoic
acids
(HPETEs),
1000
(15S)-Hydroperoxyeicosatetraenoic
acid([15S]-HPETE),
1003
Hydrophilic
materials,
42
Hydrophobic
bonding,
264
Hydrophobic
collapse,
286–287
Hydrophobic
effect,
262–264
Hydrophobic
forces,
44
and
enzyme
substrate
specificity,
470F
in
integral
membrane
proteins,
406
in
nucleic
acid
bases,
1156–1157
and
protein
stability,
262–264
and
reverse
turns,
304
I-26
Index
Hydrophobic
interaction
chromatography
(HIC),
132T,
145
Hydrophobic
interactions,
44
Hydrophobic
materials,
42
Hydropyrimidine
hydratase,
1136F
Hydroxide
ions,
45,
45T,
46,
688
6-Hydroxy-1,6-dihydropurine
ribonucleoside
(HDPR),
1132
8-Hydroxy-7,8-dimethyl-5-deazariboflavin,
1215
-Hydroxyacyl-ACP
dehydrase
(DH),
965
3-
L
-Hydroxyacyl-CoA,
947,
947F
3-
L
-Hydroxyacyl-CoA
dehydrogenase,
see
HAD
3-Hydroxyanthranilate,
1042
Hydroxyapatite,
540,
677
Hydroxyapatite
chromatography,
144,
157
-Hydroxybutyrate,
831
D
--Hydroxybutyrate,
959
D
--Hydroxybutyrate
dehydrogenase,
960
-Hydroxybutyric
acid,
32T
25-Hydroxycholecalciferol,
678
(15R)-Hydroxyeicosatetraenoic
acid
([15R]-HETE),
1004
(15S)-Hydroxyeicosatetraenoic
acid
([15S]-HETE),
1003
Hydroxyethylthiamine
pyrophosphate,
616–617
3-Hydroxykynurenine,
1041–1042
Hydroxylamine,
312–313
point
mutations
caused
by,
1340,
1340F
prion
reactivation
with,
312–313,
313F
Hydroxyl
groups,
43F
Hydroxyl
radical,
325,
865
5-Hydroxylysine
(Hyl),
78,
79F,
236
Hydroxymethylbilane,
1053
Hydroxymethylbilane
synthase,
1053
5-Hydroxymethylcytosine
residue,
1247
Hydroxymethylglutaryl-CoA,
see
HMG-CoA
p-Hydroxyphenylpyruvate,
1045,
1047F
p-Hydroxyphenylpyruvate
dioxygenase,
1045
4-Hydroxyproline
(Hyp),
78,
79F,
236
3-Hydroxyproline,
236
Hydroxypyruvate,
935
8-Hydroxyquinone,
1119
5-Hydroxytryptophan,
1046,
1060
Hydroxyurea,
347,
1119
Hyl
(5-hydroxylysine),
236
Hyp
(4-hydroxyproline),
236
Hyperacute
rejection,
121
Hyperammonemia,
1023,
1025
Hypercholesterolemia,
456–457,
466,
989–991
Hyperchromic
effect,
92
Hyperglycemia,
1102,
1103
Hyperhomocysteinemia,
1034–1035
Hyperinsulinism/hyperammonemia
(HI/HA),
1023,
1025
Hyperlysinemia,
1041
Hyperlysinuria,
1041
Hyperphenylalaninemia,
1045
Hypertension,
547F
Hyperthermophiles,
266
Hyperthyroidism,
677
Hypervariable
position,
188
Hyperventilation,
357
Hypoglycemia,
666
Hypoglycin
A,
948,
948F
Hypothalamus,
672F,
682
hunger
signal
transmission,
1099
integration
of
signals,
1099,
1100F
leptin
expression,
1098
Hypothyroidism,
677
Hypotonic
solutions,
130
Hypoxanthine,
127,
1108,
1130F,
1135,
1339–1340
Hypoxanthine–guanine
phosphoribosyltransferase
(HGPRT),
1114
Hypoxia,
331,
864
Hypoxic,
324
I
i
6
A,
see
N
6
-Isopentenyladenosine
IAPP
(islet
amyloid
polypeptide),
310–311,
311F
IB,
1414
Ibandronate,
679F
Ibuprofen,
78,
78F
IC
50
,
539
ICATs,
see
Isotope-coded
affinity
tags
Ice,
41–42,
41F
I-cell
disease,
439
Icosahedral
symmetry,
268,
268F
IDL
(intermediate
density
lipoproteins),
449,
449T,
986,
1322
D
-Idose,
360F
IEF
(isoelectric
focusing),
150–152
IF,
see
Initiation
factor
IF-1,
1375–1376,
1375T
IF
1
protein,
865
IF-2,
1375–1376,
1375T
IF-3,
1375–1376,
1375T
I-FABP
(intestinal
fatty
acid-binding
protein),
943–944,
944F
I
gene,
1262
IgG,
see
Immunoglobulin
G
IHF
(integration
host
factor),
1195
IHP
(inositol
hexaphosphate),
330
IB
kinase
(IKK),
1420
IL-1,
see
Interleukin-1
IL-3
receptors,
717
IL-5
receptors,
717
Ile,
see
Isoleucine
IleRS,
1352,
1356–1357,
1357F
Illegitimate
recombination,
1236
Illumina
system,
184
ilv
operon,
1299,
1299T
Image
reconstruction,
1363F
Imatinib,
719
Imidazole,
513
,-Imido
nucleoside
triphosphate,
1275
Iminoaceticpropionic
acid,
32T
Iminodiacetic
acid,
32T
Immobilized
pH
gradients,
151
Immune
electron
microscopy,
1365
Immune
system,
1132
Immunoaffinity
chromatography,
143
Immunoblotting,
149–150,
150F
Immunochemical
procedures,
131–132
Immunofluorescence,
408
Immunoglobulins,
163
Immunoglobulin
fold,
251,
251F
Immunoglobulin
G
(IgG),
154F,
282,
380
Immunophilins,
292,
724
IMP
(inosine
monophosphate),
1108
animal
catabolism
pathway,
1130F
conversion
to
AMP
or
GMP,
1112F
synthesis,
1108–1111,
1109F
IMP
cyclohydrolase
(PurJ),
1109F,
1111
IMP
dehydrogenase,
1112F
IMS,
see
Intermembrane
space
Inactivation,
of
ion
channels,
774–775
Inactivators,
494
Inborn
errors
of
metabolism,
26
Inclusion
bodies,
117,
117F
Indels,
see
Insertion/deletion
mutations
Independent
assortment,
21–22,
22F
Independent
segregation,
23F
Indinavir,
550F,
551
Indirect
readout,
1290
Indole-3-glycerol
phosphate,
1075
Indolepropanol
phosphate
(IPP),
1078
Induced-fit
hypothesis,
352
Induced-fit
model,
of
allosteric
interactions,
352
Inducers,
97,
97F,
1261
Inducible
enzymes,
1261
Inducible
NOS
(iNOS),
686–688
-ine
suffix,
73
Infarction,
456
Inflammatory
response,
993,
1003–1004
Influenza
virus
neuraminidase,
466
Ingen-Housz,
J.,
901
Ingold,
C.,
76
Ingram,
V.,
186
Inheritance,
20–26
Inherited
diseases,
see
Genetic
diseases
Inhibition,
of
enzymes,
see
Enzyme
inhibition
Inhibitors,
351,
492
Inhibitory
synapses,
778
Initial
velocity,
489
Initiating
codon,
100–101,
100T
48S
Initiation
complex,
1379
Initiation
factor
(IF),
1375–1376,
1375T
Inorganic
pyrophosphatase,
582,
946
iNOS
(inducible
NOS),
686–688
Inosine,
1130F,
1347F
Inosine
monophosphate,
see
IMP
Inosine
triphosphate,
see
ITP
myo-Inositol,
364,
389T
Inositol-1,4,5-triphosphate,
see
IP
3
Inositol
hexaphosphate
(IHP),
330
Inositol
polyphosphate
1-phosphatase,
736
Inositol
polyphosphate
3-phosphatases,
736
Inositol
polyphosphate
phosphatases,
734–736
Insects,
mutation
rate
of,
192
Insertion/deletion
mutations
(indels),
196,
1340
Insertion
sequences
(IS),
1236
In
situ
gene
therapy,
122–123
In
situ
hybridization,
113–114,
114F
InsR,
see
Insulin
receptor
Insulin,
164–165,
165F,
673T,
1099
affinity
chromatographic
isolation,
142
in
fatty
acid
metabolism
regulation,
974
in
glycogen
metabolism
regulation,
660
glycogen
synthase
kinase-3
inhibition,
660
isoelectric
point,
134T
and
passive-mediated
glucose
transport,
751–752
pyruvate
dehydrogenase
phosphatase
activation,
805
recombinant
human,
119
renaturation,
280–281
sequencing
of
bovine,
165F
Insulin-dependent
diabetes,
1102,
1400
Insulinlike
growth
factor
II
receptor,
890
Insulin
receptor
(InsR),
142,
699–703,
737F
Insulin
receptor
substrate
(IRS),
710,
1103
Insulin
resistance,
1103,
1103F
Insulin
signaling
system,
736–738
Insulin-stimulated
protein
kinase,
659–660
Integral
membrane
proteins,
399–406
Integrase,
545,
1245
Integration
host
factor
(IHF),
1195
Intein
Database,
1407
Inteins,
1405–1407,
1406F
Intensive
quantities,
61
Intercalating
agents,
1160–1162,
1272
Intercalation,
157
Interfacial
activation,
941
Interferons,
1399–1400,
1400F
Index
Intergenic
suppressors,
1362
Interleukins,
657,
671,
717
Interleukin-1
(IL-1),
671,
1414
Interleukin-1-
converting
enzyme,
see
ICE
Interleukin-2,
671
Intermediates,
reaction,
483
Intermediate
density
lipoproteins,
see
IDL
Intermediate
fibers,
10–11
Intermediate
filaments,
10–11
Intermembrane
space
(IMS),
9,
446,
448
Internal
conversion,
904
Internally
compensated
molecules,
76
Internal
nodes,
phylogenetic
trees,
203–204,
203F
Internal
resolution
site,
1237
Internal
ribosome
entry
site
(IRES),
1379
Interphase,
20F,
21F
Intervening
sequences,
97,
1304
Interwound
helix,
1160,
1160F
Intestinal
fatty
acid-binding
protein,
see
I-FABP
Intragenic
suppressors,
1340
Intrasteric
mechanism,
658
Intrinsic
dissociation
constants,
348
Intrinsic
factor,
956
Intrinsic
membrane
proteins,
see
Integral
membrane
proteins
Intrinsic
proteins,
399–406
Intrinsic
terminators,
1273–1275,
1273F
Intronic
splicing
enhancers
(ISEs),
1306
Intronic
splicing
silencers
(ISSs),
1306
Introns,
98,
1304–1305
AU-AC,
1319
Group
I,
1306–1309,
1307T
Group
II,
1307T,
1308
in
prokaryotes
vs.
eukaryotes,
1316
types
of,
1307T
Invariant
residues,
188
Invertase,
367,
488
Inverted
micelles,
51
Invert
sugar,
367
In
vivo
gene
therapy,
123
Iodoacetic
acid,
168–169
Ions,
solvation
of,
43F
Ion-driven
active
transport,
768–771
Ion
exchange,
135
Ion
exchange
chromatography,
132T,
135–138,
136F,
157
Ion
exchangers,
137–138,
138T
Ionic
charge,
protein
purification
and,
132
Ionic
interactions,
259–260,
1158
Ionic
mobility,
44–45,
45T
Ionic
strength,
133–134,
133F
Ionization
constants,
47,
49–50,
497,
502–503
Ionizing
radiation,
1214
Ionophores,
748–749,
748F
Ion
pair,
259–260,
260F
IP
3
(inositol-1,4,5-triphosphate),
661,
665,
725–726
IP
3
receptor,
726
IPP
(indolepropanol
phosphate),
1078
IPTG
(isopropylthiogalactoside),
117,
621,
1261,
1295
IRES
(internal
ribosome
entry
site),
1379
Iron,
in
heme
biosynthesis,
1056
Iron-protoporphyrin
IX,
316,
316F,
324,
838,
904F.
See
also
Heme
b
Iron–sulfur
clusters,
808F,
809,
834–835
Iron–sulfur
protein
(ISP),
840
Irreversible
thermodynamics,
587
IRS,
see
Insulin
receptor
substrate
IS
(insertion
sequences),
1236
IS1,
1236,
1236T
IS2,
1236,
1236T
IS4,
1236T
IS5,
1236T
Ischemia,
325,
864
IS
elements,
1236
ISEs
(intronic
splicing
enhancers),
1306
Islest
of
Langerhans,
675
Islet
amyloid
polypeptide,
see
IAPP
Isoaccepting
tRNAs,
1351
Isoalloxazine,
566
Isocaudamers,
128
Isocitrate,
789,
790F,
809
Isocitrate
dehydrogenase,
568,
789,
809–810,
810F,
815–816
Isocitrate
lyase,
880
Isoelectric
focusing
(IEF),
132T,
150–152
Isoelectric
point
(pI),
72,
134,
134T,
150
Isoelectric
precipitation,
134
Isoflurane,
398–399
Isoforms,
543
Isoionic
point,
81
Isolated
systems,
52
Isolation,
protein,
129–133
Isoleucine:
biosynthesis,
1075
chiral
centers,
76,
77F
degradation,
1034–1039
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246
half-life,
1413T

helix/
sheet
propensity,
302T
in
native
unfolded
proteins,
283
side
chains,
70,
264T
stereoisomers,
77F
structure
and
general
properties,
68T
(2S,3S)-Isoleucine,
76,
77F
Isomaltose,
367,
367F
Isomerases,
479T
Isomerization,
567
N
6
-Isopentenyladenosine
(i
6
A),
976,
1347F
Isopentenyl
pyrophosphate,
977,
977F,
978F
Isopentenyl
pyrophosphate
isomerase,
978,
978F
Isopeptide
bond,
1409
Isoprene,
406,
975
Isoprenoids,
976–977,
976F
Isoprenoid
groups,
406
Isoprenylation
site,
406
-Isopropylmalate,
1075
Isopropylthiogalactoside,
see
IPTG
Isoproterenol,
680
Isopycnic
ultracentrifugation,
156,
157F
Isoschizomers,
127–128
Isotonic
saline
solution,
161
Isotopes,
573T
Isotope-coded
affinity
tags
(ICATs),
577–578,
577F
Isotope
effects,
572
Isotope
studies,
500–501,
572–575
Isotope
tests,
813–814
Isozymes,
202F,
277,
543
ISP
(iron–sulfur
protein),
840
ISSs
(intronic
splicing
silencers),
1306
Iterative
annealing
model
(GroEL/ES
system),
299–300
ITP
(inosine
triphosphate),
1273
Iwata,
S.,
838,
916
J
Jacob,
F.,
1262,
1264–1265
Jaenisch,
R.,
1251
Jaffe,
E.,
1050
Jahn,
R.,
441,
444
JAK
(Janus
kinase),
718
JAK1,
718
JAK2,
718
I-27
JAK3,
718
JAK4,
718
JAK–STAT
pathway,
717–718
Jamaican
vomiting
sickness,
948
James,
M.,
523
Jansonius,
J.,
403
Janus,
283
Janus
kinase
(JAK),
718
Jap,
B.,
840
Jaundice,
1056
Jefferson,
T.,
116
Jelly
roll,
252,
253F
Jencks,
W.,
515
JIP-1,
see
JNK
interacting
protein-1
Jmol,
256T,
257
JNK,
714
JNK
interacting
protein-1
(JIP-1),
714,
743
Johnson,
A.,
424
Johnson,
L.,
640,
658
Joliet,
P.,
917
Jones,
M.
E.,
1117
Jorgensen,
R.,
1323
Joshua-Tor,
L.,
1184
Joule
(unit),
53,
53T
Jpred3
algorithm,
304
Jun,
705,
713,
737F
Junk
DNA,
1317
Juvenile-onset
diabetes,
310,
1102
K
K
M
(Michaelis
constant),
489
K
a
,
see
Dissociation
constant
Kaback,
R.,
770
Kacser,
H.,
620
Kahn,
R.,
1104
Kaiser,
D.,
109
Kaiser,
T.,
450
Kalckar,
H.,
578
Kallikrein,
525T
Kamen,
M.,
813,
903
Kaplan,
N.,
791
Kaptein,
R.,
1295
Karplus,
M.,
307,
857
Kauzmann,
W.,
264
kb
(kilobase
pairs),
95
k
B
,
see
Boltzman
constant
K

channels,
752–755,
753F,
754F
KDEL
receptors,
440
KDO
(2-keto-3-deoxyoctanoate),
379F
Ke,
H.,
725
Keilin,
D.,
838
Kelvin
temperature
scale,
53T
Kendrew,
J.,
246,
331
Kennedy,
E.,
419,
823,
946
Kent,
S.,
209
K
eq
,
see
Equilibrium
constant
Keratan
sulfate,
371F,
372,
373
Keratin,
10–11,
10F,
233–235

Keratins,
233–235,
234F

Keratins,
233–235
2-Keto-3-deoxy-6-phosphogluconate,
637F
2-Keto-3-deoxy-
D
-arabinoheptulosonate-7-
phosphate,
see
DAHP
2-Keto-3-deoxyoctanoate
(KDO),
379F
2-Keto
acid
dehydrogenases,
799
Ketoacidosis,
961,
1102
-Ketoacyl-ACP
reductase
(KR),
965
-Ketoacyl-ACP
synthase
(KS),
965
-Ketoacyl-CoA,
947F,
949F
-Ketoacyl-CoA
thiolase,
see
KT
3-Ketoacyl-CoA
transferase,
961
-Ketoadipate,
1042
-Ketobutyrate,
1034,
1075
Keto-enol
tautomerization,
506–507,
507F
I-28
Index
Keto
forms,
of
nucleotide
bases,
88
Ketogenic
amino
acids,
1029–1030,
1090,
1094
-Ketoglutarate,
789,
809,
1034,
1067F
-Ketoglutarate
dehydrogenase
(E1o),
789,
799,
810,
815–816
-Ketoglutarate
dehydrogenase
complex,
799
Keto
groups,
hydrogen
bonding
in,
43F
-Ketoisovalerate,
1075
-Ketoisovalerate
dehydrogenase,
1039
Ketones,
361F
Ketone
bodies,
959–961,
973,
1095,
1101
Ketonogenesis,
959–961
Ketopentose,
360
Ketoses,
360F,
361,
361F
Ketosis,
961
3-Ketosphinganine,
1008
3-Ketosphinganine
reductase,
1009
3-Ketosphinganine
synthase,
1008
KF
(Klenow
fragment),
177,
1177–1178,
1178F,
1180–1181
KFERQ
proteins,
1409
Khorana,
H.
G.,
209,
211,
1342
Kidneys,
871,
1091F,
1095
Kidney
stones,
1134
Kieselguhr,
144
Kilobase
pairs
(kb),
95
Kim,
J.-J.,
948
Kim,
K.
K.,
1151
Kim,
P.,
282
Kim,
S.,
1346
Kim,
S.-H.,
840
Kinases,
513,
581,
597
Kinemages,
257
Kinesin,
440
Kinetics:
chemical,
54,
482–486
enzyme,
487–492
membrane
transport,
745–757
Kinetic
barrier,
486
KiNG,
256T,
257
King,
J.,
289
Kinosita,
K.,
Jr.,
857,
1271
Kirchhausen,
T.,
431
Kjeldgaard,
M.,
1381,
1388
Kleinschmidt
procedure,
94F
Klenow
fragment,
see
KF
Klentaq1,
1178–1180,
1223
Klinefelter’s
syndrome,
682
Klug,
A.,
1346,
1363
KNF
model,
of
allosteric
interactions,
352
Knockout
mice,
121,
572
Knoop,
F.,
572,
791,
945
Knowles,
J.,
565
Kohda,
D.,
446
Kok,
B.,
917
Kool,
E.,
1177
Kornberg,
A.,
1116,
1176,
1194,
1195,
1281
Kornberg,
R.,
1277–1278
Kornfeld,
S.,
884,
888
Koshland,
D.,
352,
513,
514,
621,
817
Kossiakoff,
A.,
684
KR
(-ketoacyl-ACP
reductase),
965
Krabbe’s
disease,
1013T
K-Ras
4A,
709
K-Ras
4B,
709
Krauss,
N.,
922
Kraut,
J.,
534
Krebs,
E.,
722
Krebs,
H.,
651,
791,
1025
Krebs
cycle,
789.
See
also
Citric
acid
cycle
Kreevoy,
M.,
536
KS
(-ketoacyl-ACP
synthase),
965
KT
(-ketoacyl-CoA
thiolase),
947,
947F,
948,
949F
Ku,
1223–1224,
1223F
Ku70,
1223
Ku80,
1223
Kuhn,
H.,
1001
Kühne,
F.
W.,
470
Kunitz,
M.,
470
Kunkel,
T.,
1205
Kurisu,
G.,
924
Kuriyan,
J.,
706,
710,
720,
1125,
1182,
1196,
1197,
1204
Kuru,
312
Kushmerick,
M.,
863
Kv1.2
channels,
773,
773F,
774F
Kv
channels,
772–774
K
w
(ionization
constant
of
water),
47
Kwashiorkor,
1087
Kynureninase,
1042
L
lacI
gene,
107F,
621,
1264
S-lac-NAD

,
614,
615F
lac
operators,
1284–1285,
1285F,
1294
lac
operon,
97,
97F,
1261–1262,
1294
lac
promoter,
117,
621,
1266,
1294
lac
repressor,
97,
107F,
117,
621,
1263–1264
allosterically
important
residues,
1296
isolation
of,
129
in
prokaryote
transcription
control,
1284–1285
structure,
1294–1296,
1296F
-Lactalbumin,
882
-Lactamase,
1237
Lactase,
367
Lactate:
converting
to
oxaloacetate,
872F
in
Cori
cycle,
880
from
fermentation,
594,
594F,
614–619
transport
in
blood,
973
Lactate
dehydrogenase,
see
LDH
Lactate
dehydrogenase
H,
153T
Lactic
acid,
32T
D
-Lactic
acid,
365
-Lactoglobulin,
133F,
134
Lactoperoxidase,
140F
Lactose,
367,
367F,
631
and
glucose,
1286
metabolism
in
E.
coli,
97
synthesis,
882
Lactose
intolerance,
367
Lactose
permease,
766,
768–771,
769F,
770F,
1261
Lactose
synthase,
883F
Lactosyl
ceramide,
1010
lacZ
gene,
107F,
120,
1294
lacZ¿
gene,
107F,
110,
111
LADH,
see
Liver
alcohol
dehydrogenase
Lagging
strand
synthesis,
103,
103F,
1175,
1175F,
1190–1191
Lake,
J.,
1365
Lamarck,
Jean
Baptiste
de,
19
Lamarckism,
19
␭
integrase,
1243–1244
Lamprey,
hemoglobin
of,
194
Lander,
E.,
181
Landick,
R.,
1273
Lands,
W.,
1005
Landscape
theory,
of
protein
folding,
287–289,
288F
Landsteiner,
K.,
414–415
Lanosterol,
982–984,
985F
Lanosterol
synthase,
982
Lanzilotta,
W.,
1055
Large
calorie
(Cal),
53,
53T
Large-T
antigen,
SV40,
1211
Lariat
structure,
1306,
1306F
late
genes,
1284
Lateral
diffusion,
396
Lathyrism,
238–239
-Latrotoxin,
780
Lattman,
E.,
282
Lauric
acid,
387T
Lavoisier,
A.,
823,
901
LBHBs
(low-barrier
hydrogen
bonds),
536
LCa
(clathrin
light
chain),
430,
432,
432F
LCA2
(Leber’s
congenital
amaurosis
2),
123
LCAT,
see
Lecithin-cholesterol
acyltransferase
LCb
(clathrin
light
chain),
430,
432,
432F
Lck,
715
LD
50
,
539
LDH
(lactate
dehydrogenase):
half-life,
1408T
in
homolactic
fermentation,
614–615,
615F
isozymes,
277
molecular
mass,
140F
X-ray
structure
of
dogfish,
254,
255F,
256
LDL
(low
density
lipoproteins),
449,
449F
and
apoB-100,
1322
and
atherosclerosis,
458
as
cholesterol
carrier,
449F
cholesterol
takeup
by,
453–455
properties,
449T
LDL
receptors
(LDLR),
453–457,
453F,
454,
1317
and
apoB-100,
1322
and
atherosclerosis,
456–457
and
cholesterol
homeostasis,
989–991,
990F
and
endocytosis
mediation,
986,
986F
L
-DOPA,
1046,
1059–1060F
Lead
compounds
(drug
discovery),
539
Leader
sequence,
1297–1298
Leading
strand
synthesis,
102–103,
1175,
1175F,
1190–1193
Leading
substrate,
498
Lead
poisoning,
1134
Leaves,
phylogenetic
trees,
203,
203F
Leberman,
R.,
1381–1382
Leber’s
congenital
amaurosis
2
(LCA2),
123
Le
Châtelier’s
principle,
59
Lecithins,
389T,
390
Lecithin-cholesterol
acyltransferase
(LCAT),
450T,
452,
453F
Lectins,
366,
885
Leder,
P.,
1342
Lederberg,
J.,
1262
Leflunomide,
1116
Left-handed
helix,
225F,
1149–1151
Left-handed

helix,
224F
Leghemoglobin,
219,
1083
Lehninger,
A.,
823,
946
Leloir,
L.,
631,
883
Leloir
pathway,
631
Lennarz,
W.,
291
Leptins,
1096–1099,
1101
Leptin-E100,
1098F
Lesch–Nyhan
syndrome,
1114,
1135
Leslie,
A.,
853,
857,
865
let-7
gene,
1326
Lethal
factor
(LF),
anthrax,
715
Letsinger,
R.,
211
Leucine,
26
basic
helix-loop-helix/leucine
zipper,
987
biosynthesis,
1075
degradation,
1040–1041
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246
half-life,
1413T
Index

helix/
sheet
propensity,
302T
inserted
by
E.
coli
nonsense
suppressor,
1362T
in
native
unfolded
proteins,
283
side
chains,
70,
264T
specific
rotation,
74
structure
and
general
properties,
68T
Leucine
aminopeptidase,
168T
Leucine-rich
repeats
(LRRs),
1412
Leuconostoc
mesenteroides,
139
Leu-enkephalin,
673T,
685
Leukocytes,
85
Leukocyte
elastase,
533
Leukocyte
interferon,
1399
Leukotrienes,
993
arachidonic
acid
precursor,
995–997
biosynthesis,
1000–1002,
1002F,
1060F
series-5,
1003
Leukotriene
A
4
(LTA
4
),
1000
Leukotriene
B
4
(LTB
4
),
1001
Leukotriene
C
4
(LTC
4
),
1001
Leukotriene
D
4
(LTD
4
),
1001
Leukotriene
E
4
(LTE
4
),
1001
Leukotriene
receptors,
689
leu
operon,
1299T
Leupeptin,
556
Levine,
P.,
83
Levinthal,
C.,
284,
287
Levinthal
paradox,
284
Levitt,
M.,
523
Levorotatory
molecules,
74
Lewis,
G.,
45
Lewis,
M.,
1294
Lewis
acids,
45,
511
Lewis
bases,
45
Lewisite,
822
LexA,
1221–1222,
1228
lexA
gene,
1221
LF
(lethal
factor),
anthrax,
715
L
forms
(amino
acids),
74–76
LH,
see
Luteinizing
hormone
LHC-II,
908–909,
909F
LHCs,
see
Light-harvesting
complexes
Licensing,
see
Pre-replicative
complex
(Pre-RC)
Lienhard,
G.,
515
Life,
3–37
and
biochemical
literature,
34–36
and
biochemistry,
14–19
chiral
molecules
and,
78
defined,
3
divergence
of
major
kingdoms,
192
eukaryotes,
6–14
evolutionary
tree,
13F
and
genetics,
19–28
origin
of,
28–34
prokaryotes,
3–6
and
thermodynamics,
52,
586–589
and
water’s
properties,
40,
41
Life
Science
Directory,
194–195
LigA,
1187
Ligament,
235
Ligands:
Adair
equation,
348–349
in
affinity
chromatography,
142,
142F
Hill
equation
for
binding,
326–328
Ligand-gated
binding,
606
Ligand-gated
channels,
771–772
Ligases,
479T
Light
absorption,
903–909
Light
chains,
clathrin,
430
Light-harvesting
complexes
(LHCs),
906–909,
908F
Light
reactions,
photosynthesis,
902–926
electron
transport
in
purple
bacteria,
909–913
light
absorption,
903–909
photophosphorylation,
925–926
two-center
electron
transport,
913–925
Lignin,
369
Lignoceric
acid,
387T,
958
Lilijas,
A.,
1385
Lima,
C.,
1327
Limit
dextrins,
385
Limited
proteolysis,
170
lin-4
gene,
1326
LIN-14
protein,
1326
Linear
concentration
gradients,
137F
Linear
gradient
elution,
137
Linear
polymers,
70
LINEs
(long
interspersed
nuclear
elements),
1246,
1249
Lineweaver–Burk
plot,
490,
490F,
494F–496F,
499F,
500F
Linked
genes,
24
Linkers,
in
gene
manipulation,
109–110,
110F
Linking
number,
1158,
1162
Link
proteins,
375
Linoleic
acid,
386,
387F,
387T,
950F,
971
-Linolenic
acid,
387F,
387T,
971,
994
-Linolenic
acid
(GLA),
387T,
994
Lipase,
153T,
941–942,
941F
Lipids,
15,
16F.
See
also
related
topics.
e.g.:
Fatty
acids
and
acid-base
groups,
48
aggregates
of,
393–399
biosynthesis,
818,
973
classification,
386–393
fluidity,
388,
397–399
metabolism,
561F
in
thylakoid
membrane,
902
Lipid
bilayers,
44F,
395F,
397F.
See
also
Membranes
dynamics,
396–399,
397F
fluidity,
397–399
liposomes,
395–396
micelles,
394–395,
394F
phospholipid
diffusion,
396F
Lipid-linked
membrane
proteins,
406–408
Lipid
metabolism,
561F,
940–944
cholesterol,
975–993
eicosanoid,
993–1004
fatty
acid
biosynthesis,
961–973
fatty
acid
oxidation,
945–959
ketone
bodies,
959–961
phospholipids
and
glycolipids,
1004–1013
regulation
of
fatty
acid
metabolism,
973–975
Lipidomics,
578
Lipid-soluble
vitamins,
474
Lipid
storage
disease,
1011,
1013
Lipid-water
interfaces,
940–941
Lipinski,
C.,
542
Lipinski’s
rule
of
five,
542
Lipitor,
990–991,
991F
Lipmann,
F.,
578,
791,
892
Lipoamide,
in
citric
acid
cycle,
794,
795F
Lipogenesis,
1096
Lipoic
acid,
473T,
794,
795T
Lipolysis,
1096
Lipopolysaccharides,
378
Lipoproteins:
characteristics
of
major
classes,
449T
dysfunctions,
456–459
function,
451–456
structure,
449–451
Lipoprotein
lipase
(LPL),
450T,
451,
943
Liposomes,
122,
395–396
I-29
Lipoxins
(LXs),
993,
1003–1004
15-epi-Lipoxin
A
4
(15-epi-LXA
4
),
1004
Lipoxin
A
4
(LXA
4
),
1003F,
1004
Lipoxin
receptors,
689
5-Lipoxygenase
(5LO),
1000
12-Lipoxygenase
(12LO),
1000
15-Lipoxygenase
(15LO),
1000,
1001
Lipoxygenase-1,
1001
5-Lipoxygenase-activating
protein
(FLAP),
1001,
1002,
1002F
Lipoyllylsyl
arm,
dihydrolipoyl
dehydrogenase,
797
Lipscomb,
W.,
476
Liquid
scintillation
counting,
572
Literature
search,
34–35
Lithgow,
T.,
445
Lithium
ion,
45T,
1158
Liver:
AMP-dependent
protein
kinase
in,
1096,
1097F
and
cholesterol
biosynthesis,
987
citric
acid
cycle
in,
816,
817
fructose
utilization
in,
630–631
glucokinase
in,
597
gluconeogenesis
in,
871
glycogen
storage
in,
638–639,
667–668
half-lives
of
enzymes
in,
1408T
heme
synthesis
regulation,
1055–1056
and
other
organs,
1091F,
1093–1094
rat
liver
cytoplasmic
ribosomes,
1370T
stress
response
of,
665F
Liver
alcohol
dehydrogenase
(LADH),
472,
505,
618–619
Liver
glycogen
synthase
deficiency,
668
Liverworts,
13F
Living
systems,
rise
of,
33–34
LKB1,
1096
5LO
(5-lipoxygenase),
1000
12LO
(12-lipoxygenase),
1000
15LO,
see
15-Lipoxygenase
Local
energy
maxima,
289
Local
mediators,
671
Lock-and-key
hypothesis,
470
Loewenstein,
W.,
416
Logan,
D.,
1385
Log
odds,
198
Log
odds
substitution
matrix,
198
Lohman,
T.,
1186
Lon,
1419
London
dispersion
forces,
260–261,
261F
Longevity,
and
caloric
restriction,
1101
Long
interspersed
nuclear
elements,
see
LINEs
Long
terminal
repeats
(LTRs),
1245–1246
Long-term
regulation,
of
fatty
acid
metabolism,
973
Loop
conformation,
230,
232
Looped
rolling
circle
replication,
1191–1193,
1192F
Lopez,
A.,
717
Lord,
R.,
1155
Lorimer,
G.,
300
Lovastatin,
990,
991F
Low-barrier
hydrogen
bonds
(LBHBs),
536
Low
density
lipoproteins,
see
LDL
Lowenstein,
J.,
1132
Lowe
syndrome,
735
Lowry,
T.,
45
loxP
gene,
1244
LPL,
see
Lipoprotein
lipase
L-protein,
1032
LRRs
(leucine-rich
repeats),
1412
LT
(heat-labile
enterotoxin),
696
LTA
4
(leukotriene
A
4
),
1000
I-30
Index
LTB
4
(leukotriene
B
4
),
1001
LTC
4
(leukotriene
C
4
),
1001
LTC
4
synthase,
1001
LTD
4
(leukotriene
D
4
),
1001
LTE
4
(leukotriene
E
4
),
1001
LTRs
(long
terminal
repeats),
1245–1246
Lu,
P.,
1294
Luciferase,
183
Luciferin,
183
Ludwig,
M.,
1036,
1037,
1125
Lührmann,
R.,
1314,
1315
Luisi,
B.,
800
Lungfish,
94T
Luteinizing
hormone
(LH),
154F,
673T,
683
LXA
4
,
see
Lipoxin
A
4
15-epi-LXA
4
(15-epi-lipoxin
A
4
),
1004
LXs,
see
Lipoxins
Lyases,
479T
Lycopenes,
905F,
907
Lydon,
N.,
719
Lynen,
F.,
791
Lyophilization,
141
Lys,
see
Lysine
Lysate,
130
Lysidine,
1347F,
1352
Lysine:
amino
group,
208F
biosynthesis,
1072–1073,
1075
degradation,
1040–1041
and
E.
coli
nonsense
suppressor,
1362T
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
half-life,
1413T

helix/
sheet
propensity,
302T
isoelectric
point,
72
in
native
unfolded
proteins,
283
side
chains,
71,
208F,
264T
structure
and
general
properties,
69T
trypsin-catalyzed
cleavage,
170
Lysis,
27,
130
Lysogenic
mode,
1243
Lysolecithin,
452
Lysophosphatidic
acid,
971
Lysophospholipase
A
2
,
942
Lysophospholipids,
942
Lysosomal
protease,
525T
Lysosomes,
7F,
9–10,
1408–1409
metabolic
functions,
562T
in
secretory
pathway,
420,
421F
and
vesicle
formation,
428–440
and
vesicle
fusion,
440–445
Lysozyme,
470,
479,
517
in
amyloid
diseases,
310–311
and
bacterial
cell
walls,
376
catalytic
mechanism,
520–525,
521F
covalent
intermediate
of,
524F
hen
egg
white,
275–276,
276T,
470,
517–525,
517F,
518F
isoelectric
point,
134T
for
protein
solubilization,
130
structure,
517–520
substrate
interactions
with,
510F
transition
state,
523F
Lysozyme
amyloidosis,
310
LysRS,
1351
Lysyl
group,
73T
Lysyl
hydroxylase,
240,
1405
Lysyl
oxidase,
238,
240
Lytic
mode,
1243
-Lytic
protease,
525T
D
-Lyxose,
360F
M
m
1
A
(1-Methyladenosine),
1347F
m
3
C
(Methylcytidine),
1347F
m
4
C(N
4
-Methylcytosine)
residue,
1246
m
5
C-MTase,
see
5-Methylcytosine
methyltransferase
m
5
C
(5-Methylcytosine)
residue,
1246
m
6
A
(N
6
-Methyladenine),
1246
M6P/IGF-II
receptor,
890
m
7
G,
see
N
7
-Methylguanosine
m
7
GDP,
1378
m
2
2
G
(N
2
,N
2
-Dimethylguanosine),
1347F
MacKinnon,
R.,
751,
752,
755,
774
MacLeod,
C.,
86
Macrocytes,
1064
Macrofibrils,
234,
234F

2
-Macroglobulin,
154F
Macromolecular
mimicry,
1386
Macromolecules,
15,
16F,
17,
257
Macrophages,
381,
457,
671
Macrophage
colony-stimulating
factor
(M-CSF),
717
Macroscopic
dissociation
constants,
348
Mad
cow
disease,
312,
315
Magnesium
ion,
45T,
1158,
1308–1309
Maintenance
methylation,
1249–1251,
1249F
Maize,
see
Corn
Major
facilitator
superfamily
(MFS),
751
Major
groove,
in
DNA
90,
1145
Major
histocompatibiliy
complex
(MHC)
proteins,
1102
Malaria,
187–188,
343,
898,
1058
Malate,
790F,
791,
813,
936
L
-Malate,
481,
947
Malate-aspartate
carrier,
827,
827F
Malate
dehydrogenase,
876,
947
in
citric
acid
cycle,
790F,
791,
813
molecular
mass,
140F
Malate
dehydrogenase,
decarboxylating,
956
Malate--ketoglutarate
carrier,
827
Malate
synthase,
880
Malathion,
527
MALDI
(matrix-assisted
laser
desorption/ionization),
172–173
Male
sex
hormones,
681
Malic
enzyme,
956
Malignant
transformation,
1211–1212
Malignant
tumors,
381,
703.
See
also
Cancer
Malonate,
493,
791,
811
Malonic
semialdehyde,
1136F
Malonyl/acetyl-CoA-ACP
transacylase
(MAT),
964
Malonyl-CoA,
961,
1136F
Malonyl/palmitoyl
transferase
(MPT),
967
Maltodetxrins,
749
Maltoheptaose,
640F
Maltoporin,
749–750,
749F
Maltose,
367,
367F
Maltose
binding
protein,
300
Maltose
phosphorylase,
501
Maltotriose,
370
Mammals.
See
also
specific
types
cloning,
1251
CpG
methylation,
1249
cytoplasmic
adenylation
of
mRNAs,
1402
DNA
base
composition,
84
energy
metabolism
strategies,
1088–1090
genomic
imprinting,
1251
glycogen
synthase,
645
homolactic
fermentation,
614–615
isoprenoid
metabolism,
976F
keratin,
232–233
LDL-receptor
mediated
endocytosis,
986,
986F
mitochiondrial
DNA
replication,
1207,
1207F
mitochondrial
deviations
from
ideal,
1344T
mRNAs,
1302
mutation
rate,
192
myoglobin,
324
POH1,
1418
signal
recognition
particles,
422
snoRNAs,
1329
Mammalian
target
of
rapamycin
(mTOR),
734,
738
Man,
see
Mannose
Manganese
ion,
1158
Maniatis,
T.,
1306
Manley,
J.,
1312
Mannose,
630,
633,
633F,
747T
D
-Mannose,
360F,
361
Mannosidase,
366
D
-Mannuronic
acid,
364
Map-based
genomic
sequencing,
180–181,
181F
MAP
(mitogen-activated
protein)
kinase,
712–714
MAP
kinase
kinase
(MKK),
713
MAP
kinase
kinase
kinase
(MKKK),
713
MAP-kinase
signaling
cascades,
712–714
Maple
syrup
urine
disease
(MSUD),
1039
Margaric
acid,
1018
Margoliash,
E.,
189
Margulis,
L.,
9
Marmur,
J.,
93
Mars,
39
Martin,
A.,
144
Martius,
C.,
791
Mas37,
449
Masking,
of
mRNA,
1401–1402
Massey,
V.,
801
Mass
spectrometry,
see
MS
Mast
cells,
372
MAT
(malonyl/acetyl-CoA-ACP
transacylase),
964
Matrix,
9,
445,
448,
824,
825F
Matrix-assisted
laser
desorption/ionization
(MALDI),
172–173
Matrix-associated
regions,
see
MARs
Matrix
processing
peptidase
(MPP),
447
Matrix
protein
1,
see
M1
Matrix
space,
9
Mattevi,
A.,
1066
Matthaei,
H.,
1341,
1343
Matthews,
B.,
282
Matthews,
D.,
1128
Matthews,
R.,
1036,
1037
Maturity-onset
diabetes,
310,
1102–1103
Maximal
velocity
(V
max
),
489
Maximum
likelihood
(ML)
tree-building
criteria,
205
Maximum
parsimony
(MP)
tree-building
criteria,
205
Mayer,
R.,
901
Mb,
see
Myoglobin
MBD
(methyl-CpG
binding
domain),
1249
MCAD
(medium-chain
acyl-CoA
dehydrogenase),
948
McArdle’s
disease,
644,
667
McCarty,
M.,
86
McClintock,
B.,
1236
McDermott,
A.,
604,
606
Mcm2,
1205
Mcm3,
1205
Mcm4,
1205
Mcm5,
1205
Mcm6,
1205
Mcm7,
1205
Mcm10,
see
DDK
MCM
complex,
1205,
1206
MCPA-CoA
(methylenecyclopropylacetyl-
CoA),
948,
948F
Index
M-CSF
(macrophage
colony-stimulating
factor),
717
Mdm10,
449
MDPK
(myotonic
dystrophy
protein
kinase),
1252
MDR
(multidrug
resistance)
transporter,
766–767
Mechanism-based
inhibitors,
1128
Mechanosensitive
channels,
772
Medial
cisternae,
428,
429F
Mediated
membrane
transport,
745–748
Medium-chain
acyl-CoA
dehydrogenase
(MCAD),
948
MedLine,
35,
195
Medulla,
679
Megaloblastic
anemia,
474T
Meiosis,
20,
21F,
24F,
1224
Meister,
A.,
1061
MEK,
713
MEKK1,
714
Melanin,
1046
-Melanocyte
stimulating
hormone
(-MSH),
1099
Melezitose,
385
Mello,
C.,
1323
Melting
curve:
DNA,
93,
93F
proteins,
265F
Melting
temperature
(T
m
):
DNA,
93,
93F
proteins,
265
Memapsin
2,
547
Membranes:
assembly
and
protein
targeting,
418–449
and
blood
groups,
414–415
composition
of,
398T
Donnan
equilibrium
for,
787
of
erythrocytes,
411–414,
411F
fluid
mosaic
model,
408–411
function
of,
386
gap
junctions,
415–416
lipid
distribution
in,
419–420
secretory
pathway,
420–428
vesicle
formation,
428–440
vesicle
fusion,
440–445
Membrane
potential,
447,
745
Membrane
proteins,
399–406
channel-forming,
416–418
integral,
399–406
lipid-linked,
406–408
Membrane
transport:
ABC
transporters,
766–768
action
potentials,
775–777
aquaporins,
756–757
ATP–ADP
translocator,
771
ATP-driven
active,
758–768
Ca
2
-ATPase,
762–764
Cl
channels,
755–756
general
scheme,
747F
group
translocation,
765–766
and
(H

–K

)-ATPase,
764–765
ion-driven
active,
768–771
in
ionophores,
748–749
K

channels,
752–755
kinetics
of
mediated
transport,
746–748
lactose
permease,
769–770
maltoporin,
749–750
mediated,
745–748
Na

–glucose
symport,
768–769
(Na

–K

)-ATPase,
758–762
and
neurotransmission,
771–784
nonmediated,
745–746
passive-mediated
glucose
transport,
750–752
thermodynamics
of,
744–745
voltage-gated
ion
channels,
771–775
Menaquinone,
910
Mendel,
G.,
20–22
Mendelian
inheritance,
20–22,
107F
Menstrual
cycle
control,
683–684
Menten,
M.,
488
2-Mercaptoethanol,
168
6-Mercaptopurine,
1142
Merozygote,
1263
Merrifield,
B.,
206,
208
Mertz,
J.,
109
Meselson,
M.,
90,
1173,
1264
Meso
form,
76
Mesophiles,
266
Mesophyll
cells,
904
Mesosomes,
4,
4F
Messenger
RNA,
see
mRNA
Met,
see
Methionine
Metabolic
adaptation,
1102–1104
Metabolic
control,
619–621
Metabolic
control
analysis,
620–624
Metabolic
flux,
620,
624
Metabolic
homeostasis,
619–620,
1096–1101
Metabolic
inhibitors,
569
Metabolic
pathways,
14,
17,
559–562
and
carbon–carbon
bonds,
567–569,
568F
in
cells,
560F
chemical
logic,
563–565
eliminations,
isomerizations,
and
rearrangements,
566–567
energy
metabolism,
1088–1090
evolution,
34
group
transfer
reactions,
564–565
interorgan
specialization,
1090–1095
organelles
in,
562T
organic
reaction
mechanisms,
562–569
oxidations
and
reductions,
565–566
Metabolic
regulation,
619
Metabolic
syndrome,
1104
Metabolism,
559.
See
also
specific
types
of
metabolism
cancer
cells,
864–865
experimental
study
of,
569–575
inborn
errors
of,
26
isotope
studies
of,
572–575
metabolic
inhibitors,
growth
studies,
and
biochemical
genetics,
569–572
organs,
cells,
and
subcellular
organelles
in,
575
oxidation–reduction
reactions,
584–586
phosphate
compound
thermodynamics,
578–583
systems
biology,
576–578
and
thermodynamics
of
life,
586–589
Metabolites,
559
Metabolite
carrier
proteins,
448
Metabolome,
576
Metabolomics,
578
Metabolons,
595,
817
Metachromatic
leukodystrophy,
1013T
Metal-activated
enzymes,
511
Metal
chelation
affinity
chromatography,
145
Metal
ion
catalysis,
511–512
Metalloenzymes,
511
Metaphase,
20F,
21F
Metastisis,
703
Metazoa,
12,
1202,
1206–1207
Met-enkephalin,
673T,
685
Methane,
32,
42
Methanococcus,
7F
Methanococcus
jannaschii,
424,
425F
Methanogens,
6
Methanol,
43T,
505
Methemoglobin
(metHb),
324,
342
I-31
Methemoglobinemia,
342
Methemoglobin
reductase,
324–325
N
5
,N
10
-Methenyltetrahydrofolate,
see
MTHF
Methionine:
biosynthesis,
1072–1073,
1075
degradation,
1034–1039
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246
half-life,
1413T

helix/
sheet
propensity,
302T
in
native
unfolded
proteins,
283
side
chains,
70,
264T
structure
and
general
properties,
68T
Methionine
sulfone,
1066
Methionine
synthase,
955,
1037
Methionyl-tRNA
synthetase
(MetRS),
100,
1352
Methotrexate,
445,
492–493,
1129
9-Methyladenine,
1156F
N
6
-Methyladenine
(m
6
A)
residue,
1246
1-Methyladenosine
(m
1
A),
1347F
N-Methylalanine,
32T
Methylamine
methyltransferase,
1361
Methyl
arachidonyl
fluorophosphonate,
405F
-N-Methylarginine,
79F
-Methylaspartate,
1033F
Methylation
analysis,
366
Methylcobalamin,
1037
Methyl-CpG
binding
domain
(MBD),
1249
-Methylcrotonyl-CoA
carboxylase,
962
Methylcytidine
(m
3
C),
1347F
N
4
-Methylcytosine
(m
4
C)
residue,
1246
5-Methylcytosine
methyltransferase
(m
5
C-MTase),
1247–1248,
1247F
5-Methylcytosine
(m
5
C)
residue,
1246
N
6
-Methyl-dA,
85
5-Methyl-dC,
85
--Methylene-ADP,
1108F
N,N¿-Methylenebisacrylamide,
147,
147F
Methylenecyclopropylacetyl-CoA,
see
MCPA-CoA
N
5
-N
10
-Methylene-tetrahydrofolate,
1031,
1062
N
5
-N
10
-Methylene-tetrahydrofolate
reductase
(MTHFR),
1035–1037
Methyl-
D
-glucosides,
363F
Methylglyoxal,
606
O
6
-Methylguanine
residue,
1216
N
7
-Methylguanosine
(m
7
G),
1302,
1347F
3-Methylhistidine,
79F
Methylmalonic
aciduria,
955
Methylmalonic
semialdehyde,
737F
Methylmalonyl-CoA,
1136F
L
-Methylmalonyl-CoA,
567
(S)-Methylmalonyl-CoA,
952,
952F,
953
Methylmalonyl-CoA
mutase,
567,
953–956,
954F,
955F,
957F
Methylmalonyl-CoA
racemase,
953
Methyl-p-nitrobenzene
sulfonate,
536–537
N-Methyl-N¿-nitro-N-nitrosoguanidine
(MNNG),
1215–1216
Methylphosphonate,
1402
O
2¿
-Methylribose,
1328
Methyl
silicones,
31
N
5
-Methyl-tetrahydrofolate,
1034,
1062
Methyl
thiocyanate,
170
4-Methylumbelliferyl--
D
-N-
acetylglucosamine,
1011
5-Methyluracil,
see
Thymine
N-Methylurea,
32T
MetJ,
1290
Metmyoglobin
(metMb),
324
Metmyoglobin
reductase,
325
met
repressor,
1290–1291,
1291F
I-32
Index
MetRS,
see
Methionyl-tRNA
synthetase
Met–tRNA
Met
f
,
1373–1374
Met–tRNA
Met
i
,
1376,
1401
Metzler,
D.,
1021
Mevacor,
990,
991F
Mevalonate,
977
Mevalonate-5-phosphotransferase,
977
Mevalonolactone,
987
Mevinolin,
990
Meyerhof,
O.,
595
Mfd
protein,
1218
MFS
(major
facilitator
superfamily),
751
Mge1,
447
MHC
(major
histocompatibiliy
complex)
proteins,
1102
M.HhaI,
1248,
1250
M.HhaI
DNA
methyltransferase,
1248F
mHsp70,
447
Mice:
cancer
cells,
382F
carcinogenesis
tests,
1224
genome
sequencing,
176,
177T
injection
with
transformed
pneumococci,
86
knockout,
121
liver
membrane
composition,
398T
monoclonal
antibodies
from,
119
obese
and
diabetic,
1098–1099
telomere
length,
1211–1212
transgenic,
86,
86F,
121F
Micelles,
44,
44F,
51,
394–395,
394F
Michaelis,
L.,
488
Michaelis
complex,
488
Michaelis
constant
(K
M
),
489
Michaelis–Menten
equation,
488–491,
488F
Michaelis–Menten
kinetics:
derivations,
501–503
for
enzymes,
489T
inhibition,
493–496
pH
dependence,
496–497
Michel,
H.,
403,
840,
907,
910
Microbodies,
10
Microdomains,
410
Microfibrils,
234,
234F
Microfilaments,
10
Microheterogeneity,
373
MicroRNAs
(miRNAs),
1325–1326
Microscopic
dissociation
constants,
348
Microscopic
ionization
constants,
49,
50
Microsomes,
154F,
883,
1362
Microsporidiae,
7F
Microtubules,
10
Microvilli,
38
middle
genes,
1284
Miescher,
F.,
85
Migration
rate
(paper
chromatography),
144
Miles,
E.,
1076
Miller,
C.,
774
Miller,
S.,
32–33
Miller–Urey
experiments,
32T
Milstein,
C.,
420
Mineral
acids,
46
Mineralcorticoids,
673T,
680,
991
Minor
groove,
in
DNA,
90,
1145
Minot,
G.,
956
miRBase
database,
1326
MiRNAs
(microRNAs),
1325–1326
Mismatch
repair,
1220,
1220F
Missense
suppressors,
1362
Mitchell,
P.,
846
Mitochondria,
7F,
9,
11F,
16F,
823–828,
825F.
See
also
Electron-transport
chain
acetyl-CoA
transport
in,
968–969
anatomy,
824,
825F
citric
acid
cycle
in,
809,
815
cytoplasmic
shuttle
systems,
827–828
fatty
acid
transport
in,
946–947,
946F
gluconeogenesis
in,
876–877,
877F
heme
biosynthesis
in,
1054
lipid
composition
of
beef
heart
membrane,
398T
membranes
of,
853F
metabolic
functions
of,
562T
mouse
liver,
833F
photorespiration
in,
935
protein
importing
in,
445,
446F
protein
targeting
in,
445–449
sedimentation
coefficient,
154F
transport
systems,
824–828,
826F
wobble
pairings
of
tRNA,
1361
Mitochondrial
carrier
family,
771
Mitochondrial
DNA,
see
mtDNA
Mitochondrial
electron-transport
chain,
see
Electron-transport
chain
Mitochondrial
import
stimulation
factor
(MSF),
445
Mitochondrial
inner
membrane,
398T
Mitochondrial
outer
membrane,
398T
Mitochondrial
trifunctional
protein,
948–949
Mitogens,
1202,
1401
Mitogen-activated
protein
(MAP)
kinase,
712–714
Mitosis,
20,
20F,
1202
Mitotic
spindle,
10,
20,
1202
Mixed
inhibition,
495–496,
496F,
502
Mixed
triacylglycerols,
388
MJ33,
943
MK-591,
1001–1002,
1002F
MK0886,
1001
MKK
(MAP
kinase
kinase),
713
MKK4,
714
MKK7,
714
MKKK
(MAP
kinase
kinase
kinase),
713
MKKK
kinase
(MKKKK),
714
ML
(maximum
likelihood
tree-building
criteria),
205
MLCK
(myosin
light
chain
kinase),
656
MLK3,
714
MMDB,
see
Molecular
Modeling
Database
MNNG
(N-methyl-N¿-nitro-N-nitrosoguani-
dine),
1215–1216
Mobile
genetic
elements,
1225–1236
Mobile
loop,
GroES
system,
294,
307F
Mobile
phase,
135
Mobility,
45–46,
45F,
45T,
745
Modrich,
P.,
1220
Modulator,
348
MoFe-protein,
1080–1081
Mohammadi,
M.,
701
Molar
extinction
coefficient,
90
Molecular
archeology,
116
Molecular
biology,
95,
95F,
1260
Molecular
chaperones,
290,
293–302.
See
also
Chaperone
proteins
Molecular
clock,
192
Molecular
cloning,
104–124
cloning
vectors,
106–109
gene
manipulation,
109–111
gene
therapy,
122–123
genomic
libraries,
113–114
and
nuclear
sequencing,
176
and
polymerase
chain
reaction,
114–117
protein
production,
117–121
and
protein
purification,
130
restriction
endonucleases,
104–106
social,
ethical,
and
legal
considerations,
123,
124F
Southern
blotting,
111–113
transgenic
organisms,
121–123
Molecular
disease,
185–187
Molecular
dynamics
simulation,
307–308,
308F,
397
Molecular
ionization
constants,
49–50
Molecularity,
reactions,
483
Molecular
mass,
5n
by
gel
filtration
chromatography,
138,
139,
140F
in
protein
sequencing,
169
by
SDS-PAGE,
150,
151F
Molecular
Modeling
Database
(MMDB),
256T,
258
Molecular
sieve
chromatography,
138
Molecular
size,
protein
purification
and,
132
Molecular
weight,
5n
Molecular
weight
cutoff,
141
Mollusks,
13F
Molten
globule,
287
Molybdopterin
complex
(Mo-pt),
1132
Mondragón,
A.,
1164–1165,
1331
Monera,
6
Monoclonal
antibodies,
119–120,
131–132,
143
Monocyclic
cascade,
650
Monod,
J.,
349,
1262,
1264–1265
Monogalactosyl
diacylglycerol,
902
Monooxygenases,
543
Monoprotic
acids,
49
Monosaccharides,
359–363.
See
also
specific
Monosaccharides
Monosodium
glutamate
(MSG),
1064
Monotopic
proteins,
404,
426
Montagnier,
L.,
545
Moody,
P.,
1216
Moore,
P.,
1365,
1366,
1383
Mo-pt
(molybdopterin
complex),
1132
Moras,
D.,
1357
Morgan,
T.
H.,
23,
24
Morikawa,
K.,
1199,
1231
Morpheeins,
1050
Mosses,
13F
Most
Representative
NMR
Structure
in
an
Ensemble,
256T
Mother
cell,
1284
Motifs,
249–251
Mouse,
see
Mice
Moving
boundary
electrophoresis,
146
Mozzarelli,
A.,
353
MPA
(mycophenolic
acid),
1112
M
phase,
1202,
1206
MPP
(matrix
processing
peptidase),
447
MPT
(Malonyl/palmitoyl
transferase),
967
MP
(maximum
parsimony)
tree-building
criteria,
205
Mre11
complex,
1224
mRNA
(messenger
RNA),
1145,
1260,
1264–1265
affinity
chromatographic
isolation,
158
base
pairing
with
16S
rRNA,
1374–1375
degradation,
1327
and
enzyme
induction,
1260–1264
masking
and
cytoplasmic
polyadenylation,
1401–1402
methylation,
1320
posttranscriptional
modification,
1302–1327
reading
of,
1342–1343,
1342F,
1372
transport
of,
1326–1327
MS
(mass
spectrometry),
169,
172–174,
172F,
366
MsbA,
767–768,
767F
MSF
(mitochondrial
import
stimulation
factor),
445
MSG
(monosodium
glutamate),
1064
-MSH
(-melanocyte
stimulating
hormone),
1099
MS/MS,
see
Tandem
mass
spectrometry
Index
mSos,
709
MspI,
105T
MspI,
1249
MSUD
(maple
syrup
urine
disease),
1039
MTase,
1247–1248
mtDNA,
116,
1207,
1207F
MTHF
(N
5
,N
10
-methenyltetrahydrofolate),
1129,
1215
MTHFR
(N
5
-N
10
-methylene-tetrahydrofolate
reductase),
1035–1037
mtHsp70,
447
mTOR,
see
Mammalian
target
of
rapamycin
Mtr3,
1327
Mucin,
381,
890,
890F
Mucolipidosis
II,
439
Mucopolysaccharides,
371
Mucus,
381
Mule,
1251
Müller-Hill,
B.,
1284,
1294
Mullis,
K.,
114
Multicellular
organisms,
12,
34,
1202.
See
also
specific
organisms
Multidrug
resistance
(MDR)
transporter,
766–767
Multienzyme
complexes,
792,
794
Multiforked
chromosomes,
1195,
1195F
Multipass
transmembrane
proteins,
426
Multiple
sclerosis,
777
Multiple
sequence
alignment,
201–203
Munc18,
441
Mupirocin,
1356,
1356F
Murein,
376
Murine
eIF4e,
1378F
Murphy,
W.,
956
Musacchio,
A.,
708
Muscarine
synapses,
778
Muscarinic
synapses,
778
Muscle,
10
AMP-dependent
protein
kinase
in,
1096,
1097F
anaerobic
glycolysis
in,
615
citric
acid
cycle
for,
792,
817
fibrous
proteins,
232
free
energy
changes
of
glycolysis
in,
625T
fructose
utilization
in,
630
glucose
uptake
regulation
in,
751F
glycogen
storage
in,
638–639,
667
glycolysis
regulation
in,
624–630
and
other
organs,
1091–1093,
1091F
slow
and
fast-twitch
fibers,
619
Muscle
fatigue,
615,
1092–1093
Muscle
glycogen
synthase
deficiency
disease,
668
Muscular
dystrophy,
1252
Mutagens,
104,
570
Mutagenesis,
119–120,
1224–1225,
1225F
Mutarotation,
362–363,
507–508
Mutase,
610
Mutations:
in
DNA
replication,
102
dynamic,
1251–1252
and
evolution,
18–19,
185
nonsense,
1362
point,
192,
1339–1340
random
nature
of,
195
rates
of,
192
up
and
down,
1266
and
viruses,
27,
27F
MutH,
1220
MutL,
1220
MutS,
1220
MWC
model,
of
allosteric
interactions,
349–351
Myasthenia
gravis,
781
Myc,
713,
737F
Mycobacterium
leprae,
1234
Mycobacterium
tuberculosis,
177T
Mycobacterium
xenopi,
1407,
1407F
Mycophenolic
acid
(MPA),
1112
Mycoplasma,
4F
Mycoplasma
genitalium,
177T
Mycoplasma
hominis,
94T
Mycoplasmas,
6
Myelin,
398T,
777
Myelination,
777–778,
778F
Myelin
membrane,
398T
Myeloma,
131
Myoadenylate
deaminase
deficiency,
1132
Myocardial
infarction,
456,
865
Myoglobin
(Mb),
323,
331–332,
332F

and

chains
of,
332T–333T
conformation
of,
306F
electron
density
map,
242F
ESI-MS
spectrum,
173,
173F
gene
duplication,
193–194

helix,
227F
H
helix,
248F
Hill
plot,
327F
isoelectric
point,
134T
mobility,
308F
in
molecular
dynamics
simulation,
308F
molecular
mass,
140F
nitric
oxide
detoxification
by,
325
oxygen
binding
by,
325–326,
326F
physical
constants
of,
153T
sequence
alignment,
197F
solubility
in
ammonium
sulfate
solution,
133F
tertiary
structure,
245–246
X-ray
structure,
241F,
245F
Myokinase,
627.
See
also
Adenylate
kinase
(AK)
Myosin,
10,
301
Myosin
light
chain
kinase
(MLCK),
656
Myotonic
dystrophy
(DM),
1252
Myotonic
dystrophy
protein
kinase,
1252
Myristic
acid,
387T,
407
Myxobacteria,
13F
Myxothiazol,
849
N
Na

,
see
Sodium
ion
N-Acetylneuraminic
acid,
see
NANA
Na

channels,
772,
776–777
NAD

(nicotinamide
adenine
dinucleotide),
82,
471F,
791
790F,
766F
biosynthesis,
1137F,
1138
in
catabolism,
561F
in
citric
acid
cycle,
794,
795T
and
DNA
ligase,
1187
domains,
248
in
glycolysis,
585,
594F
in
glyoxylate
cycle,
880
in
oxidation-reduction
reactions,
565
and
yeast
alcohol
dehydrogenase,
471–472
NADD,
471
NADH
(nicotinamide
adenine
dinucleotide,
reduced
form):
766F,
766F
in
catabolism,
561F
in
citric
acid
cycle,
789,
791,
819
as
electron-transfer
coenzyme,
586
in
electron-transport
chain,
823,
824F,
828,
829
in
fatty
acid
oxidation,
950
in
glycolysis,
585,
594F
in
oxidation–reduction
reactions,
565
and
yeast
alcohol
dehydrogenase,
471–472
I-33
NADH:Coenzyme
Q
reductase,
see
Complex
II
NADH-cytochrome
b
5
reductase,
971
NADH
dehydrogenase,
see
Complex
I
NADH-dependent
dehydrogenases,
472
NAD

kinase,
1137F,
1138
NADP

(nicotinamide
adenine
dinucleotide
phosphate),
471F,
473,
931,
1137F
NADPH
(nicotinamide
adenine
dinucleotide
phosphate,
reduced
form):
in
Calvin
cycle,
931
in
metabolic
pathways,
561,
561F
and
photorespiration,
935
in
photosynthesis,
902,
926
and
yeast
alcohol
dehydrogenase
activity,
471F
NADPH-P450
reductase,
543–545
NAD

pyrophosphorylase,
1137F,
1138
NAG
(N-Acetylglucosamine),
365,
371,
376,
377F
lysozyme
catalytic
mechanism,
517–520,
517F,
522–525
in
peptidoglycan,
377F
rates
of
hydrolysis,
518T
X-ray
structure
of,
518F
NAG-(1
n
4)-2-deoxy-2-fluoro--
D-glucopyranosyl
fluoride
(NAG2FGlcF),
524
Nagai,
K.,
1314,
1315

Na
–glucose
symport,
768–769,
768F,
769F
Nails,
233,
234,
275
Nakamura,
Y.,
1394
(Na

–K

)-ATPase
((Na

–K

)
pump),
758–762,
761F
NAM
(N-acetylmuramic
acid),
365,
365F,
376,
377F
lysozyme
catalytic
mechanism,
517,
517F,
519–520,
522–525
rates
of
hydrolysis,
518T
NANA
(N-acetylneuraminic
acid),
365,
365F,
1010
NAS,
see
Normalized
alignment
score
Nathans,
D.,
105
National
Center
for
Biotechnology
Information
(NCBI),
35,
201
Native
chemical
ligation,
209,
209F
Native
form
(DNA),
88
Native
proteins,
221,
264
crystalline,
243
folding
into,
278
free
energy,
57
unfolded
forms,
283–284,
284F
Natural
selection,
see
Evolution
Navia,
M.,
549,
724
NCBI,
see
National
Center
for
Biotechnology
Information
NDB,
see
Nucleic
Acid
Database
NDP,
see
Nucleoside
diphosphate
Neandertals,
116
Nearest-neighbor
analysis,
127
NEDD8,
1421
Needleman,
S.,
199
Needleman–Wunsch
sequence
alignment
algorithm,
199–201,
200F
Negative
allosteric
effect,
348
Negative
design,
of
proteins,
305
Negatively
cooperative
binding,
327
Negative
regulator,
1286
Neighbor-joining
(N-J)
method,
for
phylogenetic
tree
construction,
204
Nelfinavir,
550F
Nelson,
N.,
923
NEM
(N-ethylmaleimide),
440–441
Nematodes,
13F,
1320.
See
also
Caenorhabditis
elegans
I-34
Index
Némethy,
G.,
352
NEMO
subunit,
1420
NEM-sensitive
fusion
protein,
see
NSF
protein
N-end
rule,
1413
NER,
see
Nucleotide
excision
repair
Nernst,
W.,
584
Nernst
equation,
584
Nernst–Planck
equation,
745
Nerve
growth
factor
(NGF),
717
Nerve
transmission,
440F
Nervonic
acid,
387T
Nested
primers,
116
Neuberg,
C.,
595
Neupert,
W.,
445
Neural
tube
defects,
1035
Neurocan,
373T
Neurofibrillary
tangles,
311,
312
Neuroglobin,
325
Neurohypophysis,
683
Neurons,
12F
Neuronal
membranes,
anesthetics
and,
398–399
Neuronal
NOS
(nNOS),
686–687,
687F
Neuropeptides,
783–784
Neuropeptide
Y
(NPY),
1099
Neurospora,
13F,
26
Neurospora
crassa,
1319,
1320F,
1344T
Neurotoxins,
442,
442F,
776–777
Neurotransmission:
action
potentials,
775–777
voltage-gated
ion
channels,
771–775
Neurotransmitters,
527,
778–784
amino
acids
as,
80
synthesis
of,
1058–1060
in
vesicles,
440
Neurotransmitter
receptors,
778–784
Neutral
drift,
188–192
Neutral
fats,
388
Neutral
solutions,
47
Neutrophils,
688
Newsholme,
E.,
629,
973
New
variant
Creutzfeldt-Jakob
disease
(nvCJD),
315
N-extein,
1406F,
1407
NFAT
p
,
724
NF-B
(nuclear
factorB),
1414
NGF
(nerve
growth
factor),
717
NH

4
,
see
Ammonium
ion
NHEJ
(nonhomologous
end-joining),
1223–1224,
1224F
N

-hydroxyl-
L
-arginine
(NOHA),
686,
686F
Niacin,
474
Niacinamide,
474
Nicholls,
A.,
259
Nicholson,
G.,
408
Nick
translation,
1181,
1187
Nicotinamide,
474T,
1137F
Nicotinamide
adenine
dinucleotide,
see
NAD

Nicotinamide
adenine
dinucleotide,
reduced
form,
see
NADH
Nicotinamide
adenine
dinucleotide
phosphate,
see
NADP

Nicotinamide
adenine
dinucleotide
phosphate,
reduced
form,
see
NADPH
Nicotinamide
coenzymes,
471F,
473T,
1136–1138
Nicotinamide
mononucleotide,
see
NMN
Nicotinamide
phosphoribosyltransferase,
1137F,
1138
Nicotinate,
1137F
Nicotinate
adenine
dinucleotide
(desamido
NAD

),
1138
Nicotinate
mononucleotide,
1137F,
1138
Nicotinate
phosphoribosyltransferase,
1136,
1137F,
1138
Nicotine,
778
Nicotinic
acid,
474
Nicotinic
synapses,
778
NIDDM,
see
Noninsulin-dependent
diabetes
Niemann–Pick
disease,
1013T
Nierhaus,
K.,
1373,
1388
Nigericin,
869
NIH
shift,
1045
19S
caps,
1414,
1417
19S
regulator,
1414
Nirenberg,
M.,
1341–1343
Nitrate
ion,
324
Nitrate
reductase,
1083
Nitric
acid,
46
Nitric
oxide
(NO),
324
binding
to
heme
group,
324
detoxification
by
myoglobin,
324
hormonal
roles,
685–688
Nitric
oxide
synthase,
685–687
Nitrification,
1083
Nitriloacetic
acid,
857
Nitrite,
1340
Nitrite
ion,
324
Nitrite
reductase,
934,
1083
3-Nitro-2-(S)-hydroxypropionate,
812
Nitrocellulose,
111,
113
Nitrogen,
31
Nitrogenase,
1080–1082
Nitrogen
cycle,
1083,
1083F
Nitrogen
excretion,
1134–1135
Nitrogen
fixation,
5–6,
1078–1083
Nitrogen-fixing
bacteria,
1080–1082
Nitrogen
mustard,
1340
Nitrogenous
bases,
83.
See
also
Nucleic
acid
bases
Nitroglycerin,
686
p-Nitrophenolate
ion,
513,
525–526
p-Nitrophenylacetate,
513,
525–526,
526F
Nitrosamines,
1340
Nitrosoheme,
687
Nitrous
acid,
1339,
1340F
N-J
method,
for
phylogenetic
tree
construction,
204
N-Linked
glycoproteins,
882–889
N-Linked
oligosaccharides,
374F,
379–380,
379F,
881,
888F
synthesis
of
glycoproteins
from,
882–889
NLS
(nuclear
localization
signal),
1414
NMN
(nicotinamide
mononucleotide),
1137F,
1138,
1187
NMR
spectroscopy:
interpretation
of
structures,
243–244
for
metabolism
studies,
569,
572
with
pulsed
H/D
exchange,
285–286
nNOS,
see
Neuronal
NOS
NO,
see
Nitric
oxide
Nodes
of
Ranvier,
777
NOESY,
see
Nuclear
Overhauser
effect
spectroscopy
NOHA,
see
N

-hydroxyl-
L
-arginine
Noller,
H.,
1364,
1366,
1387,
1388,
1392,
1394
Nomenclature:
amino
acid,
72–73
enzymes,
479
Nomura,
M.,
1365
Noncompetitive
(mixed)
inhibition,
495–496,
496F,
502
Nonconjugate
flow,
587
Noncooperative
binding,
327
Nonequilibrium
thermodynamics,
587
Nonessential
amino
acids,
1019,
1064–1072,
1065T
Nonhomologous
end-joining,
see
NHEJ
Noninsulin-dependent
diabetes
(NIDDM),
310,
1102–1104,
1103F
Nonketonic
hyperglycinemia,
1032–1033
Nonmediated
membrane
transport,
745–746
Nonpolar
amino
acids,
70–71
Nonreceptor
tyrosine
kinases
(NRTKs),
715
Nonsense
codons,
1343
Nonsense
mutations,
1362
Nonsense
suppression,
1362
Nonshivering
thermogenesis,
629,
860–861
Nonstandard
amino
acids,
78–80,
79F,
80F
Nonsteroidal
anti-inflammatory
drugs
(NSAIDs),
994,
995,
998–999,
999F
Nonviral
retrotransposons,
1246,
1246F
Noonan
syndrome,
721
Norepinephrine,
673T,
679–680,
1046
controls
fatty
acids
in
brown
fat,
861
role
in
fatty
acid
metabolism
regulation,
973
role
in
glycogen
metabolism
regulation,
660
synthesis
from
tyrosine,
1058–1060
Normalized
alignment
score
(NAS),
196,
198F
Northern
transfer
(Northern
blot),
113
Northrop,
J.,
470
NO
synthase
(NOS),
685–687
Novobiocin,
1167,
1169,
1170,
1175
NPCs
(nuclear
pore
complexes),
1327
NPY
(neuropeptide
Y),
1099
NPY/AgRP
cell
type,
1099
N-Ras,
709
NRTKs
(nonreceptor
tyrosine
kinases),
715
NSAIDs,
see
Nonsteroidal
anti-
inflammatory
drugs
nSec1,
433F,
442–444
NSF
(NEM-sensitive
fusion)
protein,
441,
444–445,
444F,
445F,
1159
nt
(nucleotides),
1175
N-terminal
nucleophile
(Ntn)
family,
1066,
1417
N-terminus
(amino
acids),
73,
165,
1371–1373
Ntn
family,
see
N-terminal
nucleophile
family
NTPase,
1275–1276
NTPs,
see
Nucleoside
triphosphates
Nuclear
envelope,
9
Nuclear
factor
B
(NF-B),
1414
Nuclear
localization
signal
(NLS),
1414
Nuclear
membrane,
7F,
9
Nuclear
Overhauser
effect
spectroscopy
(NOESY),
243,
244F
Nuclear
pore
complexes
(NPCs),
1327
Nucleases,
101
Nucleation,
346,
347F
Nuclei,
in
landscape
theory
of
protein
folding,
287–289,
288F
Nucleic
acids,
15,
82–95.
See
also
DNA;
RNA
and
amino
acid
sequence,
70
base
pairing,
1154–1156
base
stacking,
1156–1157
as
buffer
components,
48
chemical
structure,
84–85,
84F
dietary,
1130
and
DNA
function,
85–88
and
DNA
structure,
88–95
double-helical
structures,
1145–1148
evolution,
33
functional
groups,
43
hydrophobic
forces,
1157–1158
and
nucleotides,
82–84
oligonucleotide
synthesis,
209–213
organization
of,
163–164
polymeric
organization,
17F
Index
sedimentation
coefficients,
154F
stability
of,
1151–1158
sugar-phosphate
chain
conformation,
1152–1154
supercoiled
DNA,
1158–1170
Nucleic
acid
bases,
82–83.
See
also
Nucleotide
bases
Chargaff’s
rules
for,
84,
85
modification
of,
85
names,
structures,
and
abbreviations,
83T
tautomeric
forms
of,
88,
88F
UV
absorbance
spectra,
92F
Nucleic
Acid
Database
(NDB),
256T,
257
Nucleic
acid
fractionation,
156–159
Nucleic
acid
sequencing,
176,
180–182
amino
acid
sequencing
contrasted,
184–185
genome
sequencing,
180–184
Sanger
method,
176–180
Nuclei
scaffolding,
287
Nucleoid,
4,
4F
Nucleolus,
7F,
9,
11F,
1328
Nucleophiles,
563,
563F,
564
Nucleophilic
catalysis,
510–513
Nucleoplasmin,
293
Nucleoporins,
1327
Nucleosidases,
1130
Nucleosides,
82–83,
83T
Nucleoside-5¿-phosphate,
83
Nucleoside
diphosphate
(NDP),
582,
1125
Nucleoside
diphosphate
kinases,
582,
644,
1113
Nucleoside
monophosphate
kinases,
1113
Nucleoside
phosphorylases,
1130
Nucleoside
triphosphates,
82
Nucleoside
triphosphates
(NTPs),
95–96,
582
Nucleosomes,
291–293
Nucleotidase,
1130F,
1136F
3¿-Nucleotide,
83
5¿-Nucleotide,
83
Nucleotides,
15,
18,
82–83
defined,
82
degradation,
1130–1136
names,
structures,
and
abbreviations,
83T
as
units,
1175
Nucleotide
bases.
See
also
Nucleic
acid
bases
in
aqueous
solution,
1156–1157
ionic
interactions,
1158
in
prebiotic
conditions,
33
Nucleotide
coenzyme
biosynthesis,
1136–1139
Nucleotide
excision
repair
(NER),
1216–1218,
1217F
Nucleotide
metabolism,
1107–1140
biosynthesis
of
nucleotide
coenzymes,
1136–1139
degradation
of
nucleotides,
1130–1136
deoxyribonucleotide
formation,
1119–1130
purine
ribonucleotide
synthesis,
1107–1114
pyrimidine
ribonucleotide
synthesis,
1114–1119
Nucleotide
sugars,
882F
Nucleus,
3,
8–9.
See
also
DNA
replication;
animal
cell,
7F
metabolic
functions,
562T
plant
cell,
11F
transport
of
mRNA
from,
1326–1327
NutraSweet
(aspartame),
1087
nvCJD
(new
variant
Creutzfeldt-Jakob
disease),
315
Nyborg,
J.,
1380,
1381,
1388
Nylon,
111
O
O-antigens,
85,
378–379
Obesity,
629,
862,
1093,
1096–1099,
1104
OB
folds,
1213
Obligate
aerobes,
6
Obligate
anaerobes,
6
O
blood
type,
22
OB-R
protein,
1098
Ochoa,
S.,
791,
1341,
1342
ochre
codon,
1343
ochre
mutants,
1408
ochre
suppressor,
1362
O
c
mutation,
1264
OCRL,
735
Octahedral
symmetry,
proteins,
268,
268F
Octanoyl-CoA,
948
Oculocerebrorenal
dystrophy,
735
ODCase,
see
OMP
decarboxylase
Odd-chain
fatty
acids,
945F,
952–957
O’Donnell,
M.,
1182,
1196,
1197,
1222
OEC
(oxygen-evolving
complex),
916
OE
(outside
end)
sequences,
1237,
1238F
OGDH
(2-Oxoglutarate
dehydrogenase),
799
O

gene,
1264
Ogston,
A.,
814
1,
25(OH)2D
(1,
25-
Dihydroxycholecalciferol),
678
Oils,
387,
393–394,
394F
Okazaki,
R.,
1175
Okazaki
fragments,
1174–1176,
1187,
1219
in
E.
coli
replication,
1193F,
1194,
1198
eukaryotes,
1207
Oleate,
44F
Oleic
acid,
386,
387F,
387T,
950F
(2¿,
5¿)-Oligoadenylate
synthetase
(2,5A
synthetase),
1400
Oligomers,
267,
270–271,
271F
Oligomycin
B,
870
Oligomycin
sensitivity
conferring
protein,
see
OSCP
Oligonucleotides,
209–214,
1402–1403
Oligonucleotide
adaptors,
110F
Oligonucleotide
probes,
112–113,
113F
Oligopeptides,
70
Oligosaccharides,
359
biosynthesis,
880–892
N-
and
O-linked,
374F,
379–380,
379F
in
plasma
membranes,
400F
synthesizing,
382–383
Oligosaccharyltransferase,
see
OST
O-Linked
glycoproteins,
890–892
O-Linked
oligosaccharides,
374F,
379–381,
380F,
881
synthesis
of
glycoproteins
from,
890–892

oxidation,
fatty
acids,
959

protein,
1163.
See
also
Topoisomerase
I
Omeprazole,
765
2¿-O¿-methyltransferase,
1302
OMP,
see
Orotidine-5¿-monophosphate
Omp85,
449
OMP
decarboxylase
(ODCase),
1115F,
1116–1117
OmpF
porin,
403–404,
405F
Oncogenes,
705–711
One
gene-one
enzyme
maxim,
26
One
gene-one
polypeptide
maxim,
26
One-intermediate
model,
of
reversible
enzyme
reactions,
491
Ontogeny,
phylogeny
and,
12
Oocytes,
mRNA
masking
and,
1401
opal
codon,
1343
opal
suppressor,
1362
Oparin,
A.,
32
Open
complex,
1267–1268
I-35
Open
conformation:
of
Klentaq1,
1179–1180,
1179F
of
Rep
helicase,
1186
Open
reading
frames
(ORFs),
182,
304
Open

sheets,
251,
254–256
Open
systems,
52,
587,
588F
Open-X
conformation,
1227F
Operators,
97
Operator
constitutive
mutation,
1264
Operon,
1262
Opiate
receptors,
685
Opsin,
689,
694
Optical
activity,
73–78
Optical
density,
in
Beer–Lambert
law,
90
Optical
isomers,
75
Optical
traps,
1273–1274
Optical
tweezers,
1274,
1274F
Oral
rehydration
therapy,
768
ORC
(origin
recognition
complex),
1205–1207
Orc1,
1205
Orc2,
1205
Orc3,
1205
Orc4,
1205
Orc5,
1205
Orc6,
1205
Order,
probability
of,
55F
Order–disorder
transition,
397,
397F
Ordered
Bi
Bi
reactions,
498–500
Ordered
mechanisms,
498
Order
of
reaction,
483
ORFs,
see
Open
reading
frames
Organs,
16F,
1090–1095.
See
also
specific
organs
Organelles,
16F,
562T
Organic
arsenicals,
799
Organic
compounds,
synthesizing,
32F
Organic
reaction
mechanisms,
562–569
Organic
solvents,
134
Organisms,
16F,
192.
See
also
specific
organisms
Organ
perfusion,
575
oriC
locus,
1194–1195,
1194F,
1199F
Orientation
effects,
enzyme
catalysis
by,
512–515
Origin-independent
replication
restart,
1235
Origin
recognition
complex,
see
ORC
Ornithine,
80,
80F,
571F,
1028,
1071
Ornithine--aminotranferase,
1070F,
1071
Ornithine
decarboxylase,
1408T
Ornithine
transcarbamoylase,
1028
Ornithorhyncus
anatinus,
177T
Orotate,
1115F,
1116
Orotate
phosphoribosyl
transferase,
1115F,
1116
Orotic
acid,
1114
Orotic
aciduria,
1118–1119
Orotidine-5¿-monophosphate
(OMP),
1115F,
1116–1117
Orthologous
proteins,
194
Orthophosphate
(P
i
),
578
Orthophosphate
cleavage,
582
OSCP
(oligomycin
sensitivity
conferring
protein),
855,
870
Osmotic
coefficient,
1156,
1157F
Osmotic
lysis,
130
OST
(oligosaccharyltransferase),
885–886,
885F
Osteoarthritis,
240
Osteoblasts,
540,
677–678
Osteoclastoma,
540
Osteoclasts,
540,
677–678
Osteocytes,
12F
Osteogenesis
imperfecta
(brittle
bone
disease),
240
I-36
Index
Osteoglycin,
373T
Osteomalacia,
677–678
Osteoporosis,
540,
678–679,
1400
Ouabain,
761–762,
761F
Outer
membrane,
6
Outgroups,
204
Outside
end
sequences,
see
OE
sequences
Ovalbumin,
134T,
140F,
1304,
1304F,
1305F
Ovarian
cancer,
1236
Ovaries,
672F
Overproducers,
117
Ovomucoid,
140F
Oxa1,
448
Oxalic
acid,
49
Oxaloacetate,
947
in
citric
acid
cycle,
791,
814
synthesis
of,
872F,
1034,
1067F
Oxalosuccinate,
789,
809
Oxidants,
584
Oxidation,
583
Oxidation-reduction
reactions,
364–365,
565–566,
584–586
Oxidative
deamination,
1023–1025,
1340F
Oxidative
phosphorylation,
386,
561F,
845–862
and
ATP
synthesis,
852–859
control
of,
862–863
and
electron-transport
chain,
823,
829,
831–833
energy
coupling
hypothesis
for,
845–846
and
glycolysis,
594F
and
other
pathways,
1090
proton
gradient
generation,
846–852
uncoupling,
859–862,
860F
Oxidizing
agent,
584
Oxidizing
atmosphere,
32
Oxidoreductases,
479T
Oxidoreduction
reactions,
583
2,3-Oxidosqualene,
982,
983f
Oxidosqualene
cyclase,
983F,
984F
2,3-Oxidosqualene
cyclase,
982,
983
2-Oxoacid
dehydrogenase
family,
799
2-Oxoglutarate
dehydrogenase
(OGDH),
799
Oxonium
ion,
520
5-Oxoprolinase,
1061
5-Oxoproline,
1062
Oxyanion
hole,
534
Oxygen:
adaptation
of
life
to,
34
partial
reduction
of,
865
production
of,
914–920,
934–937
transport
of,
56,
323–234,
329
Oxygenated
hemoglobin
(oxyHb),
325,
329,
332,
333F–335F
Oxygenated
myoglobin
(oxyMb),
325
Oxygen
binding,
by
hemoglobin,
325–328
and
BPG,
329–331,
329F–331F
cooperativity,
334–340,
351–354
free
energy
and
saturation
curves,
339F
Oxygen
debt,
880
Oxygen
electrode,
830,
830F
Oxygen-evolving
complex
(OEC),
916
Oxygen
tension,
325
oxyHb,
see
Oxygenated
hemoglobin
Oxyluciferin,
183
oxyMb
(oxygenated
myoglobin),
325
Oxytocin,
205,
673T,
683
Oxytricha
nova,
1212,
1212F
P
P1
plasmids,
1259
p44
subunit,
1218
p51,
1208–1209,
1209F
p53,
1211,
1414
p66,
1208–1209,
1209F
p85,
PI3K
subunit,
732
p101,
PI3K
subunit,
733
p150,
PI3K
subunit,
733
P680,
916–917
P700,
922–923
P870,
909
P960,
912
PA
(protective
antigen),
anthrax,
715
PA26,
1418–1419,
1418F
PA28,
1418
PA700,
1414
Pääbo,
S.,
116
PAB
II
(poly(A)-binding
protein
II),
1303
PABP
(poly(A)-binding
protein),
1303,
1304F
Pace,
N.,
1331
Pacific
Biosciences,
184
Packing
density,
247
PAF
(platelet-activating
factor),
1008
PAGE
(polyacrylamide
gel
electrophoresis),
147–148.
See
also
SDS-PAGE
PAH
(phenylalanine
hydroxylase),
1043
Pai,
E.,
1133
Pain,
prostaglandins
and,
993–994
Pairwise
alignment,
196,
201
PaJaMo
experiment,
1236F,
1262–1263
Palade,
G.,
9,
1362
PALA
(N-(phosphonacetyl)-
L
-aspartate),
476–477
Palindromes,
105,
106
Palmitate,
44F
Palmitic
acid,
386,
387T,
407
Palmitoleic
acid,
387T
1-Palmitoleoyl-2,3-dioleoyl-glycerol,
940
1-Palmitoleoyl-2-linoleoyl-3-stearoyl-
glycerol,
388
Palmitoyl-ACP,
965
Palmitoyl
thioesterase
(TE),
965
PAM
(presequence
translocase-associated
motor),
447
PAM-1
matrix,
198
Pam16,
447
Pam17,
447
Pam18,
447
PAM-250
log
odds
substitution
matrix,
198–199,
199F,
201,
203
PAM
units
(Percentage
of
Accepted
point
Mutations),
189,
197–199
Pancreas,
672F
Pancreatic

cells,
675
Pancreatic
aciner
cells,
12F,
525
Pancreatic

cells,
675,
973
Pancreatic

cells,
661,
675,
973,
1102–1103
Pancreatic
cancer,
1236
Pancreatic
DNase,
157
Pancreatic
DNase
I,
1160
Pancreatic
islet
hormones,
675
Pancreatic
phospholipase
A
2
,
942–943,
942F,
943F
Pandit,
Jayvardhan,
982
Pangenes,
19
Pangenesis,
19
Pantothenate,
474T,
1138,
1139F
Pantothenate
kinase,
1138,
1139F
Pantothenic
acid,
792
Pan
troglodytes,
177T
PAP
(poly(A)
polymerase),
1302,
1303F
Paper
chromatography,
132T,
144–145,
144F
Paper
electrophoresis,
146–147,
147F
PapG-protein,
382
PAPS
(3¿-phosphoadenosine-
5¿-
phosphosulfate),
1010,
1072
Parabiosis,
1096–1099
Paracrine
glands,
671
Parallel

pleated
sheets,
224F,
229–230
Paralogous
proteins,
194
Parathion,
527
Parathyroid,
672F
Parathyroid
hormone
(PTH),
673T,
677
Pardee,
A.,
475,
1262
Parent
DNA,
1174F
Parker,
M.,
718
Parkinson’s
disease,
309,
720,
1059,
1060
Parnas,
J.,
595
Parodi,
A.,
883
Paromomycin,
1395T,
1396F,
1397,
1397F
Partial
molar
free
energy,
58
Partial
specific
volume,
153
Partition
coefficient,
144,
540,
745–746
PAS
(periodic
acid-Schiff’s
reagent),
411–412
pas
(primosome
assembly
site),
1190
Passenger
RNAs,
1324
Passive-mediated
transport,
745,
750–752
Pastan,
I.,
1286
Pasteur,
L.,
469,
593,
619,
864
Pasteur
effect,
619,
864,
1088
Patel,
D.,
1300,
1324
Path
dependence,
53
Pauling,
L.,
185–186,
221,
226,
229,
515,
1355
Pavletich,
N.,
736,
1412,
1413
PBG
(porphobilinogen),
1048
PBGS,
see
Porphobilinogen
synthase
P
bodies,
1325
PbRCs
(purple
photosynthetic
bacteria
RCs),
909
PC,
see
Plastocyanin
PCC,
see
Protein-conducting
channel
P-cluster,
1081
PCNA
(proliferating
cell
nuclear
antigen),
1204,
1204F,
1206
PCR,
see
Polymerase
chain
reaction
PDB,
see
Protein
Data
Bank
PDBid,
256–257
PDC,
see
Pyruvate
decarboxylase;
Pyruvate
dehydrogenase
multienzyme
complex
PDGFR
(platelet-derived
growth
factor
receptor),
699
PDI
(protein
disulfide
isomerase),
280,
290–292,
290F,
291F
PDK-1
(phosphoinositide-dependent
protein
kinase-1),
731
PDZ
domain,
708
PE,
see
Phosphatidylethanolamine
Pearl,
L.,
1234
Peas,
19T,
20–22
PEG
(polyethylene
glycol),
1132
PEG-ADA,
1132
Pellagra,
474,
1138
Penetrance,
of
diseases,
1251
Penicillin,
377–378,
377F,
378F,
1395
Penicillinase,
378
Penicillinoic
acid,
378F
Pentoses,
82–83,
360F
Pentose
phosphate
pathway,
892–898,
893F,
1090
PEP,
see
Phosphoenolpyruvate
PEP
carboxykinase
(PEPCK),
818,
1089
in
gluconeogenesis,
872–873,
876,
876F,
879
PEP
carboxylase,
1408T
PEPCK,
see
PEP
carboxykinase
Pepsin,
134T,
169T,
470,
547,
547F
Pepsinogen,
675
Peptidases,
79
Peptides,
70.
See
also
Polypeptides
mass
spectrometry
of,
172–175,
172F
in
protein
sequencing,
169–171
release
of,
1392–1394
Index
Peptide-N
4
-(N-acetyl--
D
-glucosaminyl)
asparagine
253F,
252F
Peptide-N
4
-(N-acetyl--
D
-glucosaminyl)
asparagine
amidase
F,
252
Peptide
bonds,
70,
99F,
222,
1384–1385
Peptide
group,
221–225
cis-Peptide
group,
222F
trans-Peptide
group,
222F
Peptide
mapping,
174–175,
175F
Peptide
recognition
particle
(prp73),
1409
Peptide
units,
70
Peptidoglycan,
376
Peptidoglycan
N-acetylmuramoyhydrolase,
479
Peptidoleukotrienes,
1000,
1001
Peptidomimemtics,
550–551
Peptidyl-
L
-amino
acid
hydrolase,
470
Peptidyl
homoserine
lactone,
170
Peptidyl
prolyl
cis-trans
isomerases
(PPIs),
290,
292
Peptidyl
site,
see
P
site
Peptidyl
transferase,
1382,
1383,
1383F,
1385F
Peptidyl-tRNA,
98F,
1373,
1391
Percentage
of
accepted
point
mutations,
see
PAM
units
Perchloric
acid,
46
per
gene,
120F
Perham,
R.,
796,
800
Periodic
acid-Schiff’s
reagent
(PAS),
411–412
Periodic
table
of
elements,
31F
Peripheral
proteins,
400
Peripheral
subunit-binding
domain
(PSBD),
796,
800,
800F
Periplasmic
space,
117,
378
PERK
(PKR-like
endoplasmic
reticulum
kinase),
1400
Perlecan,
373T
Permeability
coefficient,
745,
747T,
775
Permeases,
745
Permethylation
analysis,
366
Permissive
conditions,
27
Pernicious
anemia,
474T,
956–957,
1064
Peroxisomal

oxidation,
fatty
acids,
958
Peroxisomes,
10,
562T,
935,
958F.
See
also
Amino
acid
metabolism;
Glyoxylate
pathway
Peroxisome
proliferator-activated
receptor

(PPAR),
1104
Peroxynitrite,
688
Pertussis
toxin
(PT),
697,
1398
Perutz,
M.,
331,
341,
1252
Perutz
mechanism,
334–340
Petsko,
G.,
308
6PF-2-K
(phosphofructokinase-2),
663–664
Pfam,
see
Protein
families
Pfanner,
N.,
445
PFGE,
see
Pulsed-field
gel
electrophoresis
PFK,
see
Phosphofructokinase
PFK-2
(phosphofructokinase-2),
663–664
PFK-2/FBPase-2,
663
Pfu
DNA
polymerase,
114
2PG,
see
2-Phosphoglycerate
3PG,
see
3-Phosphoglycerate
PG
(polygalacturonase),
1403
PGAs,
994
PGE
2
,
997
PGEs,
994
PGF

,
994
PGF

,
994
PGFs,
994
PGF
2
,
997
PGG
2
,
997
PGH
2
,
997
PGH
synthase
(PGHS),
997–999,
997F,
999F
PGI,
see
Phosphoglucose
isomerase
PGI
2
,
see
Prostacyclin
I
2
PGK,
see
Phosphoglycerate
kinase
P-glycoprotein,
766–767
PGM,
see
Phosphoglycerate
mutase
PGs,
see
Prostaglandins
pH,
47–48
and
biochemical
standard
state,
60
and
buffers,
48
in
disc
electrophoresis,
148
immobilized
pH
gradients,
150
in
ion
exchange
chromatography,
136
and
isoelectric
focusing,
150,
151
and
Michaelis–Menten
kinetics,
496–497
and
protein
denaturation,
265
and
protein
solubility,
133F,
134
and
protein
stabilization,
130–131
Phages,
see
Bacteriophages
Pharmacodynamics,
539
Pharmacogenomics,
545
Pharmacokinetics,
542
Pharmacology,
539,
542–545
Phase
variation,
1243,
1243F
PHAS-I,
1401
PHAS-II,
1401
PH
(pleckstrin
homology)
domain,
435,
708,
729
Phe,
see
Phenylalanine
pheA
operon,
1299T
Phen
(phentermine),
543
Phenolphthalein,
51
Phenotypes,
21–22,
22F
Phenoxazone
ring
system,
1272
Phentermine
(phen),
543
Phentolamine,
680
Phenylacetic
acid,
945
Phenylaceturic
acid,
945
Phenylalanine:
aromatic
ring
flipping
and
protein
core
mobility,
308–309
biosynthesis,
1075–1078
degradation,
570,
570F,
1043–1047
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1341–1342,
1343T
in
globular
proteins,
246
half-life,
1413T

helix/
sheet
propensity,
302T
in
native
unfolded
proteins,
283
Ramachandran
diagram,
225
side
chains,
70–71,
264T
structure
and
general
properties,
68T,
71F
Phenylalanine
hydroxylase
(PAH),
1043
Phenylethanolamine
N-methyltransferase,
1060F
2-Phenylethyl
boronic
acid,
556
Phenylisothiocyanate,
see
PITC
Phenylketonuria
(PKU),
569–570,
948,
1045–1047
-Phenylpropionate,
527
Phenylpyruvate,
570,
1045
Phenylthiocarbamyl
(PTC),
165
Phenylthiohydantoin
(PTH),
165
Pheophytin
a
(Pheo
a),
916
Pheromones,
671–672,
976
PheRS,
1351
Philadelphia
chromosome,
718
Phillips,
D.,
252,
517,
519,
521–524
Phillips,
S.,
1290,
1291
PhK,
see
Phosphorylase
kinase
Phlorizin,
768
PHLPP
protein
phosphatase,
732
pH
meter,
47
PhoE
porin,
403–404
Phosphagens,
583
Phosphatase,
140F
I-37
5-Phosphatase
II,
735
Phosphate,
578
Phosphate
carrier,
448,
826
Phosphate
compound
thermodynamics,
578–583
Phosphatidic
acid
phosphatase,
971
Phosphatidic
acids,
389,
389T,
398T
Phosphatidylcholine,
389T,
398T
Phosphatidylethanolamide:
serine
transferase,
1004
Phosphatidylethanolamine
(PE),
389T,
398T,
419
Phosphatidylglycerol,
389T,
398T,
1004,
1006F
Phosphatidylglycerol
phosphate,
1005
Phosphatidylinositol
(PI),
891F
Phosphatidylinositol
(PtdIns),
389T,
398T,
732,
1004–1006,
1006F
Phosphatidylinositol-4,5-bisphosphate
(PtdIns-4,5-P
2
),
435,
665,
725
Phosphatidylserine,
389T,
398T,
1004,
1005F
Phosphinothricin,
1068
3¿-Phosphoadenosine-5¿-phosphosulfate,
see
PAPS
3¿-Phosphoadenosine-5¿-phosphosulfate
(APS)
reductase,
1072
Phosphoanhydride
bond,
578
Phosphoarginine,
580
Phosphocholine,
1004
Phosphocreatine,
570–571,
580,
583,
1092
(2¿,5¿)-Phosphodiesterase,
1400
Phosphodiesterases,
176,
653,
688–689
Phosphodiester
groups,
84
Phosphodiester
method,
of
oligonucleotide
synthesis,
209,
211
Phosphoenolpyruvate
(PEP),
581F,
596F,
612,
872
Phosphoenolpyruvate
carboxykinase,
see
PEP
carboxykinase
Phosphoenolpyruvate
carboxykinase
(PEPCK),
571
Phosphoenolpyruvate-dependent
phospho-
transferase
(PTS)
system,
765,
765F
Phosphoester
bond,
578
Phosphoethanolamine,
1004
Phosphofructokinase
(PFK),
667
allosteric
control,
479
binding
to
erythrocyte
membrane,
412
in
gluconeogenesis,
872
in
glycolysis,
596F,
600,
625–627,
626F,
627F,
630
and
integration
of
pathways,
1088
Phosphofructokinase-2
(PFK-2),
663–664
Phosphoglucokinase,
642
Phosphoglucomutase,
632,
639,
642
6-Phosphogluconate,
637F,
894,
894F
6-Phosphogluconolactonase,
894
6-Phosphoglucono--lactone,
894
Phosphoglucose
isomerase
(PGI),
596F,
598–600,
599F
Phosphoglycerate
kinase
(PGK),
596F,
608–610,
609F
Phosphoglycerate
mutase
(PGM),
596F,
610–612,
610F
2-Phosphoglycerate
(2PG),
594–595,
610
3-Phosphoglycerate
(3PG),
594–595,
608
Phosphoglycerides,
389–390
Phosphoglycohydroxamate,
603
2-Phosphoglycolate,
603,
934–935
Phosphoguanidines,
580,
581F
3-Phosphohydroxypyruvate,
1070F,
1071
Phosphoimager,
111
Phosphoinositide
3-kinases
(PI3Ks),
732–734
Phosphoinositide
4-kinases
(PIP4Ks),
732
Phosphoinositide
5-kinases
(PIP5Ks),
732
I-38
Index
Phosphoinositide
cascade,
725–738
inositol
polyphosphate
phosphatases,
734–736
phosphoinositide
3-kinases,
732–734
phospholipases
C,
727–730
protein
kinases
C,
730–732
second
messengers,
725–727
Phosphoinositide-dependent
protein
kinase-1
(PDK-1),
731
Phosphoinositol,
994
Phospholipases,
408,
410
Phospholipase
A
2
,
942–943,
942F,
943F,
994,
1017
Phospholipase
C,
664,
706,
725,
727–730,
728F,
994
Phospholipase
C-
(PLC-),
690,
692
Phospholipase
C-,
706
Phospholipids,
400F,
410F,
419–420
Phospholipid
exchange
proteins,
420
Phospholipid
metabolism,
1004
glycerophospholipids,
1004–1008
sphingoglycolipids,
1008–1013
sphingophospholipids,
1008–1009
Phospholipid
translocases,
420
Phosphomannose
isomerase,
633
Phosphomevalonate
kinase,
977
N-(Phosphonacetyl)-
L
-aspartate
(PALA),
476–477
Phosphopantetheine
transferase,
961
Phosphopantetheine
transferase
(PPT),
967
Phosphopantothenoylcysteine
decarboxylase,
1138,
1139F
Phosphopantothenoylcysteine
synthetase,
1138,
1139F
Phosphopentose
epimerase,
929
Phosphoprotein
phosphatase-1
(PP1),
651,
658–660
Phosphoprotein
phosphatase-2A,
963
Phosphoramidite
method,
of
oligonucleotide
synthesis,
210F,
211
-5-Phosphoribosylamine
(PRA),
1108,
1109F,
1111
5-Phosphoribosyl--pyrophosphate
(PRPP),
1078,
1108,
1109F,
1114
5-Phosphoribosylpyrophosphate
synthetase,
1108
Phosphoribulokinase,
927
Phosphoric
acid
(H
3
PO
4
),
49F
Phosphorothioate
oligonucleotides,
1402
Phosphorus,
31
Phosphorylase,
see
Glycogen
phosphorylase
Phosphorylase
kinase
(PhK),
651,
655,
658,
667,
670
Phosphoryl
groups,
578
Phosphoryl
group-transfer
potentials,
578–579
Phosphoryl
group-transfer
reactions,
565,
565F,
578–579
O-Phosphoserine,
79F
Phosphotyrosine-binding
(PTB)
domain,
707
Photoautotrophs,
5–6
Photooxidation,
905
Photophosphorylation,
582,
912–913,
925–926
Photoprotective
agents,
976
Photoreactivating
enzymes,
1214–1215
Photorespiration,
934–937,
935F
Photosynthesis,
5–6,
559,
901.
See
also
Calvin
cycle
carbohydrates
product
of,
359
chloroplasts
as
site
of,
11–12,
901–902
dark
reactions,
902,
926–937
electron
transport
in
purple
bacteria,
909–913
evolution,
34
light
absorption,
903–909
light
reactions,
902–926
membrane
process,
386
photophosphorylation,
925–926
photorespiration
and
C
4
cycle,
934–937
two-center
electron
transport,
913–925
Photosynthetic
bacteria,
6
Photosynthetic
reaction
center
(PRC),
905
integral
membrane
proteins,
403,
404F
purple
bacteria,
909–911,
909F,
911F
Photosystem
I
(PS
I),
913–925,
922F,
923F,
925F
Photosystem
II
(PS
II),
913–925,
918F,
925F
Phototrophs,
559
Phycobiliproteins,
909
Phycocyanin,
905F,
909
Phycocyanobilin,
909
Phycoerythrin,
905F,
909
R-Phycoerythrin,
140F
Phycoerythrobilin,
909
Phylloquinone,
922
Phylogenesis,
6
Phylogenetic
trees,
6,
7F,
13F
and
bioinformatics,
203–205,
203F
and
protein
sequencing,
189,
190F
Phylogeny,
eukaryotes,
12–14
Phytanic
acid,
958
Phytanic
acid
storage
syndrome,
959
Phytanoyl-CoA
hydroxylase,
958
Phytol,
903
PI,
see
Phosphatidylinositol
pI,
see
isoelectric
point
P
i
(orthophosphate),
578
PI3Ks
(phosphoinositide
3-kinases),
732–734
PIC
(preinitiation
complex),
1376–1377
Pickart,
C.,
1417
Picket-fence
Fe-porphyrin
complexes,
328,
328F
Picot,
D.,
920
Pigs,
121,
130
Helix,
224F,
228
Pili,
4,
4F
Pilkis,
S.,
663
Ping
Pong
reactions,
498–499,
499F,
501
PIP
2
,
see
Phosphatidylinositol-4,5-
bisphosphate
PIP4Ks
(phosphoinositide
4-kinases),
732
PIP5Ks
(phosphoinositide
5-kinases),
732
PIR
(Protein
Information
Resource),
195T
PISA
(Protein
Interfaces,
Surfaces
and
Assemblies),
256T
Pisum
sativum,
20
PITC
(phenylisothiocyanate),
165,
167F
Pitch,
of
helix,
89,
225
Pituitary,
672F,
682
PK,
see
Pyruvate
kinase
pK,
47
of
amino
acid
ionizable
groups,
68T–69T,
70
and
pH,
48
of
polyprotic
acids,
49–50
of
weak
acids,
46T
PKA,
see
Protein
kinase
A
PKB,
see
Protein
kinase
B
PKC,
see
Protein
kinase
C
PKR
(double-stranded
RNA-activated
protein
kinase),
1400
PKR-like
endoplasmic
reticulum
kinase
(PERK),
1400
PKU,
see
Phenylketonuria
Placebo,
542
Planck’s
constant,
903
Planck’s
law,
903
Plants,
7F,
12,
13F.
See
also
Photosynthesis
C
3
and
C
4
,
936
cell
structure
of,
11,
11F
divergence
from
other
kingdoms,
192
glycogen
synthase,
645
glyoxylate
cycle,
880–881
mitochondrial
deviations
from
ideal,
1344T
mutation
rate,
192
transgenic,
122
Plantae,
12
Plant
cells,
11,
11F
Plant
medicines,
539
Plaques,
27
Plasma
glucose,
1103F
Plasmalogens,
390,
574,
1005,
1007–1008,
1007F
Plasma
membranes,
4.
See
also
Cell
membrane
composition,
398T
of
eukaryotes,
8,
11F
of
prokaryotes,
4F
schematic
diagram,
400F
secretory
pathway,
420–428
sedimentation
coefficient,
154F
vesicle
formation,
428–440
vesicle
fusion,
440–445
Plasmids,
106–108,
1228F,
1262,
1262F
Plasmid-based
cloning
vectors,
106–108
Plasmin,
525T
Plasminogen,
458
Plasmodesma,
11F
Plasmodium
falciparum,
177T,
188,
898,
1058
Plastids,
901
Plastocyanin
(PC),
916,
921–922,
921F
Plastoquinol
(QH
2
),
915
Plastoquinone
(Q),
915
Platelet-activating
factor
(PAF),
1008
Platelet-derived
growth
factor
receptor
(PDGFR),
699
PLC-,
see
Phospholipase
C-
Pleckstrin,
735
Pleckstrin
homology
domain,
see
PH
domain
Pleurodeles
waltl,
1271F
P-loop,
710
PLP,
see
Pyridoxal-5¿-phosphate
Pmf
(proton-motive
force),
846
PMP
(pyridoxamine-5¿-phosphate),
1020
Pneumococci,
S
and
R
form,
86,
86F
PNP,
see
Purine
nucleoside
phosphorylase
POH1,
1418
Point
mutations,
192,
1339–1340
Point
symmetry,
267
pol,
1246
Pol

(DNA
polymerase
),
1202–1203
Pol
/primase,
1203,
1206,
1207
Pol

(DNA
polymerase
),
1205
Pol

(DNA
polymerase
),
1202,
1205
Pol

(DNA
polymerase
),
1202–1207,
1203F
Pol
ε
(DNA
polymerase
ε),
1202,
1205,
1206
Pol
(DNA
polymerase
),
1205,
1223
Pol
␩
(DNA
polymerase
␩),
1205,
1223
Pol
(DNA
polymerase
),
1205,
1223
Pol

(DNA
polymerase
),
1205,
1223
Pol
I,
see
DNA
polymerase
;
RNAP
I
Pol
II,
see
DNA
polymerase
II;
RNAP
II
Pol
III,
see
DNA
polymerase
III;
RNAP
III
Pol
III
core,
1182,
1198,
1222
Pol
III
holoenzyme,
1182,
1183F,
1190,
1191
in
E.
coli
replication,
195,
1193F,
1194
in
SOS
repair,
1222
Pol
IV,
see
DNA
polymerase
IV
Pol
V,
see
DNA
polymerase
V
Pol
V
mutasome,
1222
POLA,
see
Pol

Polarimeter,
74,
74F
Polarity,
132,
1398
Polar
side
chains,
amino
acid,
71
POLB,
see
Pol

polC
gene,
1182T
Index
polC
mutants,
1182
POLD1,
see
Pol

POLE,
see
Pol
ε
POLG,
see
Pol

POLH,
see
Pol
␩
POLI,
see
Pol
Poliomyelitis,
1404
POLK,
see
Pol

Polubiqtuitin,
1404
Poly(A),
1157F,
1302–1303
Poly(A)-binding
protein,
see
PABP
Poly(A)-binding
protein
II
(PAB
II),
1303
Polyacrylamide
gel,
139,
140T,
147,
147F
Polyacrylamide
gel
electrophoresis,
see
PAGE
Polyadenylation,
1401–1402
Polyadenylic
acid
[poly(A)]
tail,
97
Poly(A)
polymerase,
see
PAP
Poly(A)
(polyadenylic
acid)
tail,
97
Poly(AUAG),
1343
Polybrene,
171
Polycistronic
mRNA,
1264
Polycythemia,
343
Polydispersity,
375
Polyelectrolytes,
136
Polyethylene
glycol
(PEG),
1132
Polygalacturonase
(PG),
1403
Polyglycine,
205,
224F,
228–229,
229F
Poly(GUAA),
1343
Polyketide
biosynthesis,
968,
969F
Polylinkers,
107
Polylysine,
205
Polymerase
chain
reaction
(PCR),
114–117,
115F,
212–213
Polymerase
switching,
1204
Polymorphic
enzymes,
545
Polynucleotides,
84,
209–213.
See
also
Nucleic
acids
Polyomavirus,
94T,
1172
Polyoxyethylene-p-isooctylphenyl
ether,
399F
Polyoxyethylenelauryl
ether,
399F
Polypeptides,
70.
See
also
specific
types,
e.g.:
Proteins
backbone
conformations,
222–225
chemical
synthesis
of,
205–209
one
gene-one
polypeptide
maxim,
26
in
protein
sequencing,
169
titration
curves,
72,
73F
Polypeptide
hormones,
673T
Polypeptide
synthesis.
See
also
Protein
synthesis
chain
elongation,
1372–1373,
1373F,
1379–1388
chain
initiation,
1373–1379
chain
termination,
1391–1395
chemical,
205–209
direction
of,
1371–1373,
1372F
summary
of,
1365
translational
accuracy
of,
1388–1391
Polyproline,
224F
Polyproline
II
helix,
228–229,
229F
Polyproteins,
HIV-1,
546
Polyproteins,
of
HIV-1,
546F
Polyprotic
acids,
48–50,
49F
Polyribonucleotides,
1342
Polyribosomes
(polysomes),
154F,
1372,
1373F
Polysaccharides,
15,
359,
365–366.
See
also
specific
polysaccharides
carbohydrate
analysis,
366–367
disaccharides,
367
glycosaminoglycans,
370–373
glycosidic
bonds
in,
363–365
polymeric
organization,
17F
storage,
369–370
structural,
367–369
Polyserine,
205
Polysomes,
154F,
1372,
1373F
Polystyrene
gels,
137
Polytopic
proteins,
402–403
Poly(UAUC),
1343
Polyubiquitin
(PolyUb),
1411
Polyunsaturated
fatty
acids,
387
Polyvinylidine
difluoride,
see
PVDF
POLZ,
see
Pol
POM/CART
cell
type,
1099
Pompe’s
disease,
666
Popot,
J.-L.,
920
P/O
ratio,
831–833,
833F
Porcine
somatotropin
(pST),
119
Porins,
403–404,
405F,
749–750,
824
Porphobilinogen
(PBG),
1048
Porphobilinogen
deaminase,
1048,
1053
Porphobilinogen
synthase
(PBGS),
1048–1051,
1051F
Porphyrias,
1056
Porphyrin,
324,
818
Porters,
745
Porter,
D.,
812
Porter,
K.,
9
Position-Specific
Iterated
BLAST,
see
PSI-BLAST
Position-specific
score
matrices,
202
Positive
allosteric
effect,
348
Positive-inside
rule,
427
Positively
cooperative
binding,
327
Positive
regulator,
1286
Postranslational
transport,
of
proteins,
428,
428F
Posttranscriptional
modification,
97–98,
97F,
1301–1331
covalent
modification,
1405
mRNA
processing,
1302–1327
protein
splicing,
1405–1408
proteolytic
cleavage,
1403–1404
rRNA
processing,
1328–1329
tRNA
processing,
1329–1331
Posttranslational
modification,
101,
1403–1408
and
renaturation,
280–281
role
in
secretory
pathway,
422
Posttranslocational
state,
1387–1388,
1387F
POT1
(protection
of
telomeres
1),
1213
Potassium
channels,
752–755,
753F,
754F
Potassium
ion,
45T,
1158
Potassium
ion
channels,
752–755,
753F,
754F
Potatoes,
19T
Poulos,
T.,
686
Poulter,
D.,
979
PP1,
see
Phosphoprotein
phosphatase-1
PPAR

(peroxisome
proliferator-activated
receptor
),
1104
ppGpp,
1301
PP
i
,
see
Pyrophosphate
P
pili,
382
PPI,
see
Peptidyl
prolyl
cis-trans
isomerase
PPM
family,
722
pppA(2¿p5¿A)
n
,
1400
PPP
family,
722–725
pppGpp,
1301
(p)ppGpp,
1301
P-protein,
1031
PPRP,
see
5-Phosphoribosyl-
-pyrophosphate
PPT
(phosphopantetheine
transferase),
967
PRA,
see
-5-Phosphoribosylamine
Prader–Willi
syndrome
(PWS),
1251
Pravachol,
990,
991F
Pravastatin,
990,
991F
PRC,
see
Photosynthetic
reaction
center
Prealbumin,
268,
268F,
269F,
677
Prebiotic
era,
29
I-39
Precipitation,
isoelectric,
134
Precursor-product
relationships,
574
Preinitiation
complex
(PIC),
1376–1377
Prelog,
V.,
76
Pre-miRNAs,
1325,
1326F
Pre-mRNAs,
1304–1305,
1312
Prenylated
proteins,
406–407,
407F
Prenylation
site,
406
Prenyltransferase,
679,
978
Preparative
ultracentrifugation,
155–156,
155F
Prephenate,
1075
Preprimosome,
1190
Preprocollagen,
1404
Preproinsulin,
1404
Preproproteins,
1404
Preproteins,
422,
1404
Pre-replicative
complex
(Pre-RC),
1205–1207,
1206F
Presequences,
422
Presequence
translocase-associated
motor
(PAM),
447
Presqualene
pyrophosphate,
979F,
980–981,
981F
Presynaptic
membrane,
440,
440F
Pretranslocational
state,
1387F,
1388
Pre-tRNA
introns,
1307T
Pre-tRNAs,
1331
PRF
(Protein
Research
Foundation),
195T
pr
gene
(fruit
fly),
25,
25F
PriA
helicase,
1191
PriA
protein,
1184T,
1185–1186,
1190,
1190T,
1191
Pribnow,
D.,
1266
Pribnow
box,
1266
PriB
protein,
1190,
1190T
PriC
protein,
1190,
1190T
Priestley,
J.,
901
Primaquine,
897–898
Primary
structure,
163,
289–290,
1345–1346.
See
also
Nucleic
acid
sequencing;
Protein
sequencing
Primary
transcripts,
1301
Primase,
101,
113F,
1176,
1188–1189,
1190T
Primers,
101–102,
103F,
116,
1176
Primer
strand,
1209
Pri-miRNAs,
1325,
1325F
Primordial
atmosphere,
32
Primosome,
1190–1193,
1190T
Primosome
assembly
site
(pas),
1190
Prions,
313
Prion
diseases,
312–316
Prion
hypothesis,
314–315
PrionProtein
(PrP),
313–315
Prn-p,
313,
314
Pro,
see
Proline
Procarboxypeptidase
A,
538
Procarboxypeptidase
B,
538
Processive
enzymes,
1177
Processivity,
of
transcription,
1271–1272
Prochiral
atoms,
77
Prochiral
differentiation,
471F
Prochymosin,
117F
Procollagen,
1403–1404,
1403F–1405F
ProCysRS,
1359
Product
inhibition
studies,
500
Proelastase,
538
Proenzymes
(zymogens),
537–538
Profiles,
sequence
alignment,
202
Proflavin,
1340
Progeria,
1211
Progesterone,
681
Progestins,
673T,
681,
991
Proinsulin,
280–281,
280F
Prokaryotae,
6
I-40
Index
Prokaryotes,
3–6,
4F.
See
also
specific
organisms
chain
elongation,
1379–1388
chain
initiation,
1373–1376
chain
termination,
1391–1392,
1392F
citric
acid
cycle,
789,
814–815
DNA
replication,
1173,
1190–1201
DNA
size,
94T
eukaryotic
protein
production
in,
118
evolution,
13F,
34
fMet,
1373–1374
genome
sequencing,
176
introns
of,
1316
mismatch
repair,
1220
mRNA
posttranscriptional
modification,
1302
nucleotide
excision
repair,
1217
ribosomes
of,
1369–1371
transcription
control,
1283–1301
transformation
by
DNA,
85–86
translational
initiation,
1375–1376
transposons
of,
1236–1244
Prokaryotic
gene
expression:
mRNA
lifetime,
101
RNAP,
1265
transcription,
96–97,
101,
1269
translation,
101
Proliferating
cell
nuclear
antigen,
see
PCNA
Proline:
amino
group,
67
biosynthesis,
1071
degradation,
1034
genetic
codes
for,
100T,
1343T

helix/
sheet
propensity,
302T
low

helix
propensity,
304
in
native
unfolded
proteins,
283
as
nonessential
amino
acid,
1065T
in
PEST
proteins,
1413
Ramachandran
diagram,
225
side
chains,
70,
264T
specific
rotation,
74
structure
and
general
properties,
68T
Proline
racemase,
516
Prolyl
3-hydroxylase,
1405
Prolyl
4-hydroxylase,
1405
Prolyl
hydroxylase,
236
Promoters,
97,
571,
1266–1267,
1284
Pronucleus,
121,
121F
Proofreading,
1201
DNA
chain,
1177
of
synthesized
proteins,
1390–1391
of
tRNA,
1355–1358
1,
2-Propanediol,
1018

Propeller,
433
Propeptides,
1403–1404
Prophase,
20F,
21F
Prophospholipase
A
2
,
538
Propionaldehyde,
1018
Propionic
acid,
32T
Propionyl-CoA
carboxylase,
952–953
Propionyl-CoA
carboxylase
reaction,
953F
Proportional
counting,
572
Propranolol,
680
Proproteins,
1403–1404
pro-R,
77,
77F
pro-S,
77,
77F
Prostacyclins,
993,
995–1000
Prostacyclin
I
2
(PGI
2
),
997,
998
Prostacyclin
receptors,
689
Prostacyclin
synthase,
998
Prostaglandins
(PGs),
971,
993–995,
994F,
995F,
997–1000
Prostaglandin
endoperoxide
synthase,
997
Prostaglandin
H
2
synthase,
406,
997
Prostaglandin
receptors,
689
Prostanoic
acid,
993–994
Prostate
cancer,
1236
Prosthetic
group,
473
Proteases,
101,
131,
1419–1420
Protease
A,
525T
Protease
B,
525T
20S
Proteasome,
1411F,
1415,
1415F
26S
Proteasome,
1411–1412,
1414
Proteasomes,
in
ubiquination,
1411–1412
Protection
of
telomeres
1
(POT1),
1213
Protective
antigen
(PA),
anthrax,
715
Proteins,
15.
See
also
related
topics,
e.g.:
Amino
acids
amino
acid
derivatives
in,
78–79,
80F
amino
acids
of,
67–73,
68T–69T
beta
structures,
229–232
in
biological
processes,
67
and
buffers,
48
chemical
evolution
of,
189–192,
191F
and
chemical
synthesis
of
polypeptides,
206–209
in
chromatin,
8
conformational
diseases,
309–316
crystal,
122
cyclic
symmetry,
268,
268F
denatured,
57
design
of,
305–306
dihedral
symmetry,
268,
268F
essential
amino
acids
in,
1064
evolution
of,
192–196,
196F,
316–318
fibrous,
see
Fibrous
proteins
functional
groups
of,
43
fusion,
118
globular,
see
Globular
proteins
helical
structures,
225–229
helical
symmetry,
269,
269F
homologous,
189–192
icosahedral
symmetry,
268,
268F
from
inclusion
bodies,
117
and
molecular
cloning,
117–121
motifs,
249–251
number
of,
70
octahedral
(cubic)
symmetry,
268,
268F
one
gene–one
polypeptide
maxim,
26
organization
of,
17F,
163–164,
281–282,
281F
physical
constants
of,
153T
polyproteins,
1404
posttranslational
modification
and
degradation
of,
101
primary
structure,
see
Protein
sequencing
pseudosymmetric,
268
for
purification,
130
quaternary
structure,
266–271,
267F
roles
of,
163
secondary
structure,
221–233,
302–304
solubilities
of,
133–135
structures
of,
230–233
subunit
interactions,
267
supersecondary
structures,
249–251
symmetry,
267–270
tertiary
structure,
245–256,
304–305
tetrahedral
symmetry,
268,
268F
titration
curves,
72,
72F
in
translation,
98–101
ubiquitin
attachment
to,
1410F

1
-Proteinase
inhibitor,
533
Proteinase
K,
1383
Protein
assays,
131–132
Protein
C,
1317
Protein-conducting
channel
(PCC),
424,
426
Protein
crystals,
134F
Protein
Data
Bank
(PDB),
256–257,
256T,
259
Protein
degradation,
1408–1411.
See
also
Polyubiquitin;
Ubiquitin
Protein
denaturation,
57,
221,
262,
265–266
Protein
disulfide
isomerase,
see
PDI
Protein
dynamics,
306–309
Protein
families
(Pfam),
256T,
258
Protein
folding,
537
accessory
proteins,
290–302
determinants,
281–284
endoplasmic
reticulum,
427–428
GroEL/ES
system,
294–302
hierarchical
nature
of,
289
landscape
theory
of,
287–289,
288F
pathways,
284–290
peptidyl
prolyl
cis-trans
isomerases,
292
protein
disulfide
isomerases,
280,
290–292,
290F,
291F
and
pulsed
H/D
exchange,
285–286
and
renaturation,
278–281
Protein
folding
funnels,
287–289,
288F
Protein
folding
problem,
278
Protein
G,
282
Protein
GB1,
282,
282F
Protein
growth
factors,
671
Protein
Information
Resource
(PIR),
195T
Protein
Interfaces,
Surfaces
and
Assemblies
(PISA),
256T
Protein
isolation,
129–133
Protein
kinases,
670,
973,
975
Protein
kinase
A
(PKA),
651–654
Protein
kinase
B
(PKB),
734,
737F
Protein
kinase
C
(PKC),
660,
698,
713,
727,
730–732
Protein
metabolism,
561F
Protein
phosphatases,
721–725
Protein
phosphatase-2A,
699,
723F
Protein
purification,
129–156
chromatographic
separations,
135–146
electrophoresis,
146–152
general
strategy,
132–133
and
protein
isolation,
129–133
and
protein
solubilities,
133–135
ultracentrifugation,
152–156
Protein
renaturation,
278–281
Protein
Research
Foundation
(PRF),
195T
Protein
sequence
databanks,
195T
Protein
sequencing,
164–165
C-terminus
identification,
165–168
disulfide
bond
cleavage,
168–169
disulfide
bond
position
assignment,
172
Edman
degradation,
165,
167F,
171,
172,
174
end
group
analysis,
165–168
N-terminus
identification,
165
nucleic
acid
sequencing
contrasted,
184–185
peptide
characterization
and
sequencing
by
mass
spectrometry,
172–174,
172F
peptide
cleavage
reactions,
169–171
peptide
fragments,
ordering,
171
peptide
fragments,
separation
and
purifi-
cation
of,
171
peptide
mapping,
174–175,
175F
separation,
purification,
and
characteriza-
tion
of
polypeptide
chains,
169
sequence
alignment,
194–203
sequence
databases,
194–195
sequence
determination,
171,
171F
Protein
Ser/Thr
phosphatases,
722
Protein
solubilization,
130
Protein
splicing,
1405–1408
Protein
stability,
130–131
and
denaturation,
265–266
and
disulfide
bonds,
264–265
electrostatic
forces,
259–261
hydrogen
bonding,
261–262
hydrophobic
forces,
262–264
thermostable
proteins,
266
Index
Protein
synthesis,
1260,
1362–1398.
See
also
related
topics,
e.g.:
Translation
and
antibiotics,
1395–1398
chain
elongation,
1372–1373,
1379–1388
chain
initiation,
1373–1379
chain
termination,
1391–1395
direction
of,
1371–1373
secretory
pathway,
420–428
translational
accuracy,
1388–1391
vesicle
formation,
428–440
vesicle
fusion,
440–445
Protein
tyrosine
kinases
(PTKs),
690,
699–703
Protein
tyrosine
phosphatases
(PTPs),
721
Proteoglycans,
373–375,
373T
Proteoglycan
subunit,
373,
375
Proteolysis,
limited,
170
Proteome,
152,
185,
258
Proteomics,
152,
576–578,
577F
Proteopedia,
256T,
257
Protista,
12,
13F
Protofilaments,
keratin,
234F
Protomers,
267
Protons,
45–46,
45F,
45T
Proton-motive
force
(pmf),
846
Proton
pump
mechanism,
846–847,
850,
850F
Proton-translocating
ATP
synthase,
852–859
Proton-translocating
ATP
synthase
(Complex
V),
see
F
1
F
0
-ATPase
Proton
wire,
800
Proto-oncogenes,
705
Protoplasts,
378
Protoporphyrin
IX,
316,
316F,
324
biosynthesis,
1053–1055
and
electron-transport
chain,
838
Protoporphyrinogen
IX,
1054
Protoporphyrinogen
oxidase,
1053–1055
Protosterol,
982
Protozoa,
13F,
185,
192,
1344T.
See
also
specific
organisms
Pro-tRNA
Pro
,
1359
Proximal
histidine,
in
hemoglobin,
332
Proximity
effects,
enzyme
catalysis
by,
512–515
PrP
(PrionProtein),
313–315
PrP
27-30,
315
Prp73
(peptide
recognition
particle),
1409
PrP
C
,
314–315
PRPP,
see
5-Phosphoribosyl--pyrophosphate
PrP
Sc
,
314–315
Prusiner,
S.,
312
PS
I,
see
Photosystem
I
PS
II,
see
Photosystem
II
PsbB,
of
photosystem,
916
PsbC,
of
photosystem,
916
PSBD,
see
Peripheral
subunit-binding
domain
Pseudoglobulin,
133F
Pseudorotation,
591
Pseudosymmetric
proteins,
268
Pseudouridine,
1219,
1346,
1347F
[PSI],
315
PSI-BLAST
(Position-Specific
Iterated
BLAST),
202–203,
304
D
-Psicose,
361F
P
site
(peptidyl
site),
98F,
1373,
1385,
1387
Psoriasis,
993
pST
(porcine
somatotropin),
119
PstI,
105T
PT,
see
Pertussis
toxin
PTB
(phosphotyrosine-binding)
domain,
707
PTC
(phenylthiocarbamyl),
165
PtdIns,
see
Phosphatidylinositol
PtdIns-4,5-P
2
,
see
Phosphatidylinositol-
4,5-bisphosphate
PTEN,
736
Pteridine,
1043
Pterins,
1043–1045
Pterin-4a-carbinolamine,
1044
Pterin-4a-carbinolamine
dehydratase,
1044
PTH,
see
Parathyroid
hormone;
Phenylthiohydantoin
PTKs,
see
Protein
tyrosine
kinases
PTPs
(protein
tyrosine
phosphatases),
721
PTS,
see
Phosphoenolpyruvate-dependent
phosphotransferase
system
pUC18
cloning
vector,
107,
107F
Puckers,
sugar-phosphate
chain,
1152–1153,
1153F
Pulmonary
emphysema,
533
Pulse-chase
experiment,
1175
Pulsed-field
gel
electrophoresis
(PFGE),
158–159,
159F
Pulsed
H/D
exchange,
284–286,
309
Pulse
labeling,
1175F
Pumped
protons,
843
PurB,
see
Adenylosuccinate
lyase
PurC,
see
SAICAR
synthetase
PurE,
1111
PurF,
see
Glutamine
PRPP
aminotransferase
PurH,
see
AICAR
transformylase
Purification
tables,
161
Purine,
83
Purine
nucleoside
phosphorylase
(PNP),
1130F,
1131
Purine
nucleotide
cycle,
1132,
1133F
Purine
repressor
(PurR),
1296
Purine
ribonucleotides,
1107–1108.
See
also
Adenine;
Guanine
AMP
synthesis,
1111–1113,
1113F
catabolism,
1130–1134
GMP
synthesis,
1111–1113,
1113F
IMP
synthesis,
1108–1111,
1113F
orientations
of,
1152F
and
purine
ring
atoms,
1107F
salvage,
1114
synthesis
regulation,
1113–1114
Purity,
132
PurJ,
see
IMP
cyclohydrolase
PurK,
1111
PurL,
see
FGAM
synthetase
PurM,
see
AIR
synthetase
PurN,
see
GAR
transformylase
Puromycin,
424,
1376,
1382,
1382F,
1395,
1395T
Purple
membrane,
402
Purple
photosynthetic
bacteria,
6,
7F,
13F,
403
electron
transport
in,
909–913,
913F
light-harvesting
complexes,
906–909
PVDF
(polyvinylidine
difluoride),
111,
171
PvuII,
105T
PWS
(Prader–Willi
syndrome),
1251
Pycnodysostosis,
540
Pyl
(pyrrolysine),
1361–1362
PylRS,
1362
Pyran,
361
Pyranoses,
361
Pyridine
nucleotides,
471F
-Pyridone,
508
Pyridoxal-5¿-phosphate
(PLP),
511,
640,
1020
Pyridoxal
phosphate,
473T
Pyridoxamine-5¿-phosphate
(PMP),
1020
Pyridoxine,
474T,
1020
Pyrimidine,
83,
475–479
Pyrimidine
dimers,
1214–1215,
1214F
Pyrimidine
ribonucleotides,
736–738,
1136.
See
also
Cytosine;
Thymine;
Uracil
CTP
synthesis,
1118–1119
sterically
allowed
orientations,
1152F
synthesis
regulation,
1118
I-41
UMP
synthesis,
1114–1118
UTP
synthesis,
1118–1119
Pyrobaculum
aerophilum,
1315
Pyroccocus
furiosus,
114
Pyrolobus
fumarii,
266
Pyrolysine,
1361–1362
Pyrophosphate
(PP
i
),
102F,
578,
1265
Pyrophosphate
cleavage,
582,
582F
Pyrophosphate
ion,
96,
96F
5-Pyrophosphomevalonate,
977
Pyrophosphomevalonate
decarboxylase,
977–978,
978
Pyrosequencing,
183,
184F
Pyrrole-2-carboxylate,
516
Pyrrole
rings,
324
-1-Pyrroline-2-carboxylate,
516

1
-Pyrroline-5-carboxylate,
1070F,
1071
Pyrroline-5-carboxylate
reductase,
1070F,
1071
Pyrrolysine
(Pyl),
1361–1362
Pyruvamide,
617
Pyruvate:
alanine
biosynthesis
from,
1067F
biosynthesis
of,
561F
in
citric
acid
cycle,
766F,
790–792,
790F,
794–795,
816
degradation
of
amino
acids
to,
1030–1034
in
Entner–Doudoroff
pathway,
637F
fermentation
of,
594F,
614–619
in
glycolysis,
593,
594F,
595,
596F
and
integration
of
pathways,
1090
and
oxaloacetate,
872–876,
872F
Pyruvate
carboxylase,
818–819,
872–876,
874F,
875F
Pyruvate
decarboxylase
(PDC),
616,
617F
Pyruvate
dehydrogenase
(E1),
794–795,
798F,
799–800,
800F
Pyruvate
dehydrogenase
kinase,
799,
804–805,
805F
Pyruvate
dehydrogenase
multienzyme
com-
plex
(PDC),
792–800,
1111
coenzymes
and
prosthetic
groups,
795T
reactions
of,
794F
regulation,
804–805,
805F
Pyruvate
dehydrogenase
phosphatase,
799,
805
Pyruvate:ferredoxin
oxidoreductase,
814–815
Pyruvate
kinase
(PK),
581–582,
1089
in
gluconeogenesis,
872
in
glycolysis,
596F,
613–614,
614F
Pyruvate-phosphate
dikinase,
936
Pythagoras,
897
PYY
3-36
,
1099
Q
Q
(plastoquinone),
915
Q
cycle,
848–849,
848F
QFR
(quinol–fumarate
reductase),
840
QH
2
(plastoquinol),
915
QSAR,
see
Quantitative
structure-activity
relationships
Q-SNAREs
(SNAP
receptors),
441,
442,
779,
780
Quantitative
structure-activity
relationships
(QSAR),
540,
540F
Quantum
yield,
912
Quasi-equivalent
subunits,
269
Quaternary
structure,
proteins,
164,
266–271,
267F
Questran,
990
Quiescence,
1202
Quinine,
539,
1058
Quinolate,
1137F,
1138
Quinolate
phosphoribosyltransferase,
1137F,
1138
I-42
Index
Quinol–fumarate
reductase
(QFR),
840
Quinolone
antibiotics,
1167,
1169–1170
Quiocho,
F.,
1131
R
R5P,
see
Ribose-5-phosphate
Rab5,
734
Rab-GAP,
441
Rab-GEF,
441
Rab
proteins,
406,
441–444
Rac1,
727–728,
728F
Racemic
mixtures,
78
Racker,
E.,
852,
860,
892
Rack
mechanism,
515
RACKs,
730
Rad50,
1224
RAD51,
1230,
1236
Radioactive
counting,
149
Radioactive
decay,
572
Radioimmunoassays,
130,
674
Raf,
712–713
Raffinose,
385
Rafts,
411
Ramachandran,
G.
N.,
223
Ramachandran
diagram,
223–226,
224F,
229
Ramakrishnan,
V.,
1365,
1389,
1392,
1394
Ran,
709
Randle,
P.,
864
Randle
cycle,
864
Random
Bi
Bi
reactions,
498–500
Random
coil
conformation,
90,
155,
230,
232
Random
mechanism,
498
Rao,
Z.,
838
RAP1,
1213
Rap1A,
713
Rapamycin,
734,
737F
Rapid
equilibrium
random
Bi
Bi
reactions,
499,
500
Rapoport,
T.,
424,
620
RasGAP,
711
Ras
proteins,
407,
434,
688,
708–709
Rats:
carcinogenesis
tests,
1224
chromosome
number,
19T
genome
sequencing,
177T
liver
cytoplasmic
ribosomes,
1370T
liver
enzymes,
1408T
liver
membrane
composition,
398T
proteins
for
purification
from,
130
Rat1
exonuclease,
1304
Rate
constant,
483
Rate-determining
step,
487
Rate
equations,
483
Ratner,
S.,
1025
Rayment,
I.,
613,
874,
1238
Rb,
1211
RB69
pol,
1223
RBD,
see
RNA-binding
domain
RBP1,
1318
Rbx1,
1412–1413,
1413F
RdRP
(RNA-dependent
RNA
polymerase),
1324
Reaction
coordinate
diagram,
485–486,
485F
Reaction
kinetics,
see
Enzyme
kinetics;
Kinetics
Reaction
rates,
non-enzymatic
reactions,
483–484
Reactions,
coupled,
60–61
Reactive
oxygen
species
(ROS),
325,
840,
865
Reading
frames,
101,
101F,
1342F
Reads,
181
Rearrangement
reactions,
567
RecA,
1221,
1222,
1239
and
recombination
in
E.
coli,
1228–1230,
1229F,
1230F
and
recombination
repair,
1234
recA
gene,
1221
RecBCD,
1230–1231,
1230F,
1231F,
1235
recB
gene,
1230
recC
gene,
1230
recD
gene,
1230
Receptors,
660
hormone
binding,
674–675
target
of
drug
design,
539
Receptor-mediated
endocytosis,
454
Receptor
tyrosine
kinases
(RTKs),
293,
699–703
Recessive
traits,
20–22
RecG,
1234
RecJ,
1220
Recognition
helix,
1288
Recognition
sites,
Type
II
restriction
enzymes,
105,
105T
Recombinant
DNA,
104,
109F,
110F,
621.
See
also
Molecular
cloning
Recombinant
proteins,
119
Recombinases,
1239
Recombination,
24,
1225–1246
chromosomal
rearrangement
by,
1242F
homologous,
1225–1236,
1227F
site-specific,
1239–1240,
1242–1246
transposition,
1236–1246
viruses,
27–28,
28F
Recombination
repair,
1222,
1234–1236,
1234F,
1235F
Recommended
names,
enzymes,
479
Red
algae,
13F
Redox
loop
mechanism,
847–849,
847F
Redox
reactions,
583.
See
also
Oxidation-
reduction
reactions
Red
tide,
777,
939
Reducing
agent,
584
Reducing
atmosphere,
32
Reducing
sugars,
364
Reductant,
584
Reduction,
583.
See
also
Oxidation-
reduction
reactions
Reduction
potentials,
585,
585T
Reductive
pentose
phosphate
cycle,
927.
See
also
Calvin
cycle
Reed,
G.,
613
Reed,
L.,
792,
798
Rees,
D.,
910,
1080
re
face,
77,
77F
Refsum’s
disease,
958
REG,
1418–1419
REG,
1418–1419
REG,
1418
Reichard,
P.,
1119,
1122
Reichert,
E.,
323
RelA
(stringent
factor),
1301
relA
gene,
1301
Relatedness
odds,
198
Relatedness
odds
matrix,
198
Related-to-ubiquitin-1
(RUB1),
1421
Relative
elution
volume,
in
gel
filtration
chromatography,
138
Relaxed
circles,
1160
Relaxed
control,
107,
1301
Release
factors,
682,
1375T.
See
also
RF-1;
RF-2;
RF-3
Release-inhibiting
factors,
682
Remington,
J.,
766,
806,
807
Remnant
receptor,
454
Renaturation:
of
DNA,
93,
93F
of
proteins,
see
Protein
renaturation
Renin,
547,
547F
Reperfusion
injury,
325
Repetitive
sequences,
181
Repetitive
sequences,
ultracentrifugation
of
nucleic
acids,
159
Rep
helicase,
1183–1186,
1191–1193
Replica
DNAs,
1174F
Replica
plating,
26,
26F
Replication,
see
DNA
replication
Replication
bubbles,
1173–1174,
1173F
Replication
eyes,
1173–1174,
1173F,
1176F
Replication
factor
C,
see
RFC
Replication
forks,
102–103,
1173–1174
in
E.
coli
replication,
1199
eukaryotes,
1206
in
recombination
repair,
1234–1235,
1234F,
1235F
Replication
fork
collapse,
1222
Replication
origin,
106,
1174,
1205–1206
Replication
protein
A
(RPA),
1206
Replicative
forms,
see
RF;
RFI;
RFII
Replicative
transposition,
1237,
1239,
1239F
Replicative
transposons,
1242
Replicons,
1205,
1226
Replisome,
1193F,
1194,
1196,
1196F
Reporter
genes,
120–121,
120F,
571
Rep
protein,
1184T
Repressors,
96
RER,
see
Rough
endoplasmic
reticulum
Research
articles,
reading
of,
35–36
Resequencing,
184
Resins,
137–138,
207–208
Resistin,
1104
Resolvase,
1239–1241,
1241F
Resonance
energy
transfer,
905
Respiration,
9,
34,
323
Respiratory
chain,
823
Respiratory
distress
syndrome,
1005
Restart
primosome,
1235
Restriction
endonucleases,
104–106,
105F
digests
from,
106F
for
gene
manipulation,
109
use
in
nucleic
acid
sequencing,
176
Restriction
enzymes,
104,
105T
Restriction-fragment
length
polymorphisms
(RFLPs),
106,
106F,
107F
Restriction
maps,
107F
Restriction-modification
systems,
104
Restrictive
conditions,
27
Retaining
-glycosidases,
524
Reticulocytes,
111–112,
1056
Retinal,
123,
402,
402F,
689,
850–851,
976
Retinol,
252
Retinol
binding
protein,
252,
252F,
310
Retrograde
transport,
428
Retrotranslocation,
428
Retrotransposons,
1244–1246
Retroviruses,
116,
545,
1207,
1245–1246,
1245F
Reverse
genetics,
185
Reverse
gyrase,
1163
Reverse-phase
chromatography
(RPC),
132T,
145,
171,
172
Reverse
transcriptase,
95F,
116,
545,
1207–1209,
1208F
Reverse
transcriptase
inhibitors,
546
Reverse
translation,
313
Reverse
turns,
232,
233F,
246,
304
Reversible
processes,
56–57
Reversible
reactions,
491–492,
501–502
Reznikoff,
W.
S.,
1237,
1238
RF
(replicative
form),
1190,
1266
RF-1
(release
factor),
1375T,
1391–1394,
1393F
RF-2
(release
factor),
1375T,
1391–1394
RF-3
(release
factor),
1375T,
1392
Index
RFC
(replication
factor
C),
1204–1205,
1204F
RF
I
(replicative
form),
1190,
1191,
1191F
RF
II
(replicative
form),
1190
RFLPs,
see
Restriction-fragment
length
polymorphisms
R
form
(RS
system),
76–77
R
Groups,
amino
acids,
70
RGS
proteins,
692
rh1
gene,
1243
L
-Rhamnose,
365
Rh
(Rhesus)
blood
group
system,
414–415
Rheumatoid
arthritis,
1409
Rhizobium,
1080F
Rho13N,
1276F
Rhodopsin,
163,
689
Rho
factor,
1275–1276,
1276F
Rho
proteins,
688,
709,
1365
Ribitol,
364
Riboflavin,
474T,
565F,
1138
Ribonuclease
A,
see
RNase
A
Ribonuclease
B,
see
RNase
B
Ribonuclease
T1,
176
Ribonucleic
acid,
see
RNA
Ribonucleoproteins,
1145
Ribonucleotides,
82,
82F
Ribonucleotide
reductase
(RNR),
844,
1119–1126
D
-Ribose,
19,
82,
360F,
361
Ribose
phosphate
isomerase,
929
Ribose
phosphate
pyrophosphokinase,
1108,
1109F,
1111
Ribose-5-phosphate
(R5P):
in
AMP/GMP
synthesis,
1112F
in
Calvin
cycle,
929
in
IMP
synthesis,
1108
in
pentose
phosphate
cycle,
892–894
Ribosomal
recycling
factor,
see
RRF
Ribosomal
RNA,
see
rRNA
5S
Ribosomal
RNA,
176
70S
Ribosome,
1363T,
1369F,
1375
Ribosomes,
1145,
1338.
See
also
Protein
synthesis
architecture,
1366–1368
binding
sites,
1368
of
E.
coli,
367F,
1363F–1366F
of
eukaryotes,
7F,
9,
1369–1371
of
prokaryotes,
4,
4F
reading
direction
in,
1342–1343,
1372
as
ribozyme,
1383–1384
RNA
synthesis
regulation,
1301
sedimentation
coefficient,
154F
self-assembly
of,
1365
structure,
1363–1371
synthesis
in
secretory
pathway,
421F
translation
by,
98–101,
1363–1398
vesicle
formation,
428–440
vesicle
fusion,
440–445
Riboswitches,
1299–1301,
1300F,
1318–1319,
1320F
Ribothymidine
(T),
1347F
Ribozymes,
82,
1078
and
Group
I
introns,
1308–1309
hammerhead,
1310–1311,
1311F
ribosomes
as,
1383–1384
D
-Ribulose,
359,
361F
Ribulose-5-phosphate
epimerase,
894,
895F
Ribulose-5-phosphate
isomerase,
894,
895F
Ribulose-5-phosphate
(Ru5P),
892–895,
895F,
927
Ribulose
bisphosphate
carboxylase
activase,
931,
933
Ribulose-1,5-bisphosphate
carboxylase-
oxygenase,
see
RuBisCO
Ribulose
bisphosphate
carboxylase
(RuBP
carboxylase),
929–931,
930F
Ribulose-1,5-bisphosphate
(RuBP),
927
Rice,
122,
122F,
177T
Rich,
A.,
236,
1149–1151,
1155,
1323,
1346,
1372
Richter,
J.,
1402
Ricin,
1395T
Rickets,
677
Rickettsia,
4F
Rickettsia
prowazeki,
177T
Rieske,
J.,
835
Rieske
iron–sulfur
proteins,
835
Rifampcin,
1176,
1269
Rifamycin
B,
1269,
1395
Right-handed
helix,
224F,
225F,
227F
rIIA
complementation
group,
28
rIIB
cistron,
1340
rIIB
complementation
group,
28
Rilling,
H.,
979
Ringe,
D.,
308,
434
RING
finger,
1410
RISC
(RNA-induced
silencing
complex),
1324
Risedronate,
679F
Ritonavir,
550F,
551
Rittenberg,
D.,
574,
961,
1048
RK
(HMG-CoA
reductase
kinase),
989
RMM
(RNA-recognition
motif),
1365
RNA-11,
1151
16S
RNA,
159
23S
RNA,
1329F
45S
RNA,
1328
RNA
(ribonucleic
acid),
4,
1145.
See
also
related
topics,
e.g.:
Translation
and
central
dogma
of
molecular
biology,
95,
1260
chemical
structure,
85
on
DNA
chips,
213
in
DNA
replication,
101–102
and
early
evolution,
33–34
fractionation,
156–159
hybridization,
93
messenger,
see
mRNA
[messenger
RNA]
metabolite-sensing,
1299–1301
modes
of
growth
for,
1270F
Northern
blot
for,
113
PCR
amplification,
116
ribosomal,
see
rRNA
[ribosomal
RNA]
synthesis
of,
95–98
transcript
editing,
185
in
transcription,
1260–1265
transfer,
see
tRNA
[transfer
RNA]
translation
of,
98–101
zonal
ultracentrifugation,
159
RNAase
D,
1328
RNAase
M5,
1328
RNAase
M16,
1328
RNAase
M23,
1328
RNA-binding
domain
(RBD),
1303.
See
also
RRM
(RNA
recognition
motif)
RNA-dependent
RNA
ATPases,
1313F
RNA-dependent
RNA
helicases,
1313F
RNA-dependent
RNA
polymerase
(RdRP),
1324
RNA-directed
DNA
polymerase,
95F,
116,
1207–1208.
See
also
Reverse
transcriptase
RNA-directed
RNA
polymerase,
95F
RNA–DNA
hybrid
helix,
96,
1151,
1151F,
1207
RNA
editing,
1320,
1322–1323
RNAi,
see
RNA
interference
RNA-induced
silencing
complex
(RISC),
1324
RNA
interference
(RNAi),
1145,
1323–1326,
1323F
RNA
ligase,
1322
RNAP
(RNA
polymerase),
96F,
1265–1283
and
AraC,
1292–1294
I-43
of
bacteriophage
M13,
1190
in
catabolite
repression,
1286
chain
elongation,
1270–1272,
1270F
chain
initiation,
1267–1269
chain
termination,
1271F,
1273–1275
eukaryotic,
1276–1283,
1277T
and
intercalating
agents,
1272
and
lac
repressor,
1285
in
replication,
1176
RNA-directed,
95F
and
stringent
response,
1301
structure,
1268,
1268F–1269F
template
binding,
1266–1267,
1266F
of
Thermus
aquaticus,
1268,
1269F
of
Thermus
thermophilus,
1268,
1268F–1269F
in
transcription,
95–96,
1265–1283
transcription
cycle
and
translocation
mechanism
of,
1280F
RNAP
A,
see
RNAP
I
RNAP
B,
see
RNAP
II
RNAP
C,
see
RNAP
III
RNAP
core
enzyme,
1265,
1267,
1269
RNAP
holoenzyme,
1265–1266
chain
elongation,
1270–1272,
1270F,
1271F
chain
initiation,
1267–1269
chain
termination,
1271F,
1273–1275
and
lac
repressor,
1285
and
template
binding,
1266–1267,
1266F
RNAP
I
(RNA
polymerase
I)
(Pol
I),
1276,
1280–1282,
1408T
RNAP
II
(RNA
polymerase
II)
(Pol
II),
1276–1283
and
amatoxins,
1280
error
correction
by,
1281,
1281F
and
mRNa
capping,
1302
and
splicing
factors,
1314
structure
of
yeast,
1277–1280,
1278F
RNAP
II
elongation
complex,
1279F
RNAP
III
(RNA
polymerase
III)
(Pol
III),
1280,
1281,
1283
RNA
polymerase,
see
RNAP
RNA
polymerase
I,
see
RNAP
I
RNA
polymerase
II,
see
RNAP
II
RNA
polymerase
III,
see
RNAP
III
RNA
primers,
101–102,
103F,
1176
of
bacteriophage
M13,
1190
in
E.
coli
replication,
1193F
eukaryotic,
1207
Pol
I
excises,
1181,
1187
RNA-recognition
motif,
see
RRM
RNase,
for
nucleic
acid
fractionation,
157
RNase
III,
1324,
1328
RNase
A
(ribonuclease
A),
63,
176,
470
acid–base
catalytic
mechanism,
508–510,
509F
denaturation
of,
265F,
266
folding
rate,
284,
381
isoelectric
point,
134T
physical
constants,
153T
renaturation,
278–281,
279F
state
of,
308
titration
curve,
73F
RNase
B
(ribonuclease
B),
380–381,
380F
RNase
E,
1328
RNase
F,
1328
RNase
H,
1151,
1207–1209
RNase
H1,
1207
RNase
L,
1400
RNase
P,
1328
RNA
sequencing,
176,
179
RNA
triphosphatase,
1302
RNA
world,
33–34,
1126
RNR,
see
Ribonucleotide
reductase
I-44
Index
Roach,
P.,
646
Roberts,
R.,
1248,
1304
Robison,
R.,
595
Rodbell,
M.,
690
Rodnina,
M.,
1384
Rofecoxib,
999–1000
Rolling
circle
replication,
1191–1193,
1192F
Rooted
trees,
203F,
204
Rop
protein,
282–283,
283F
ROS,
see
Reactive
oxygen
species
Rosbash,
M.,
1306
Rose,
G.,
262,
281,
282,
304
Rose,
I.,
1119
Roseman,
S.,
765,
766
Rosetta
algorithm,
305,
306
Rossman,
M.,
256,
615
Rossman
fold,
256
Rotamases,
292
Rotamers,
306
Rotation
angles,
222–225
Rotation
symmetry,
protein,
268
Rotenone,
831
Rothman,
J.,
419,
442,
888
Rough
endoplasmic
reticulum
(RER),
7F,
9
metabolic
functions,
562T
secretory
pathway
in,
420–424
vesicle
formation,
428–440
vesicle
fusion,
440–445
Round-up,
1075
Roundworms,
trans-splicing
in,
1320
Rous,
P.,
704
Rous
sarcoma
virus
(RSV),
704
RPA
(replication
protein
A),
1206
RPC,
see
Reverse-phase
chromatography
RPE65
gene,
123
Rpn11,
1418
Rpr4,
1327
Rpr6,
1327
Rpr40,
1327
Rpr41,
1327
Rpr42,
1327
Rpr43,
1327
Rpr44,
1327
Rpr45,
1327
Rpr46,
1327
Rpt5,
1417
RRF
(ribosomal
recycling
factor),
1375T,
1392,
1394,
1394F
RRM
(RNA
recognition
motif),
1303–1304,
1304F,
1365
5.8S
rRNA,
1328,
1370
5S
rRNA,
1301,
1328,
1364,
1370
16S
rRNA,
1328,
1364–1366,
1370F
base
pairing
with
rRNA,
1374–1375
and
stringent
response,
1301
18S
rRNA,
1328,
1370
23S
rRNA,
1301,
1328,
1364,
1366
28S
rRNA,
1328,
1370
30S
rRNA,
1370
40S
rRNA,
1370T
50S
rRNA,
1370
60S
rRNA,
1370T
80S
rRNA,
1370T,
1371,
1371F
rRNA
(ribosomal
RNA),
1260.
See
also
Ribosomes
methylation,
1328
posttranscriptional
modification,
1328–1329,
1328F
in
protein
synthesis,
98
structure
of,
213
zonal
ultracentrifugation,
159
RS75091,
1001
R-SNAREs
(SNAP
receptors),
441,
442,
779,
780
RS
system,
76–77
R
state
(oxyHb
quaternary
conformation),
333–334,
336–339,
336F,
337F
and
hemoglobin
cooperativity,
352–353
and
sequential
model
of
allosterism,
351
and
symmetry
model
of
allosterism,
349–351
R
state,
ATCase,
476–479,
477F
RSV
(Rous
sarcoma
virus),
704
RTKs,
see
Receptor
tyrosine
kinases
Rtt103
protein,
1304
R-type
pneumococci,
86,
86F
Ru5P,
see
Ribulose-5-phosphate
RUB1
(related-to-ubiquitin-1),
1421
Ruben,
S.,
813,
903
RuBisCo
(ribulose-1,5-bisphosphate
carboxylase-oxygenase),
299–300,
934–935,
934F
RuBP
(ribulose-1,5-bisphosphate),
927
RuBP
carboxylase,
see
Ribulose
bisphosphate
carboxylase
Rubredoxin,
135F
Running
gel,
in
disc
electrophoresis,
148
Rupley,
J.,
520
Rutter,
W.,
530
RuvA,
1231–1233,
1232F,
1234
RuvAB,
1231,
1234,
1235
RuvABC,
1230–1234
RuvABC
resolvosome,
1234
RuvB,
1231–1234
RuvC,
1233,
1234
Rye,
H.,
299
S
S,
see
Entropy
S1P,
see
Site-1
protease
S2P
(site-2
protease),
988
s
4
U
(4-thiouridine),
1347F
S6¿,
1417
S7P,
see
Sedoheptulose-7-phosphate
S20/L26,
1364
Sabatini,
D.,
420
Sac1,
736
Saccharides,
359.
See
also
Glycoproteins;
Monosaccharides;
Polysaccharides
Saccharomyces
cerevisiae
(Baker’s
yeast):
Cdc6,
1206–1207
genome
sequencing,
177T,
182
mitochondrial
deviations
from
ideal,
1344T
replication
origins,
1205
replication
studies,
1202
RNAP
II
structure,
1277–1280,
1278F
RNAP
subunits,
1277T
as
source
of
proteins
for
purification,
130
topoisomerase
II,
1167–1168,
1168F
Saccharopine,
1040
Sacchetini,
J.,
944,
1407
Saenger,
W.,
916,
922
Saibil,
H.,
297
SAICAR,
see
5-Aminoimidazole-
4-(N-
succinylocarboxamide)
ribotide
SAICAR
synthetase
(PurC),
1109F,
1111
Salamanders,
14F
SalI,
105T
Sali,
A.,
1371
Salmine,
134T
Salmonella
typhimurium,
1224,
1243
Salts:
dissolution
in
water,
42–43
and
protein
denaturation,
265–266
protein
solubilities
and
concentrations
of,
133–134,
133F
Saltatory
conduction,
777
Salt
bridges,
259–260,
262,
339
Salting
in,
132T,
133–134
Salting
out,
132T,
134
Salvage
pathways,
1114
SAM
(S-adenosylmethionine),
80,
80F,
1004,
1034
and
Dam/Dcm
MTases,
1247,
1247F
as
methylating
agent,
1062,
1214F,
1218
met
repressor
complexed
with,
1290–1291,
1291F,
1297
and
mRNA
capping,
1302
rRNA
methylation,
1328
Sam35,
449
Sam37,
449
Sam50,
449
SAM
complex,
448–449
Samuelson,
B.,
994
Sancar,
A.,
1217
Sandhoff’s
disease,
1013T
Sanger,
F.,
164,
165,
176,
1344
Sanger
method,
of
nucleic
acid
sequencing,
176–180,
184
Santi,
D.,
1127,
1247
SAP-A,
1011
SAP-B,
1011
SAP-C,
1011
SAP-D,
1011
Saposins,
1011
SAPs
(sphingolipid
activator
proteins),
1011
Saquinavir,
550F,
551
Sar1,
430
Sar1p,
437
-Sarcin,
1395T
Sarcomas,
704
Sarcoplasmic
reticulum
(SR),
761,
763
Sarcosine,
32T
Sareste,
M.,
708
Sarin,
782
SARs
(structure–activity
relationships),
540
SASPs
(small
acid-soluble
spore
proteins),
1149
Satellite
bands,
159
Sattler,
M.,
1314
Saturated
enzymes,
489
Saturated
fatty
acids,
387–388,
387T
Saturation
function,
747
Saturation
kinetics,
747
Sax,
M.,
616
Saxitoxin,
777
Sazanov,
L.,
835
SBPase,
see
Sedoheptulose
bisphosphatase
SCA
(spinocerebellar
ataxia),
1252
Scaffold-attachment
regions,
see
SARs
Scaffold
proteins,
713–714
Scalar
protons,
843
Scanning
microcalorimeter,
59
SCAP,
see
SREBP
cleavage-activating
protein
Scatchard,
G.,
674
Scatchard
plot,
674
Scavenger
Receptor
Class
B
type
I
(SR-BI),
456
Scavenger
receptors,
457
SCF
Skp2
,
1412,
1413F
SCF
complexes,
1412
Schachman,
H.,
475
Schaftingen,
E.,
663
Schally,
A.,
683
Schatz,
G.,
445
Schiff
base,
510,
568,
569F,
1020–1021
Schiffer,
M.,
910
Schimmel,
P.,
1351,
1356
Schimmel,
P.
R.,
1329
Schindelin,
H.,
291
Schirmer,
H.,
803
Schirmer,
T.,
749
Schistosoma
mansoni,
1310–1311,
1311F
Index
Schizosaccharomyces
pombe,
1202,
1206–1207
Schleiden,
M.,
3
Schleif,
R.,
1292,
1293
Schlessinger,
J.,
729
Schoenheimer,
R.,
1408
Schofield,
C.,
534
Schulman,
L.,
1351
Schultz,
S.,
1212
Schulz,
G.,
403,
628,
803,
983
Schwann,
T.,
3
Schwann
cell,
778F
SCID,
see
Severe
combined
immunodeficiency
disease
SCID-X1,
123
SciFinder
Scholar,
35
Scintillation
counter,
149
SCIPs,
735
Scissile
peptide
bond,
169
SCOP,
see
Structural
Classification
of
Proteins
Scorpion
venom,
777
Scott,
W.,
1310
Scrapie,
312–315,
313F
Screens,
for
drugs,
539
Scrunching,
1268
Scurvy,
236,
364
SDS
(sodium
dodecyl
sulfate),
150,
169,
171,
399F
SDS-PAGE
(polyacrylamide
gel
electrophoresis),
150,
151F,
169,
411F.
See
also
PAGE
(polyacrylamide
gel
electrophoresis)
Sec
(selenocysteine),
1361
Sec1,
441
Sec7,
435
Sec12p,
437
Sec13/31,
430,
438–439,
438F
Sec23/24,
430
Sec61,
424
Sec62/Sec63
complex,
428
SecA,
428
SecB,
428
Secondary
lysosome,
455F
Secondary
structure,
163,
221–233
helical,
225–229,
225F
nonrepetitive,
230,
232
peptide
group
in,
221–225
predicting,
for
proteins,
302–304
proteins,
221–233
tRNA,
1345–1346,
1346F
Second
law
of
thermodynamics,
54–57
Second
messengers,
661,
725–727
Second-order
rate
equation,
484
Second-order
reactions,
483,
484F
Secretary
proteins,
421F
-Secretase,
312,
547
-Secretase,
312
Secretin,
673T,
675
Secretory
pathway,
420–428
Secretory
vesicles,
429F,
1405
SecY,
424–425,
425F
SeCys
(selenocysteine),
1361
Sedimentation,
152–153
Sedimentation
coefficient,
153,
154F
Sedoheptulose-7-phosphate
(S7P),
636,
894
Sedoheptulose
bisphosphatase
(SBPase),
929,
933F
Seeberger,
P.,
383
Seed
sequence,
1325
Séguin,
A.,
823
SELB,
1361
Selectable
markers,
111
Selenocysteine
(Sec)
(SeCys),
1361
SELEX
(Systematic
Evolution
of
Ligands
by
EXponential
enrichment),
213–214
Self-assembly,
17,
278,
302
Self-compartmentalized
proteases,
1419–1420
Self
organization,
29,
30F
Self-splicing
genes,
1306–1308
Sem-5,
709
Semiconservative
replication,
90
Semiconservative
replication,
of
DNA,
90,
1173–1174
Semidiscontinuous
replication,
of
DNA,
1175–1176,
1175F
Semi-invariant
position,
1346
Sendai
virus,
408,
409F
Senebier,
J.,
901
Senescence,
703,
1210
Sense
RNA,
1323
Sense
strand,
203,
1266,
1267F
Sephadex
gels,
139
Sepharose
gels,
139
Septic
shock,
688
seqA
gene,
1196
SeqA
protein,
1196
Sequence
databases,
194–195
Sequence-tagged
connectors
(STCs),
181
Sequence-tagged
sites
(STSs),
181
Sequencing,
see
Nucleic
acid
sequencing;
Protein
sequencing
Sequencing
gel,
177–178,
178F,
179F
Sequential
model,
of
allosteric
interactions,
351–352
Sequential
reactions,
498–501,
500F
Sequestration,
1195
SER,
see
Smooth
endoplasmic
reticulum
Ser,
see
Serine
SERCA
complex,
762–764,
762F,
763F
Series-5
leukotrienes,
1003
Serine:
amino
group,
208F
biosynthesis,
1071–1072
degradation,
1030–1034
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246–247
in
glycerophospholipids,
389T
half-life,
1413T

helix/
sheet
propensity,
302T
inserted
by
E.
coli
nonsense
suppressor,
1362T
in
native
unfolded
proteins,
283
as
nonessential
amino
acid,
1065T
in
PEST
proteins,
1413
side
chains,
71,
208F,
264T
structure
and
general
properties,
69T
Serine
carboxypeptidase
II,
531,
531F
Serine
dehydratase,
1031,
1408T
Serine
hydroxymethyltransferase,
1031,
1033–1034,
1129
Serine
palmitoyltransferase,
1008
Serine
proteases,
525T
catalytic
mechanism,
531–537,
532F
evolutionary
relationships
among,
530–531
kinetics
and
catalytic
groups,
525–527
specificity
pockets,
529F
transition
state
stabilization,
534F
X-ray
structures,
527–531
zymogens,
537–538
Serine
recombinase,
1239
Serotonin,
783,
1046,
1059
Serotonin
receptors,
689
Serpentine
receptors,
689
SerRS,
1351
Serum,
disc
electrophoresis
of,
149F
Serum
albumin,
134T,
140F,
944–945,
945F
I-45
Serum
albumin
C,
133F
Serum
albumin
dimer,
140F
Seryl-adenylate,
1358
Severe
combined
immunodeficiency
disease
(SCID),
122,
123,
1132
Sex
chromosomes,
22–23
sex-lethal
(sxl)
gene
(Drosophila
melanogaster),
1318
Sex
linked
genes,
24
SF1
(splicing
factor
1),
1312
S
form
(RS
system),
76–77
SH1
domains,
706
SH2-containing
inositol-
5-phosphatases
(SHIPs),
735
SH2
domains,
706–707,
1317
SH3
domains,
708,
1317
Sharon,
N.,
523
Sharp,
K.,
259
Sharp,
P.,
1304,
1306
Shc,
707,
709–710
Shear
degradation,
DNA,
95
Sheep,
scrapie
in,
312–315
Shelterin,
1213
Shemin,
D.,
574,
1048
Shi,
Y.,
722
Shimomura,
O.,
120
Shine,
J.,
1374
Shine–Dalgarno
sequences,
1300,
1301,
1374–1375,
1398
SHIP2,
735
Shipley,
G.,
696
SHIPs
(SH2-containing
inositol-
5-phosphatases),
735
Shirakawa,
M.,
1250
Shoelson,
S.,
721
Shoolingin-Jordan,
P.,
1053
Short,
strong
hydrogen
bonds,
536
Short
tandem
repeats
(STRs),
115–116
Short-term
regulation,
of
fatty
acid
metabolism,
973
Shotgun
cloning,
113
Shotgun
sequencing,
181
Shotton,
D.,
529
SHP-2,
721–722
Shulman,
G.,
1103
Shuman,
S.,
1188
Shuttle
vectors,
118
Sialic
acid,
1010
Sialic
acids,
365,
392F.
See
also
NANA
Sialidase,
381
Sickle-cell
anemia,
185–188,
343–347
gene
therapy,
123
Southern
blot
for
diagnosis
or
prenatal
detection,
112–113
Sickle-cell
hemoglobin,
81.
See
also
Hemoglobin
S
Sickle-cell
trait,
187–188
Side
chains,
of
amino
acids,
70–71,
208F,
264T,
511
SIDS
(sudden
infant
death
syndrome),
948
si
face,
77,
77F
Sigler,
P.,
294,
692,
729,
942,
1288

32
,
1284

54
,
1284

gp28
,
1284

gp33/34
,
1284

70
,
1265,
1284

factors,
1265,
1266,
1284
-Replication,
1191–1193,
1192F
Sigmoidal
shape,
oxygen-binding
curve,
326,
326F,
339
Signal-anchor
sequence,
426
Signal-gated
channels,
772
Signal
peptidase,
422,
1404
Signal
peptides,
420,
1404
I-46
Index
Signal
recognition
particle,
see
SRP
Signal
sequence,
117
Signal
transducers
and
activators
of
transcription
(STATS),
718
Signal
transduction,
671,
1099.
See
also
related
topics,
e.g.:
Hormones
Sildenafil,
699,
743
Silica,
138,
144,
145
Silica
gel,
144
Silicon,
31
Silicones,
31
Silk,
233F
Silver
stain,
149
Simian
sarcoma
virus,
705
Simian
virus
40,
see
SV40
Simmons,
D.,
1000
Simon,
M.,
1243
Simple
sugars,
359
Simple
transposition,
1237
Simple
triacylglycerols,
388
Simvastatin,
990,
991F
Singer,
J.,
408
Single
blind
tests,
542
Single-displacement
reactions,
498,
501
Single
nucleotide
polymorphisms
(SNPs),
184,
213
Single-pass
transmembrane
proteins,
426
Single-strand
binding
protein,
see
SSB
Single-stranded
DNA,
see
ssDNA
Single-strand
nicks,
1230,
1235F
Single-tailed
lipids,
394,
394F
Sinning,
I.,
424
siRNAs
(small
interfering
RNAs),
1323–1324
Site-1
protease
(S1P),
988,
989
Site-2
protease
(S2P),
988
Site-directed
mutagenesis,
119–120
Site-specific
recombination,
1237,
1239–1240,
1242–1246
-Sitosterol,
393
60S
subunit
(ribosome),
1370T,
1371
Size
exclusion
chromatography,
138
Sjöstrand,
F.,
9
Skeletal
muscle,
1091–1092
Skin,
16F,
235,
238F,
240T
Skp1,
1412–1413,
1412F,
1413F
Skp2,
1412–1413,
1412F
Slab
gel
electrophoresis,
148F.
See
also
Gel
electrophoresis
Slack,
R.,
936
Slater,
E.,
845
Slicer,
1324
Sliding
clamp,
Pol
III,
1182–1183,
1183F,
1196–1198
Slime
molds,
7F,
13F
Slow
reacting
substances
of
anaphylaxis
(SRS-A),
1000
Slow-twitch
muscle
fibers,
619
SL
(spliced
leader)
RNA,
1320
Small
acid-soluble
spore
proteins
(SASPs),
1149
Small
interfering
RNAs
(siRNAs),
1323–1324
Small
nuclear
ribonucleoproteins,
see
snRNPs
Small
nuclear
RNAs,
see
snRNAs
Small
nucleolar
RNAs,
see
snoRNAs
Small
ubiquitin-related
modifier
(SUMO),
1421
Sm
core
domain,
1315–1316
Smith,
C.,
158
Smith,
E.,
189
Smith,
H.,
105,
181
Smith,
J.,
920
Smith,
M.,
119
Smith,
T.,
200,
1023
Smith–Waterman
alignment
algorithm,
201
Smoking,
458
Smooth
endoplasmic
reticulum
(SER),
7F,
9,
562T
SM
proteins,
441
Sm
proteins,
1314,
1315F
Sm
RNA
motif,
1314
S
N
2
reaction,
514,
514F
Snake
venom,
781,
1017
Snake
venom
phosphodiesterase,
176
SNAP-25,
441,
441F,
443,
444
SNAP
receptors
(SNAREs),
441–445,
443F
SNAPs,
see
Soluble
NSF
attachment
proteins
SNAREs,
see
SNAP
receptors
Snell,
E.,
1021
Snorkeling,
406
snoRNAs,
1329
snoRNPs,
1329
SNPs,
see
Single
nucleotide
polymorphisms
snRNAs,
1311–1312
snRNPs
(small
nuclear
ribonucleoproteins),
1312,
1314
Snu114,
1313F
SOD,
see
Superoxide
dismutase
Sodium
azide,
131
Sodium
channels,
772,
776–777
Sodium
cholate,
399F
Sodium
deoxycholate,
399F
Sodium
dodecyl
sulfate,
see
SDS
Sodium
ion,
45T,
1158
Solid
phase
peptide
synthesis
(SPPS),
206,
206F
SOLiD
system,
184
Söll,
D.,
1358
Solubility,
protein,
132–135
Solubilization,
protein,
130
Soluble
NSF
attachment
proteins
(SNAPs),
441,
444
Solution
methods,
for
nucleic
acid
fractionation,
156–157
Solvated
ions,
43
Solvents:
dielectric
constants
and
dipole
moments,
43T
water
and
nonpolar,
262–264,
263T
water
as,
42–44
Somatic
cells,
19,
20
Somatomedins,
673T,
683
Somatostatin,
673T,
675,
683
Somatotropin,
119,
673T,
683
Sondek,
J.,
728
Sonenberg,
N.,
1378
Sonication,
95,
130,
395
D
-Sorbose,
361F
Sorensen,
S.,
47
Soret
bands,
838
Sorting
sequence,
of
LDL
receptors,
457
Sos,
709–711
SOS
box,
1221
SOS
repair,
1222–1223
SOS
response,
1181,
1221–1223,
1221F,
1234
Southern,
E.,
111
Southern
blotting
(Southern
transfer
tech-
nique),
111–113,
112F,
149,
1207–1208
Sowadski,
J.,
653
Spacer
gel,
148
Spacer
groups,
142
Special
pair,
in
photosynthesis,
910–912,
913F
Specific
rotation,
74
Spectrin,
412,
413F
Sperm
cells,
12F,
1211
Sperm
whale
myoglobin,
see
Myoglobin
SPGA
(Streptomyces
griseus
protease
A),
530–531
S
phase,
1202,
1205,
1207
Spheroplasts,
378
Sphinganine,
1009
Sphingoglycolipids,
391,
1004,
1008–1013,
1009F
Sphingolipids,
390–392,
395,
1004F
Sphingolipid
activator
proteins
(SAPs),
1011
Sphingolipid
storage
diseases,
392,
1011,
1013
Sphingomyelins,
390–391,
391F,
398T,
1008,
1008F
Sphingophospholipids,
390–391,
1004,
1008–1009
Sphingosine,
390,
391F,
392F
Spiegelman,
S.,
1264–1265
Spina
bifida,
1035
Spinocerebellar
ataxia
(SCA),
1252
Spirilla,
4
Spirillum,
4F
Spirochetes,
4F
Spleen
phosphodiesterase,
176
Spliced
leader
(SL)
RNA,
1320
Spliceosomes,
1308,
1312–1313,
1312F,
1313F
AU-AC,
1319
structures,
1314–1316,
1316F
Splicing,
see
Gene
splicing
Splicing
factor
1
(SF1),
1312
Sponges,
13F
Spontaneity,
52,
57–58,
57T
Spontaneous
processes,
52,
57–58,
57T
Spores,
4,
117,
1149,
1284
Sporulation,
1149
SPPS,
see
Solid
phase
peptide
synthesis
SQS,
see
Squalene
synthase
Squalene,
975,
975F,
983F
cyclization,
982–983
formation,
978–982,
979F
Squalene
epoxidase,
982
Squalene-hopene
cyclase,
406,
983
Squalene
synthase
(SQS),
978,
982F
SR,
see
Sarcoplasmic
reticulum;
SRP
receptor
SR,
423
SR,
423
SR1
mutant,
299–300
SRA
domain,
1250
SR-BI
(Scavenger
Receptor
Class
B
type
I),
456
Src,
244F,
706–707,
715
Src
family,
715
Src
homology
domains,
see
SH
1
domains;
SH2
domains;
SH3
domains
SRE
(sterol
regulatory
element),
987
SREBP,
see
Sterol
regulatory
element
bind-
ing
protein
SREBP
cleavage-activating
protein
(SCAP),
987–989
SRP
(signal
recognition
particle),
420–424,
421F,
423F,
1404
SRP9,
422
SRP14,
422
SRP19,
422
SRP54,
422
SRP68,
422
SRP72,
422
SRP
receptor
(SR),
420–421,
421F,
423
SR
proteins,
1314
SRS-A
(slow
reacting
substances
of
anaphylaxis),
1000
SSB
(single-strand
binding
protein),
1183–1184,
1184F,
1184T,
1187,
1187F,
1195
(SSB)
35
,
1187
(SSB)
65
,
1187
ssDNA
(single-stranded
DNA),
1180,
1185,
1187
Index
Stabilization,
protein,
130–131
Stacked-X
conformation,
1227F
Stacking
associations,
in
tRNAs,
1348–1349
Stacking
gel,
148
Stadtman,
E.,
1068
Stadtman,
T.,
1361
Staggered
conformation,
222,
223F
Stahl,
F.,
90,
1173
Staining,
149,
158
Standard
free
energy
changes,
59–60
Standard
redox
potential,
584,
585T
Standard
state,
58–60
Stanley,
C.,
1023
Staphylococcal
nuclease,
143F
Staphylococcus,
4F
Starch,
359,
369–370,
932F
Starch-branching
enzyme,
931
Starch
synthase,
645,
931
Stark,
H.,
1315–1316
Starvation,
871,
973,
1101
State,
of
a
system,
53,
56
State
functions,
53,
54
Statins,
990–991
Stationary
phase,
135
Statistical
factors,
348
STATS
(signal
transducers
and
activators
of
transcription),
718
Stavudine,
1208
STCs
(sequence-tagged
connectors),
181
Ste5p,
713–714
Steady
state,
488–490,
588
Stearic
acid,
386,
387F,
387T,
392F
1-Stearoyl-2-oleoyl-3-phosphatidylcholine,
390F
Steatorrhea,
943
Steitz,
J.,
1311,
1329,
1356
Steitz,
T.,
597,
968,
1177,
1178,
1208,
1229,
1240,
1286,
1353,
1366,
1375,
1383
Stem
cells,
121
Step-wise
elution,
136–137,
136F
Stercobilin,
1056,
1057
Stereoelectronic
assistance,
514–515
Stereoelectronic
control,
514
Stereoisomers,
75
Stereo
pair,
271
Stereo
pictures,
271,
271F
Stereospecificity,
enzymes,
470–472
Stereospecific
numbering,
389F
Steric
interference,
polypeptides,
222–225,
223F
Steroid
hormone
receptors,
291–293
Steroid
hormones,
392,
393,
673T,
680–682,
976
biosynthesis,
991–993,
992F
Sterol,
392
Sterol
regulatory
element
(SRE),
987
Sterol
regulatory
element
binding
protein
(SREBP),
988,
988F,
989
Sterol-sensing
domain,
987
Steven,
A.,
436
Stevens,
R.,
404
Sticky
ends,
105,
117–118
Stigmasterol,
393
Stigmatellin,
849
Stöffler,
G.,
1365
Stokes
equation,
155
Stokes
radius,
155
Stomata,
904
Stoops,
J.,
798
Stop
codons,
99,
100T,
1343
Stopped-flow
device,
284,
284F
Stop-transfer
anchor
sequence,
426
Storage
polysaccharides,
369–370
Stout,
D.,
808
Strain,
lysozyme
catalytic
mechanism
and,
522–523
Strand
passage
mechanism,
1163–1165,
1164F
Streptavidin,
298,
857–858,
873
Streptomyces
alboniger,
1382
Streptomyces
antibioticus,
1272
Streptomyces
griseus
protease
A
(SPGA),
530–531
Streptomyces
mediterranei,
1269
Streptomycin,
1263F,
1388,
1395,
1395T,
1396F,
1397
Streptomycin-resistant
mutants,
1395,
1397
Stringent
control,
107,
1301
Stringent
factor,
see
RelA
Stringent
response,
1301,
1397
Stroke,
865
Stroma,
11–12,
902
Stromal
lamellae,
902
Strong
acids,
46–47
Strong
bases,
47–48,
48F
Stroud,
R.,
529,
817
STRs
(short
tandem
repeats),
115–116
Structural
Classification
of
Proteins
(SCOP),
256T,
258
Structural
genes,
117,
203,
1262
Structural
genomics
project,
258–259
Structural
polysaccharides,
367–369
Structure-activity
relationships
(SARs),
540
Structure-based
drug
design,
541
STSs
(sequence-tagged
sites),
181
Stubbe,
J.,
1119
Stueher,
D.,
686
Sturtevant,
A.,
24
S-type
pneumococci,
86,
86F
su1
nonsense
suppressor,
1362T
su2
nonsense
suppressor,
1362T
su3
nonsense
suppressor,
1362T
su4
nonsense
suppressor,
1362T
su5
nonsense
suppressor,
1362T
su6
nonsense
suppressor,
1362T
su7
nonsense
suppressor,
1362T
Sublactam,
378
Submitochondrial
particles,
852
Substania
nigra,
1060
Substiuents,
of
prochiral
centers,
77
Substrates,
58,
348,
469,
1128
Substrate
cycles,
624,
628–629
Substrate-level
phosphorylation,
582
Substrate
specificity,
470–473,
470F
Subtilisin,
119,
525T,
531,
531F,
534
Subunits,
protein:
composition,
270–271
interactions,
266,
267
and
nucleic
acid
subunits,
164
Subunit
IV,
of
cytochrome
b,
920
Succinate,
493,
791,
811,
947
Succinate
dehydrogenase,
see
Complex
II
Succinate
thiokinase,
810
Succinic
acid,
32T,
49
Succinylcholine,
782
Succinyl-CoA,
567,
956
from
amino
acids,
1034–1039
in
citric
acid
cycle,
766F,
789,
810–811,
811F
in
heme
biosynthesis,
1048
Succinyl-CoA
synthetase,
791,
810–811,
811F
Succinyl-phosphate,
810
Suck,
D.,
1233
Sucrase,
370
Sucrose
(table
sugar),
144,
265,
367,
367F,
488,
932F
Sucrose-6-phosphate,
932
Sucrose-phosphate
phosphatase,
932
Sucrose-phosphate
synthase,
932
Sucrose
phosphorylase,
501
I-47
Sudden
infant
death
syndrome
(SIDS),
948
Sugar-phosphate
chain
conformation,
1152–1154,
1152F,
1153F
Sugars,
15,
359.
See
also
Monosaccharides;
Polysaccharides
synthesis
in
prebiotic
conditions,
33
Suicide
substrates,
1128
Sulfanilamide,
1064
Sulfate
ion,
45T
Sulfate-reducing
bacteria,
6
Sulfatides,
391,
1008,
1010,
1010F
Sulfite
reductase,
934,
1072
Sulfolobus
solfataricus,
1222,
1222F
Sulfonamides,
1064,
1111
Sulfoquinovosyl
diacylglycerol,
902
Sulfuric
acid,
46
Sulston,
J.,
181
Sumner,
J.,
132,
470
SUMO
(small
ubiquitin-related
modifier),
1421
Sundaralingam,
M.,
1153
Sup35
protein,
315–316
Superacids,
511
Supercoiled
DNA,
1158–1170,
1160F,
1270–1271
measurements
of
supercoiling,
1160–1162
superhelix
topology,
1158–1160
topoisomerases,
1162–1170
Superhelix,
433,
1158–1160
Superhelix
density,
1162
Superoxide
dismutase
(SOD),
489T,
491,
491F,
866
Superoxide
ion,
325,
341
Superoxide
radical,
491
Superrepressed
mutants,
1336
Supersecondary
structures,
249–251
Supertwisting,
1158
Suppressors,
1340
Suppressor
tRNAs,
1362
Supramolecular
assemblies,
15,
16F
Surface-active
molecules,
51
Surface
hydrophobicity,
145
Surface
labeling,
400
Surfactants,
51
Surroundings,
52
Sutherland,
E.,
661,
722
Sutton,
W.,
22
SV40
(Simian
virus
40):
enhancers,
1282–1283
GC
boxes,
1282
large-T
antigen,
1211
replication
studies,
1202
supercoiling,
1162,
1162F
Svedberg,
T.,
152
Svedbergs
(unit),
153
Swiss-Pdb
Viewer,
256T,
257
SWISS-PROT,
195,
203
Swiss-Prot
Protein
Knowledgebase,
195T
Swiss
roll
barrel,
252,
252F
sxl
(sex-lethal)
gene
(Drosophila
melanogaster),
1318
SXL
protein,
1318
SYBR
Safe,
158
Symmetry,
proteins,
267–270
Symmetry
model,
of
allosteric
interactions,
349–351
Symport,
758,
758F
Synapses,
440,
440F,
527,
778
Synaptic
cleft,
440,
440F,
778
Synaptic
complex,
1237
Synaptic
vesicles,
440,
441F,
779,
780
Synaptobrevin,
441,
441F,
444
Synaptojanin1,
736
Synaptosomes,
440,
779,
1241F
Synaptotagmin
I,
779
I-48
Index
Synchrotrons,
241
Syn
conformation,
1152F
Synechocystis
sp.,
177T
Synge,
R.,
144
Synonyms,
in
genetic
code,
99,
1343
Syntaxin,
433F,
441,
441F,
443,
444
2,5A
synthetase
([2¿,5¿]-oligoadenylate
syn-
thetase),
1400
Syphilis,
arsenicals
for,
799
SYPRO
dyes,
149
Systematic
Evolution
of
Ligands
by
EXpo-
nential
enrichment
(SELEX),
213–214
Systematic
names,
enzymes,
479
Systemic
lupus
erythematosus,
1204,
1312
Systems,
52–53
Systems
biology,
576–578,
576F
Szent-Györgyi,
A.,
791
Szostak,
J.,
1210
T
T
(ribothymidine),
1347F
T1
G6P
translocase,
665F
T2
transporter,
665F
T3
transporter,
665F
T4
Endonuclease
VII,
1233–1234,
1233F
T4
Lysozyme,
282,
304
T7
gene
4
helicase/primase,
1184,
1184F,
1188
T7
gp4,
1184,
1184F
Tabun,
782
Tacrolimus,
724
Tagamet,
764
D
-Tagatose,
361F
Tail
spike
protein,
289–290
Tainer,
J.,
686,
1126,
1219
D
-Talose,
360F
Tandem
mass
spectrometry
(MS/MS),
173–175,
174F,
175F
Tangier
disease,
458
Taq
DNA
polymerase,
114,
179
TaqI,
105T
Taq
RNAP,
1268,
1269,
1269F
T
arm,
1346
Tarui’s
disease,
667
TATA
box,
1282F
Tatum,
E.,
26,
570,
1262
Tau
protein,
312
Taurine
conjugates,
993,
993F
Taxonomy,
6,
12,
189
Taylor,
S.,
653,
654
Tay–Sachs
disease,
123,
392,
1011,
1013,
1013F
TBSV
(tomato
bushy
stunt
virus),
277
TC
arm,
1346
TC10,
738
TCA
(tricarboxylic
acid)
cycle,
789.
See
also
Citric
acid
cycle
T
cell
receptor,
724
T
cells,
123,
292–293,
671
TCR
(transcription-coupled
repair),
1217
TD
50
,
539
TDF
(testes-determining
factor),
682
TE
(palmitoyl
thioesterase),
965
TEBP
(telomere
end-binding
protein),
1212–1213,
1212F
Teeth,
235
Teichoic
acids,
378,
378F
Telomerase,
1209–1213
Telomere
end-binding
protein,
see
TEBP
Telomere
repeat-binding
factor
1
(TRF1),
1213
Telomere
repeat-binding
factor
2
(TRF2),
1213
Telomeres,
109,
1209–1213
Telomeric
T-loops,
1213,
1213F
Telophase,
20F,
21F
Temin,
H.,
545,
1207
Temperature:
denaturation,
57
and
entropy,
56F
and
lipid
bilayer
fluidity,
397–399
Temperature-jump,
284
Template
binding,
RNAP,
1266–1267,
1266F
Template
strand,
96,
102F
Tendons,
232,
233,
235,
240T
Tensin,
736
TER,
1210
TerA,
1199
TerB,
1199
TerC,
1199
TerD,
1199
TerE,
1199
TerF,
1199
TerG,
1199
TerH,
1199
TerI,
1199
TerJ,
1199
Terminal
deoxynucleotidyl
transferase,
109,
109F
Terminal
desaturases,
970–971
Terminal
transferase,
109,
109F
Terminal
uridylyltransferase
(TUTase),
1322
Termites,
369
Termolecular
reactions,
483
Terpenoids,
976–977
Ter
sites,
1199,
1206
TERT
(telomerase
subunit),
1210,
1211,
1211F
Tertiary
structure,
163
/
barrels,
252,
254
domains,
247–249,
251–253,
253F
globular
proteins,
245–256

helices
and

sheets,
246
open

sheets,
254–256
predicting,
for
proteins,
304–305
and
protein
folding,
287
side
chain
polarity,
246–247
supersecondary
structures,
249–251
tRNA,
1348–1349
Testes,
672F
Testes-determining
factor
(TDF),
682
Testicular
feminization,
681
Testosterone,
681
Tetanus,
442
Tethering
factors,
441
Tetracycline,
128,
1395T,
1396F,
1397
Tetracycline-resistant
bacterial
strains,
1397
Tetrahedral
intermediate,
531–533
Tetrahedral
symmetry,
proteins,
268,
268F
5,6,7,8-Tetrahydrobiopterin,
see
BH
4
Tetrahydrofolate,
473T,
492
Tetrahydrofolate
(THF),
1062–1064
Tetrahydrofuran-2-carboxylate,
516
Tetrahymena
thermophila:
Group
I
introns,
1307–1310,
1307F,
1309F,
1310F
telomerase,
1209–1210
Tetraloop,
1308
2,3,4,6-O-Tetramethyl--
D
-glucose,
508
Tetramethyl-p-phenylenediamine
(TMPD),
831
Tetranucleotide
hypothesis,
85
Tetrapeptides,
73F
Tetraubiquitin,
1411F
Tetrazole,
211
Tetrodotoxin,
777
TeTx,
442
TFIIH,
1218
TFIIS
protein,
1281–1282
TG,
see
Thapsigargin
TGN,
see
Trans
Golgi
network
Thalassemias,
219,
342
Thalidomide,
78,
78F
Thapsigargin
(TG),
763,
763F
ThDP
(thiamin
diphosphate),
616
Theoretical
plate,
in
chromatography,
135
Therapeutic
index,
539
Thermal
stability,
proteins,
266
Thermatoga
maritima,
1394F
Thermoacidophiles,
6
Thermocycler,
114
Thermodynamics,
52–61.
See
also
Equilibrium
chemical
equilibria,
58–61
defined,
52
electron-transport
chain,
828–829
first
law,
52–54
free
energy,
57–58,
61
glycogen
metabolism,
643–644
of
life,
586–589
of
membrane
transport,
744–745
of
phosphate
compounds,
578–583
second
law,
54–57
transition
state,
486
units
and
constants,
53T
Thermogenesis,
629,
860–861,
1099–1001
Thermogenin,
861,
1101
Thermolysin,
169T
Thermoplasma
acidophilum,
1415,
1415F
Thermoproteus,
7F
Thermosomes,
301
Thermostable
proteins,
266
Thermus
aquaticus,
179,
466
DNA
polymerase
I
(Klentaq1),
1178–1180
EF-Tu,
1381F
in
PCR,
114
RNAP,
1268,
1269,
1269F
Thermus
thermophilus:
30S
subunit,
1389–1390
Argonaute,
1324,
1325F
EF-G
complex
with
GDP,
1385–1386,
1386F
proteinase
K,
1383
ribosomal
complex,
1384,
1392–1394,
1393F,
1394F
ribosomal
subunits,
1366–1368,
1371,
1386F
RNAP,
1268,
1268F–1269F
RuvB,
1231–1233,
1232F

replication,
1174,
1175F

structures,
1174
THF,
see
Tetrahydrofolate
Thiamin
diphosphate
(ThDP),
616
Thiamine,
474T,
618
Thiamine
pyrophosphate,
see
TPP
Thiazolidinediones
(TZDs),
1103–1104
Thiazolinone,
165
Thiazolium
ring,
616
thi
box,
1300
Thin
layer
chromatography
(TLC),
145
Thiogalactoside
transacetylase,
1261
Thiohemiacetal,
608
Thiokinases,
945
Thiolase,
947,
958,
976
Thiolase
reaction,
949–950
Thioredoxin
(Trx),
291,
933–934,
934F,
1124
Thioredoxin
reductase
(TrxR),
1125
4-Thiouridine
(s
4
U),
1347F
30S
subunit
(ribosome),
363,
1363T,
1368,
1368F,
1369F,
1370
path
of
mRNa
through,
1375,
1376F
Thirumalai,
D.,
300
Thr,
see
Threonine
Thr-AMS,
1358
Threading
(fold
recognition),
305
Index
3
10
Helix,
224F,
226,
228
3¿
end,
of
nucleic
acids,
84
3.6
13
Helix,
see

helix
Threonine:
biosynthesis,
1072–1073,
1075
degradation,
1030–1034
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246–247
half-life,
1413T

helix/
sheet
propensity,
302T
PEST
proteins
rich
in,
1413
side
chains,
71,
264T
stereoisomers,
75–76,
76F,
77F
structure
and
general
properties,
69T
D
-Threonine,
75,
76,
76F
L
-Threonine,
75,
76,
76F
(2S,3R)-Threonine,
76,
77F
Threonine
dehydrogenase,
1034
Threonyl
adenylate,
1357
D
-Threose,
360F
Thrombin,
525T,
735
Thromboxanes,
993,
995–1000
Thromboxane
A
2
(TxA
2
),
998
Thromboxane
receptors,
689
Thromboxane
synthase,
998
thr
operon,
1299T
ThrRS,
1358
Thr-tRNA
Thr
,
1358
Thy,
see
Thymine
Thylakoids,
12,
902,
916F,
926,
926F
Thymidylate
synthase
(TS),
1062,
1126–1128
Thymidylate
synthesis,
1126–1130
Thymine,
18,
83,
83T,
1177.
See
also
Watson–
Crick
base
pairs
origin,
1126–1130
and
point
mutation
generation,
1339–1340
in
pyrimidine
catabolism,
1136F
tautomeric
forms,
88F
Thymine
dimer,
1214–1215,
1214F
Thyroid,
672F
Thyroid
hormones,
676–677
Thyroid
hormone
deiodinases,
1361
Thyroid
hormone
receptor,
677
Thyroid
hormone
response
element
(TRE),
879
Thyroid-stimulating
hormone
(TSH),
683
Thyroperoxidase
(TPO),
676
Thyrotropin,
673T,
683
Thyrotropin-releasing
factor
(TRF),
673T,
683
Thyroxine,
80,
80F,
310,
673T,
676–677
TIM
(triose
phosphate
isomerase)
(TPI):
in
Calvin
cycle,
929
of
chicken
muscle,
231F,
252,
254F
in
glycolysis,
596F,
603–606,
605F
Tim9,
448
Tim10,
448
Tim12,
448
Tim14,
447
Tim16,
447
Tim17,
447
Tim18,
448
Tim21,
447
Tim22,
448
Tim23,
446–448
Tim44,
447
Tim50,
447
Tim54,
448
TIM
barrel,
252,
254F,
300
TIM
proteins,
445–449
TIN2,
1213
Tiselius,
A.,
146
Tissues,
16F
Tissue
culture,
575
Tissue
regeneration,
1163
Tissue
slices,
575
Tissue-type
plasminogen
activator
(t-PA),
recombinant,
119
Titin,
1305
Titration
curves,
47–48,
47F,
48F
of
proteins
and
polypeptides,
72,
72F,
73F
TLC
(thin
layer
chromatography),
145
T-loops,
telomeric,
1213,
1213F
TLS
(translesion
synthesis),
1222
T
m
,
see
Melting
temperature
TMPD
(tetramethyl-p-phenylenediamine),
831
TM
proteins,
see
Transmembrane
proteins
Tn3,
1237,
1239
Tn5,
1237–1239
Tn5
transposase,
1237–1239,
1238F
TNBS
(trinitrobenezesulfonic
acid),
419,
419F
TNF-,
see
Tumor
necrosis
factor-
TNFs,
see
Tumor
necrosis
factors
TnpA,
1237
tnpA
gene,
1237
TnpR,
1237,
1239
tnpR
gene,
1237
Toads,
1409
Tob35,
449
Tob55,
449
TOB
complex,
448,
449
Todd,
A.,
84
Tollen’s
reagent,
364
Toluene,
130
Tom5,
446
Tom6,
446
Tom7,
446
Tom20,
446,
447F
Tom22,
446
Tom37,
449
Tom38,
449
Tom40,
446
Tom55,
449
Tom70,
446
Tomato
bushy
stunt
virus
(TBSV),
277
TOM
complex,
446,
447
TOM
core
complex,
446,
447,
447F
TOM
proteins,
445–447
Tong,
L.,
604
Tonks,
N.,
721
Top
7
protein,
306,
306F
Topogenesis,
427
Topoisomerases,
1162–1170
Topoisomerase
I,
1165–1166,
1165F
Topoisomerase
II,
1163,
1166–1169,
1169F
Topoisomerase
III,
1163,
1164F
Topoisomerase
IV,
1166
Topoisomerase
V,
1166
Topoisomerase
VI,
1166
Topoisomerase
inhibitors,
1169–1170
Topologically
bound
polynucleotide
strands,
1159F
Topological
switch
point,
255
Topology:
of
integral
proteins,
406
polypeptide
strands,
230
Toprim
fold,
1189
TORC2,
1096
Toroidal
helix,
1160,
1160F
Torpedo
model,
1304
Torsion
angles,
222–225
Tosyl-
L
-phenylalanine
chloromethyl
ketone,
see
TPCK
Toxoplasma
gondii,
1116
Toxoplasmosis,
1116
Toyoshima,
C.,
760,
763
t-PA,
recombinant,
119
I-49
TPCK
(tosyl-
L
-phenylalanine
chloromethyl
ketone),
527,
527F
TPI
(triose
phosphate
isomerase),
see
TIM
TPO
(thyroperoxidase),
676
TPP
(thiamine
pyrophosphate),
473T,
511,
795,
795T
in
alcoholic
fermentation,
616,
616F
synthesis
of,
1300,
1319,
1320F
TPP1,
1213
T-protein,
1032
TR
(telomerase
subunit),
1211
tra-2
(transformer-2)
gene
(Drosophila
melanogaster),
1318
TRA2
protein,
1318
TRAM
(translocating
chain-associated
membrane
protein),
426
Trans-acting
factors,
1264
Transaldolase,
894,
896–897,
896F
Transaminases,
498,
1020–1023
Transamination,
935,
1020–1023
Trans
cisternae,
428,
429F
Transcobalamins,
957
Trans
configuration
gene
mutations,
28
Transcortin,
681
Transcription,
9,
19,
95–98,
1145,
1260–1333.
See
also
Posttranscriptional
modification;
RNAP
DNA
replication
vs.,
1173
monitoring,
120–121
posttranscriptional
modification,
1301–1331
prokaryotic
control
of,
1283–1301
proportion
of
genome
transcribed,
182
RNA
in,
1260–1265
RNAP
in,
1265–1283
speed
and
accuracy,
1271–1272
Transcription
bubble,
96,
96F,
1267,
1270–1271
Transcription-coupled
repair
(TCR),
1217
Transcription
factors,
96,
572
Transcription
repair
coupling
factor
(TRCF),
1218
Transcriptome,
213
Transcriptomics,
576
Transducin
(G
t
),
691,
693F
Transduction,
1225
Transfection,
87
Transferase
reactions,
497–498
Transferases,
479T
Transferrin,
140F,
1056
Transfer
RNA,
see
tRNA
Transformation,
86,
110–111,
704
Transformation
competent
cells,
108
transformer-2
(tra-2)
gene
(Drosophila
melanogaster),
1318
transformer
(tra)
pre-mRNA
(Drosophila
melanogaster),
1318
Transforming
principle,
DNA
as,
85–86
Transgenes,
121
Transgenic
organisms,
86,
86F,
121–122,
570–572
Trans
Golgi
network
(TGN),
428,
429F
Transient
phase,
488
Transimination,
1022
Transitions,
1339
Transition
state,
485–486,
515–516
Transition
state
analogs,
516
Transition
state
diagram,
485–486,
485F,
487F
Transition
state
theory,
484–487
Transition
temperature,
397
Transketolase,
894–896,
895F,
929
Translation,
19,
95,
98–101,
98F,
1145.
See
also
Genetic
code;
Ribosomes
accuracy
of,
1388–1391
and
antibiotics,
1395
I-50
Index
Translation,
(Contd.)
control
of
eukaryotic,
1398–1402
defined,
1338
E.
coli
initiation
sequences,
1375F
genetic
code,
1338–1345
initiation
in
E.coli,
1376F
posttranslational
modification,
1403–1408
protein
degradation,
1408–1421
ribosomes
and
polypeptide
synthesis,
1362–1398
tRNA
aminoacylation,
1345–1362
Translational
coupling,
1398
Translesion
synthesis
(TLS),
1222
Translocating
chain-associated
membrane
protein
(TRAM),
426
Translocation,
1379,
1387–1388,
1387F
Translocators,
745
Translocon,
420,
426–427,
1404
Translocon-associated
membrane
protein
(TRAP),
425F,
426
Transmembrane
helices,
426–427,
426F
Transmembrane
(TM)
proteins,
251,
400–404,
426–427,
427F
Transmissible
spongiform
encephalopathy
(TSE),
309,
312
Transmission
coefficient,
486
Transpeptidation,
1379,
1382–1384
Transplantation,
transgenic
organisms
for,
121–122
Transporters,
745
Transport
proteins,
744,
745.
See
also
Membrane
transport
Transposable
elements,
1236
Transposase,
1236
Transposition,
1236–1246
Transposons,
1236–1246
Trans-Schiffization,
1022
Trans-SNARE
complex,
442
Trans-splicing,
1319–1320,
1321F
Transthyretin,
268,
268F,
269F,
310
Transverse
diffusion,
396
Transversion,
1339
TRAP,
see
Translocon-associated
membrane
protein
tra
(transformer)
pre-mRNA
(Drosophila
melanogaster),
1318
TRA
protein,
1318
Traps,
optical,
1273–1274
Trastuzumab,
119–120
TRCF
(transcription
repair
coupling
factor),
1218
-TrCP,
1414
TRE,
see
Thyroid
hormone
response
element
TRF,
see
Thyrotropin-releasing
factor
TRF1
(telomere
repeat-binding
factor
1),
1213
TRF2
(telomere
repeat-binding
factor
2),
1213
Triacylglycerol
lipase,
941,
1089–1090
Triacylglycerols,
388–389,
940.
See
also
Fatty
acids;
Lipids
and
cholesterol
biosynthesis,
986
and
dietary
EPA,
1003
and
liver,
1094
synthesis,
971–973,
972F
transport
in
blood,
452F,
973
Triad
family,
1066
Tricarboxylate
transport
system,
968
Tricarboxylic
acid
(TCA)
cycle,
See
Citric
acid
cycle
TRiC
chaperonins,
301–302,
301F
Trichloracetic
acid,
211
Tricorn
protease,
1420,
1420F
Triggered
conformational
changes,
307
Trigger
factor,
293
Triglycerides,
388–389,
940
Triglycerols,
940
Triiodothyronine,
673T,
676
Trimethoprim,
1129
N,N,N-Trimethylalanine,
79F
ε-N,N,N-Trimethyllysine,
79F
Trinitrobenezesulfonic
acid,
see
TNBS
Trinucleotide
repeat
expansions,
1251–1252
Triolein,
388
Trioleoylglycerol,
388
Trioses,
360F
Triose
phosphate
isomerase,
231F,
see
TIM
Tripeptides,
70
Triple
binding
assays,
1342
Triplet
codons,
1340–1341
Tris(2,3-dibromopropyl)
phosphate,
1225
Triskelions,
430F,
431
Tristearin,
388
Tristearoylglycerol,
388
Triton
X-20,
399F
Triton
X-100,
399F,
411
tRNA
(transfer
RNA),
1145,
1260,
1338
aminoacylation,
1345–1362
bases
of,
85
cloverleaf
form,
98F
isoaccepting,
1351
modified
bases,
1346,
1347F
posttranscriptional
modification,
1329–1331
primary
structure,
1345–1346
role
in
gene
expression,
95F
role
in
protein
synthesis,
98–101
secondary
structure,
1345–1346,
1346F
sedimentation
coefficients,
154F
sequencing,
176
structure
and
function
of,
213
tertiary
structure,
1348–1349
tRNA
Ala
,
176,
1345,
1351F,
1352,
1352F
tRNA
Arg
,
1352
tRNA
Asp
,
1349,
1351F,
1354–1355,
1354F,
1355F
tRNA
Cys
,
1352
tRNA
Gln
,
1351F,
1352–1354,
1353F,
1355F
tRNA
Ile
,
1352,
1355–1358,
1356F,
1357F
tRNA
Met
f
,
1374,
1374F
tRNA
Met
m
,
1374
tRNA
Phe
,
1346,
1346F,
1348,
1352
tRNA
Pyl
,
1362
tRNA
Sec
,
1361
tRNA
Ser
,
1351F
tRNA
Tyr
,
1331
tRNA
Val
,
1356
Trophic
hormones,
682
Tropocollagen,
240
Tropomodulin,
412F–413F
Tropomyosin,
134T,
412F–413F
-Tropomyosin,
1317,
1317F
Trout,
1409
Trp,
see
Tryptophan
trpL
sequence,
1297–1299,
1297F–1299F
trp
operon,
1296–1299,
1297F–1299F,
1299T
trp
repressor,
1288,
1290,
1290F
Trx,
see
Thioredoxin
TrxR
(thioredoxin
reductase),
1125
Trypanosoma
brucei,
1418
Trypanosomiasis,
arsenicals
for,
799
Trypansomes,
1320
Trypsin,
470,
525,
525T,
529T
catalytic
mechanism,
533,
533F
cytochrome
b
5
cleavage,
401
gene
duplication,
194
proenzymes,
537,
537F
specificity,
169–170,
169T
X-ray
structure,
528F,
529
Trypsinogen,
537,
537F
Tryptophan:
biosynthesis,
1075–1078,
1297
degradation,
1041–1042
as
essential
amino
acid,
1065T
and
fluorescence
resonance
energy
transfer,
286
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246–247

helix/
sheet
propensity,
302T
inserted
by
E.
coli
nonsense
suppressor,
1362T
in
native
unfolded
proteins,
283
nicotinamide
coenzyme
from,
1137F,
1138
side
chains,
70–71,
264T
structure
and
general
properties,
68T
Tryptophan
hydroxylase,
1045,
1059
Tryptophan
synthase,
1075–1078
Tryptophanyl-tRNA
Trp
,
1298,
1299F
TS,
see
Thymidylate
synthase
TSE,
see
Transmissible
spongiform
encephalopathy
T-segment,
of
DNA,
1169
TSH
(thyroid-stimulating
hormone),
683
Tsien,
R.,
121
t-SNAREs
(SNAP
receptors),
441
T
state
(deoxyHb
quaternary
conformation),
333–334,
336–339,
336F,
337F
and
hemoglobin
cooperativity,
352–353
and
sequential
model
of
allosterism,
351
and
symmetry
model
of
allosterism,
349–351
T
state,
ATCase,
476–479,
477F
Tsukihara,
T.,
416,
1417
Tswett,
M.,
135
d-Tubocurarine,
781
Tubulin,
10,
10F,
269
Tubulin
,
301
Tubulin
,
301
Tumor
necrosis
factor-
(TNF-),
715,
1096,
1414
Tumor
necrosis
factors
(TNFs),
715,
717
Tumor
promoters,
730–731
Tumor
suppressors,
736,
1414
Tumor
viruses,
704–705,
1163
Tunicamycin,
888,
889F
Tunicates,
368
Turkeys,
19T
Turner’s
syndrome,
682
Turnover
number,
490
tus
gene,
1199
Tus
protein,
1199,
1199F,
1206
TUTase
(terminal
uridylyltransferase),
1322
Tweezers,
optical,
1274,
1274F
Twilight
zone,
196
Twin-bulb
apparatus,
54,
55F,
56
Twintrons,
1307T
Twist,
of
superhelix,
1158–1159,
1159F
Twitchin
kinase,
658
2.2
7
Ribbon,
224F,
226,
228
Two-dimensional
(2D)
gel
electrophoresis,
152,
152F,
175
Two-dimensional
NMR
spectroscopy,
243–244,
285–286
Two-dimensional
paper
chromatography,
144–145,
145F
Two-hybrid
system,
705
TxA
2
(thromboxane
A
2
),
998
Ty1,
1245
TYA,
1246
TYB,
1246
Tyk2,
718
Type
0
glycogen
storage
disease,
668
Index
Type
IA
topoisomerases,
1162–1165,
1163F,
1164F
Type
IB
topoisomerases,
1162,
1165–1166,
1165F
Type
IC
topoisomerases,
1162
Type
1
diabetes,
310,
1102,
1400
Type
I

bends,
232,
233F
Type
I
glycogen
storage
disease,
661,
666
Type
I
restriction
endonucleases,
104–105
Type
I
TM
proteins,
426
Type
I
topoisomerases,
1163–1166
Type
IIA
topoisomerases,
1163
Type
IIB
topoisomerases,
1163
Type
2
diabetes,
310,
1102–1103
Type
II

bends,
232,
233F
Type
II
glycogen
storage
disease,
666
Type
II
restriction
endonucleases,
105,
105T
Type
II
TM
proteins,
426,
427F
Type
II
topoisomerase
inhibitors,
1169–1170
Type
II
topoisomerases,
1163,
1166–1170,
1175
Type
III
glycogen
storage
disease,
667
Type
III
restriction
endonucleases,
104–105
Type
III
TM
proteins,
426,
427F
Type
IV
glycogen
storage
disease,
667
Type
IV
restriction
endonucleases,
105
Type
IV
TM
proteins,
426–427
Type
V
glycogen
storage
disease,
667
Type
VI
glycogen
storage
disease,
667
Type
VII
glycogen
storage
disease,
667
Type
VIII
glycogen
storage
disease,
667
Type
IX
glycogen
storage
disease,
667
Type
A
blood,
22,
415
Type
AB
blood,
22,
415
Type
B
blood,
22,
415
Type
O
blood,
22,
415
Type

interferon,
1399
Type

interferon,
1399
Type

interferon,
1399
Tyr,
see
Tyrosine
Tyrosine:
aromatic
ring
flipping
and
protein
core
mobility,
308–309
biosynthesis,
1075–1078
degradation,
1043–1047
and
E.
coli
nonsense
suppressor,
1362T
and
fluorescence
resonance
energy
transfer,
286
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246–247
half-life,
1413T

helix/
sheet
propensity,
302T
in
native
unfolded
proteins,
283
in
neurotransmitter
synthesis,
1059–1060
as
nonessential
amino
acid,
1065T
side
chains,
71,
264T
structure
and
general
properties,
69T
Tyrosine
aminotransferase,
1408T
Tyrosine
hydroxylase,
1045,
1059
Tyrosine
kinase-based
signaling,
699
binding
modules,
adaptors,
GEFs,
and
GAPs,
705–711
and
cancer,
703–705
MAP-kinase
signaling
cascades,
712–714
protein
phosphatases,
721–725
tyrosine
kinase-associated
receptors,
699–703,
715–720
Tyrosine
recombinase,
1239
Tyvelose,
379F
TZDs
(thiazolidinediones),
1103–1104
U
U1-70K,
1315
U1-A,
1315,
1316
U1-C,
1315
U1-snRNA,
1312,
1315–1316
U1-snRNP,
1312,
1315–1316,
1316F
U2-snRNA,
1312
U2-snRNP,
1312
U4atac–U6atac,
1319
U4-snRNA,
1312
U4–U6-snRNP,
1312
U5,
1319
U5-snRNP,
1312
U6-snRNA,
1312
U6-snRNP,
1312
U11,
1319
U12,
1319
UAA
(codon),
1343,
1362,
1362T
UAG
(codon),
1343,
1362,
1362T
UbcH7,
1412–1413,
1412F
UBDs
(ubiquitin-binding
domains),
1420
Ubiquinol,
836F
Ubiquinone,
see
Coenzyme
Q
Ubiquitin,
989,
1404,
1410–1421,
1410F.
See
also
Polyubiquitin
Ubiquitin-activating
enzyme
(E1),
1410
Ubiquitination,
1414–1421
Ubiquitination
signals,
1410
Ubiquitin-binding
domains
(UBDs),
1420
Ubiquitin-conjugating
enzyme
(E2),
1410–1421
Ubiquitinlike
modifiers
(Ubls),
1421
Ubiquitin-protein
ligase
(E3),
1410–1421,
1410F
Ubisemiquinone,
836F
Ubls
(ubiquitinlike
modifiers),
1421
Ubr1,
1413
UCP,
see
Uncoupling
protein
UCP1,
1100
UCP2,
862,
1101
UCP3,
862,
1101
UDG
(uracil–DNA
glycosylase),
1218–1219,
1219F
UDPG,
see
UDP-glucose
UDP–galactose,
631
UDP–galactose-4-epimerase,
632
UDP–glucose
(UDPG),
631,
644
UDP–glucose:glycoprotein
glucosyltransferase
(GT),
886
UDP-glucose
pyrophosphorylase,
644
3¿-U-exo
(3¿-U-exonuclease),
1322
UGA
(codon),
1343,
1362,
1362T
UGA-1
nonsense
suppressor,
1362T
UGA-2
nonsense
suppressor,
1362T
Uhlenbeck,
O.,
1351
UHRF1
protein,
1250,
1250F
Ultracentrifugation,
132T,
152–156,
159
Ultrafiltration,
117,
132T,
141
Umami,
1064
UMP
(uridine
monophosphate),
83T,
1114–1118,
1136F
umuC
gene,
1222
UmuD,
1222
UmuD¿
2
C,
1222
umuD
gene,
1222
Uncompetitive
inhibition,
495,
495F,
502
Uncoupling
protein
(UCP),
861–862,
1100–1101
Unexpressed
DNA,
1304–1305,
1316–1317
UNG
(uracil
N-glycosylase),
1218
ung
E.
coli
mutants,
1218–1219
Unidirectional
replication,
1174,
1175F
Uniform
resource
locator
(URL),
194
Unimolecular
reactions,
483
Uniport,
758,
758F
Unit
cells,
270
Unit
evolutionary
period,
190
Universal
donors
(blood),
466
I-51
Universal
recipients
(blood),
466
Unrooted
trees,
203F,
204
Unsaturated
fatty
acids,
386–388,
387T,
950–952,
950F
Unwin,
N.,
402,
781
uORFs
(upstream
open
reading
frame),
1400–1401
Up-and-down

Barrels,
251–252
UP
elements,
see
Upstream
promoter
elements
Up
mutations,
1266
Upstream
open
reading
frame
(uORFs),
1400–1401
Upstream
promoter
elements
(UP
elements),
1266,
1282
Ura,
see
Uracil
Uracil,
19,
83,
83T.
See
also
Watson-Crick
base
pairs
and
genetic
code,
100T,
1343T
and
mutations,
1218–1219,
1339–1340
in
pyrimidine
catabolism,
1136F
in
tRNAs,
1347F
Uracil–DNA
glycosylase,
see
UDG
Uracil
N-glycosylase
(UNG),
1218
Urate
oxidase,
1134
URE2
gene
(yeast),
315
Ure2p,
315
Urea,
1025
in
Miller–Urey
experiments,
32T
in
protein
sequencing,
169,
171
for
renaturation
of
proteins,
117
in
stopped-flow
apparatus,
284
from
uric
acid
breakdown,
1135F
Urea
cycle,
791
arginase,
1025–1029
argininosuccinase,
1028
argininosuccinate
synthetase,
1028
carbamoyl
phosphate
synthetase,
1025–1028
ornithine
transcarbamoylase,
1028
regulation
of,
1028–1029
Urease,
132,
140F,
323,
470,
489T
-Ureidoisobutyrate,
1136F
-Ureidopropionase,
1136F
-Ureidopropionate,
1136F
Ureotelic
organism,
1025
Urey,
H.,
32–33
Uric
acid,
1025,
1107,
1134–1135
Uricotelic
organism,
1025
Uridine,
83T,
1136F
Uridine
diphosphate
glucose
(UDP-
glucose),
644
Uridine
monophosphate,
see
UMP
Uridine
phosphorylase,
1136F
Uridine
triphosphate,
see
UTP
Uridylic
acid,
see
UMP
Uridyltransferase,
1071
Urine,
1095
Urkingdoms,
6
URL
(uniform
resource
locator),
194
Urobilin,
1056,
1057
Urobilinogen,
1056,
1057
Urochordates,
13F
Uronic
acids,
364
Uroporphyrinogen
decarboxylase,
1053,
1054
Uroporphyrinogen
III,
1053,
1054
Uroporphyrinogen
III
synthase,
1052–1054
Uroporphyrinogen
synthase,
1053
UTP
(uridine
triphosphate),
96,
1118–1119,
1265
UV
absorbance
spectra,
90,
92,
92F,
285F
UV
absorption,
gel
electrophoresis
and,
149
UvrABC
endonuclease,
1217
UV
radiation,
32,
104,
1214
uvrA
gene,
1217
I-52
Index
UvrA
protein,
1217
uvrB
gene,
1217
UvrB
protein,
1217
uvrC
gene,
1217
UvrC
protein,
1217
UvrD
protein,
1217,
1220
Uyeda,
K.,
663
V
V
max
(maximal
velocity),
489
Vaccines,
205
Vacuoles,
7F,
11,
11F
Vagelos,
R.,
961
Val,
see
Valine
Val-AMS
(5¿-O¿-[N-(L-valyl)
sulfamoyl]adenosine),
1356–1357
Valine:
and
-amino--chlorobutyrate,
1408
biosynthesis,
1075
degradation,
1034–1039
as
essential
amino
acid,
1065T
genetic
codes
for,
100T,
1343T
in
globular
proteins,
246
half-life,
1413T

helix/
sheet
propensity,
302T
in
native
unfolded
proteins,
283
side
chains,
70,
264T
structure
and
general
properties,
68T
Valinomycin,
79,
748,
749F
ValRS,
1356–1357
Valyl-adenylate,
1356–1357
5¿-O¿-[N-(L-valyl)sulfamoyl]adenosine
(Val-AMS),
1356–1357
VAMP
(Vesicle
Associated
Membrane
Protein),
441
Vanadate,
758
van
der
Waals
distance,
41,
224F
van
der
Waals
forces,
260
Van
Duyne,
G.,
1244
Vane,
J.,
994
van
Helmont,
J.-B.,
901
van
Leeuwenhoek,
A.,
4
van
Niel,
C.,
903
Van
Roey,
P.,
252
van’t
Hoff
plot,
59
Variable
arm,
1346
Variant
surface
glycoprotein
(VSG),
892
Varmus,
H.,
705
Varshavsky,
A.,
1413
Vasopressin,
673T,
683,
784
Vassylyev,
D.,
1268
VAST
(Vector
Alignment
Search
Tool),
256T,
258
vCJD
(new
variant
Creutzfeldt-Jakob
disease),
315
V(D)J
recombination,
1223
Vector
Alignment
Search
Tool,
see
VAST
Vectorial
nature,
of
active
transport,
760
Vectorial
protons,
843
Vectors:
cloning,
104,
106–109
shuttle,
118
Vegetative
cell,
1284
Velocity,
of
reactions,
483,
488,
489F
Vennesland,
B.,
470,
471
Venom,
see
Snake
venom
Venter,
C.,
176,
181,
182
v-erbB
oncogene,
705
Verdine,
G.,
1216
Versican,
373T
Vertebrates,
13F.
See
also
specific
types
collagen
of,
235
introns
of,
1316
open
reading
frames
for,
182
rRNA
methylation
sites
of,
1328–1329
Very
low
density
lipoproteins,
see
VLDL
Vesicle
Associated
Membrane
Protein
(VAMP),
441
Vesicle
formation,
428–440
Vesicle
fusion,
430,
440–445
Vesicular
stomatitis
virus
(VSV),
885
v-fos
proto-oncogene,
705
vg
gene
(fruit
fly),
25F
Viagra,
699,
743
Vibrio
cholerae,
576
Villafranca,
E.,
724
Villafranca,
J.,
1128
Vimentin,
10F
Vinograd,
J.,
1160
Vioxx,
543,
999–1000
Viral
strand,
bacteriophage
M13,
1190
Virions,
545
Virus-based
cloning
vectors,
108
Viruses,
3.
See
also
specific
viruses
budding
of,
466
and
cancer,
704–705
DNA
size,
94T
in
gene
therapy,
122
genetics
of,
26–28,
27F,
28F
life
cycle,
27F
RNA
and
DNA,
85
and
RNAi,
1324–1325
and
RNA
polymerases,
96
sedimentation
coefficients,
154F
vaccines
for,
205
Viscosity,
155
Vitalism,
587
Vitamins,
474,
474T,
993
Vitamin
A,
122,
252,
474,
943.
See
also
Retinol
Vitamin
B
1
,
474T,
618
Vitamin
B
2
,
474T,
565F
Vitamin
B
6
,
474T,
640,
1020
Vitamin
B
12
,
474T,
956–957
Vitamin
C
(ascorbic
acid),
236,
364–365,
364F
Vitamin
D,
474,
673T,
677–679,
679F,
943
Vitamin
D
2
,
678
Vitamin
D
3
,
677–678
Vitamin
D-binding
protein,
678
Vitamin
D
intoxification,
678
Vitamin
E,
866,
943
Vitamin
K,
943
Vitamin
K
1
,
922
Vitamin
K
2
,
910
Vitravene
(Fomivirsen),
1403
v-Jun
proto-oncogene,
705
VLDL
(very
low
density
lipoproteins),
449,
456,
944
and
apoB-100,
1322
and
atherosclerosis,
458
degradation,
452
formation,
986
properties,
449T
transport
in
blood,
973
Void
volume,
in
gel
filtration
chromatogra-
phy,
138
Voltage-gated
ion
channels,
771–775,
772F,
779
von
Euler,
U.,
993
von
Gierke’s
disease,
666,
1135
von
Liebig,
J.,
470
v-Ras
proto-oncogene,
705
VSG
(variant
surface
glycoprotein),
892
v-sis
oncogene,
705
v-SNAREs
(SNAP
receptors),
441
v-Src
protein,
704–705
VSV
(vesicular
stomatitis
virus),
885
VSV
G-protein,
885,
887F
V-type
ATPases,
758
W
Wagner,
G.,
1216,
1378
Wakil,
S.,
961
Waksman,
G.,
1178,
1186
Waksman,
S.,
1395
Walker,
J.,
853,
857,
865
Walker
A
motif,
855
Walker
B
motif,
855
Walsh,
C.,
562
Walz,
T.,
431
Wang,
A.,
1149
Wang,
J.,
1162
Warburg,
O.,
575,
595,
823,
864,
892
Warfarin,
543F
Warshel,
A.,
523
Water,
40–45
activity
of,
60
dielectric
constant
and
dipole
moment,
43T
in
glycerophospholipids,
389T
ionization
constant,
47
and
nitrogen
excretion,
1134
and
nonpolar
solvents,
262–264,
263T
proton
mobility,
44–45
reactant
in
Miller–Urey
experiments,
32,
33
solvent
properties,
42–44
structure
and
interactions,
40–42,
40F–42F
Waterman,
M.,
200
Water-oxidizing
center
(WOC),
916
Water-soluble
vitamins,
474
Watson,
H.,
529
Watson,
J.,
88,
182,
1146,
1173,
1363
Watson–Crick
base
pairs,
89–90,
89F,
104,
1145–1146,
1154–1156
and
DNA
polymerase
I,
1178–1180
electronic
complementarity,
1155–1156
geometric
complementarity,
1154–1155
and
Pol
I,
1178–1180
Watson–Crick
structure:
of
B-DNA,
88–90
real
DNA
vs.,
1146–1148
Waxes,
387
WD40
service
motif,
433
WD
repeat,
987
Weak
acids,
46–48,
48F
Weber,
P.,
686
Web
of
Science,
35
Weinberg,
R.,
1211
Weis,
W.,
443,
444
Weismann,
A.,
19
Weiss,
S.,
1265
Westbrook,
E.,
696
Westerhoff,
H.,
863
Western
blot,
149
Westheimer,
F.,
470,
471
WGSA,
see
Whole
genome
shotgun
sequencing
Whelan,
W.,
645
wh
gene
(fruit
fly),
24,
25,
25F
Whole
genome
shotgun
sequencing
(WGSA),
180F,
181
Wigley,
D.,
1231
Wikipedia,
35
Wikström,
M.,
844
Wild
type,
23–24
Williams,
C.,
803,
1125
Williams,
J.,
606
Williams,
L.,
1148
Williams,
R.,
728,
733
Wilson,
K.,
1112
Winged
helix
motif,
1291
Withers,
S.,
524
Wittinghofer,
A.,
711
Wittmann,
H.
-G.,
1365
Wittmann-Liebold,
B.,
1365
Index
Wlodawer,
A.,
549
Wobble
pairing,
1360–1361,
1360F,
1360T
WOC
(water-oxidizing
center),
916
Woese,
C.,
6,
8
Wolberger,
C.,
1293
Wolcott–Rallison
syndrome,
1400
Wolfenden,
R.,
515,
1384
Wolman’s
disease,
466
Wolynes,
P.,
287
Woodward,
R.
B.,
975
Wool,
233,
235
Work,
53–54,
57–58
World
Wide
Web,
195T,
256T
Writhing
number,
of
superhelix,
1159–1160,
1159F
Wunsch,
C.,
199
Wüthrich,
K.,
243,
314
WW
domain,
708
Wyman,
J.,
349
X
Xanthine,
1112,
1130F
Xanthine
dehydrogenase,
1133
Xanthine
oxidase
(XO),
1130F,
1132–1133
Xanthomas,
457
Xanthosine,
1130F
Xanthosine
monophosphate,
see
XMP
X
chromosome,
22–23
Xenobiotics,
542
Xenopus
borealis,
1283
Xenopus
laevis,
1163
Xenotransplantation,
121–122
XerC,
1243
XerD,
1243
Xeroderma
pigmentosum
(XP),
1217–1218,
1223,
1224
X-gal
(5-bromo-4-chloro-3-indolyl--
D
-
galactoside),
110
XhoI,
105T
X-linked
phosphorylase
kinase
deficiency,
667
XMP
(xanthosine
monophosphate),
1112,
1130F
XO,
see
Xanthine
oxidase
XP,
see
Xeroderma
pigmentosum
XPA,
1217
XPB,
1217,
1218
XPC,
1217
XPD,
1217,
1218
XPE,
1217
XPF,
1217
XPG,
1217,
1218
XPV,
1217
X-ray
crystallography:
and
double
helix
of
DNA,
88,
88F
of
enzyme–substrate
complexes,
470
interpretation
of,
241–245
and
NMR,
244
protein
dynamics
studies,
306
Xrcc4,
1223–1224
Xrn1
exonuclease,
1327
Xrn2
exonuclease,
1304
Xu,
W.,
722
Xu5P,
see
Xylulose-5-phosphate
Xylitol,
365
XylNAc
residue
(N-acetylxylosamine),
523
Xylose,
597–598
D
-Xylose,
360F,
361
D
-Xylulose,
361
Xylulose-5-phosphate
(Xu5P),
892–894,
929
Y
YACs
(yeast
artificial
chromosomes),
108–109,
113,
114,
180–181
YADH,
see
Yeast
alcohol
dehydrogenase
Yalow,
R.,
674
Yang,
W.,
1222
Yanoffsky,
C.,
1296,
1298,
1337
Yarus,
M.,
1383
Y
chromosome,
23
Yeast,
13F.
See
also
Saccharomyces
cerevisiae
(Baker’s
yeast)
20S
proteasome,
1416F–1417F
chromosome
number,
19T
cloning
of,
in
host
organism,
104.
See
also
YACs
[yeast
artificial
chromosomes]
DNA
size,
94T
eEF1A-eEF1Bb,
1389F
exon
splicing,
1305–1306
fermentation,
593–594,
616–619
GCN2,
1400–1401
genome
sequencing,
176,
177T,
182
introns
in,
1316
prions
in,
315–316
protein
disulfide
isomerase,
291–292,
291F
RAD51,
1230
Rpn11,
1418
80S
rRNA,
1371F
rRNA
methylation
sites,
1328–1329
I-53
shuttle
vectors,
118
snoRNAs,
1329
transposons,
1244
tRNA
Ala
,
1345F,
1346
tRNA
Asp
,
1349
tRNA
Phe
,
1346,
1346F,
1348
vesicle
fusion,
440
Yeast
alanine
tRNA,
176
Yeast
alcohol
dehydrogenase
(YADH),
618,
619
geometric
specificity,
472–473
molecular
mass,
140F
stereospecificity,
470–472
Yeast
artificial
chromosomes,
see
YACs
Yellow
mosaic
virus
protein,
153T
Yersinia
pestis,
1420–1421
Y

gene,
1261–1262,
1264
Ylid,
616
-yl
suffix,
73
Yokoyama,
S.,
1355–1357
Yonath,
A.,
1365,
1366,
1376
Yonetani,
T.,
354
YopJ,
1420
Yoshida,
M.,
857
Yoshikawa,
S.,
841
Young,
W.,
594
Z
Z,
1150–1151,
1150F
Zalcitabine,
1208
Zamecnik,
P.,
1345,
1362
Zamore,
Phillip,
1323
ZAP-70,
1412,
1412F
Z-DNA,
1146F,
1147F,
1148T,
1149–1151
Zero
order
reactions,
488
Z

gene,
1261–1262,
1264
Zidovudine,
see
3¿-Azido-3¿-deoxythymidine

Zigzag,
433
Zimm,
B.,
94
Zinc,
473,
511–513
Zinc
fingers,
1402
Zipping,
443F
Zocor,
990,
991F
Zonal
ultracentrifugation,
155,
156F,
159
Zone
electrophoresis,
146
Z-scheme,
914,
915F,
917F
Zwitterions,
67F,
70
Zygote,
20
Zymase,
594
Zymogens,
537–538
